Winters Declaration

Date: 2024-11-13

Summary

Exhibit A to Doc 742-2, filed November 13, 2024 in In re Vyaire Medical, Inc., et al., No. 24-11217 (BLS), in the U.S. Bankruptcy Court for the District of Delaware: the declaration of Spencer A. Winters supporting the interim fee application of Kirkland & Ellis LLP and Kirkland & Ellis International LLP for the period June 9, 2024 through August 31, 2024. Winters, a partner of the firms, certifies that the fees and disbursements sought are permissible and billed at customary rates. He certifies that the fees exceed the budgeted amount by more than 10%, attributing the variance to complex international sale transactions, bidding volume and tax structuring, and that compensation is sought for about 50 hours and $51,000.00 spent redacting time records. Exhibit B reproduces the order entered as Doc 350 on August 5, 2024 authorizing retention of the firms effective as of June 9, 2024.

Summary drafted by a model from the document's text below and checked by script against that text before publication. It is a navigation aid, not a reading of what the document proves. Where AI is used

Full text

Full text shows the first 300 of 631 pages; the complete document is the PDF above.

Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 1 of 631

Exhibit A

Winters Declaration
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 2 of 631

IN THE UNITED STATES BANKRUPTCY COURT
FOR THE DISTRICT OF DELAWARE

)
In re: ) Chapter 11
)
VYAIRE MEDICAL, INC., et al.,1 ) Case No. 24-11217 (BLS)
)
Debtors. ) (Jointly Administered)
)

DECLARATION OF SPENCER A. WINTERS IN
SUPPORT OF THE INTERIM FEE APPLICATION OF KIRKLAND &
ELLIS LLP AND KIRKLAND & ELLIS INTERNATIONAL LLP, ATTORNEYS
FOR THE DEBTORS AND DEBTORS IN POSSESSION FOR THE INTERIM
FEE PERIOD FROM JUNE 9, 2024 THROUGH AND INCLUDING AUGUST 31, 2024

I, Spencer A. Winters, being duly sworn, state the following under penalty of perjury:

1. I am the president of Spencer A. Winters, P.C., a partner in the law firm of

Kirkland & Ellis LLP, located at 333 West Wolf Point Plaza, Chicago, IL 60654, and a partner

of Kirkland & Ellis International, LLP (together with Kirkland & Ellis LLP, “K&E”).2 I am one

of the lead attorneys from K&E working on the above-captioned chapter 11 cases. I am a

member in good standing of the Bar of the State of Illinois, and I have been admitted to practice

in United States District Court for the Northern District of Illinois. There are no disciplinary

proceedings pending against me.

2. I have read the foregoing interim fee application of K&E, attorneys for the

Debtors, for the Fee Period (the “Fee Application”). To the best of my knowledge, information,

1
The last four digits of Debtor Vyaire Medical, Inc.’s federal tax identification number are 6495. A complete list
of each of the Debtors in these chapter 11 cases and each such Debtor’s federal tax identification number may
be obtained on the website of the Debtors’ claims and noticing agent at https://omniagentsolutions.com/Vyaire.
The location of Debtor Vyaire Medical, Inc.’s principal place of business and the Debtors’ service address in
these chapter 11 cases is 26125 North Riverwoods Boulevard, Mettawa, Illinois, USA 60045.
2
Capitalized terms used but not otherwise defined herein shall have the meaning as set forth in the Fee
Application.
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 3 of 631

and belief, the statements contained in the Fee Application are true and correct. In addition, I

believe that the Fee Application complies with Local Bankruptcy Rule 2016-2.

3. In connection therewith, I hereby certify that:

a) to the best of my knowledge, information, and belief, formed after
reasonable inquiry, the fees and disbursements sought in the Fee
Application are permissible under the relevant rules, court orders, and
Bankruptcy Code provisions, except as specifically set forth herein;

b) except to the extent disclosed in the Fee Application, the fees and
disbursements sought in the Fee Application are billed at rates customarily
employed by K&E and generally accepted by K&E’s clients. In addition,
none of the professionals seeking compensation varied their hourly rate
based on the geographic location of the Debtors’ case;

c) the fees sought exceed the fees budgeted for the same time period in the
Budget and Staffing Plan by more than 10% for the following reasons:

i. the sale of the Debtors’ businesses involved multiple complex,
international transactions requiring significant time and specialized
expertise;

ii. the volume of activity in the sales processes significantly exceeded
expectations, including the number of active bidders and the
extent, duration, and complexity of negotiations with the bidders,
the lenders, and other stakeholders; and

iii. the sale transactions required significant complex, international tax
structuring analysis.

The reasons justifying the variance have been discussed at length with the
Debtors;

d) K&E is seeking compensation with respect to the approximately 50 hours
and $51,000.00 in fees spent reviewing time records to redact privileged
or confidential information;

e) in providing a reimbursable expense, K&E does not make a profit on that
expense, whether the service is performed by K&E in-house or through a
third party;

f) in accordance with Rule 2016(a) of the Federal Rules of Bankruptcy
Procedure and 11 U.S.C. § 504, no agreement or understanding exists
between K&E and any other person for the sharing of compensation to be
received in connection with the above cases except as authorized pursuant

2
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 4 of 631

to the Bankruptcy Code, Bankruptcy Rules, and Local Bankruptcy Rules;
and

g) all services for which compensation is sought were professional services
on behalf of the Debtors and not on behalf of any other person.

[Remainder of Page Intentionally Blank]

3
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 5 of 631

Pursuant to 28 U.S.C. § 1746, I declare under penalty of perjury that the foregoing is true

and correct to the best of my knowledge and belief.

Dated: November 13, 2024 Respectfully submitted,

/s/ Spencer A. Winters
Spencer A. Winters
as President of Spencer A. Winters, P.C., as
Partner of Kirkland & Ellis LLP; and as Partner
of Kirkland & Ellis International LLP
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 6 of 631

Exhibit B

Retention Order
Case
Case
24-11217-BLS
24-11217-BLS Doc
Doc
742-2
350 Filed
Filed 11/13/24
08/05/24 Page
Page 71 of
of 6
631

IN THE UNITED STATES BANKRUPTCY COURT
FOR THE DISTRICT OF DELAWARE

)
In re: ) Chapter 11
)
VYAIRE MEDICAL, INC., et al.,1 ) Case No. 24-11217 (BLS)
)
Debtors. ) (Jointly Administered)
)
) Re: Docket No. 259

ORDER AUTHORIZING THE RETENTION
AND EMPLOYMENT OF KIRKLAND & ELLIS LLP AND
KIRKLAND & ELLIS INTERNATIONAL LLP AS ATTORNEYS FOR THE
DEBTORS AND DEBTORS IN POSSESSION EFFECTIVE AS OF JUNE 9, 2024

Upon the application (the “Application”)2 of the above-captioned debtors and debtors in

possession (collectively, the “Debtors”) for the entry of an order (the “Order”) authorizing the

Debtors to retain and employ Kirkland & Ellis LLP and Kirkland & Ellis International LLP

(collectively, “Kirkland”) as their attorneys effective as of the Petition Date, pursuant to

sections 327(a) and 330 of title 11 of the United States Code (the “Bankruptcy Code”),

rules 2014(a) and 2016 of the Federal Rules of Bankruptcy Procedure (the “Bankruptcy Rules”),

and rules 2014-1 and 2016-1 of the Local Bankruptcy Rules for the District of Delaware

(the “Local Rules”); and the Court having reviewed the Application, the declaration of Spencer A.

Winters, the president of Spencer A. Winters, P.C., a partner of Kirkland & Ellis LLP and a partner

of Kirkland & Ellis International LLP (the “Winters Declaration”), and the declaration of John

Bibb, the Group Chief Executive Officer of Vyaire Medical, Inc. (the “Bibb Declaration”); and the

1 The last four digits of Debtor Vyaire Medical, Inc.’s federal tax identification number are 6495. A complete list
of each of the Debtors in these chapter 11 cases and each such Debtor’s federal tax identification number may be
obtained on the website of the Debtors’ claims and noticing agent at https://omniagentsolutions.com/Vyaire. The
location of Debtor Vyaire Medical, Inc.’s principal place of business and the Debtors’ service address in these
chapter 11 cases is 26125 North Riverwoods Boulevard, Mettawa, Illinois, USA 60045.

2 Capitalized terms used but not otherwise defined herein shall have the meanings set forth in the Application.
Case
Case
24-11217-BLS
24-11217-BLS Doc
Doc
742-2
350 Filed
Filed 11/13/24
08/05/24 Page
Page 82 of
of 6
631

Court having found that the Court has jurisdiction over this matter pursuant to 28 U.S.C. §§ 157

and 1334; and the Court having found that the Application is a core proceeding pursuant to

28 U.S.C. § 157(b)(2); and the Court having found that venue of this proceeding and the

Application in this district is proper pursuant to 28 U.S.C. §§ 1408 and 1409; and the Court having

found based on the representations made in the Application and in the Winters Declaration that (a)

Kirkland does not hold or represent an interest adverse to the Debtors’ estates and (b) Kirkland is

a “disinterested person” as defined in section 101(14) of the Bankruptcy Code and as required by

section 327(a) of the Bankruptcy Code; and the Court having found that the relief requested in the

Application is in the best interests of the Debtors’ estates, their creditors, and other parties in

interest; and the Court having found that the Debtors provided adequate and appropriate notice of

the Application under the circumstances and that no other or further notice is required; and the

Court having reviewed the Application and having heard statements in support of the Application

at a hearing held before the Court (the “Hearing”); and the Court having determined that the legal

and factual bases set forth in the Application and at the Hearing establish just cause for the relief

granted herein; and any objections to the relief requested herein having been withdrawn or

overruled on the merits; and after due deliberation and sufficient cause appearing therefor, IT IS

HEREBY ORDERED THAT:

1. The Application is granted to the extent set forth herein.

2. The Debtors are authorized to retain and employ Kirkland as their attorneys

effective as of the Petition Date in accordance with the terms and conditions set forth in the

Application and in the Engagement Letter attached hereto as Exhibit 1.

2
Case
Case
24-11217-BLS
24-11217-BLS Doc
Doc
742-2
350 Filed
Filed 11/13/24
08/05/24 Page
Page 93 of
of 6
631

3. Kirkland is authorized to provide the Debtors with the professional services as

described in the Application and the Engagement Letter. Specifically, but without limitation,

Kirkland will render the following legal services:

a. advising the Debtors with respect to their powers and duties as debtors in
possession in the continued management and operation of their businesses
and properties;

b. advising and consulting on their conduct during these chapter 11 cases,
including all of the legal and administrative requirements of operating in
chapter 11;

c. attending meetings and negotiating with representatives of creditors and
other parties in interest;

d. taking all necessary actions to protect and preserve the Debtors’ estates,
including prosecuting actions on the Debtors’ behalf, defending any action
commenced against the Debtors, and representing the Debtors in
negotiations concerning litigation in which the Debtors are involved,
including objections to claims filed against the Debtors’ estates;

e. preparing pleadings in connection with these chapter 11 cases, including
motions, applications, answers, orders, reports, and papers necessary or
otherwise beneficial to the administration of the Debtors’ estates;

f. representing the Debtors in connection with obtaining authority to continue
using cash collateral and postpetition financing;

g. advising the Debtors in connection with any potential sale of assets;

h. appearing before the Court and any appellate courts to represent the interests
of the Debtors’ estates;

i. advising the Debtors regarding tax matters;

j. taking any necessary action on behalf of the Debtors to negotiate, prepare,
and obtain approval of a disclosure statement and confirmation of a
chapter 11 plan and all documents related thereto; and

k. performing all other necessary legal services for the Debtors in connection
with the prosecution of these chapter 11 cases, including: (i) analyzing the
Debtors’ leases and contracts and the assumption and assignment or
rejection thereof; (ii) analyzing the validity of liens against the Debtors’
assets; and (iii) advising the Debtors on corporate and litigation matters.

3
Case
Case
24-11217-BLS
24-11217-BLSDocDoc
742-2
350 Filed
Filed11/13/24
08/05/24 Page
Page10
4 of
of 6631

4. Kirkland shall apply for compensation for professional services rendered and

reimbursement of expenses incurred in connection with the Debtors’ chapter 11 cases in

compliance with sections 330 and 331 of the Bankruptcy Code and applicable provisions of the

Bankruptcy Rules, Local Rules, and any other applicable procedures and orders of the Court.

Kirkland also intends to make a reasonable effort to comply with the U.S. Trustee’s requests for

information and additional disclosures as set forth in the Guidelines for Reviewing Applications

for Compensation and Reimbursement of Expenses Filed under 11 U.S.C. § 330 by Attorneys in

Larger Chapter 11 Cases Effective as of November 1, 2013, both in connection with the

Application and the interim and final fee applications to be filed by Kirkland in these chapter 11

cases.

5. Notwithstanding anything in the Engagement Letter to the contrary, Kirkland shall

apply any remaining amounts of its prepetition special purpose retainer as a credit toward

postpetition fees and expenses, after such postpetition fees and expenses are approved pursuant to

an order of the Court awarding fees and expenses to Kirkland. Kirkland is authorized without

further order of the Court to reserve and apply amounts from the prepetition special purpose

retainer that would otherwise be applied toward payment of postpetition fees and expenses as are

necessary and appropriate to compensate and reimburse Kirkland for fees or expenses incurred on

or prior to the Petition Date consistent with its ordinary course billing practices.

6. Notwithstanding anything to the contrary in the Application, the Engagement

Letter, or the Declarations attached to the Application, the reimbursement provisions allowing the

reimbursement of fees and expenses incurred in connection with participating in, preparing for, or

responding to any action, claim, suit, or proceeding brought by or against any party that relates to

the legal services provided under the Engagement Letter and fees for defending any objection to

4
Case
Case
24-11217-BLS
24-11217-BLSDocDoc
742-2
350 Filed
Filed11/13/24
08/05/24 Page
Page11
5 of
of 6631

Kirkland’s fee applications under the Bankruptcy Code are not approved pending further order of

the Court.

7. Notwithstanding anything contained in the Application, its exhibits, and/or any

supporting filings, including the Engagement Letter, the Debtors’ rights to object to interim and/or

final allowance of Kirkland’s fees are fully reserved under the applicable bankruptcy law and the

procedures set forth in the Interim Compensation Procedures Order.

8. Kirkland shall not charge a markup to the Debtors with respect to fees billed by

contract attorneys who are hired by Kirkland to provide services to the Debtors and shall ensure

that any such contract attorneys are subject to conflict checks and disclosures in accordance with

the requirements of the Bankruptcy Code and Bankruptcy Rules.

9. Kirkland shall provide ten-business-days’ notice to the Debtors, the U.S. Trustee,

and the Committee before any increases in the rates set forth in the Application or the Engagement

Letter are implemented and shall file such notice with the Court. The U.S. Trustee retains all rights

to object to any rate increase on all grounds, including the reasonableness standard set forth in

section 330 of the Bankruptcy Code, and the Court retains the right to review any rate increase

pursuant to section 330 of the Bankruptcy Code.

10. The Debtors and Kirkland are authorized to take all actions necessary to effectuate

the relief granted pursuant to this Order in accordance with the Application.

11. Notice of the Application as provided therein is deemed to be good and sufficient

notice of such Application, and the requirements of the Local Rules are satisfied by the contents

of the Application.

12. To the extent the Application, the Winters Declaration, the Bibb Declaration, or the

Engagement Letter is inconsistent with this Order, the terms of this Order shall govern.

5
Case
Case
24-11217-BLS
24-11217-BLSDocDoc
742-2
350 Filed
Filed11/13/24
08/05/24 Page
Page12
6 of
of 6631

13. The terms and conditions of this Order shall be immediately effective and

enforceable upon its entry.

14. The Court retains jurisdiction with respect to all matters arising from or related to

the implementation of this Order.

Dated: August 5th, 2024 BRENDAN L. SHANNON
Wilmington, Delaware UNITED STATES BANKRUPTCY JUDGE

6
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 13 of 631

Exhibit C

Engagement Letter
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 14 of 631

Execution Version

601 Lexington Avenue
New York, NY 10022
Josh Sussberg, P.C. United States
To Call Writer Directly: Facsimile:
+1 212 446 4829 +1 212 446 4800 +1 212 446 4900
joshua.sussberg@kirkland.com
www.kirkland.com

March 28, 2024

Via E-mail CONFIDENTIAL

Mr. Vikram Bajaj
Chief Financial Officer
26125 North Riverwoods Boulevard
Mettawa, Illinois 60045

Re: Retention to Provide Legal Services

Dear Mr. Vikram Bajaj:

We are very pleased that you have asked us to represent Vyaire Holding Company and its
affiliates and direct and indirect subsidiaries listed on Addendum A to this letter (collectively,
and as may be updated from time to time, “you” or “Client”) in connection with a potential
restructuring. Please note, the Firm’s representation is only of Client; the Firm does not and will
not represent any direct or indirect shareholder, director, officer, partner, employee, affiliate, or
joint venturer of Client or of any other entity.

General Terms. This retention letter (this “Agreement”) sets forth the terms of Client’s
retention of Kirkland & Ellis LLP and its affiliates (collectively, the “Firm,” “we,” “our” or “us”)
to provide legal services and constitutes an agreement between the Firm and Client (the
“Parties”). This Agreement (notwithstanding any guidelines for outside counsel that Client may
provide to the Firm) sets forth the Parties’ entire agreement for rendering professional services
for the current matter, as well as for all other existing or future matters (collectively, the
“Engagement”), except where the Parties otherwise agree in writing.

Fees. The Firm will bill Client for fees incurred at its regular hourly rates and in
quarterly increments of an hour (or in smaller time increments as otherwise required by a court).
The Firm reserves the right to adjust the Firm’s billing rates from time to time in the ordinary
course of the Firm’s representation of Client.

Although the Firm will attempt to estimate fees to assist Client in Client’s planning if
requested, such estimates are subject to change and are not binding unless otherwise expressly
and unequivocally stated in writing.

Mr. Vikram Bajaj
CONFIDENTIAL
March 28, 2024
Page 2

Expenses. Expenses related to providing services shall be included in the Firm’s
statements as disbursements advanced by the Firm on Client’s behalf. Such expenses include
photocopying, printing, scanning, witness fees, travel expenses, filing and recording fees, certain
secretarial overtime, and other overtime expenses, postage, express mail, and messenger charges,
deposition costs, computerized legal research charges, and other computer services, and
miscellaneous other charges. Client shall pay directly (and is solely responsible for) certain
larger costs, such as consultant or expert witness fees and expenses, and outside suppliers’ or
contractors’ charges, unless otherwise agreed by the Parties. By executing this Agreement
below, Client agrees to pay for all charges in accordance with the Firm’s schedule of charges, a
copy of which is attached hereto as Schedule I, as revised from time to time.

Billing Procedures. The Firm’s statements of fees and expenses are typically delivered
monthly, but the Firm reserves the right to alter the timing of delivering its statements
depending on circumstances. Client may have the statement in any reasonable format it chooses,
but the Firm will select an initial format for the statement unless Client otherwise requests in
writing. Depending on the circumstances, however, estimated or summary statements may be
provided, with time and expense details to follow thereafter.

Retainer. Client agrees to provide to the Firm a “special purpose retainer” (also known
as an “advance payment retainer”) as defined in Rule 1.5(d) of the Illinois Rules of Professional
Conduct, Dowling v. Chicago Options Assoc., Inc., 875 N.E.2d 1012, 1018 (Ill. 2007), and In re
Caesars Entm’t Operating Co., Inc., No. 15-01145 (ABG) (Bankr. N.D. Ill. May 28, 2015) (and
cases cited therein), in the amount of $2,500,000. In addition, Client agrees to provide one or
more additional special purpose retainer upon request by the Firm so that the amount of any
special purpose retainer remains at or above the Firm’s estimated fees and expenses. The Firm
may apply the special purpose retainer to any outstanding fees as services are rendered and to
expenses as they are incurred. Client understands and acknowledges that any special purpose
retainer is earned by the Firm upon receipt, any special purpose retainer becomes the property of
the Firm upon receipt, Client no longer has a property interest in any special purpose retainer
upon the Firm’s receipt, any special purpose retainer will be placed in the Firm’s general account
and will not be held in a client trust account, and Client will not earn any interest on any special
purpose retainer; provided, however, that solely to the extent required under applicable law, at
the conclusion of the Engagement, if the amount of any special purpose retainer held by the Firm
is in excess of the amount of the Firm’s outstanding and estimated fees, expenses, and costs, the
Firm will pay to Client the amount by which any special purpose retainer exceeds such fees,
expenses, and costs. Client further understands and acknowledges that the use of a special
purpose retainer is an integral condition of the Engagement, and is necessary to ensure that:
Client continues to have access to the Firm’s services; the Firm is compensated for its
representation of Client; the Firm is not a pre-petition creditor in the event of a Restructuring
Case (as defined below); and that in light of the foregoing, the provision of the special purpose
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 16 of 631

Mr. Vikram Bajaj
CONFIDENTIAL
March 28, 2024
Page 3

retainer is in Client’s best interests. The fact that Client has provided the Firm with a special
purpose retainer does not affect Client’s right to terminate the client-lawyer relationship.

Please be advised that there is another type of retainer known as a “security retainer,” as
defined in Dowling v. Chicago Options Assoc., 875 N.E.2d at 1018, and In re Caesars Entm’t
Operating Co., Inc., No. 15-01145 (ABG) (Bankr. N.D. Ill. May 28, 2015) (and cases cited
therein). A security retainer remains the property of the client until the lawyer applies it to
charges for services that are actually rendered and expenses that are incurred. Any unearned
funds are then returned to the client. In other circumstances not present here, the Firm would
consider a security retainer and Client’s funds would be held in the Firm’s segregated client trust
account until applied to pay fees and expenses. Funds in a security retainer, however, can be
subject to claims of Client’s creditors and, if taken by creditors, may leave Client unable to pay
for ongoing legal services, which may result in the Firm being unable to continue the
Engagement. Moreover, a security retainer creates clawback risks for the Firm in the event of an
insolvency proceeding. The choice of the type of retainer to be used is Client’s choice alone, but
for the Engagement and for the reasons set forth above, the Firm is unwilling to represent Client
in the Engagement without using the special purpose retainer.

Termination. The Engagement may be terminated by either Party at any time by written
notice by or to Client. The Engagement will end at the earliest of (a) Client’s termination of the
Engagement, (b) the Firm’s withdrawal, and (c) the substantial completion of the Firm’s
substantive work. If permission for withdrawal is required by a court, the Firm shall apply
promptly for such permission, and termination shall coincide with the court order for withdrawal.
If this Agreement or the Firm’s services are terminated for any reason, such termination shall be
effective only to terminate the Firm’s services prospectively and all the other terms of this
Agreement shall survive any such termination.

Upon cessation of the Firm’s active involvement in a particular matter (even if the Firm
continues active involvement in other matters on Client’s behalf), the Firm will have no further
duty to inform Client of future developments or changes in law as may be relevant to such
matter. Further, unless the Parties mutually agree in writing to the contrary, the Firm will have
no obligation to monitor renewal or notice dates or similar deadlines that may arise from the
matters for which the Firm had been retained.

Cell Phone and E-Mail Communication. The Firm hereby informs Client and Client
hereby acknowledges that the Firm’s attorneys sometimes communicate with their clients and
their clients’ professionals and agents by cell telephone, that such communications are capable of
being intercepted by others and therefore may be deemed no longer protected by the attorney-
client privilege, and that Client must inform the Firm if Client does not wish the Firm to discuss
privileged matters on cell telephones with Client or Client’s professionals or agents.
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 17 of 631

Mr. Vikram Bajaj
CONFIDENTIAL
March 28, 2024
Page 4

The Firm hereby informs Client and Client hereby acknowledges that the Firm’s
attorneys sometimes communicate with their clients and their clients’ professionals and agents
by unencrypted e-mail, that such communications are capable of being intercepted by others and
therefore may be deemed no longer protected by the attorney-client privilege, and that Client
must inform the Firm if Client wishes to institute a system to encode all e-mail between the Firm
and Client or Client’s professionals or agents.

File Retention. All records and files will be retained and disposed of in compliance with
the Firm’s policy in effect from time to time. Subject to future changes, it is the Firm’s current
policy generally not to retain records relating to a matter for more than five years. Upon Client’s
prior written request, the Firm will return client records that are Client’s property to Client prior
to their destruction. Although we will return your records (i.e., your client file) to you at any
time upon your written request, you agree that your client file will not include our Firm’s internal
files including administrative materials, internal communications, and drafts. It is not
administratively feasible for the Firm to advise Client of the closing of a matter or the disposal of
records. The Firm recommends, therefore, that Client maintain Client’s own files for reference
or submit a written request for Client’s client files promptly upon conclusion of a
matter. Notwithstanding anything to the contrary herein, Client acknowledges and agrees that
any applicable privilege of Client (including any attorney-client and work product privilege or
any duty of confidentiality) (collectively, the “Privileges”) belongs to Client alone and not to any
successor entity (including without limitation the Client after a change in control or other similar
restructuring or non-restructuring transaction (including without limitation a reorganized Client
after the effective date of a plan of reorganization), whether through merger, asset or equity sale,
business combination, or otherwise, irrespective of whether such transaction occurs in a
Restructuring Case or on an out-of-court basis (in each case, a “Transaction”)). Client hereby
waives any right, title, and interest of such successor entity to all information, data, documents,
or communications in any format covered by the Privileges that is in the possession of the Firm
(“Firm Materials”), to the extent that such successor entity had any right, title, and interest to
such Firm Materials. For the avoidance of doubt, Client agrees and acknowledges that after a
Transaction, such successor entity shall have no right to claim or waive the Privileges or request
the return of any such Firm Materials; instead, such Firm Materials shall remain in the Firm’s
sole possession and control for its exclusive use, and the Firm will (a) not waive any Privileges
or disclose the Firm Materials, (b) take all reasonable steps to ensure that the Privileges survive
and remain in full force and effect, and (c) assert the Privileges to prevent disclosure of any Firm
Materials.

Data Protection. You further agree that, if you provide us with personal data, you have
complied with applicable data protection legislation and that we may process such personal data
in accordance with our Data Transfer and Privacy Policy at www.kirkland.com. We process
your personal data in order to (i) carry out work for you; (ii) share the data with third parties such
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 18 of 631

Mr. Vikram Bajaj
CONFIDENTIAL
March 28, 2024
Page 5

as expert witnesses and other professional advisers if our work requires; (iii) comply with
applicable laws and regulations and (iv) provide you with information relating to our Firm and
its services.

Conflicts of Interest. As is customary for a law firm of the Firm’s size, there are
numerous business entities, with which Client currently has relationships, that the Firm has
represented or currently represents in matters unrelated to Client. The Firm notes that the Firm
currently represents or has represented Apax Partners, L.P. and/or its affiliates (collectively, the
“Interested Parties”) in a variety of matters and will continue to do so in such unrelated matters.
Because Client is engaged in activities (and may in the future engage in additional activities) in
which Client’s interests may diverge from those of the Interested Parties or the Firm’s other
clients, the possibility exists that the Interested Parties or one of the Firm’s clients may take
positions adverse to Client.

Further, in undertaking the representation of Client, the Firm wants to be fair not only to
Client’s interests but also to those of the Firm’s other clients. Because Client is engaged in
activities (and may in the future engage in additional activities) in which its interests may
diverge from those of the Firm’s other clients, the possibility exists that one of the Firm’s current
or future clients may take positions adverse to Client (including litigation or other dispute
resolution mechanisms) in a matter in which such other client may have retained the Firm or one
of Client’s adversaries may retain the Firm in a matter adverse to another entity or person.

In the event a present conflict of interest exists between Client and the Firm’s other
clients or in the event one arises in the future, Client agrees to waive any such conflict of interest
or other objection that would preclude the Firm’s representation of another client (a) in other
current or future matters substantially unrelated to the Engagement or (b) other than during a
Restructuring Case (as defined below), in other matters related to Client (such representation, an
“Allowed Adverse Representation”). By way of example, such Allowed Adverse
Representations might take the form of, among other contexts: litigation (including arbitration,
mediation and other forms of dispute resolution); transactional work (including consensual and
non-consensual merger, acquisition, and takeover situations, financings, and commercial
agreements); counseling (including advising direct adversaries and competitors); and
restructuring (including bankruptcy, insolvency, financial distress, recapitalization, equity and
debt workouts, and other transactions or adversarial adjudicative proceedings related to any of
the foregoing and similar matters).

Client also agrees that it will not, for itself or any other entity or person, assert that either
(i) the Firm’s representation of Client or any of Client’s affiliates in any past, present, or future
matter or (ii) the Firm’s actual or possible possession of confidential information belonging to
Client or any of Client’s affiliates is a basis to disqualify the Firm from representing another
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 19 of 631

Mr. Vikram Bajaj
CONFIDENTIAL
March 28, 2024
Page 6

entity or person in any Allowed Adverse Representation. Client further agrees that any Allowed
Adverse Representation does not breach any duty that the Firm owes to Client or any of Client’s
affiliates. Client also agrees that the Firm’s representation in the Engagement is solely of Client
and that no member or other entity or person related to it (such as a shareholder, parent,
subsidiary, affiliate, director, officer, partner, employee, or joint venturer) has the status of a
client for conflict of interest purposes.

In addition, if a waiver of a conflict of interest necessary to allow the Firm to represent
another client in a matter that is not substantially related to the Engagement is not effective for
any reason, Client agrees that the Firm may withdraw from the Engagement. Should that occur,
Client will not, for itself or any other entity or person, seek to preclude such termination of
services or assert that either (a) the Firm’s representation of Client or any of Client’s affiliates in
any past, present, or future matter or (b) the Firm’s actual or possible possession of confidential
information belonging to Client or any of Client’s affiliates is a basis to disqualify the Firm from
representing such other client or acting on such adverse matter.

It is important that you review this letter carefully and consider all of the advantages and
disadvantages of waiving certain conflicts of interests that would otherwise bar the Firm from
representing parties with interests adverse to you during the time in which the Firm is
representing you. You also understand that because this waiver includes future issues and future
clients that are unknown and unknowable at this time, it is impossible to provide you with any
more details about those prospective clients and matters. Thus, in choosing to execute this
waiver, you have recognized the inherent uncertainty about the array of potential matters and
clients the Firm might take on in matters that are adverse to you but have nonetheless decided it
is in your interest to waive conflicts of interest regarding the Allowed Adverse Representations
and waive rights to prohibit the Firm’s potential withdrawal should a conflict waiver prove
ineffectual.

The Firm informs Client that certain entities owned by current or former Firm attorneys
and senior staff (“attorney investment entities”) have investments in funds or companies that
may, directly or indirectly, be affiliated with Client, hold investments in Client’s debt or equity
securities, may be adverse to Client, or conduct commercial transactions with Client (each, a
“Passive Holding”). The attorney investment entities are passive and have no management or
other control rights in such funds or companies. The Firm notes that other persons may in the
future assert that a Passive Holding creates, in certain circumstances, a conflict between the
Firm’s exercise of its independent professional judgment in rendering advice to Client and the
financial interest of Firm attorneys participating in the attorney investment entities, and such
other persons might seek to limit Client’s ability to use the Firm to advise Client on a particular
matter. While the Firm cannot control what a person might assert or seek, the Firm believes that
the Firm’s judgment will not be compromised by virtue of any Passive Holding. Please let us
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 20 of 631

Mr. Vikram Bajaj
CONFIDENTIAL
March 28, 2024
Page 7

know if Client has any questions or concerns regarding the Passive Holdings. By executing this
letter, Client acknowledges the Firm’s disclosure of the foregoing.

Restructuring Cases. If it becomes necessary for Client to commence restructuring
cases under chapter 11 of the U.S. Bankruptcy Code (a “Restructuring Case”), the Firm’s
ongoing employment by Client will be subject to the approval of the court with jurisdiction over
the petitions. If necessary, the Firm will take steps necessary to prepare the disclosure materials
required in connection with the Firm’s retention as lead restructuring counsel. In the near term,
the Firm will begin conflicts checks on potentially interested parties as provided by Client.

If necessary, the Firm will prepare a preliminary draft of a schedule describing the Firm’s
relationships with certain interested parties (the “Disclosure Schedule”). The Firm will give
Client a draft of the Disclosure Schedule once it is available. Although the Firm believes that
these relationships do not constitute actual conflicts of interest, these relationships must be
described and disclosed in Client’s application to the court to retain the Firm.

If in the Firm’s determination a conflict of interest arises in Client’s Restructuring Case
requiring separate conflicts counsel, then Client will be required to use separate conflicts counsel
in those matters.

No Guarantee of Success. It is impossible to provide any promise or guarantee about
the outcome of Client’s matters. Nothing in this Agreement or any statement by Firm staff or
attorneys constitutes a promise or guarantee. Any comments about the outcome of Client’s
matter are simply expressions of judgment and are not binding on the Firm.

Consent to Use of Information. In connection with future materials that, for marketing
purposes, describe facets of the Firm’s law practice and recite examples of matters the Firm
handles on behalf of clients, Client agrees that, if those materials avoid disclosing Client’s
confidences and secrets as defined by applicable ethical rules, they may identify Client as a
client, may contain factual synopses of Client’s matters, and may indicate generally the results
achieved.

Reimbursement of Fees and Expenses. Client agrees to promptly reimburse the Firm
for all internal or external fees and expenses, including the amount of the Firm’s attorney and
paralegal time at normal billing rates, as incurred by the Firm in connection with participating in,
preparing for, or responding to any action, claim, objection, suit, or proceeding brought by or
against any third-party that relates to the legal services provided by the Firm under this
Agreement. Without limiting the scope of the foregoing, and by way of example only, this
paragraph extends to all such fees and expenses incurred by the Firm in responding to document
subpoenas, and preparing for and testifying at depositions and trials; and with respect to the
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 21 of 631

Mr. Vikram Bajaj
CONFIDENTIAL
March 28, 2024
Page 8

filing, preparation, prosecution or defense of any applications by the Firm for approval of fees
and expenses in a judicial, arbitral, or similar proceeding. Further, Client understands,
acknowledges, and agrees that in connection with a Restructuring Case, if Client has not objected
to the payment of a Firm invoice or to a Firm fee and expense application, has in fact paid such
invoice, or has approved such fee and expense application, then Client waives its right (and the
right of any successor entity as a result of a Transaction or otherwise) to subsequently object to
the payment of fees and expenses covered by such invoice or fee application.

LLP. Kirkland & Ellis LLP is a limited liability partnership organized under the laws of
Illinois, and Kirkland & Ellis International LLP is a limited liability partnership organized under
the laws of Delaware. Pursuant to those statutory provisions, an obligation incurred by a limited
liability partnership, whether arising in tort, contract or otherwise, is solely the obligation of the
limited liability partnership, and partners are not personally liable, directly or indirectly, by way
of indemnification, contribution, assessment or otherwise, for such obligation solely by reason of
being or so acting as a partner.

Governing Law. This Agreement shall be governed by, and construed in accordance
with, the laws of the State of Illinois, without giving effect to the conflicts of law principles
thereof.

Miscellaneous. This Agreement sets forth the Parties’ entire agreement for rendering
professional services. It can be amended or modified only in writing and not orally or by course
of conduct. Each Party signing below is jointly and severally responsible for all obligations due
to the Firm and represents that each has full authority to execute this Agreement so that it is
binding. This Agreement may be signed in one or more counterparts and binds each Party
countersigning below, whether or not any other proposed signatory ever executes it. If any
provision of this Agreement or the application thereof is held invalid or unenforceable, the
invalidity or unenforceability shall not affect other provisions or applications of this Agreement
which can be given effect without such provisions or application, and to this end the provisions
of this Agreement are declared to be severable. Any agreement or waiver contained herein by
Client extends to any assignee or successor in interest to Client, including without limitation the
reorganized Client upon and after the effective date of a plan of reorganization in a Restructuring
Case.

This Agreement is the product of arm’s-length negotiations between sophisticated parties,
and Client acknowledges that it is experienced with respect to the retention of legal counsel.
Therefore, the Parties acknowledge and agree that any otherwise applicable rule of contract
construction or interpretation which provides that ambiguities shall be construed against the
drafter (and all similar rules of contract construction or interpretation) shall not apply to this
Agreement. The Parties further acknowledge that the Firm is not advising Client with respect to
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 22 of 631

Mr. Vikram Bajaj
CONFIDENTIAL
March 28, 2024
Page 9

this Agreement because the Firm would have a conflict of interest in doing so, and that Client
has consulted (or had the opportunity to consult) with legal counsel of its own choosing. Client
further acknowledges that Client has entered into this Agreement and agreed to all of its terms
and conditions voluntarily and fully-informed, based on adequate information and Client’s own
independent judgment. The Parties further acknowledge that they intend for this Agreement to
be effective and fully enforceable upon its execution and to be relied upon by the Parties.

***
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 23 of 631

Mr. Vikram Bajaj
CONFIDENTIAL
March 28, 2024
Page 10

Please confirm your agreement with the arrangements described in this letter by signing
the enclosed copy of this letter in the space provided below and returning it to us. Please
understand that, if we do not receive a signed copy of this letter within twenty-one days, we will
withdraw from representing you in this Engagement.

Very truly yours,

KIRKLAND & ELLIS LLP

By:
Printed Name: Joshua A. Sussberg, P.C.
Title: Partner

Agreed and accepted this 3rd day of April, 2024

VYAIRE HOLDING COMPANY

By:
Name: Vikram Bajaj
Title: Chief Financial Officer
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 24 of 631

Mr. Vikram Bajaj
CONFIDENTIAL
March 28, 2024
Page 10

Very truly yours,

KIRKLAND & ELLIS LLP

By:
Printed Name: Joshua A. Sussberg, P.C.
Title: Partner

Agreed and accepted this 4th day of April, 2024

VYAIRE HOLDING COMPANY

By:
Name: Vikram Bajaj
Title: Chief Financial Officer
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 25 of 631

Mr. Vikram Bajaj
CONFIDENTIAL
March 28, 2024
Page 11

Addendum A: List of Client Subsidiaries

1. Vyaire Company 36. Vyaire GmbH
2. Vyaire Finance B.V. 37. Vyaire Medical GmbH
3. Vyaire Medical, Inc. 38. Vyaire Medical Private Limited
4. Bird Products Corporation 39. Vyaire S.r.l.
5. Breathe US Holdco Inc. 40. Vyaire Medical S.r.l.
6. Breathe US Holdings LP 41. Vyaire Medical SDN BHD
7. EME Medical, Inc. 42. Vyaire Medical Cooperatief U.A.
8. Revolutionary Medical Devices, Inc. 43. Vyaire Medical International B.V.
9. SensorMedics Corporation 44. Vyaire Medical Holdings B.V.
10. VIASYS Holdings Inc. 45. Vyaire B.V.
11. Vyaire Medical 202, Inc. 46. Vyaire Medical B.V.
12. Vyaire Medical 203, Inc. 47. Vyaire Medical Products Limited (Spółka z
13. Vyaire Medical 205, Inc. ograniczoną odpowiedzialnością) - Poland
14. Vyaire Medical 206, Inc. Branch
15. Vyaire Medical 211, Inc. 48. Vyaire Limited Liability Company
16. Vyaire Medical BR LLC 49. imtmedical Pte. Ltd.
17. Vyaire Medical Capital LLC 50. Vyaire Medical Pte. Ltd.
18. Vyaire Medical Consumables LLC 51. Vyaire Medical Korea Ltd.
19. Vyaire Medical International LLC 52. Vyaire Medical AB
20. Vyaire Medical LLC 53. Acutronic Medical Systems AG
21. Vyaire Medical Payroll LLC 54. Advanced Respiratory Care AG
22. Vyaire Respiratory Diagnostics LLC 55. imtmedical ag
23. Vyaire Financial Holdings LLC 56. Vyaire Medical Sarl
24. VM Finance Sub LLC 57. Vyaire Turkey Tibbi Cihazlar Ticaret
25. Vyaire Receivables LLC Anonim Sirketi
26. Vyaire TSR Sub, LLC 58. Vyaire DMCC
27. Vyaire TSR Midco, LLC 59. Carefusion U.K. 235 Limited
28. Vyaire Medical Pty Ltd 60. CareFusion U.K. 232 Limited
29. Intermed Equipamento Medico Hospitalar 61. Vyaire UK 236 Limited
LTDA 62. Vyaire Medical Products Limited
30. Servicos De Assistencia Tecnica A
Equipmaneto Medico Hospitalar LTDA
31. Vyaire Medical Products ULC
32. Beijing Branch of Vyaire Medical Products
(Shanghai) Co., Ltd.
33. Vyaire Medical Products (Shanghai) Co.,
Ltd.
34. Vyaire Medical Denmark Branch, Filial of
Vyaire Medical AB
35. MIM Medizinische Instrumente und
Monitoring GmbH
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 26 of 631

KIRKLAND & ELLIS LLP

SCHEDULE I: CLIENT-REIMBURSABLE EXPENSES AND OTHER CHARGES

Effective 01/01/2024

The following outlines Kirkland & Ellis LLP’s (“K&E LLP”) policies and standard charges for
various services performed by K&E LLP and/or by other third parties on behalf of the client
which are often ancillary to our legal services. Services provided by in-house K&E LLP
personnel are for the convenience of our clients. Given that these services are often ancillary to
our legal services, in certain instances it may be appropriate and/or more cost efficient for these
services to be outsourced to a third-party vendor. If services are provided beyond those outlined
below, pricing will be based on K&E LLP’s approximate cost and/or comparable market pricing.

 Duplicating, Reprographics and Printing: The following list details K&E LLP’s
charges for duplicating, reprographics and printing services:

 Black and White Copy or Print (all sizes of paper):
 $0.16 per impression for all U.S. offices
 €0.10 per impression in Munich
 £0.15 per impression in London
 HK$1.50 per impression in Hong Kong
 CNY1.00 per impression in Beijing and Shanghai
 Color Copy or Print (all sizes of paper):
 $0.55 per impression
 Scanned Images:
 $0.16 per page for black and white or color scans
 Other Services:
 CD/DVD Duplicating or Mastering - $7/$10 per CD/DVD
 Binding - $0.70 per binding
 Large or specialized binders - $13/$27
 Tabs - $0.13 per item
 OCR/File Conversion - $0.03 per page
 Large Format Printing - $1.00 per sq. ft.

 Secretarial and Word Processing: Clients are not charged for secretarial and word
processing activities incurred on their matters during standard business hours.

 Overtime Charges: Clients will be charged for overtime costs for secretarial and
document services work if either (i) the client has specifically requested the after-hours
work or (ii) the nature of the work being done for the client necessitates out-of-hours
overtime and such work could not have been done during normal working hours. If these
conditions are satisfied, costs for related overtime meals and transportation also will be
charged.

1
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 27 of 631

 Travel Expenses: We charge clients our out-of-pocket costs for travel expenses
including associated travel agency fees. We charge coach fares (business class for
international flights) unless the client has approved business-class, first-class or an
upgrade. K&E LLP personnel are instructed to incur only reasonable airfare, hotel and
meal expenses. K&E LLP negotiates, uses, and passes along volume discount hotel and
air rates whenever practicable. However, certain retrospective rebates may not be passed
along.

 Catering Charges: Clients will be charged for any in-house catering service provided in
connection with client matters.

 Communication Expenses: We do not charge clients for telephone calls, conference
calls, videoconferences or faxes made from K&E LLP’s offices.

Charges incurred for conference calls, videoconferences, cellular telephones, and calls
made from other third-party locations will be charged to the client at the actual cost
incurred. Further, other telecommunication expenses incurred at third-party locations
(e.g., phone lines at trial sites, Internet access, etc.) will be charged to the client at the
actual cost incurred.

 Overnight Delivery/Postage: We charge clients for the actual cost of overnight and
special delivery (e.g., Express Mail, FedEx, and DHL), and U.S. postage for materials
mailed on the client’s behalf. K&E LLP negotiates, uses, and passes along volume
discount rates whenever practicable.

 Messengers: We charge clients for the actual cost of a third-party vendor messenger.

 Library Research Services: Library Research staff provides research and document
retrieval services at the request of attorneys, and clients are charged per hour for these
services. Any expenses incurred in connection with the request, such as outside retrieval
service or online research charges, are passed on to the client at cost, including any
applicable discounts.

 Online Research Charges: K&E LLP charges for costs incurred in using third-party
online research services in connection with a client matter. K&E LLP negotiates and
uses discounts or special rates for online research services whenever possible and
practicable and passes through the full benefit of any savings to the client based on actual
usage.

 Inter-Library Loan Services: Our standard client charge for inter-library loan services
when a K&E LLP library employee borrows a book from an outside source is $25 per
title. There is no client charge for borrowing books from K&E LLP libraries in other
cities or from outside collections when the title is part of the K&E LLP collection but
unavailable.

 Off-Site Legal Files Storage: Clients are not charged for off-site storage of files unless
the storage charge is approved in advance.

2
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 28 of 631

 Electronic Data Storage: K&E LLP will not charge clients for costs to store electronic
data and files on K&E LLP’s systems if the data stored does not exceed 100 gigabytes
(GB). If the data stored for a specific client exceeds 100GB, K&E LLP will charge
clients $6.00 per month/per GB for all network data stored until the data is either returned
to the client or properly disposed of. For e-discovery data on the Relativity platform,
K&E LLP will also charge clients $6.00 per month/per GB until the data is either
returned to the client or properly disposed of.

 Tax Filings: Clients will be charged a fixed fee for certain tax filings. Our standard
charge is $400 per Form 8832 election; $250 per Form 83(b) election for the first 20
forms, $100 per form for any additional forms; $1,000 each for Form SS-4 (Foreign);
$100 each for Form SS-4 (Domestic); and $75 for each FIRPTA certificate.

 Calendar Court Services: Our standard charge is $25 for a court filing and other court
services or transactions.

 Supplies: There is no client charge for standard office supplies. Clients are charged for
special items (e.g., a minute book, exhibit tabs/indexes/dividers, binding, etc.) and then at
K&E LLP’s actual cost.

 Contract Attorneys and Contract Non-Attorney Billers: If there is a need to utilize a
contract attorney or contract non-attorney on a client engagement, clients will be charged
a standard hourly rate for these billers unless other specific billing arrangements are
agreed between K&E LLP and client.

 Expert Witnesses, Experts of Other Types, and Other Third Party Consultants: If
there is a need to utilize an expert witness, expert of other type, or other third party
consultant such as accountants, investment bankers, academicians, other attorneys, etc.
on a client engagement, clients will be requested to retain or pay these individuals
directly unless specific billing arrangements are agreed between K&E LLP and client.

 Third Party Expenditures: Third party expenditures (e.g., corporate document and lien
searches, lease of office space at Trial location, IT equipment rental, SEC and regulatory
filings, etc.) incurred on behalf of a client, will be passed through to the client at actual
cost. If the invoice exceeds $50,000, it is K&E LLP’s policy that wherever possible such
charges will be directly billed to the client. In those circumstances where this is not
possible, K&E LLP will seek reimbursement from our client prior to paying the vendor.

Unless otherwise noted, charges billed in foreign currencies are based on current U.S. charges at
an appropriate exchange rate.

3
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 29 of 631

Exhibit D

Budget and Staffing Plan
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 30 of 631

Budget and Staffing Plan

(For Matter Categories for the Period Beginning on June 9, 2024 and Ending on September 7,
2024)

Budget

Matter Matter Category
Hours Budgeted Total Compensation Budgeted
Number Description
Chapter 11 Bankruptcy Filing
4 160 - 248 $180,000 - $280,000
and First Day Preparation
Corporate and Governance
5 60 - 93 $90,000 - $140,000
Matters
Disclosure Statement, Plan,
6 257 - 400 $270,000 - $420,000
and Confirmation
DIP Financing and Cash
7 153 - 237 $180,000 - $280,000
Collateral
8 Cash Management 79 - 122 $90,000 - $140,000
9 Automatic Stay Issues 68 - 106 $67,500 - $105,000
Asset Sales/Section 363
10 Issues: Use, Sale, and 1,080 - 1,680 $1,575,000 - $2,450,000
Disposition of Property
Executory Contracts and
11 88 - 136 $90,000 - $140,000
Unexpired Leases
12 Business Operations 95 - 147 $139,500 - $217,000
13 Claims Administration 66 - 102 $74,250 - $115,500
Schedules and Statements
14 61 - 95 $68,850 - $107,100
(SOFAs)
Creditor and Stakeholder
15 46 - 71 $58,050 - $90,300
Communications
U.S. Trustee Matters and
16 53 - 82 $73,800 - $114,800
Communication
17 Hearings 61 - 94 $76,500 - $119,000
18 Insurance and Surety Matters 59 - 91 $67,500 - $105,000
19 Utilities 59 - 91 $67,500 - $105,000
20 Tax Matters 107 - 166 $135,000 - $210,000
21 Case Administration 188 - 292 $225,000 - $350,000
22 K&E Fee Applications 266 - 414 $405,000 - $630,000
Non-K&E Fee / Employment
23 99 - 154 $132,750 - $206,500
Applications
24 Vendor Matters 96 - 149 $126,000 - $196,000
25 Litigation 101 - 156 $135,000 - $210,000
27 Non-Working Travel Time 12 - 17 $11,250 - $17,500
28 Creditors’ Committee Issues 34 - 53 $45,000 - $70,000
29 Employee and Labor Matters 73 - 114 $88,650 - $137,900
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 31 of 631

Staffing Plan

Number of Timekeepers
Expected to Work on Average
Category of Timekeeper
the Matter Categories Hourly Rate1
During the Budget Period
Partner 31 $1,789
Associate 49 $1,122
Legal Assistant 12 $502
Total 92 $1,244

1
The Average Hourly Rate is a weighted average based on the individual hourly rate of, and projected number of
hours worked by, each timekeeper over the course of the chapter 11 cases.

4
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 32 of 631

Exhibit E

Voluntary Rate Disclosures

• The blended hourly rate for all K&E timekeepers (including both professionals and
paraprofessionals) who billed to non-bankruptcy matters (collectively, the “Non-Bankruptcy
Matters”)1 during the 12-month period beginning September 2023 and ending August 2024
(the “Comparable Period”) was, in the aggregate, approximately $1,275.89 per hour
(the “Non-Bankruptcy Blended Hourly Rate”).2

• The blended hourly rate for all K&E timekeepers (including both professionals and
paraprofessionals) who billed to the Debtors during the Fee Period was
approximately $1,263.50 per hour (the “Debtor Blended Hourly Rate”).3

• A detailed comparison of these rates is as follows:

Debtor Blended Hourly Rate Non-Bankruptcy Blended
Position at K&E
for This Fee Application Hourly Rate
Partners 1,776.57 1,734.42
Associates 1,147.76 1,041.58
Paralegal 567.91 513.30
Junior Paralegal 355.00 315.33
Support Staff 364.59 545.40
Attorneys &
1,263.50 1,275.89
Paraprofessionals

1
It is the nature of K&E’s practice that certain non-bankruptcy engagements require the advice and counsel of
professionals and paraprofessionals who work primarily within K&E’s Restructuring Group. Accordingly,
“Non-Bankruptcy Matters” consist of matters for which K&E domestic timekeepers represented a client in a
matter other than an in-court bankruptcy proceeding. Moreover, the Non-Bankruptcy Matters include time
billed by K&E domestic timekeepers who work primarily within K&E’s Restructuring Group.

2
K&E calculated the blended rate for Non-Bankruptcy Matters by dividing the total dollar amount billed by
K&E domestic timekeepers to the Non-Bankruptcy Matters during the Comparable Period by the total number
of hours billed by K&E domestic timekeepers to the Non-Bankruptcy Matters during the Comparable Period.
3
K&E calculated the blended rate for timekeepers who billed to the Debtors by dividing the total dollar amount
billed by such timekeepers during the Fee Period by the total number of hours billed by such timekeepers
during the Fee Period.
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 33 of 631

Exhibit F

Summary of Total Fees Incurred and Hours Billed During the Fee Period

Fees Billed
Hourly Rate Billed
Fees Billed Hours Billed Number of In this Application
Date of
Attorney Name Position Department In this In this Rate In the First at First Interim
Admission In this
Application Application Increases Interim Application
Application Billing Rate
Application
Rebecca H. Associate ECEB - Executive 2017 9,307.50 8.50 N/A 1,095.00 1,095.00 9,307.50
Arnall Compensation
Rebecca H. Associate ECEB - Executive 2017 17,204.00 13.60 N/A 1,265.00 1,095.00 14,892.00
Arnall Compensation
Cooper Associate Corporate - General 2023 5,623.50 6.90 N/A 815.00 815.00 5,623.50
Barghols
Cooper Associate Corporate - General 2023 5,362.50 5.50 N/A 975.00 815.00 4,482.50
Barghols
Wes Benter Associate ECEB - Labor/Employment 2019 787.50 0.50 N/A 1,575.00 1,575.00 787.50
Samantha Associate Technology & IP Transactions 2019 9,415.00 7.00 N/A 1,345.00 1,345.00 9,415.00
Bradley
Chris Ceresa Associate Restructuring 2020 161,669.00 120.20 N/A 1,345.00 1,345.00 161,669.00
Chris Ceresa Associate Restructuring 2020 498,852.00 357.60 N/A 1,395.00 1,345.00 480,972.00
Tiffani Chanroo Associate Restructuring 2021 133,837.00 105.80 N/A 1,265.00 1,265.00 133,837.00
Tiffani Chanroo Associate Restructuring 2021 299,128.00 222.40 N/A 1,345.00 1,265.00 281,336.00
Kenny Associate Restructuring 2023 51,426.50 63.10 N/A 815.00 815.00 51,426.50
Chiaghana
Kenny Associate Restructuring 2023 84,727.50 86.90 N/A 975.00 815.00 70,823.50
Chiaghana
Erica D. Clark Associate Restructuring 2019 167,315.50 104.90 N/A 1,595.00 1,595.00 167,315.50
Dominique Associate ECEB - Executive 2020 1,861.50 1.70 N/A 1,095.00 1,095.00 1,861.50
Collins Compensation
Dominique Associate ECEB - Executive 2020 506.00 0.40 N/A 1,265.00 1,095.00 438.00
Collins Compensation
Georgia Cooper- Associate Litigation - General 2021 1,066.50 0.90 N/A 1,185.00 1,185.00 1,066.50
Dervan
Joseph A. Associate Litigation - General 2021 7,110.00 6.00 N/A 1,185.00 1,185.00 7,110.00
D’Antonio
Joseph A. Associate Litigation - General 2021 7,533.50 6.10 N/A 1,235.00 1,185.00 7,228.50
D’Antonio
Jaina Desai Associate Restructuring 2023 98,289.00 120.60 N/A 815.00 815.00 98,289.00
Jaina Desai Associate Restructuring 2023 389,025.00 399.00 N/A 975.00 815.00 325,185.00
Shareen Dhillon Associate Technology & IP Transactions 2018 2,530.00 2.00 N/A 1,265.00 1,265.00 2,530.00
Luke Finn Associate Corporate - M&A/Private 2021 335,981.00 249.80 N/A 1,345.00 1,345.00 335,981.00
Equity
Justin M. Associate Technology & IP Transactions 2022 10,042.50 10.30 N/A 975.00 975.00 10,042.50
Garfinkle
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 34 of 631

Fees Billed
Hourly Rate Billed
Fees Billed Hours Billed Number of In this Application
Date of
Attorney Name Position Department In this In this Rate In the First at First Interim
Admission In this
Application Application Increases Interim Application
Application Billing Rate
Application
Justin M. Associate Technology & IP Transactions 2022 91,323.00 83.40 N/A 1,095.00 975.00 81,315.00
Garfinkle
Emanuel Goetz Associate Taxation 2024 2,170.00 3.50 N/A 620.00 620.00 2,170.00
Emanuel Goetz Associate Taxation 2024 63,225.00 84.30 N/A 750.00 620.00 52,266.00
Palmer Associate Taxation 2023 28,645.50 33.90 N/A 845.00 845.00 28,645.50
Gunderson
Palmer Associate Taxation 2023 138,006.50 138.70 N/A 995.00 845.00 117,201.50
Gunderson
David Hackel Associate Restructuring 2023 108,907.50 111.70 N/A 975.00 975.00 108,907.50
David Hackel Associate Restructuring 2023 48,399.00 44.20 N/A 1,095.00 975.00 43,095.00
Yoonie Han Associate Corporate - Debt Finance 2019 25,528.50 18.30 N/A 1,395.00 1,395.00 25,528.50
Yoonie Han Associate Corporate - Debt Finance 2019 14,805.00 9.40 N/A 1,575.00 1,395.00 13,113.00
Liz Ji Associate Taxation 2021 18,330.00 15.60 N/A 1,175.00 1,175.00 18,330.00
Liz Ji Associate Taxation 2021 16,833.50 13.10 N/A 1,285.00 1,175.00 15,392.50
Olivia Associate Corporate - Healthcare 2023 19,890.00 20.40 N/A 975.00 975.00 19,890.00
Kaufmann
Olivia Associate Corporate - Healthcare 2023 35,587.50 32.50 N/A 1,095.00 975.00 31,687.50
Kaufmann
Sooah Kim Associate ECEB - Employee Benefits 2022 4,485.00 4.60 N/A 975.00 975.00 4,485.00
Sooah Kim Associate ECEB - Employee Benefits 2022 16,206.00 14.80 N/A 1,095.00 975.00 14,430.00
Brian King Associate Corporate - Healthcare 2017 4,842.00 3.60 N/A 1,345.00 1,345.00 4,842.00
Maggie Kate Associate Technology & IP Transactions 2021 15,877.50 14.50 N/A 1,095.00 1,095.00 15,877.50
King
Maggie Kate Associate Technology & IP Transactions 2021 70,587.00 55.80 N/A 1,265.00 1,095.00 61,101.00
King
Sabrina Associate Restructuring 2023 112,388.50 137.90 N/A 815.00 815.00 112,388.50
Lieberman
Sabrina Associate Restructuring 2023 156,975.00 161.00 N/A 975.00 815.00 131,215.00
Lieberman
Savannah Associate Antitrust/Competition 2023 9,964.50 9.10 N/A 1,095.00 1,095.00 9,964.50
Malnar-Cole
Savannah Associate Antitrust/Competition 2023 4,933.50 3.90 N/A 1,265.00 1,095.00 4,270.50
Malnar-Cole
Jennifer Associate Litigation - General 2022 1,387.50 1.50 N/A 925.00 925.00 1,387.50
Mancini
Jennifer Associate Litigation - General 2022 4,837.50 4.50 N/A 1,075.00 925.00 4,162.50
Mancini
Rebecca J. Associate Restructuring 2021 162,679.00 128.60 N/A 1,265.00 1,265.00 162,679.00
Marston
Rebecca J. Associate Restructuring 2021 214,796.50 159.70 N/A 1,345.00 1,265.00 202,020.50
Marston
Brandan Associate Corporate - M&A/Private 2021 159,113.50 118.30 N/A 1,345.00 1,345.00 159,113.50

7
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 35 of 631

Fees Billed
Hourly Rate Billed
Fees Billed Hours Billed Number of In this Application
Date of
Attorney Name Position Department In this In this Rate In the First at First Interim
Admission In this
Application Application Increases Interim Application
Application Billing Rate
Application
Matthews Equity
Grant Associate Corporate - Healthcare 2023 1,630.00 2.00 N/A 815.00 815.00 1,630.00
McClernon
Ruan J. Meintjes Associate Corporate - Healthcare 2022 27,885.00 28.60 N/A 975.00 975.00 27,885.00
Ruan J. Meintjes Associate Corporate - Healthcare 2022 74,460.00 68.00 N/A 1,095.00 975.00 66,300.00
Julienne Associate Corporate - General 2023 12,958.50 15.90 N/A 815.00 815.00 12,958.50
Miranda
Julienne Associate Corporate - General 2023 780.00 0.80 N/A 975.00 815.00 652.00
Miranda
Jake Moeller Associate Corporate - General 2022 6,132.00 5.60 N/A 1,095.00 1,095.00 6,132.00
Michael Associate Corporate - General 2022 9,457.50 9.70 N/A 975.00 975.00 9,457.50
William Morgan
Michael Associate Corporate - General 2022 328.50 0.30 N/A 1,095.00 975.00 292.50
William Morgan
Jai Mudhar Associate Restructuring 2020 8,855.00 7.00 N/A 1,265.00 1,265.00 8,855.00
Jai Mudhar Associate Restructuring 2020 27,438.00 20.40 N/A 1,345.00 1,265.00 25,806.00
Trent Nachbar Associate Corporate - M&A/Private 2022 35,916.00 32.80 N/A 1,095.00 1,095.00 35,916.00
Equity
Trent Nachbar Associate Corporate - M&A/Private 2022 149,649.50 118.30 N/A 1,265.00 1,095.00 129,538.50
Equity
Dan O’Connor Associate Corporate - M&A/Private 2021 79,062.50 62.50 N/A 1,265.00 1,265.00 79,062.50
Equity
Dan O’Connor Associate Corporate - M&A/Private 2021 232,147.00 172.60 N/A 1,345.00 1,265.00 218,339.00
Equity
Sarah Osborne Associate Restructuring 2023 85,004.50 104.30 N/A 815.00 815.00 85,004.50
Sarah Osborne Associate Restructuring 2023 144,007.50 147.70 N/A 975.00 815.00 120,375.50
Carolin Paus Associate Restructuring 2023 21,762.00 35.10 N/A 620.00 620.00 21,762.00
Carolin Paus Associate Restructuring 2023 21,975.00 29.30 N/A 750.00 620.00 18,166.00
D. Taylor Associate Corporate - General 2023 28,567.50 29.30 N/A 975.00 975.00 28,567.50
Petersen
Joseph Cermak Associate Corporate - Debt Finance 2022 17,842.50 18.30 N/A 975.00 975.00 17,842.50
Profancik
Joseph Cermak Associate Corporate - Debt Finance 2022 8,760.00 8.00 N/A 1,095.00 975.00 7,800.00
Profancik
Joshua Raphael Associate Restructuring 2023 16,380.00 16.80 N/A 975.00 975.00 16,380.00
Joshua Raphael Associate Restructuring 2023 99,864.00 91.20 N/A 1,095.00 975.00 88,920.00
Adrian Salmen Associate Restructuring 2021 32,521.50 29.70 N/A 1,095.00 1,095.00 32,521.50
Adrian Salmen Associate Restructuring 2021 64,641.50 51.10 N/A 1,265.00 1,095.00 55,954.50
Seth Sanders Associate Restructuring 2021 92,637.00 84.60 N/A 1,095.00 1,095.00 92,637.00
Seth Sanders Associate Restructuring 2021 39,215.00 31.00 N/A 1,265.00 1,095.00 33,945.00
Florian Schuette Associate Taxation 2023 1,125.00 1.50 N/A 750.00 750.00 1,125.00
Scottie Associate Technology & IP Transactions 2018 30,969.00 22.20 N/A 1,395.00 1,395.00 30,969.00

8
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 36 of 631

Fees Billed
Hourly Rate Billed
Fees Billed Hours Billed Number of In this Application
Date of
Attorney Name Position Department In this In this Rate In the First at First Interim
Admission In this
Application Application Increases Interim Application
Application Billing Rate
Application
Shermetaro
Scottie Associate Technology & IP Transactions 2018 251,212.50 159.50 N/A 1,575.00 1,395.00 222,502.50
Shermetaro
Daniel Shin Associate Technology & IP Transactions 2023 36,660.00 37.60 N/A 975.00 975.00 36,660.00
Noah Spector Associate Litigation - General 2021 537.50 0.50 N/A 1,075.00 1,075.00 537.50
Noah Spector Associate Litigation - General 2021 91,126.50 76.90 N/A 1,185.00 1,075.00 82,667.50
Matt Swanson Associate Environment - Transactional 2021 885.50 0.70 N/A 1,265.00 1,265.00 885.50
Matt Swanson Associate Environment - Transactional 2021 3,766.00 2.80 N/A 1,345.00 1,265.00 3,542.00
Kyle Nolan Associate Restructuring 2020 78,292.50 71.50 N/A 1,095.00 1,095.00 78,292.50
Trevett
Kyle Nolan Associate Restructuring 2020 46,678.50 36.90 N/A 1,265.00 1,095.00 40,405.50
Trevett
Josh Valletta Associate Restructuring 2023 292.50 0.30 N/A 975.00 975.00 292.50
Paul Vasiloff Associate ECEB - Labor/Employment 2021 7,337.00 5.80 N/A 1,265.00 1,265.00 7,337.00
Paul Vasiloff Associate ECEB - Labor/Employment 2021 13,181.00 9.80 N/A 1,345.00 1,265.00 12,397.00
Donatus Wang Associate Restructuring 2022 32,761.00 36.20 N/A 905.00 905.00 32,761.00
Donatus Wang Associate Restructuring 2022 18,528.00 19.30 N/A 960.00 905.00 17,466.50
Quin Wetzel Associate Restructuring 2023 44,580.50 54.70 N/A 815.00 815.00 44,580.50
Quin Wetzel Associate Restructuring 2023 50,505.00 51.80 N/A 975.00 815.00 42,217.00
Ann-Kathrin Associate Restructuring 2018 12,600.00 12.00 N/A 1,050.00 1,050.00 12,600.00
Ziegler
Ann-Kathrin Associate Restructuring 2018 31,030.00 29.00 N/A 1,070.00 1,050.00 30,450.00
Ziegler
Kon Partner Restructuring 2000 103,725.00 45.00 N/A 2,305.00 2,305.00 103,725.00
Asimacopoulos
Marin Boney Partner Antitrust/Competition 2008 4,712.50 2.50 N/A 1,885.00 1,885.00 4,712.50
John G. Caruso Partner Real Estate 1992 18,189.00 8.60 N/A 2,115.00 2,115.00 18,189.00
Adam Thomas Partner Corporate - M&A/Private 2013 20,748.00 10.40 N/A 1,995.00 1,995.00 20,748.00
Clifford, P.C. Equity
Bernadette Partner Technology & IP Transactions 2013 130,567.50 82.90 N/A 1,575.00 1,575.00 130,567.50
Coppola
Hannah Partner Restructuring 2015 10,367.50 6.50 N/A 1,595.00 1,595.00 10,367.50
Crawford
Sion Davies Partner Antitrust/Competition 2016 8,032.50 5.10 N/A 1,575.00 1,575.00 8,032.50
Tabitha J. De Partner Litigation - General 2015 148,235.50 103.30 N/A 1,435.00 1,435.00 148,235.50
Paulo
Anthony M. Del Partner Corporate - Healthcare 2014 120,901.00 75.80 N/A 1,595.00 1,595.00 120,901.00
Rio
Michael Ehret Partner Taxation 2001 291,072.00 153.60 N/A 1,895.00 1,895.00 291,072.00
Emma L. Flett Partner Technology & IP Transactions 2009 11,421.00 5.40 N/A 2,115.00 2,115.00 11,421.00
Susan D. Partner Restructuring 1988 9,760.00 6.10 N/A 1,600.00 1,600.00 9,760.00
Golden

9
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 37 of 631

Fees Billed
Hourly Rate Billed
Fees Billed Hours Billed Number of In this Application
Date of
Attorney Name Position Department In this In this Rate In the First at First Interim
Admission In this
Application Application Increases Interim Application
Application Billing Rate
Application
Luci Hague Partner International Trade 2015 630.00 0.40 N/A 1,575.00 1,575.00 630.00
Kate Hardey Partner Corporate - Healthcare 2003 97,755.00 49.00 N/A 1,995.00 1,995.00 97,755.00
Erik Hepler Partner Corporate - Debt Finance 1990 423.00 0.20 N/A 2,115.00 2,115.00 423.00
Andrew Partner Corporate - Debt Finance 2009 5,985.00 3.00 N/A 1,995.00 1,995.00 5,985.00
Idrizovic, P.C.
Partha Kar Partner Restructuring 2002 44,025.50 19.10 N/A 2,305.00 2,305.00 44,025.50
Sarah Kimmer Partner Litigation - General 2015 2,730.00 2.00 N/A 1,365.00 1,365.00 2,730.00
Daniel Lewis, Partner Technology & IP Transactions 2008 60,547.00 31.70 N/A 1,910.00 1,910.00 60,547.00
P.C.
Mario Mancuso, Partner International Trade 1997 480.00 0.20 N/A 2,400.00 2,400.00 480.00
P.C.
Sean McClay Partner Corporate - Debt Finance 2018 13,387.50 8.50 N/A 1,575.00 1,575.00 13,387.50
Mark McKane, Partner Litigation - General 1999 12,390.00 6.00 N/A 2,065.00 2,065.00 12,390.00
P.C.
Alisa Melekhina Partner Litigation - General 2015 84,375.50 52.90 N/A 1,595.00 1,595.00 84,375.50
James Morgan Partner Taxation 2004 7,090.50 2.90 N/A 2,445.00 2,445.00 7,090.50
Mavnick Nerwal Partner Taxation 2008 1,132.50 0.50 N/A 2,265.00 2,265.00 1,132.50
Maureen D. Partner ECEB - Employee Benefits 1998 39,127.50 18.50 N/A 2,115.00 2,115.00 39,127.50
O’Brien
Rakesh Patel Partner Taxation 2000 4,162.50 2.50 N/A 1,665.00 1,665.00 4,162.50
Evangelia Partner ECEB - Labor/Employment 2016 41,107.50 26.10 N/A 1,575.00 1,575.00 41,107.50
Podaras
Scott D. Price, Partner ECEB - Executive 1998 6,510.50 2.90 N/A 2,245.00 2,245.00 6,510.50
P.C. Compensation
William T. Partner Litigation - General 2004 1,356.00 0.80 N/A 1,695.00 1,695.00 1,356.00
Pruitt
Jay M. Ptashek, Partner Corporate - Debt Finance 1993 4,490.00 2.00 N/A 2,245.00 2,245.00 4,490.00
P.C.
Risa Salins Partner ECEB - Labor/Employment 2002 44,626.50 21.10 N/A 2,115.00 2,115.00 44,626.50
Yusuf Salloum Partner Restructuring 2018 250,734.00 157.20 N/A 1,595.00 1,595.00 250,734.00
Anna Partner Corporate - Capital Markets 2002 9,468.00 7.20 N/A 1,315.00 1,315.00 9,468.00
Schwander
Noah Shier Partner Technology & IP Transactions 2017 14,962.50 9.50 N/A 1,575.00 1,575.00 14,962.50
Jessica H. Sicsu Partner Corporate - M&A/Private 2002 1,221.50 0.70 N/A 1,745.00 1,745.00 1,221.50
Equity
Josh Sussberg, Partner Restructuring 2004 16,365.50 7.10 N/A 2,305.00 2,305.00 16,365.50
P.C.
Paul D. Tanaka, Partner Environment - Transactional 2003 34,474.50 16.30 N/A 2,115.00 2,115.00 34,474.50
P.C.
Michael D. Partner Antitrust/Competition 2010 1,017.00 0.60 N/A 1,695.00 1,695.00 1,017.00
Thorpe
Steve Toth Partner Corporate - M&A/Private 2005 605,150.00 332.50 N/A 1,820.00 1,820.00 605,150.00

10
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 38 of 631

Fees Billed
Hourly Rate Billed
Hours Billed Number of In this Application
Paraprofessional Date of Fees Billed
Position Department In this Rate In the First at First Interim
Name Admission In this Application In this
Application Increases Interim Application Billing
Application Rate
Application
Amy Donahue Paralegal Restructuring N/A 20,055.00 38.20 N/A 525.00 525.00 20,055.00
Angela Leonard Paralegal Litigation - General N/A 16,812.50 26.90 N/A 625.00 625.00 16,812.50
Barbara M. Paralegal Technology & IP N/A 1,653.00 3.80 N/A 435.00 435.00 1,653.00
Siepka Transactions
Hayley Smith Paralegal Technology & IP N/A 1,250.00 2.00 N/A 625.00 625.00 1,250.00
Transactions
Henry Rosas Paralegal Corporate - Debt N/A 312.50 0.50 N/A 625.00 625.00 312.50
Finance
Julia R. Foster Paralegal Restructuring N/A 34,807.50 66.30 N/A 525.00 525.00 34,807.50
Lauren Austgen Paralegal Technology & IP N/A 652.50 1.50 N/A 435.00 435.00 652.50
Transactions
Michelle L. Paralegal Technology & IP N/A 31,875.00 51.00 N/A 625.00 625.00 31,875.00
Nowicki Transactions
Rob Soneson Paralegal Technology & IP N/A 6,250.00 10.00 N/A 625.00 625.00 6,250.00
Transactions
Robert Orren Paralegal Restructuring N/A 312.50 0.50 N/A 625.00 625.00 312.50
Ashley Brittanie Junior Paralegal Technology & IP N/A 248.50 0.70 N/A 355.00 355.00 248.50
Miller Transactions
Georgia Meadow Junior Paralegal Restructuring N/A 177.50 0.50 N/A 355.00 355.00 177.50
Stephanie Choi Junior Paralegal Litigation - General N/A 20,803.00 58.60 N/A 355.00 355.00 20,803.00
Tanzila Zomo Junior Paralegal Restructuring N/A 23,394.50 65.90 N/A 355.00 355.00 23,394.50
Eric Nyberg Support Staff Conflicts Analysis N/A 7,650.00 22.50 N/A 340.00 340.00 7,650.00
Marta Dudyan Support Staff Conflicts Analysis N/A 8,500.00 25.00 N/A 340.00 340.00 8,500.00

11
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 39 of 631

12
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 40 of 631

Exhibit G

Summary of Actual and Necessary Expenses for the Fee Period

Unit Cost
Expense Vendor (if any) Amount
(if applicable)
Third Party Telephone Charges $0
Standard Copies or Prints Kirkland & Ellis LLP $0.10 $467.70
Tabs/Indexes/Dividers Kirkland & Ellis LLP $0
Color Copies or Prints $1,161.60
Scanned Images Kirkland & Ellis LLP $0
Local Transportation $855.10
Travel Expense $3,961.94
Airfare $4,803.29
Transportation to/from airport $1,904.94
Travel Meals $369.65
Court Reporter Fee/Deposition $72.90
Filing Fees $0
Other Court Costs and Fees $32,208.66
Working Meals/K&E Only $1,046.19
Outside Retrieval Service $2,357.56
Computer Database Research $1,940.62
Westlaw Research $5,484.51
LexisNexis Research $684.41
Overtime Transportation $1,122.65
Overtime Meals - Attorney $1,063.78
Secretarial Overtime Kirkland & Ellis LLP $0
Document Services Overtime Kirkland & Ellis LLP $0
Rental Expenses $5,142.16
Overnight Delivery – Hard $242.67
Computer Database Research - Soft $109.90
Total $65,000.23
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 41 of 631

Exhibit H

Summary of Fees and Expenses by Matter for the Fee Period

Matter Matter Category Hours Total Compensation
Number Description Budgeted Billed Budgeted Billed
Chapter 11 Bankruptcy
4 Filing and First Day 160 - 248 429.70 $180,000 - $280,000 $468,189.00
Preparation
Corporate and Governance
5 60 - 93 127.50 $90,000 - $140,000 $142,227.00
Matters
Disclosure Statement, Plan,
6 257 - 400 272.00 $270,000 - $420,000 $280,303.00
and Confirmation
DIP Financing and Cash
7 153 - 237 281.70 $180,000 - $280,000 $358,618.50
Collateral
8 Cash Management 79 - 122 4.60 $90,000 - $140,000 $5,548.00
9 Automatic Stay Issues 68 - 106 3.10 $67,500 - $105,000 $3,069.50
Asset Sales/Section 363
$1,575,000 -
10 Issues: Use, Sale, and 1,080 - 1,680 3,882.40 $5,242,847.00
$2,450,000
Disposition of Property
Executory Contracts and
11 88 - 136 70.70 $90,000 - $140,000 $78,689.50
Unexpired Leases
12 Business Operations 95 - 147 103.20 $139,500 - $217,000 $118,732.50
13 Claims Administration 66 - 102 55.70 $74,250 - $115,500 $58,921.50
Schedules and Statements
14 61 - 95 86.60 $68,850 - $107,100 $104,485.00
(SOFAs)
Creditor and Stakeholder
15 46 - 71 32.30 $58,050 - $90,300 $32,215.50
Communications
U.S. Trustee Matters and
16 53 - 82 31.90 $73,800 - $114,800 $38,906.50
Communication
17 Hearings 61 - 94 28.00 $76,500 - $119,000 $39,653.00
18 Insurance and Surety Matters 59 - 91 5.40 $67,500 - $105,000 $5,713.00
19 Utilities 59 - 91 17.10 $67,500 - $105,000 $18,139.50
20 Tax Matters 107 - 166 645.70 $135,000 - $210,000 $946,173.00
21 Case Administration 188 - 292 327.10 $225,000 - $350,000 $327,834.00
22 K&E Fee Applications 266 - 414 332.90 $405,000 - $630,000 $314,096.00
Non-K&E Fee / Employment
23 99 - 154 142.80 $132,750 - $206,500 $152,778.50
Applications
24 Vendor Matters 96 - 149 54.80 $126,000 - $196,000 $60,255.00
25 Litigation 101 - 156 237.50 $135,000 - $210,000 $256,302.50
27 Non-Working Travel Time 12 - 17 33.30 $11,250 - $17,500 $46,201.50
28 Creditors’ Committee Issues 34 - 53 104.60 $45,000 - $70,000 $118,611.00
29 Employee and Labor Matters 73 - 114 76.90 $88,650 - $137,900 $115,569.00
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 42 of 631

Exhibit I

Detailed Description of Services Provided
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 43 of 631

601 Lexington Avenue
New York, NY 10022

FEIN 36-1326630

August 29, 2024

Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045

Attn: Vikram Bajaj

Invoice Number: 1050102691
Client Matter: 48520-4

In the Matter of Chapter 11 Filing & First Day Pleadings

For legal services rendered through June 30, 2024
(see attached Description of Legal Services for detail) $ 468,189.00
Total legal services rendered $ 468,189.00

Austin Bay Area Beijing Boston Brussels Chicago Dallas Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 44 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102691
Vyaire Medical Inc. Matter Number: 48520-4
Chapter 11 Filing & First Day Pleadings

Summary of Hours Billed

Name Hours Rate Amount
Kon Asimacopoulos 23.30 2,305.00 53,706.50
Chris Ceresa 34.70 1,345.00 46,671.50
Tiffani Chanroo 29.80 1,265.00 37,697.00
Kenny Chiaghana 19.20 815.00 15,648.00
Hannah Crawford 0.20 1,595.00 319.00
Joseph A. D'Antonio 5.30 1,185.00 6,280.50
Tabitha J. De Paulo 1.60 1,435.00 2,296.00
Anthony M. Del Rio 0.40 1,595.00 638.00
Jaina Desai 28.90 815.00 23,553.50
Amy Donahue 23.90 525.00 12,547.50
Julia R. Foster 30.20 525.00 15,855.00
Susan D. Golden 1.00 1,600.00 1,600.00
David Hackel 58.40 975.00 56,940.00
Kate Hardey 0.50 1,995.00 997.50
Sabrina Lieberman 20.60 815.00 16,789.00
Rebecca J. Marston 16.60 1,265.00 20,999.00
Mark McKane, P.C. 0.80 2,065.00 1,652.00
Jai Mudhar 0.70 1,265.00 885.50
Sarah Osborne 28.20 815.00 22,983.00
Carolin Paus 3.50 620.00 2,170.00
Joseph Cermak Profancik 5.50 975.00 5,362.50
Yusuf Salloum 23.50 1,595.00 37,482.50
Seth Sanders 0.60 1,095.00 657.00
Josh Sussberg, P.C. 0.30 2,305.00 691.50
Kyle Nolan Trevett 25.90 1,095.00 28,360.50
Quin Wetzel 25.60 815.00 20,864.00
Spencer A. Winters, P.C. 20.50 1,685.00 34,542.50

TOTALS 429.70 $ 468,189.00

2
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 45 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102691
Vyaire Medical Inc. Matter Number: 48520-4
Chapter 11 Filing & First Day Pleadings

Description of Legal Services

Date Name Hours Description
06/09/24 Chris Ceresa 16.00 Review, revise first day motions (3.9);
telephone conferences with Y. Salloum,
Company re filing (2.9); review, analyze legal
issues re same (3.9); conferences with CS
team re first day motions (1.6); conferences
with T. Chanroo, K&E team re filing (3.7).
06/09/24 Tiffani Chanroo 16.00 Review, revise first day motions (3.9);
telephone conferences with Alix team re first
day diligence (3.9); review, analyze legal
issues re same and pleadings (3.4);
conferences with CS team re first day motions
(1.1); conferences with C. Ceresa, K&E team
re filing (3.7).
06/09/24 Kenny Chiaghana 11.50 Attend to first day preparations.
06/09/24 Tabitha J. De Paulo 1.60 Review, analyze first day motions and bid
procedures motion.
06/09/24 Jaina Desai 12.00 Revise bidding procedures motion (4.2);
conference with R. Marston, C. Ceresa re
same (.4); revise bidding procedures order
(1.1); conference with R. Marston, C. Ceresa
re same (.6); revise NOL motion (3.2);
correspond with T. Chanroo re same (.2);
conference with T. Chanroo re same (.3);
draft sale process org chart (.5); revise first
day declaration (.3); correspond with D.
Hackel re same (.2); conference with S.
Lieberman re 156(c) retention application
(.4); revise customer programs motion (.2);
conference with T. Chanroo re same (.1);
correspond with T. Chanroo re same (.1);
revise bidding procedures notices (.2).
06/09/24 Amy Donahue 14.00 Prepare for Chapter 11 filing (3.5);
conference with K&E team re work in process
(1.0); review and revise first day motions
(3.5); correspond with K&E team re case
filing logistics (1.5); download filed voluntary
petitions and organize on DMS (2.0);
download filed motions and organize on DMS
(2.5).

3
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 46 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102691
Vyaire Medical Inc. Matter Number: 48520-4
Chapter 11 Filing & First Day Pleadings

Date Name Hours Description
06/09/24 Julia R. Foster 11.20 Prepare voluntary petitions for filing (3.9);
review, revise first day motions (3.9);
conference with K&E team re work in process
(.5); correspond with C. Ceresa re filing
logistics (.9); review, revise resolutions and
consents re petitions (2.0).
06/09/24 Julia R. Foster 7.00 Assist with Chapter 11 filing (3.9);
conference with K. Chiaghana, K&E team re
same (.5); continue to assist with Chapter 11
filing (2.6).
06/09/24 Susan D. Golden 1.00 Review, revise creditor matrix redaction
motion (.8); correspond with K&E team re
same (.2).
06/09/24 David Hackel 16.00 Review, analyze issues re first day
declaration, first day presentation, case status,
chapter 11 filing (4.5); correspond with Y.
Salloum, K&E team, external parties,
Company re same (1.3); conferences with Y.
Salloum, K&E team, external parties,
Company re same (.4); revise first day
declaration and exhibits (2.3); review, analyze
Company materials, DIP documents, sale
documents, RSA, bidding procedures (3);
analyze issues re deal status, sale process
(1.4); review, revise various first day motions
(1.2); research re same (1.0); revise first day
presentation (.9).
06/09/24 Sabrina Lieberman 12.00 Review and revise motion to seal retention
applications (1.9); review and revise motion
to retain claims agent (2.4); review and revise
tax motion (1.9); review and revise critical
vendors motion (2.3); conference with Omni
re service (.5); conference with Cole Schotz
re filing timeline (1.2); conference with C.
Ceresa and K&E team re filing timeline (1.1);
conference with AlixPartners re tax motion
and critical vendors motion (.7).
06/09/24 Sabrina Lieberman 2.00 Correspond with Company re NDAs (.2);
review and revise summary re same (1.3);
correspond with C. Ceresa and K&E team
(.1); review and revise motion to seal
retention applications (.4).

4
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 47 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102691
Vyaire Medical Inc. Matter Number: 48520-4
Chapter 11 Filing & First Day Pleadings

Date Name Hours Description
06/09/24 Rebecca J. Marston 16.00 Review and revise bidding procedures
pleadings (6.4); conference with C. Ceresa,
K&E team re first day hearing preparations
(.7); correspond with NDA counterparties,
PJT team (.4); review and revise first day
pleadings (7.6); correspond with C. Ceresa,
K&E team re same (.3); conference with Cole
Schotz team re sealing motions (.6).
06/09/24 Sarah Osborne 15.50 Review, revise joint administration motion
(1.2); review, revise RSA term sheet (4.5);
review, revise RSA (3.9); review, revise
wages motion (2.1); review, revise first day
presentation (3.0); compile signature pages
and filing checklist (.8).
06/09/24 Carolin Paus 3.50 Compile signature pages for standstill
agreement (1.2); draft, revise standstill
agreement (1.0); correspond with Finkenhof
on execution of standstill agreement (.5); draft
accession notices for Brazilian entities (.8).
06/09/24 Joseph Cermak Profancik 5.50 Coordinate with local Dutch counsel re Dutch
deliverables (.5); draft and revise K&E
opinion (2.0); coordinate responses to KYC
requests (.3); draft and revise closing
checklist (1.5); draft and revise credit
agreement schedules (1.0); review and
analyze Vyaire receivables LLCA (.1); draft
and revise borrowing notice (.1).
06/09/24 Yusuf Salloum 16.00 Review, revise documentation in connection
with preparing for chapter 11 filing (3.8);
research re same (3.5); conferences with
lenders' counsel, company-side advisors re
same (2.5); finalize filing documentation
(3.5); commence filing process (2.7).
06/09/24 Kyle Nolan Trevett 14.20 Office conference re chapter 11 filing (3.9);
research re same (3.1); participate in office
conference re chapter 11 filing (3.8); continue
research re same (3.4).
06/09/24 Quin Wetzel 16.00 Review, revise filing consents (2.9); review,
revise creditor matrix motion (1.3); review,
revise DIP declarations (2.1); review, revise
DIP roll-up summary (4.7); review, revise
insurance motion (2.2); compile and
proofread documents for filing (2.8).

5
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 48 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102691
Vyaire Medical Inc. Matter Number: 48520-4
Chapter 11 Filing & First Day Pleadings

Date Name Hours Description
06/09/24 Spencer A. Winters, P.C. 8.90 Review, revise first day declaration (1.8);
review, analyze RSA issues (2.3); prepare for
and attend board meeting (.5); review,
analyze filing issues (2.5); correspond and
telephone conferences with multiple parties re
same (1.8).
06/10/24 Kon Asimacopoulos 1.50 Review, analyze international entity filing
issues.
06/10/24 Chris Ceresa 6.00 Conference with T. Chanroo, K&E team re
first day hearing (3.9); research re same (2.1).
06/10/24 Tiffani Chanroo 13.80 Conference with C. Ceresa, K&E team re
filing of chapter 11 cases (2.4); review, revise
first day motions (2.6); review, analyze issues
re same (1.4); conference with C. Ceresa,
K&E team re filing (.9); prepare for first day
hearing (1.6); review, revise talking points
(3.9); conference with N. Warther and K&E
team re first day motion (.5); conference with
U.S. Trustee re first day open diligence (.5).
06/10/24 Kenny Chiaghana 2.30 Conference with T. Chanroo, K&E team re
case filing.
06/10/24 Kenny Chiaghana 4.10 Analyze, revise first day motion talking points
(3.1); research re same (1.0).
06/10/24 Joseph A. D'Antonio 5.30 Conference with advisors re first day hearing
preparation (1.0); conference with
AlixPartners re same (.5); conference with
Company re same (.5); draft hearing outline
documents re same (3.3).
06/10/24 Anthony M. Del Rio 0.40 Review draft motions.
06/10/24 Jaina Desai 5.00 Revise customer programs motion (.9);
conference with T. Chanroo re same (.1);
revise bidding procedures motion (.6);
conference with C. Ceresa re same (.4); revise
bidding procedures motion (.6); conference
with C. Ceresa re same (.4); revise net
operating loss motion (.7); conference with T.
Chanroo re same (.3); revise bidding
procedures notices (.9); conference with C.
Ceresa re same (.1).

6
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 49 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102691
Vyaire Medical Inc. Matter Number: 48520-4
Chapter 11 Filing & First Day Pleadings

Date Name Hours Description
06/10/24 Jaina Desai 1.30 Correspond with T. Chanroo re customer
programs (.1); revise talking points re NOL
motion (.2); revise talking points re 156(c)
retention application (.3). correspond with
AlixPartners, T. Chanroo re customer
programs motion (.3); review, analyze
customer programs precedent (.2); revise
customer programs order (.1); correspond
with T. Chanroo, D. Hackel re same (.1).
06/10/24 Jaina Desai 1.50 Revise customer programs motion (.5);
correspond with T. Chanroo re same (.2);
revise NOL motion (.6); correspond with T.
Chanroo re same (.2).
06/10/24 Jaina Desai 4.30 Draft talking points for first day hearing (3.0);
review, analyze first day transcripts re NOL
motion (.4); review, analyze first day
transcripts re customer programs motion (.3);
review, analyze NOL motion (.4); correspond
with T. Chanroo re same (.1); correspond with
Y. Salloum re same (.1).
06/10/24 Jaina Desai 1.00 Revise talking points (.7); correspond with S.
Lieberman re same (.3).
06/10/24 Amy Donahue 3.70 Assist with Chapter 11 filing.
06/10/24 Amy Donahue 6.00 Assist with preparations for first day hearing
(3.5); prepare hearing binders for K&E
presenters (2.5).
06/10/24 Julia R. Foster 0.60 Draft notice of revised proposed orders re
interim NOL and interim customer programs.
06/10/24 Julia R. Foster 4.90 Prepare materials for June 11, 2024 hearing
(3.9); correspond with Y. Salloum re June 11,
2024 hearing logistics (.3); continue to
prepare materials for June 11, 2024 hearing
(.7).
06/10/24 Julia R. Foster 1.00 Research precedent re Judge Shannon hearing
transcripts.
06/10/24 David Hackel 10.50 Revise first day presentation (2.3); revise
talking points re first day hearing (2.1);
research re first day presentation, talking
points (1.5); correspond with S. Winters,
K&E team, Cole Schotz, Company re first
day hearing matters (1.4); conferences with S.
Winters, K&E team, Cole Schotz, Company
re same (.6); coordinate issues re first day
hearing (2.6).

7
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 50 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102691
Vyaire Medical Inc. Matter Number: 48520-4
Chapter 11 Filing & First Day Pleadings

Date Name Hours Description
06/10/24 Sabrina Lieberman 6.60 Revise talking points re first-day motions
(3.4); correspond with T. Chanroo and K&E
team re same (1.0); review, analyze
transcripts re first-day hearings (1.5);
conference with T. Chanroo re first-day
hearing (.3); correspond with T. Chanroo re
same (.2); conference with D. Hackel re first
day declaration (.2).
06/10/24 Sarah Osborne 5.70 Prepare for chapter 11 filing (3.9); draft
notice of revised order (.5); further review,
revise same (.4); compile updated first day
motions for U.S. Trustee (.6); correspond with
T. Chanroo re same (.3).
06/10/24 Sarah Osborne 0.50 Review, revise first day hearing talking
points.
06/10/24 Sarah Osborne 3.00 Review, revise first day motion talking points
(1.5); review, analyze first day hearing
transcripts (1.5).
06/10/24 Yusuf Salloum 3.00 Research re filing, first day hearing.
06/10/24 Seth Sanders 0.60 Revise first-day presentation.
06/10/24 Josh Sussberg, P.C. 0.30 Review, analyze issues re first day hearing.
06/10/24 Kyle Nolan Trevett 11.70 Conference with C. Ceresa, K&E team re
chapter 11 filing (3.9); further conference
with C. Ceresa, K&E team re chapter 11
filing (1.5); review, revise interim DIP order,
motion, related pleadings (3.9); further
review, revise interim DIP order, motion, and
related pleadings (2.4).
06/10/24 Quin Wetzel 4.40 Review, revise first day motions (3.8);
correspond with local counsel re same (.6).
06/10/24 Quin Wetzel 4.20 Conference with C. Ceresa and T. Chanroo re
first day hearing (.4); review, analyze hearing
transcripts (2.6); draft talking points re first
day hearing (1.2).
06/10/24 Spencer A. Winters, P.C. 8.40 Draft first day hearing talking points (3.3);
review, revise first day presentation (1.3);
prepare for first day hearing (2.5); correspond
and telephone conferences with multiple
parties re same (1.3).
06/11/24 Kon Asimacopoulos 2.20 Review, analyze international entity filing
issues.

8
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 51 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102691
Vyaire Medical Inc. Matter Number: 48520-4
Chapter 11 Filing & First Day Pleadings

Date Name Hours Description
06/11/24 Chris Ceresa 0.80 Review, analyze legal issues re filing (.6);
correspond and conference with Y. Salloum,
K&E team, advisors re same (.2).
06/11/24 Kenny Chiaghana 1.30 Annotate first day hearing remarks re cash
management and utilities motions.
06/11/24 Jaina Desai 2.00 Prepare for first day hearing (.6); attend first
day hearing (1.0); conference with S.
Lieberman re same (.1); draft correspondence
re same (.3).
06/11/24 Amy Donahue 0.20 Correspond with T. Chanroo, K&E team,
Cole Schotz re revised interim orders.
06/11/24 Julia R. Foster 5.20 Prepare first day orders for court submission
(2.7); review and revise same (2.5).
06/11/24 Rebecca J. Marston 0.60 Correspond with K. Chiaghana, J. Desai,
K&E team re first day hearing, first day
pleading issues.
06/11/24 Mark McKane, P.C. 0.80 Correspond with T. De Paulo re first day
hearing issues.
06/11/24 Sarah Osborne 1.50 Prepare for first day hearing (.5); attend first
day hearing (1.0).
06/11/24 Spencer A. Winters, P.C. 2.80 Review, revise talking points (.8); review,
analyze first day presentation (.7); review,
analyze issues re first day motions (.6);
prepare for first day hearing (.7).
06/12/24 Kon Asimacopoulos 2.20 Review, analyze international entity filing
issues.
06/12/24 Chris Ceresa 3.50 Review, analyze legal issues re filing (2.5);
correspond and conference with T. Chanroo,
K&E team, advisors re same (1.0).
06/12/24 Jaina Desai 1.50 Review, analyze NOL order (.5); correspond
with J. Foster re same (.3); correspond with T.
Chanroo re same (.2); revise NOL order (.3);
correspond with T. Chanroo, S. Golden re
same (.2).
06/12/24 Julia R. Foster 0.30 Correspond with J. Desai re NOL interim
order notice.
06/13/24 Kon Asimacopoulos 1.50 Review, analyze international entity filing
issues.
06/13/24 Chris Ceresa 2.30 Review, analyze legal issues re filing (1.3);
correspond and conference with K.
Chiaghana, K&E team, advisors re same
(1.0).

9
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 52 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102691
Vyaire Medical Inc. Matter Number: 48520-4
Chapter 11 Filing & First Day Pleadings

Date Name Hours Description
06/13/24 David Hackel 1.00 Research re chapter 11 filing deck (.8);
correspond with J. Foster, K&E team re same
(.1); conference with T. Chanroo re same (.1).
06/14/24 Kon Asimacopoulos 2.20 Review, analyze international entity filing
issues.
06/14/24 David Hackel 1.80 Research re chapter 11 filing deck (.8);
review, analyze precedent materials re same
(.4); review, revise postpetition chapter 11
management presentation (.6).
06/14/24 Sarah Osborne 0.30 Review, analyze first day pleadings for
deadlines and reporting obligations (.2);
correspond with K. Chiaghana re same (.1).
06/15/24 Jaina Desai 0.30 Review, analyze NOL motion (.1); review,
analyze customer programs motion, 156(c)
retention application (.1); correspond with K.
Chiaghana re same (.1).
06/17/24 Kon Asimacopoulos 1.20 Review, analyze international entity legal
issues.
06/17/24 David Hackel 5.80 Research re chapter 11 management deck
(1.7); review, analyze precedent materials,
first day pleadings, RSA and declarations re
same (2.6); review, revise chapter 11
management deck (1.5).
06/17/24 Kate Hardey 0.50 Review, analyze first day filing information.
06/18/24 Kon Asimacopoulos 2.20 Review, analyze international entity filing
issues.
06/18/24 Chris Ceresa 2.20 Review, analyze service, noticing issues re
FDMs (1.2); correspond and conference with
S. Lieberman, K&E team, advisors re same
(1.0).
06/18/24 David Hackel 7.10 Research re chapter 11 management deck (.4);
review, analyze precedent materials, first day
pleadings, DIP credit agreement and other
DIP documents, RSA and declarations re
same (3.9); further analyze same (.3); review,
revise chapter 11 management deck (1.9);
correspond with T. Chanroo, K&E team re
same (.6).
06/19/24 Kon Asimacopoulos 2.20 Review, analyze international entity filing
issues.

10
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 53 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102691
Vyaire Medical Inc. Matter Number: 48520-4
Chapter 11 Filing & First Day Pleadings

Date Name Hours Description
06/19/24 David Hackel 6.20 Review, revise chapter 11 post-petition deck
(3.2); review, analyze pleadings, DIP
materials, RSA, Company documents re same
(2.6); correspond with K. Chiaghana re same
(.4).
06/20/24 Chris Ceresa 1.00 Conference with T. Chanroo re first day
motions and next steps.
06/20/24 David Hackel 1.20 Review, revise chapter 11 post-petition deck
(.7); research re same (.3); correspond with K.
Chiaghana re same (.2).
06/21/24 David Hackel 3.60 Review, revise chapter 11 post-petition deck
(3.1); review, analyze pleadings, DIP
materials, RSA, Company documents re same
(.2); correspond with K. Chiaghana, K&E
team re same (.3).
06/24/24 David Hackel 0.40 Review, analyze issues re chapter 11 post-
petition deck.
06/25/24 Kon Asimacopoulos 2.20 Review, analyze international entity filing
issues.
06/25/24 Chris Ceresa 2.60 Review, analyze first day motions for second
day (1.6); review, analyze other second day
hearing motions (1.0).
06/25/24 David Hackel 1.50 Review, analyze issues re chapter 11 post-
petition deck (.7); correspond with K.
Chiaghana re same (.1); review, analyze
correspondence from C. Ceresa, K&E team re
second day pleadings (.5); review, analyze
summary of case (.1); correspond with J.
Sussberg, K&E team re same (.1).
06/25/24 Jai Mudhar 0.70 Telephone conference with P. Kar re
advisor services (.5); correspond with P. Kar,
Company re same (.2).
06/25/24 Yusuf Salloum 2.50 Review, revise second day pleadings.
06/25/24 Spencer A. Winters, P.C. 0.40 Review, analyze second day motions.
06/26/24 Kon Asimacopoulos 2.20 Review, analyze international entity filing
issues.
06/26/24 David Hackel 0.30 Review, analyze issues re chapter 11 post-
petition deck.
06/26/24 Quin Wetzel 1.00 Review, revise final insurance order re
insurance carrier comments.
06/27/24 Kon Asimacopoulos 1.50 Review, analyze international entity filing
issues.

11
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 54 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102691
Vyaire Medical Inc. Matter Number: 48520-4
Chapter 11 Filing & First Day Pleadings

Date Name Hours Description
06/27/24 Hannah Crawford 0.20 Review, analyze correspondence re
international filing analysis.
06/27/24 David Hackel 1.20 Review, analyze issues re chapter 11 post-
petition deck (.3); review, revise same (.6);
review, analyze case status, first and second
day pleadings and orders re same (.3).
06/27/24 Sarah Osborne 1.10 Review, revise proposed final wages and
interim compensation orders for second day
hearing (.9); correspond with C. Ceresa, K&E
team re same (.2).
06/27/24 Yusuf Salloum 2.00 Review, revise second day pleadings.
06/28/24 Kon Asimacopoulos 2.20 Review, analyze international entity filing
issues.
06/28/24 Chris Ceresa 0.30 Review, analyze first day motions for second
day (.2); review, analyze other second day
hearing motions (.1).
06/28/24 David Hackel 0.30 Review, analyze issues re chapter 11 post-
petition deck (.1); review, analyze issues re
second day hearing and related
correspondence from C. Ceresa, K&E team
(.2).
06/28/24 Sarah Osborne 0.60 Review, revise proposed final first day
hearing orders (.4); correspond with C.
Ceresa, K&E team re same (.2).
06/29/24 David Hackel 1.50 Draft, revise summary of case, chapter 11
filing (.5); research re same (.2); review,
analyze case materials re same (.2);
correspond with C. Ceresa re same (.2);
review, analyze issues re chapter 11 deck (.2);
correspond with K. Chiaghana re same (.2).

Total 429.70

12
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 55 of 631

601 Lexington Avenue
New York, NY 10022

FEIN 36-1326630

August 29, 2024

Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045

Attn: Vikram Bajaj

Invoice Number: 1050102692
Client Matter: 48520-5

In the Matter of Corporate & Governance Matters

For legal services rendered through June 30, 2024
(see attached Description of Legal Services for detail) $ 75,642.50
Total legal services rendered $ 75,642.50

Austin Bay Area Beijing Boston Brussels Chicago Dallas Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 56 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102692
Vyaire Medical Inc. Matter Number: 48520-5
Corporate & Governance Matters

Summary of Hours Billed

Name Hours Rate Amount
Kon Asimacopoulos 1.50 2,305.00 3,457.50
Chris Ceresa 1.90 1,345.00 2,555.50
Kenny Chiaghana 7.00 815.00 5,705.00
Hannah Crawford 0.20 1,595.00 319.00
Tabitha J. De Paulo 0.30 1,435.00 430.50
Luci Hague 0.20 1,575.00 315.00
Partha Kar 2.60 2,305.00 5,993.00
Sabrina Lieberman 1.70 815.00 1,385.50
Sean McClay 4.00 1,575.00 6,300.00
Mark McKane, P.C. 0.60 2,065.00 1,239.00
Julienne Miranda 0.20 815.00 163.00
Jai Mudhar 1.40 1,265.00 1,771.00
Sarah Osborne 7.00 815.00 5,705.00
Carolin Paus 10.60 620.00 6,572.00
Seth Sanders 1.10 1,095.00 1,204.50
Donatus Wang 22.00 905.00 19,910.00
Cristina Weidner 2.70 1,665.00 4,495.50
Quin Wetzel 6.10 815.00 4,971.50
Ann-Kathrin Ziegler 3.00 1,050.00 3,150.00

TOTALS 74.10 $ 75,642.50

2
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 57 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102692
Vyaire Medical Inc. Matter Number: 48520-5
Corporate & Governance Matters

Description of Legal Services

Date Name Hours Description
06/10/24 Sean McClay 4.00 Review, analyze revisions to DIP credit
agreement (1.9); review, analyze DIP order
(2.1).
06/10/24 Julienne Miranda 0.20 Correspond with J. Profancik and Q. Wetzel
re omnibus consent.
06/11/24 Donatus Wang 3.50 Review and analyze correspondence from
Swiss auditor on solvency status of Swiss
entities and Swiss audit (.2); telephone
conference with client re same (.4); analyze
implications of solvency concerns re Swiss
entities for German entities (1.0); review,
analyze material contract review prepared by
C. Paus (.4); correspond with Finkenhof re
DIP budget and cash flow forecast (.2);
telephone conference with Finkenhof re
potential options for legal and operational
structuring (1.1); coordinate telephone
conference with Company and Finkenhof (.2).
06/12/24 Sabrina Lieberman 0.20 Correspond with Cole Schotz and Company
re special committee investigation.
06/12/24 Jai Mudhar 1.00 Review, analyze Swiss letter (.3); correspond
and conferences with Swiss counsel,
Company re same (.7).
06/12/24 Carolin Paus 1.20 Telephone conference with Company and
Finkenhof re cashflow forecast of Vyaire
Medical GmbH and post filing shipping (.7);
summarize call and next steps (.5).
06/12/24 Seth Sanders 1.10 Draft special committee update (.8);
correspond with C. Ceresa, K&E team re
same (.3).
06/12/24 Donatus Wang 4.80 Telephone conference with Company and
Finkenhof re German cash flow forecast and
shipping of products from Germany to US
entities and summarize takeaways (2.7);
correspond with Company re cash flow
forecasts (.3); correspond with AlixPartners re
allocation of payments (.2); telephone
conference with client account payables team
re open issues (.7); correspond with Company
re standstill agreement (.5); correspond with
Y. Salloum, K&E team re US law
considerations (.4).

3
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 58 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102692
Vyaire Medical Inc. Matter Number: 48520-5
Corporate & Governance Matters

Date Name Hours Description
06/13/24 Tabitha J. De Paulo 0.30 Conference with Company re status of
investigation.
06/13/24 Sabrina Lieberman 0.60 Conference with M. McKane and K&E team
re special committee investigation.
06/13/24 Mark McKane, P.C. 0.60 Conference with T. De Paulo, K&E team re
ongoing investigation, second day hearing
and next steps.
06/13/24 Donatus Wang 0.40 Correspond with AlixPartners re allocation of
payments by US entities (.1); review and
consider updated issues and workstreams list,
next steps (.2); correspond with C. Paus re
same (.1).
06/13/24 Quin Wetzel 0.70 Correspond with C. Ceresa, Company re
corporate governance documents and chapter
11 requirements.
06/14/24 Partha Kar 0.50 Conference with J. Mudhar, K&E team re
standstill, international liquidity
considerations.
06/14/24 Jai Mudhar 0.20 Conference with P. Kar, K&E team re
standstill, European liquidity (.1); correspond
with Company, P. Kar, K&E team re same
(.1).
06/14/24 Donatus Wang 1.10 Correspond with Company re standstill
agreement (.5); conference with J. Mudhar,
K&E team re same (.2); correspond with
Company re German cash flow forecasts and
allocation of payments by US entities to
German entities, discuss related next steps
with J. Mudhar, K&E team (.4).
06/15/24 Jai Mudhar 0.20 Correspond with Company re Switzerland.
06/17/24 Hannah Crawford 0.20 Correspond with various parties re standstill
agreement.
06/17/24 Partha Kar 1.50 Correspond with Company re auditor issues
in Switzerland (.6); telephone conference with
Swiss counsel re same, standstill document
(.9).
06/17/24 Quin Wetzel 0.60 Review, analyze governance consents (.4);
correspond with C. Ceresa re same (.2).
06/17/24 Ann-Kathrin Ziegler 0.20 Telephone conference with Company, J.
Mudhar and K&E team re scope of global
standstill agreement.
06/18/24 Sabrina Lieberman 0.10 Correspond with Cole Schotz re special
committee investigation.

4
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 59 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102692
Vyaire Medical Inc. Matter Number: 48520-5
Corporate & Governance Matters

Date Name Hours Description
06/18/24 Sarah Osborne 2.10 Review, analyze RSA and RSA term sheet re
Company specific obligations (.9); correspond
with D. Hackel, K&E team re same (.2);
review, analyze wages motion for Company
specific obligations (.8); correspond with K.
Chiaghana re same (.2).
06/18/24 Donatus Wang 0.20 Conference and correspond with Finkenhof re
cash flow forecasts and other documents
requests for German entities.
06/19/24 Kenny Chiaghana 2.60 Analyze, revise company obligations
presentation.
06/19/24 Ann-Kathrin Ziegler 0.50 Conference with D. Wang, K&E team re
German and Swiss workstreams.
06/20/24 Kon Asimacopoulos 1.50 Review, analyze international entity filing
issues.
06/20/24 Chris Ceresa 0.70 Conference with special committee re open
issues (.5); draft minutes re same (.2).
06/20/24 Kenny Chiaghana 3.10 Analyze, revise company obligations
presentation.
06/20/24 Donatus Wang 3.00 Research re aspects of German capital
maintenance and claw-back in insolvency
(1.0); review, analyze correspondence
between Company and Baker McKenzie on
documentation required for audit of Swiss
entities (.2); review and comment on draft
going-concern assessment by board of
directors (1.3); correspond with Baker
McKenzie re same (.1); correspond with
Finkenhof re standstill agreement (.4).
06/20/24 Cristina Weidner 1.50 Telephone conference with Finkenhof re
updates (.5); correspond with Finkenhof re
same (1.0).
06/20/24 Ann-Kathrin Ziegler 1.70 Telephone conference with Company, FH re
Vyaire Medical GmbH workstreams (.8);
prepare for same (.2); review and revise draft
letter to Swiss auditor (.7).
06/21/24 Kenny Chiaghana 1.30 Analyze, revise company obligations
presentation.

5
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 60 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102692
Vyaire Medical Inc. Matter Number: 48520-5
Corporate & Governance Matters

Date Name Hours Description
06/21/24 Donatus Wang 1.80 Review, analyze revised draft going-concern
assessment letter by board of directors,
correspond with Baker McKenzie re same
(.4); correspond with Company and Baker
McKenzie re documentation required for
audit (1.0); telephone conference with Baker
McKenzie re same, debrief with A. Ziegler,
K&E team (.4).
06/21/24 Quin Wetzel 0.90 Draft special committee board minutes (.8);
correspond with C. Ceresa re same (.1).
06/21/24 Ann-Kathrin Ziegler 0.60 Draft correspondence to C. Weidner, K&E
team re Swiss auditor comfort letter (.3);
review, analyze revised Swiss letter to auditor
(.3).
06/22/24 Donatus Wang 0.50 Review, analyze draft soft commitment letter
of US entities re funding of Swiss entities
(.3); correspond with Y. Salloum, K&E team
and Baker McKenzie re same (.2).
06/24/24 Sabrina Lieberman 0.10 Correspond with Company re outstanding
special committee investigation diligence.
06/24/24 Donatus Wang 1.50 Finalize draft soft commitment letter by US
entities for funding of Swiss entities (.8);
correspond with Baker McKenzie on same
(.3); correspond with S. Lieberman re signing
of same (.4).
06/24/24 Cristina Weidner 1.20 Correspond with various parties re Swiss
auditor.
06/24/24 Quin Wetzel 1.20 Correspond with S. Osborne re board minutes
(.2); review, revise special committee minutes
(1.0).
06/25/24 Chris Ceresa 0.60 Review, revise corporate minutes (.4);
correspond with S. Osborne, K&E team re
same (.2).
06/25/24 Sarah Osborne 0.80 Review, revise meeting minutes (.4);
correspond with C. Ceresa, K&E team re
same (.2); correspond with Company re same
(.2).
06/25/24 Sarah Osborne 0.80 Review, analyze board meeting minutes for
approval.
06/25/24 Carolin Paus 6.40 Draft presentation re German RDx business
(3.5); research re same (2.9).

6
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 61 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102692
Vyaire Medical Inc. Matter Number: 48520-5
Corporate & Governance Matters

Date Name Hours Description
06/25/24 Donatus Wang 2.60 Correspond with S. Lieberman re signing of
draft soft commitment letter by US entities for
funding of Swiss entities (.8); correspond with
Baker McKenzie re same and audit process
(.3); review, analyze cash flow forecast for
Company and overview of underlying
assumptions (.8); correspond with A. Ziegler
and K&E team re same (.3); correspond with
Company and Finkenhof re same (.4).
06/26/24 Chris Ceresa 0.60 Review, revise corporate minutes (.4);
correspond with Q. Wetzel, K&E team re
same (.2).
06/26/24 Sabrina Lieberman 0.10 Correspond with Cole Schotz, S. Sanders and
K&E team re virtual data room.
06/26/24 Sarah Osborne 2.50 Draft special committee meeting minutes (.7);
correspond with C. Ceresa, K&E team re
same (.2); review, revise same (.4);
correspond with Company re same (.2); draft
full board minutes (.8); correspond with C.
Ceresa re same (.2).
06/26/24 Quin Wetzel 1.30 Draft notes for special committee meeting
(.5); correspond with C. Ceresa re same (.2);
draft minutes re same (.4); correspond with S.
Osborne re special committee minutes (.2).
06/27/24 Luci Hague 0.20 Correspond with W. Phalen re CFIUS
assessment.
06/27/24 Partha Kar 0.60 Correspond with J. Mudhar, K&E team re
SPA and foreign law input.
06/27/24 Sabrina Lieberman 0.60 Correspond with Y. Salloum and K&E re
board resolutions.
06/27/24 Sarah Osborne 0.80 Review, analyze prior minutes.
06/27/24 Carolin Paus 3.00 Research re treatment of intercompany
claims.
06/27/24 Donatus Wang 2.60 Review and consider shipment issues and
conference with Company re same (.4);
correspond with Finkenhof and Company re
same (.2); review and consider update from
Baker McKenzie Switzerland re feedback
from Swiss auditor, discuss next steps with
K&E team (.3); correspond with Company,
Finkenhof re cash flow forecast (.2); review,
analyze draft material contracts review (1.5).

7
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 62 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102692
Vyaire Medical Inc. Matter Number: 48520-5
Corporate & Governance Matters

Date Name Hours Description
06/27/24 Quin Wetzel 1.40 Review, analyze responsible officer positions
(.7); analyze corporate governance structure
(.4); correspond with C. Ceresa, J. Raphael re
same (.3).

Total 74.10

8
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 63 of 631

601 Lexington Avenue
New York, NY 10022

FEIN 36-1326630

August 29, 2024

Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045

Attn: Vikram Bajaj

Invoice Number: 1050102693
Client Matter: 48520-6

In the Matter of Disclosure Statement/Plan/Confirmation

For legal services rendered through June 30, 2024
(see attached Description of Legal Services for detail) $ 198,253.50
Total legal services rendered $ 198,253.50

Austin Bay Area Beijing Boston Brussels Chicago Dallas Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 64 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102693
Vyaire Medical Inc. Matter Number: 48520-6
Disclosure Statement/Plan/Confirmation

Summary of Hours Billed

Name Hours Rate Amount
Kon Asimacopoulos 3.40 2,305.00 7,837.00
Chris Ceresa 12.70 1,345.00 17,081.50
Jaina Desai 22.90 815.00 18,663.50
Julia R. Foster 2.80 525.00 1,470.00
Palmer Gunderson 0.10 845.00 84.50
David Hackel 4.10 975.00 3,997.50
Liz Ji 4.00 1,175.00 4,700.00
Sarah Osborne 26.30 815.00 21,434.50
Joshua Raphael 4.70 975.00 4,582.50
Yusuf Salloum 4.00 1,595.00 6,380.00
Seth Sanders 50.00 1,095.00 54,750.00
Kyle Nolan Trevett 35.60 1,095.00 38,982.00
Donatus Wang 3.10 905.00 2,805.50
Quin Wetzel 19.00 815.00 15,485.00

TOTALS 192.70 $ 198,253.50

2
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 65 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102693
Vyaire Medical Inc. Matter Number: 48520-6
Disclosure Statement/Plan/Confirmation

Description of Legal Services

Date Name Hours Description
06/13/24 Jaina Desai 1.40 Telephone conference with K. Trevett re
disclosure statement motion (.3); review,
analyze correspondence re same (.1);
correspond with Q. Wetzel re same (.1);
research re Delaware disclosure statement
precedent (.8); draft correspondence re same
(.1).
06/13/24 Sarah Osborne 0.30 Correspond with K. Trevett re disclosure
statement.
06/13/24 Joshua Raphael 4.00 Draft, revise plan (3.5); research re same (.5).
06/13/24 Seth Sanders 2.30 Draft plan.
06/13/24 Kyle Nolan Trevett 1.20 Research re plan, disclosure statement issues.
06/14/24 Chris Ceresa 0.30 Correspond with S. Sanders, K&E team re
plan issues (.2); analyze same (.1).
06/14/24 Jaina Desai 2.30 Research re release rights re disclosure
statement motion (1.2); correspond with K.
Trevett re same (.2); research re solicitation
periods (.7); draft correspondence re same
(.2).
06/14/24 Sarah Osborne 2.20 Draft disclosure statement (1.0); research
precedent re same (1.2).
06/14/24 Joshua Raphael 0.70 Review, revise plan.
06/14/24 Seth Sanders 4.80 Draft plan (2.8); research precedent re same
(2.0).
06/14/24 Kyle Nolan Trevett 3.50 Research re plan, disclosure statement issues
(2.5); telephone conference with C. Ceresa re
same (.5); telephone conference with Cole
Schotz re same (.5).
06/15/24 Sarah Osborne 4.00 Draft disclosure statement (3.5); research
precedent re same (.5).
06/15/24 Seth Sanders 4.70 Draft liquidating plan (3.7); research re same
(1.0).
06/15/24 Kyle Nolan Trevett 2.00 Review, analyze plan and disclosure
statement issues (1.2); correspond with C.
Ceresa re same (.8).
06/16/24 Seth Sanders 3.80 Draft liquidating plan (2.9); analyze precedent
re same (.9).

3
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 66 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102693
Vyaire Medical Inc. Matter Number: 48520-6
Disclosure Statement/Plan/Confirmation

Date Name Hours Description
06/16/24 Kyle Nolan Trevett 1.00 Review, revise correspondence re plan and
disclosure statement research (.4); research re
same (.6).
06/17/24 Jaina Desai 0.80 Correspond with K. Trevett re disclosure
statement motion (.1); correspond with Q.
Wetzel re same (.1); telephone conference
with K. Trevett re disclosure statement
motion (.5); correspond with Q. Wetzel re
same (.1).
06/17/24 Jaina Desai 0.40 Review, analyze disclosure statement motion
precedent (.2); review, analyze disclosure
statement motion exhibits (.2).
06/17/24 Julia R. Foster 2.80 Draft disclosure statement motion (1.2); draft
disclosure statement motion schedules (1.6).
06/17/24 Kyle Nolan Trevett 0.40 Telephone conference with J. Desai and Q.
Wetzel re disclosure statement motion.
06/17/24 Quin Wetzel 2.60 Conference with K. Trevett, J. Desai re
disclosure statement motion and exhibits (.5);
review, analyze precedent re same (2.1).
06/18/24 Jaina Desai 1.10 Review, analyze DS motion exhibits (.6);
correspond with Q. Wetzel re same (.1);
review, analyze plan (.4).
06/18/24 Kyle Nolan Trevett 1.60 Review, revise case timeline (1.5); correspond
with C. Ceresa, T. Chanroo, Cole Schotz team
re same (.1).
06/18/24 Quin Wetzel 3.40 Research disclosure statement precedent (.9);
draft disclosure statement (2.2); correspond
with K. Trevett re same (.3).
06/19/24 Jaina Desai 2.00 Draft disclosure statement motion exhibits
(1.3); review, analyze plan (.3); review,
analyze disclosure statement motion (.2);
review, analyze case timeline (.1); correspond
with Q. Wetzel re same (.1).
06/19/24 Jaina Desai 1.20 Revise disclosure statement motion exhibits.
06/19/24 Sarah Osborne 0.30 Review, analyze RSA for key dates and
deadlines (.2); correspond with C. Ceresa re
same (.1).
06/19/24 Seth Sanders 7.80 Draft plan (3.9); research re same (3.9).
06/20/24 Jaina Desai 3.70 Revise disclosure statement motion exhibits
(2.5); review, analyze disclosure statement
motion exhibits (1.1); review, analyze
comments re disclosure statement exhibits
(.1).

4
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 67 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102693
Vyaire Medical Inc. Matter Number: 48520-6
Disclosure Statement/Plan/Confirmation

Date Name Hours Description
06/20/24 Sarah Osborne 3.90 Review, revise disclosure statement (3.8);
correspond with K. Trevett re same (.1).
06/20/24 Seth Sanders 3.60 Draft plan (3.3); correspond with C. Ceresa re
same (.3).
06/20/24 Kyle Nolan Trevett 4.40 Review, revise disclosure statement,
disclosure statement motion (3.9); correspond
with S. Osborne, J. Desai, Q. Wetzel re same
(.3); continue to review, revise disclosure
statement, disclosure statement motion (.2).
06/20/24 Quin Wetzel 3.80 Review, revise disclosure statement motion
(2.1); research precedent re combined
hearings (1.4); correspond with K. Trevett re
same (.3).
06/21/24 Kon Asimacopoulos 2.20 Review, analyze international entity filing
issues.
06/21/24 Jaina Desai 4.50 Review, analyze disclosure statement exhibits
(1.1); review, analyze comments to disclosure
statement exhibits (.1); revise disclosure
statement exhibits (2.7); correspond with K.
Trevett re same (.1); further revise disclosure
statement exhibits (.2); correspond with K.
Trevett re same (.1); correspond with Q.
Wetzel re same (.2).
06/21/24 Sarah Osborne 2.70 Review, revise disclosure statement (2.3);
correspond with K. Trevett re same (.1);
further review, revise same (.3).
06/21/24 Yusuf Salloum 2.00 Review, revise plan, disclosure statement.
06/21/24 Seth Sanders 3.20 Revise plan (2.9); correspond with Y.
Salloum re same (.3).
06/21/24 Kyle Nolan Trevett 2.10 Review, revise disclosure statement,
disclosure statement motion (1.9); correspond
with C. Ceresa, K&E team re same (.1);
correspond with AlixPartners team re same
(.1).
06/21/24 Quin Wetzel 3.90 Review, revise disclosure statement motion
(2.9); review, analyze plan (.7); correspond
with J. Desai, K. Trevett re same (.3).
06/22/24 Sarah Osborne 2.00 Review, revise disclosure statement for plan
updates.
06/22/24 Yusuf Salloum 2.00 Review, revise chapter 11 plan.
06/22/24 Seth Sanders 2.80 Revise plan (2.4); correspond with Y.
Salloum, K&E team re DS, plan (.4).

5
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 68 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102693
Vyaire Medical Inc. Matter Number: 48520-6
Disclosure Statement/Plan/Confirmation

Date Name Hours Description
06/22/24 Kyle Nolan Trevett 0.90 Review, revise disclosure statement (.8);
correspond with S. Osborne, K&E team re
same (.1).
06/23/24 Sarah Osborne 2.40 Review, revise disclosure statement (2.3);
correspond with K. Trevett re same (.1).
06/23/24 Seth Sanders 3.90 Revise, draft plan (2.1); analyze, research
precedent re same (1.6); correspond with K.
Trevett, K&E team re same (.2).
06/23/24 Kyle Nolan Trevett 2.70 Review, revise disclosure statement (2.6);
correspond with Y. Salloum, K&E team re
same (.1).
06/24/24 Kon Asimacopoulos 1.20 Review, analyze international entity filing
issues.
06/24/24 Chris Ceresa 2.30 Review, revise plan (2.0); correspond with S.
Sanders, K&E team re same (.3).
06/24/24 David Hackel 4.10 Review, revise disclosure statement (3.6);
review, analyze first day declaration, first day
pleadings, Company documents, related
materials re same (.4); correspond with T.
Chanroo, K&E team re discharge research
(.1).
06/24/24 Sarah Osborne 0.50 Review, revise disclosure statement.
06/24/24 Seth Sanders 1.90 Analyze 363 plan precedent (1.1); analyze
DIP commitment signatories (.6); correspond
with Y. Salloum re same (.2).
06/24/24 Kyle Nolan Trevett 1.60 Review, revise disclosure statement, motion
(1.5); correspond with C. Ceresa, K&E team
re same (.1).
06/24/24 Quin Wetzel 2.00 Review, revise disclosure statement motion re
updated case timeline (1.8); correspond with
K. Trevett re same (.2).
06/25/24 Chris Ceresa 5.10 Review, revise plan (3.9); correspond with S.
Sanders, K&E team re same (1.0); research re
same (.2).
06/25/24 Jaina Desai 5.00 Review, analyze plan (1.4); review, analyze
disclosure statement (.5); correspond with Q.
Wetzel re case timeline (.1); revise disclosure
statement exhibits (3.0).
06/25/24 Jaina Desai 0.20 Review, analyze comments re disclosure
statement exhibits (.1); revise disclosure
statement exhibits (.1).
06/25/24 Palmer Gunderson 0.10 Telephone conference with L. Ji re disclosure
statement.

6
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 69 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102693
Vyaire Medical Inc. Matter Number: 48520-6
Disclosure Statement/Plan/Confirmation

Date Name Hours Description
06/25/24 Liz Ji 0.50 Correspond with N. Warther, K&E team re
disclosure statement.
06/25/24 Sarah Osborne 1.90 Review, revise disclosure statement (1.6);
correspond with D. Hackel, K&E team re
same (.3).
06/25/24 Seth Sanders 1.70 Revise plan.
06/25/24 Kyle Nolan Trevett 3.40 Review, revise case timeline (.5); review,
revise disclosure statement, motion (2.5);
correspond with Y. Salloum, K&E team re
same (.2); correspond with AlixPartners team
re liquidation analysis (.2).
06/26/24 Chris Ceresa 4.40 Review, revise, analyze, comment on draft
disclosure statement (3.9); correspond with S.
Osborne, K&E team re same (.5).
06/26/24 Sarah Osborne 4.40 Research re winddown disclosure statements
and data destruction (2.1); review, revise
disclosure statement (2.3).
06/26/24 Seth Sanders 5.10 Revise plan (3.1); correspond with C. Ceresa,
K&E team re same (.2); further revise plan
(1.1); analyze plan re tax considerations (.5);
correspond with C. Ceresa, K&E team re
same (.2).
06/26/24 Kyle Nolan Trevett 6.30 Review, revise disclosure statement (3.9);
further review, revise same (2.1); correspond
with S. Osborne, C. Ceresa re same (.3).
06/27/24 Chris Ceresa 0.40 Review, revise plan (.2); correspond with S.
Sanders, K&E team re same (.2).
06/27/24 Jaina Desai 0.30 Correspond with K. Trevett and Q. Wetzel re
disclosure statement exhibits.
06/27/24 Liz Ji 3.50 Review disclosure statement and chapter 11
plan.
06/27/24 Sarah Osborne 1.70 Review, revise disclosure statement (1.6);
correspond with K. Trevett re same (.1).
06/27/24 Seth Sanders 3.30 Revise plan (3.1); correspond with Y.
Salloum, K&E team, Gibson Dunn re same
(.2).
06/27/24 Kyle Nolan Trevett 2.40 Review, revise disclosure statement, motion
(2.3); correspond with Q. Wetzel re same (.1).
06/27/24 Quin Wetzel 2.80 Review, revise disclosure statement motion re
updated plan (1.2); revise disclosure
statement exhibits re updated (1.3);
correspond with J. Desai, K. Trevett re same
(.3).

7
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 70 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102693
Vyaire Medical Inc. Matter Number: 48520-6
Disclosure Statement/Plan/Confirmation

Date Name Hours Description
06/28/24 Chris Ceresa 0.20 Review, revise, analyze, comment on draft
disclosure statement (.1); correspond with K.
Trevett, K&E team re same (.1).
06/28/24 Seth Sanders 1.10 Analyze issues re classification of sponsor
commitments (.7); correspond with C. Ceresa,
K&E team re same (.4).
06/28/24 Kyle Nolan Trevett 2.10 Research re setoff issues (1.9); correspond
with C. Ceresa re same (.2).
06/28/24 Donatus Wang 3.10 Review, analyze draft overview of structuring
options for sale of German RDx business
(share deal vs. asset deal) (1.3); revise same
and prepare mark-up (.7); research re related
aspects under German law, consider related
input from K&E team (1.1).
06/29/24 Quin Wetzel 0.50 Review, analyze disclosure statement motion
(.3); correspond with S. Osborne, K. Trevett
re same (.2).

Total 192.70

8
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 71 of 631

601 Lexington Avenue
New York, NY 10022

FEIN 36-1326630

August 29, 2024

Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045

Attn: Vikram Bajaj

Invoice Number: 1050102694
Client Matter: 48520-7

In the Matter of DIP Financing and Cash Collateral

For legal services rendered through June 30, 2024
(see attached Description of Legal Services for detail) $ 158,836.50
Total legal services rendered $ 158,836.50

Austin Bay Area Beijing Boston Brussels Chicago Dallas Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 72 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102694
Vyaire Medical Inc. Matter Number: 48520-7
DIP Financing and Cash Collateral

Summary of Hours Billed

Name Hours Rate Amount
Chris Ceresa 7.30 1,345.00 9,818.50
Tabitha J. De Paulo 1.60 1,435.00 2,296.00
Amy Donahue 0.80 525.00 420.00
David Hackel 2.10 975.00 2,047.50
Yoonie Han 18.00 1,395.00 25,110.00
Erik Hepler 0.20 2,115.00 423.00
Andrew Idrizovic, P.C. 3.00 1,995.00 5,985.00
Sean McClay 3.50 1,575.00 5,512.50
Julienne Miranda 15.70 815.00 12,795.50
Joseph Cermak Profancik 12.60 975.00 12,285.00
Joshua Raphael 2.70 975.00 2,632.50
Henry Rosas 0.50 625.00 312.50
Yusuf Salloum 15.40 1,595.00 24,563.00
Adrian Salmen 18.60 1,095.00 20,367.00
Seth Sanders 25.70 1,095.00 28,141.50
Kyle Nolan Trevett 5.00 1,095.00 5,475.00
Quin Wetzel 0.80 815.00 652.00

TOTALS 133.50 $ 158,836.50

2
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 73 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102694
Vyaire Medical Inc. Matter Number: 48520-7
DIP Financing and Cash Collateral

Description of Legal Services

Date Name Hours Description
06/09/24 Tabitha J. De Paulo 0.40 Review and comment on redactions to fee
letter.
06/09/24 Yoonie Han 4.70 Review, revise various closing deliverables,
including but not limited to guaranty
agreement, CA exhibits, fee letters, escrow
agreement and ancillaries (3.5); supervise
overall process (1.2).
06/09/24 Andrew Idrizovic, P.C. 2.50 Attend board meeting (.5); analyze issues re
same (2).
06/09/24 Sean McClay 3.50 Review, analyze revisions to DIP credit
agreement and related DIP orders.
06/09/24 Seth Sanders 15.00 Revise DIP declarations (1.7); correspond
with S. Winters, K&E team, declarants re
same (1.3); draft, revise DIP credit agreement
(5.4); correspond with C. Ceresa, K&E team
re same (.3); correspond with GDC re same
(.4); analyze, revise research re roll-up
precedent (2.1); telephone conferences with
PJT re same (.3); revise evidentiary exhibit
(1.4); correspond with Y. Han, K&E team re
DIP credit agreement ancillaries (.5); revise
escrow agreement (1.6).
06/10/24 Tabitha J. De Paulo 1.20 Conference with PJT team re declaration in
support of DIP financing (.5); review, analyze
declarations and prepare for conference with
PJT (.7).
06/10/24 Yoonie Han 5.40 Revise credit agreement exhibits (1.6);
correspond with S. McClay, K&E team,
lenders' counsel and financial advisors re
same (.8); revise escrow agreement (.9);
correspond with S. McClay, K&E team,
lenders' counsel and financial advisors re
escrow arrangement (.7); finalize legal
opinion (.3); revise credit agreement
schedules (.4); correspond with Company re
know-your-customer items (.3); review and
revise final compiled debtor‑in‑possession
financing documents (.4).
06/10/24 Erik Hepler 0.20 Review, analyze comments to DIP financing
opinion.
06/10/24 Andrew Idrizovic, P.C. 0.50 Participate in discussions re DIP financing.

3
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 74 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102694
Vyaire Medical Inc. Matter Number: 48520-7
DIP Financing and Cash Collateral

Date Name Hours Description
06/10/24 Julienne Miranda 1.20 Revise signature pages for DIP documents.
06/10/24 Julienne Miranda 3.50 Revise ancillary documents.
06/10/24 Julienne Miranda 0.50 Correspond with Y. Han, K&E team and
Gibson Dunn team re Company’s signature
pages and compiled ancillaries in escrow.
06/10/24 Julienne Miranda 1.20 Draft support certificate.
06/10/24 Julienne Miranda 0.50 Correspond with J. Profancik and H. Rosas re
bringdown good standings.
06/10/24 Julienne Miranda 0.50 Correspond with C. Ceresa re K&E opinion
exhibits.
06/10/24 Joseph Cermak Profancik 2.50 Coordinate closing details re DIP credit
agreement (.2); review and analyze compiled
DIP documents (.3); draft and revise credit
agreement schedules (1.2); coordinate
responses to know‑your‑customer requests
(.6); correspond with Company re same (.2).
06/10/24 Henry Rosas 0.50 Conferences with J. Profancik and J. Miranda
re DIP closing, status (.1); review, revise
credit closing documents (.2); correspond
with J. Welch re bring down good standings
(.2).
06/10/24 Yusuf Salloum 7.30 Review, revise DIP documents (3.8); prepare
for hearing on DIP facility (3.5).
06/10/24 Seth Sanders 6.50 Telephone conferences with PJT re DIP
declaration (.7); revise PJT declaration re
same (.9); correspond with PJT team re same
(.3); telephone conference with AlixPartners
re DIP declaration (.4); correspond with
Gibson Dunn, Y. Salloum, K&E team re
finalizing DIP documents (.4); revise same
(1.1); coordinate re filing of same (.5);
correspond with Cole Schotz re filed DIP
documents (.4); revise escrow agreement (.3);
correspond with Y. Han re same (.1);
correspond Y. Han, K&E team, Gibson Dunn
re DIP funding (.4); telephone conference
with AlixPartners re funds flow (.3);
conference with Y. Salloum re same (.2);
correspond with Y. Han, K&E team re
partially pledged entities (.5).

4
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 75 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102694
Vyaire Medical Inc. Matter Number: 48520-7
DIP Financing and Cash Collateral

Date Name Hours Description
06/11/24 Yoonie Han 2.20 Review and analyze credit agreement (.2);
correspond with K&E team re same (.2);
revise form of withdrawal notice (.5);
correspond with S. Sanders, K&E team,
lenders' counsel and financial advisors re
credit agreement exhibits (.4); revise escrow
agreement (.4); correspond with Y. Han, K&E
team, lenders' counsel, escrow agent's counsel
and financial advisors re escrow arrangement
(.3); correspond with Company re know‑your-
customer items (.2).
06/11/24 Julienne Miranda 0.50 Correspond with Y. Han, K&E team and
Gibson Dunn team re Company’s signature
pages and compiled ancillaries in escrow.
06/11/24 Julienne Miranda 1.50 Revise ancillary documents.
06/11/24 Julienne Miranda 0.30 Review and revise compiled guaranty and fee
letter.
06/11/24 Joseph Cermak Profancik 1.80 Correspond with Company re responses to
know‑your‑customer requests (.7); coordinate
execution of DIP documents (.5); correspond
with various parties re same (.3); review and
analyze same (.3).
06/11/24 Yusuf Salloum 6.80 Finalize DIP credit documentation (3.8);
finalize DIP order (1.5); research precedent re
same (1.5).
06/11/24 Seth Sanders 2.60 Correspond with GDC re unredacted fee
letters (.2); telephone conferences with Y.
Salloum, GDC re DIP funding (.9);
correspond with GDC re same (.3);
correspond with J. Profancik, K&E team re
DIP funding timing (.2); telephone
conferences with AlixPartners re same (.2);
coordinate re filing of revised compiled
interim DIP order (.8).
06/11/24 Kyle Nolan Trevett 5.00 Review, revise interim DIP order (3.9);
continue to review, revise interim DIP order
(1.1).
06/11/24 Quin Wetzel 0.80 Review, revise interim DIP order (.6);
correspond with Cole Schotz re same (.2).

5
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 76 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102694
Vyaire Medical Inc. Matter Number: 48520-7
DIP Financing and Cash Collateral

Date Name Hours Description
06/12/24 Yoonie Han 1.20 Revise legal opinion (.2); correspond with S.
Sanders re debtor-in-possession order (.3);
review and analyze final credit agreement
(.2); correspond with financial advisors re
debtor-in-possession budget (.3); organize
closing of debtor-in-possession facility (.2).
06/12/24 Joseph Cermak Profancik 2.50 Coordinate closing deliverables with lender's
counsel (1.9); review and analyze DIP budget
(.2); correspond with company advisors re
same (.1); correspond with Y. Han and K&E
team re K&E opinion (.3).
06/12/24 Seth Sanders 0.50 Correspond with Y. Han, K&E team re DIP
funding timing (.2); correspond with Cole
Schotz re same (.3).
06/13/24 Yoonie Han 0.90 Correspond with Company's Dutch counsel re
closing (.4); prepare closing set re debtor-in-
possession facility (.5).
06/13/24 Julienne Miranda 5.00 Draft and compile closing set (3.9); research
re same (1.1).
06/13/24 Joseph Cermak Profancik 0.70 Coordinate and prepare closing set for
Company records.
06/14/24 Yoonie Han 0.30 Review and analyze closing set of debtor-in-
possession documents.
06/14/24 Julienne Miranda 0.50 Correspond with Y. Han and J. Profancik re
closing set.
06/14/24 Joseph Cermak Profancik 0.50 Prepare closing set of existing 1L, 2L and
note purchase agreement documents.
06/17/24 Yoonie Han 0.20 Correspond with J. Profancik, K&E team re
DIP.
06/17/24 Julienne Miranda 0.50 Correspond with J. Profancik, K&E team and
Company re closing set.
06/17/24 Joseph Cermak Profancik 0.50 Prepare and coordinate delivery of closing set
documents.
06/17/24 Yusuf Salloum 0.80 Analyze issues re escrow funding (.6);
correspond with AlixPartners re same (.2).
06/18/24 Chris Ceresa 2.20 Correspond with advisors, Y. Salloum, K&E
team re DIP professional fees weekly
statement items (1.7); conference with Y.
Salloum, K&E team re same (.5).

6
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 77 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102694
Vyaire Medical Inc. Matter Number: 48520-7
DIP Financing and Cash Collateral

Date Name Hours Description
06/18/24 Yoonie Han 0.70 Correspond with D. Hackel re preparation of
the summary deck of company obligations
under DIP credit facility (.3); correspond with
J. Provancik re preparation of such summary
of DIP obligations (.2); analyze sample
summaries of DIP obligations (.2).
06/18/24 Joseph Cermak Profancik 0.50 Draft and revise compliance guide for DIP
credit agreement.
06/18/24 Seth Sanders 0.50 Analyze issues re DIP reporting obligations
(.3); correspond with C. Ceresa re same (.2).
06/19/24 Chris Ceresa 0.70 Correspond and telephone conference with
advisors, Y. Salloum, K&E team re DIP
professional fees weekly statement items (.2);
conference with Y. Salloum, K&E team re
same (.5).
06/19/24 Joseph Cermak Profancik 2.90 Draft and revise compliance guide re DIP
credit agreement (2.0); review and analyze
DIP credit agreement (.9).
06/19/24 Joshua Raphael 0.50 Draft correspondence re DIP professional fee
reporting (.4); correspond with C. Ceresa re
same (.1).
06/20/24 Chris Ceresa 0.40 Correspond and telephone conference with
advisors, K&E team re DIP pro fees weekly
statement items.
06/20/24 Joseph Cermak Profancik 0.50 Draft and revise compliance certificate (.4);
correspond with Y. Han re same (.1).
06/20/24 Joshua Raphael 0.30 Conference with A. Salemen, K&E team re
DIP coordination (.2); correspond with
professionals, C. Ceresa re DIP professional
fees (.1).
06/20/24 Adrian Salmen 2.30 Conference with J. Raphael, K&E team re
DIP workstreams (.5); correspond with C.
Ceresa, K&E team re same (.8); draft final
DIP order (1.0).
06/20/24 Seth Sanders 0.20 Telephone conference with A. Salmen re DIP.
06/21/24 Chris Ceresa 0.20 Correspond with advisors, Y. Salloum, K&E
team re DIP professional fees weekly
statement items (.1); conference with Y.
Salloum, K&E team re same (.1).
06/21/24 Adrian Salmen 2.20 Correspond with J. Raphael, K&E team re
DIP matters (.2); draft final DIP order (2.0).

7
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 78 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102694
Vyaire Medical Inc. Matter Number: 48520-7
DIP Financing and Cash Collateral

Date Name Hours Description
06/23/24 Yoonie Han 1.40 Analyze debtor-in-possession credit
agreement (.6); revise summary chart of
obligations under debtor-in-possession credit
agreement (.8).
06/24/24 Chris Ceresa 0.20 Review, analyze DIP reporting requirements.
06/24/24 David Hackel 2.10 Review, revise DIP credit agreement
compliance guide re same (.9); review,
analyze DIP credit agreement and related
materials re same (1.0); correspond with A.
Salmen, K&E team re same (.2).
06/24/24 Joseph Cermak Profancik 0.20 Correspond with C. Ceresa, K&E team re
credit agreement signatories (.1); review and
analyze credit agreement (.1).
06/24/24 Adrian Salmen 1.70 Review, analyze correspondence re
professional fees budget (.4); review, analyze
DIP CA re compliance terms (.9); correspond
with D. Hackel, J. Raphael re same (.4).
06/25/24 Adrian Salmen 0.50 Review, analyze correspondence from various
parties re professional fees (.4); correspond
with C. Ceresa re same (.1).
06/25/24 Seth Sanders 0.40 Correspond with J. Profancik, K&E team re
DIP signatories.
06/26/24 Chris Ceresa 0.30 Review, analyze DIP reporting requirements
(.1); review, revise officer cert re same (.1);
correspond with A. Salmen, K&E team,
advisors re draft reporting (.1).
06/26/24 Adrian Salmen 2.30 Correspond with C. Ceresa, K&E team,
lender advisors re professional fees (2.0);
review, analyze correspondence re same (.3).
06/27/24 Chris Ceresa 2.80 Review, analyze DIP reporting requirements
(1.2); review, revise officer certificate re same
(.3); review, revise draft reporting (.3);
correspond with A. Salmen, K&E team,
advisors re same (1.0).
06/27/24 Amy Donahue 0.80 Draft and revise DIP reply shell in support of
DIP motion.
06/27/24 Yoonie Han 0.70 Analyze officer's certificate delivery
requirement under DIP credit agreement (.4);
analyze final DIP order (.3).

8
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 79 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102694
Vyaire Medical Inc. Matter Number: 48520-7
DIP Financing and Cash Collateral

Date Name Hours Description
06/27/24 Joshua Raphael 0.40 Correspond with various parties re variance
reporting (.1); review, analyze DIP CA,
responsible officer requirements (.1);
correspond with responsible officer (.1);
correspond with Q. Wetzel, K&E team re
same (.1).
06/27/24 Adrian Salmen 6.90 Review, analyze variance report (.9); review,
analyze precedent re same (1.8); correspond
with C. Ceresa, AlixPartners re same (.3);
review, analyze precedent DIP replies (.7);
correspond with lender advisors, creditor
counsel re DIP reply (.4); review, analyze
final DIP order (2.8).
06/28/24 Chris Ceresa 0.50 Review, analyze DIP reporting requirements
(.2); review, revise officer certificate re same
(.1); review, revise draft reporting (.1);
correspond with A. Salmen, K&E team,
advisors re same (.1).
06/28/24 Yoonie Han 0.30 Advise various parties re variance report
officer's certificate requirement.
06/28/24 Joshua Raphael 1.50 Draft variance reporting officer certificate and
draft correspondence re same (.9); review,
revise same (.3); correspond with C. Ceresa,
K&E team re same (.3).
06/28/24 Yusuf Salloum 0.50 Review, analyze final DIP order.
06/28/24 Adrian Salmen 2.70 Correspond with R. Raphael, K&E team,
lenders re DIP order (.3); review, analyze
same (2.4).

Total 133.50

9
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 80 of 631

601 Lexington Avenue
New York, NY 10022

FEIN 36-1326630

August 29, 2024

Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045

Attn: Vikram Bajaj

Invoice Number: 1050103251
Client Matter: 48520-8

In the Matter of Cash Management

For legal services rendered through June 30, 2024
(see attached Description of Legal Services for detail) $ 3,668.50
Total legal services rendered $ 3,668.50

Austin Bay Area Beijing Boston Brussels Chicago Dallas Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 81 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050103251
Vyaire Medical Inc. Matter Number: 48520-8
Cash Management

Summary of Hours Billed

Name Hours Rate Amount
Rebecca J. Marston 2.90 1,265.00 3,668.50

TOTALS 2.90 $ 3,668.50

2
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 82 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050103251
Vyaire Medical Inc. Matter Number: 48520-8
Cash Management

Description of Legal Services

Date Name Hours Description
06/10/24 Rebecca J. Marston 2.90 Review, revise cash management talking
points (2.7); correspond with K. Chiaghana,
K&E team re same (.2).

Total 2.90

3
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 83 of 631

601 Lexington Avenue
New York, NY 10022

FEIN 36-1326630

August 29, 2024

Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045

Attn: Vikram Bajaj

Invoice Number: 1050102695
Client Matter: 48520-9

In the Matter of Automatic Stay Issues

For legal services rendered through June 30, 2024
(see attached Description of Legal Services for detail) $ 2,651.00
Total legal services rendered $ 2,651.00

Austin Bay Area Beijing Boston Brussels Chicago Dallas Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 84 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102695
Vyaire Medical Inc. Matter Number: 48520-9
Automatic Stay Issues

Summary of Hours Billed

Name Hours Rate Amount
Tiffani Chanroo 0.50 1,265.00 632.50
Sarah Osborne 1.40 815.00 1,141.00
Joshua Raphael 0.90 975.00 877.50

TOTALS 2.80 $ 2,651.00

2
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 85 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102695
Vyaire Medical Inc. Matter Number: 48520-9
Automatic Stay Issues

Description of Legal Services

Date Name Hours Description
06/20/24 Tiffani Chanroo 0.50 Conference with C. Ceresa, local counsel re
application of automatic stay.
06/20/24 Sarah Osborne 1.40 Research re automatic stay for proceedings
initiated by debtor (1.3); correspond with C.
Ceresa re same (.1).
06/20/24 Joshua Raphael 0.90 Research re automatic stay and tolling (.6);
correspond with C. Ceresa re same (.3).

Total 2.80

3
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 86 of 631

601 Lexington Avenue
New York, NY 10022

FEIN 36-1326630

August 29, 2024

Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045

Attn: Vikram Bajaj

Invoice Number: 1050102696
Client Matter: 48520-10

In the Matter of Asset Sales/Section 363 Issues: Use, Sale & Disposition of Property

For legal services rendered through June 30, 2024
(see attached Description of Legal Services for detail) $ 706,449.50
Total legal services rendered $ 706,449.50

Austin Bay Area Beijing Boston Brussels Chicago Dallas Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 87 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102696
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Summary of Hours Billed

Name Hours Rate Amount
Rebecca H. Arnall 6.50 1,095.00 7,117.50
Cooper Barghols 2.50 815.00 2,037.50
Marin Boney 1.60 1,885.00 3,016.00
John G. Caruso 2.70 2,115.00 5,710.50
Chris Ceresa 35.10 1,345.00 47,209.50
Kenny Chiaghana 5.00 815.00 4,075.00
Adam Thomas Clifford, P.C. 6.40 1,995.00 12,768.00
Dominique Collins 1.70 1,095.00 1,861.50
Bernadette Coppola 18.10 1,575.00 28,507.50
Tabitha J. De Paulo 0.50 1,435.00 717.50
Anthony M. Del Rio 17.90 1,595.00 28,550.50
Jaina Desai 65.80 815.00 53,627.00
Amy Donahue 1.30 525.00 682.50
Michael Ehret 3.40 1,895.00 6,443.00
Julia R. Foster 0.50 525.00 262.50
Justin M. Garfinkle 10.30 975.00 10,042.50
Emanuel Goetz 0.50 620.00 310.00
David Hackel 2.60 975.00 2,535.00
Yoonie Han 0.30 1,395.00 418.50
Kate Hardey 11.00 1,995.00 21,945.00
Liz Ji 9.90 1,175.00 11,632.50
Olivia Kaufmann 14.80 975.00 14,430.00
Sooah Kim 4.60 975.00 4,485.00
Brian King 1.20 1,345.00 1,614.00
Maggie Kate King 14.50 1,095.00 15,877.50
Daniel Lewis, P.C. 7.50 1,910.00 14,325.00
Sabrina Lieberman 12.50 815.00 10,187.50
Savannah Malnar-Cole 9.10 1,095.00 9,964.50
Rebecca J. Marston 35.00 1,265.00 44,275.00
Sean McClay 1.00 1,575.00 1,575.00
Grant McClernon 2.00 815.00 1,630.00
Ruan J. Meintjes 23.20 975.00 22,620.00

2
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 88 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102696
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Name Hours Rate Amount
Michael William Morgan 9.60 975.00 9,360.00
Jai Mudhar 1.00 1,265.00 1,265.00
Trent Nachbar 32.80 1,095.00 35,916.00
Michelle L. Nowicki 8.70 625.00 5,437.50
Maureen D. O'Brien 3.00 2,115.00 6,345.00
Dan O'Connor 60.30 1,265.00 76,279.50
Sarah Osborne 11.50 815.00 9,372.50
Carolin Paus 5.50 620.00 3,410.00
Scott D. Price, P.C. 0.70 2,245.00 1,571.50
Joshua Raphael 5.40 975.00 5,265.00
Risa Salins 0.50 2,115.00 1,057.50
Yusuf Salloum 11.60 1,595.00 18,502.00
Adrian Salmen 9.30 1,095.00 10,183.50
Seth Sanders 0.50 1,095.00 547.50
Florian Schuette 0.50 750.00 375.00
Scottie Shermetaro 22.20 1,395.00 30,969.00
Matt Swanson 0.70 1,265.00 885.50
Paul D. Tanaka, P.C. 3.10 2,115.00 6,556.50
Steve Toth 22.50 1,820.00 40,950.00
Kyle Nolan Trevett 1.00 1,095.00 1,095.00
Sarah Ullathorne 1.20 1,575.00 1,890.00
Paul Vasiloff 4.30 1,265.00 5,439.50
Donatus Wang 4.70 905.00 4,253.50
Nicholas Warther 1.10 1,665.00 1,831.50
Spencer A. Winters, P.C. 22.10 1,685.00 37,238.50

TOTALS 572.80 $ 706,449.50

3
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 89 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102696
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Description of Legal Services

Date Name Hours Description
06/10/24 Adam Thomas Clifford, P.C. 1.50 Analyze bidding procedures (.7); prepare for
and participate in telephone conference with
Company re sale process (.8).
06/10/24 Jaina Desai 0.10 Correspond with R. Marston re sale org chart.
06/10/24 Rebecca J. Marston 0.50 Correspond with J. Desai re bidding
procedures talking points (.2); review, analyze
same (.3).
06/10/24 Carolin Paus 0.70 Telephone conference with S. Zablotney,
K&E team re potential tax implications for
German entities in connection with previous
and envisaged sales processes.
06/10/24 Steve Toth 1.50 Participate in telephone conference with
Company, S. Zablotney, K&E team, BDO
and PwC (.8); discuss sale process matters
with Company, Y. Salloum, K&E team (.4);
prepare correspondence re sale process
timeline (.3).
06/10/24 Donatus Wang 0.50 Correspond with C. Ceresa, K&E team re DIP
funding, cash flow forecasts and correspond
with Company re German cash flow forecasts.
06/10/24 Nicholas Warther 0.40 Telephone conference with Company, S.
Zablotney, K&E team re sale process.
06/11/24 Adam Thomas Clifford, P.C. 0.80 Review, analyze 363 sale process materials
and status.
06/11/24 Anthony M. Del Rio 1.30 Review, analyze EU regulatory notice
obligations (.5); review, analyze change of
ownership notice requirements (.8).
06/11/24 Kate Hardey 0.50 Review, analyze correspondence re
pre‑market authorization products (.3);
conference with R. Meintjes re state license
review (.2).
06/11/24 Sabrina Lieberman 0.20 Correspond with NDA counterparty re NDA.
06/11/24 Rebecca J. Marston 5.10 Review and revise NDAs (1.9); correspond
with C. Ceresa, K&E team, counterparties re
same (.2); correspond with C. Ceresa re
sublease issues (.2); conference with C.
Ceresa re sublease issues (.4); review and
revise process letter (2.2); correspond with C.
Ceresa, K&E team re same (.2).

4
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 90 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102696
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
06/11/24 Ruan J. Meintjes 0.50 Review and analyze US state licenses and
permits (.4); conference with A. Del Rio,
K&E team re same (.1).
06/11/24 Steve Toth 1.40 Telephone conference with D. O’Connor re
transaction structure and bankruptcy
considerations (.3); analyze, revise process
letter (1.1).
06/11/24 Spencer A. Winters, P.C. 1.70 Review and analyze sale process issues (.8);
telephone conference with Y. Salloum, K&E
team re same (.5); review process letter (.4).
06/12/24 Chris Ceresa 1.30 Analyze legal issues re sale and contract
designation process (.5); correspond with R.
Marston, K&E team, advisors re same (.4);
telephone conference with R. Marston, K&E
team, advisors re same (.4).
06/12/24 Tabitha J. De Paulo 0.20 Review and comment on bidding procedures
motion.
06/12/24 Anthony M. Del Rio 0.30 Review, analyze EU regulatory notice
obligations.
06/12/24 Jaina Desai 0.40 Review, analyze correspondence re sale
stream (.3); correspond with R. Marston re
same (.1).
06/12/24 Kate Hardey 0.50 Review, analyze correspondence re
pre‑market authorization products (.3);
conference with R. Meintjes re state license
review (.2).
06/12/24 Sabrina Lieberman 0.70 Execute NDA (.3); correspond with PJT and
C. Ceresa re same (.2); revise summary re
same (.2).
06/12/24 Rebecca J. Marston 3.10 Correspond with Cole Schotz team, C.
Ceresa, K&E team re bidding procedures
noticing parties (.8); review, analyze
precedent re sale process (1.8); correspond
with C. Ceresa re same (.2); correspond with
Cole Schotz team re bidding procedures
declarations (.3).
06/12/24 Ruan J. Meintjes 0.70 Review and analyze state licensure,
permitting re change of ownership
considerations (.5); correspond with K.
Hardey, K&E team re same (.2).
06/12/24 Ruan J. Meintjes 0.50 Review, analyze change of ownership
analysis.

5
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 91 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102696
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
06/12/24 Ruan J. Meintjes 0.50 Research pre-market notification change of
ownership requirements (.3); analyze and
draft summary of same (.2).
06/12/24 Yusuf Salloum 2.70 Analyze issues re sale processes (2.0);
conference with C. Ceresa, K&E team re
same (.7).
06/12/24 Spencer A. Winters, P.C. 1.70 Review and analyze sale process, strategy
issues (.8); correspond with Y. Salloum, K&E
team re same (.5); telephone conference with
Y. Salloum, K&E team re same (.4).
06/13/24 Anthony M. Del Rio 0.50 Review, analyze license and registration.
06/13/24 Jaina Desai 4.30 Draft bidding procedure declaration (2.2);
telephone conference with R. Marston re
same (.3); correspond with R. Marston re
same (.1); draft correspondence re bidding
procedures (.3); review, analyze work in
process chart (.1); revise bidding procedures
declaration (.2); correspond with T. De Paulo
re same (.1); revise bidding procedures
declaration (1.0).
06/13/24 Kate Hardey 0.20 Conference with R. Meintjes re pre‑market
authorization re sales process.
06/13/24 Sooah Kim 1.20 Telephone conference with Company re
employee benefits transaction considerations
(.6); review, analyze correspondence from
Company (.2); draft employee benefits issues
list (.4).
06/13/24 Sabrina Lieberman 0.80 Correspond with PJT, C. Ceresa, K&E team
re NDAs (.3); review and revise NDA
summary (.3); correspond with Omni, Cole
Schotz, T. Chanroo, K&E team re service of
M&A parties (.2).
06/13/24 Rebecca J. Marston 3.60 Correspond with PJT team re bidding
procedures declaration (.3); review and revise
same (2.1); correspond with J. Desai re same
(.4); correspond with S. Lieberman, K&E
team re NDAs (.5); correspond with C. Ceresa
re sale workstreams (.3).
06/13/24 Sean McClay 1.00 Telephone conference with Company and
advisor teams re status of potential bidders for
sale.

6
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 92 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102696
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
06/13/24 Ruan J. Meintjes 1.20 Review and analyze pre‑market authorization
approvals re sales process (.5); draft analysis
re same (.5); conference with K. Hardey re
pre‑market authorization (.2).
06/13/24 Dan O'Connor 0.80 Telephone conference with Company, PJT, Y.
Salloum, K&E team re sale process (.7);
conference with Company re permits and
license matters (.1).
06/13/24 Joshua Raphael 0.10 Review, revise sale NDA.
06/13/24 Yusuf Salloum 2.00 Review, analyze sale transaction structuring
and diligence.
06/13/24 Seth Sanders 0.50 Telephone conference with PJT, S. Winters,
K&E team re sale process.
06/13/24 Steve Toth 0.50 Discuss sale process with Company, PJT,
AlixPartners, Y. Salloum, K&E team.
06/13/24 Spencer A. Winters, P.C. 3.00 Review and analyze issues re sale process,
case strategy (.8); prepare for telephone
conference re non-insider retention (.1);
telephone conference re non-insider retention
(.4); prepare for telephone conference with
AlixPartners, PJT re waterfall analysis (.2);
telephone conference with AlixPartners, PJT
re same (.3); prepare for telephone conference
with Company re sale process update (.2);
telephone conference with Company re same
(.3); telephone conferences with Y. Salloum,
K&E team, PJT re same (.7).
06/14/24 Chris Ceresa 0.60 Analyze legal issues re sale and contract
designation process (.3); correspond with R.
Marston re same (.1); telephone conference
with R. Marston, K&E team, advisors re same
(.2).
06/14/24 Chris Ceresa 0.50 Correspond with R. Marston, K&E team re
sale NDA issues.
06/14/24 Adam Thomas Clifford, P.C. 0.50 Analyze legal issues re 363 transaction
structure.
06/14/24 Anthony M. Del Rio 2.30 Review, analyze pre‑market authorization
considerations and draft questions (.8);
review, analyze transaction structure (1.0);
conference with A. Clifford, K&E team re
regulatory analysis considerations implicated
by transaction (.5).

7
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 93 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102696
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
06/14/24 Kate Hardey 0.50 Conference with R. Meintjes, K&E team re
state-level license change of ownership
review.
06/14/24 Rebecca J. Marston 0.80 Correspond with J. Raphael, K&E team re
NDAs (.2); review and revise same (.3);
correspond with J. Desai re sale work streams
(.3).
06/14/24 Ruan J. Meintjes 1.70 Research, analyze change of ownership
notification requirements re state licenses
(1.2); conference with K. Hardey, K&E team
re same (.5).
06/14/24 Joshua Raphael 0.50 Review, revise sale process NDA (.3);
correspond with R. Marston re same (.2).
06/14/24 Yusuf Salloum 0.50 Review, analyze legal issues re sale
transactions.
06/14/24 Kyle Nolan Trevett 1.00 Telephone conference with Company re
privacy issues (.5); telephone conference with
Frejka re same (.3); telephone conference
with C. Ceresa re same (.2).
06/14/24 Spencer A. Winters, P.C. 1.40 Review and analyze issues re sale process,
case strategy (.7); correspond with A.
Clifford, K&E team re same (.3); telephone
conference with A. Clifford, K&E team re
same (.4).
06/15/24 Chris Ceresa 0.30 Correspond with S. Winters, K&E team re
sale NDA issues.
06/15/24 Rebecca J. Marston 0.70 Review and revise NDAs (.5); correspond
with J. Raphael re same (.1); correspond with
S. Lieberman re bidding procedures notice
parties (.1).
06/15/24 Joshua Raphael 0.30 Review, revise NDA (.2); correspond with C.
Ceresa re same (.1).
06/16/24 Anthony M. Del Rio 1.10 Review, research licensure filings (.8); review
and analyze wind-down considerations (.3).
06/17/24 Chris Ceresa 1.30 Review, analyze, comment on bidding
procedures declaration (.7); review, analyze,
comment on sale motion (.6).
06/17/24 Adam Thomas Clifford, P.C. 0.50 Review, analyze bidder diligence.
06/17/24 Tabitha J. De Paulo 0.30 Review, revise Schlappig declaration in
support of bid procedures motion.

8
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 94 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102696
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
06/17/24 Jaina Desai 2.30 Review, analyze comments re AlixPartners
declaration (.4); revise AlixPartners
declaration (1.6); correspond with R. Marston
re same (.2); correspond with Omni re escrow
account (.1).
06/17/24 Jaina Desai 1.20 Review, analyze litigation comments re
bidding procedures declaration (.2); revise
PJT declaration (.4); correspond with R.
Marston re same (.1); review, analyze
comments re AlixPartners declaration (.1);
revise AlixPartners declaration (.2);
correspond with C. Ceresa re same (.2).
06/17/24 Jaina Desai 1.00 Correspond with R. Marston, K&E team
re bidding procedures (.5); review, analyze
bidding procedures talking points (.3); revise
bidding procedures talking points (.2).
06/17/24 Jaina Desai 1.70 Review, analyze declaration precedent (.2);
review, analyze PJT declaration (.2);
correspond with R. Marston re same (.1);
review, analyze sale NDA (.4); review,
analyze bidding procedures order (.1); draft
sale NDA (.6); correspond with J. Raphael re
same (.1).
06/17/24 Sabrina Lieberman 0.80 Revise NDA progress summary (.2);
correspond with C. Ceresa and K&E team re
same (.2); correspond with PJT and NDA
counterparties re NDAs (.2); review and
analyze NDAs (.2).
06/17/24 Rebecca J. Marston 2.90 Review and revise Braley declaration in
support of bidding procedures (1.0);
correspond with J. Desai re same (.1); review
and revise NDA (1.6); correspond with NDA
parties re same (.2).
06/17/24 Ruan J. Meintjes 1.40 Research and analyze change of ownership
regulatory considerations (1.1); telephone
conference with S. Winters, K&E team re
same (.3).
06/17/24 Joshua Raphael 1.30 Review, revise sale NDAs.
06/17/24 Yusuf Salloum 0.80 Review, analyze matters re sale transactions.
06/17/24 Florian Schuette 0.50 Review, analyze transaction structure (.3);
conference with E. Goetz re same (.2).

9
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 95 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102696
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
06/17/24 Spencer A. Winters, P.C. 1.10 Review and analyze issues re sale process,
case strategy (.6); telephone conferences with
Y. Salloum, K&E team re same (.5).
06/18/24 Marin Boney 0.50 Telephone conference with A. Clifford, K&E
team re deal status (.4); correspond with S.
Malnar-Cole re antitrust analysis (.1).
06/18/24 Chris Ceresa 0.40 Conference with T. Chanroo, K&E team,
Company, advisors re sale issues.
06/18/24 Kenny Chiaghana 1.50 Research re bidding procedures notice.
06/18/24 Adam Thomas Clifford, P.C. 0.30 Review, analyze 363 transaction structuring
issues.
06/18/24 Anthony M. Del Rio 2.30 Correspond with A. Clifford, K&E team re
review of licenses and impact of winddown
considerations (1.5); telephone conference
with AlixPartners re regulatory transactional
considerations (.8).
06/18/24 Jaina Desai 4.20 Review, analyze precedent re stalking horse
purchase agreements (1.1); correspond with
R. Marston, C. Ceresa re same (.1); review,
analyze escrow agreement (.6); draft escrow
agreement (.4); correspond with R. Marston
re same (.1); analyze, research escrow
agreement precedent (1.3); revise
AlixPartners declaration (.4); correspond with
R. Marston, C. Ceresa re same (.2).
06/18/24 Jaina Desai 2.40 Research noticing addresses (2.3); correspond
with R. Marston, S. Lieberman re same (.1).
06/18/24 Jaina Desai 1.10 Draft sale organization chart (1.0); correspond
with R. Marston re same (.1).
06/18/24 Jaina Desai 0.50 Revise sale organization chart (.4);
correspond with R. Marston re same (.1).
06/18/24 David Hackel 1.30 Research legal issues re bidding procedures.
06/18/24 Kate Hardey 3.50 Conference with G. McClernon, K&E team re
product transitions and FDA regulatory
matters (.5); review, analyze transition
services agreement terms re same (1.7);
prepare list of device wholesale and
manufacturer licenses for filing (1.3).
06/18/24 Brian King 1.20 Review, analyze change of ownership re
licensing requirements.

10
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 96 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102696
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
06/18/24 Sabrina Lieberman 0.60 Correspond with PJT, NDA counterparties,
and C. Ceresa re NDAs (.4); revise summary
re same (.2).
06/18/24 Rebecca J. Marston 4.90 Review and revise NDAs (1.6); correspond
with counterparties, C. Ceresa, K&E team re
same (.4); review and revise bidding
procedures declarations (1.9); correspond
with J. Desai re same (.3); correspond with J.
Desai re sale escrow account (.3); review and
revise sale organizational chart (.2);
correspond with J. Desai re same (.2).
06/18/24 Grant McClernon 0.50 Telephone conference with A. Del Rio and K.
Hardey, Company re diligence questions.
06/18/24 Ruan J. Meintjes 1.00 Research and analyze state licensure change
of ownership filings (.8); correspond with K.
Hardey, K&E team re same (.2).
06/18/24 Dan O'Connor 0.50 Telephone conference with S. Toth, K&E
team re antitrust matters.
06/18/24 Steve Toth 0.20 Discuss antitrust matters with A. Clifford,
K&E team.
06/19/24 Marin Boney 0.30 Correspond with S. Malnar-Cole re risk
assessment.
06/19/24 Chris Ceresa 0.60 Review, analyze draft NDA markups (.4);
correspond with S. Lieberman, K&E team re
same (.2).
06/19/24 Chris Ceresa 1.80 Telephone conference with R. Marston, K&E
team re open sale items (.6); correspond with
R. Marston re same (.1); analyze open items
re sale and contract designation process (1.1).
06/19/24 Kenny Chiaghana 0.20 Research re sale escrow account.
06/19/24 Adam Thomas Clifford, P.C. 0.80 Telephone conference with advisors re 363
documentation process.
06/19/24 Jaina Desai 0.50 Draft correspondence re bidding procedures
milestones (.2); correspond with R. Marston,
C. Ceresa re same (.1); review, analyze
bidding procedures motion re same (.1);
correspond with Gibson Dunn re same (.1).
06/19/24 Jaina Desai 0.40 Review, analyze correspondence re contract
noticing (.3); correspond with C. Ceresa,
AlixPartners re same (.1).

11
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 97 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102696
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
06/19/24 Jaina Desai 0.60 Review, analyze PJT declaration (.1); review,
analyze correspondence re same (.1); revise
PJT declaration (.3); correspond with R.
Marston, Gibson Dunn re same (.1).
06/19/24 Jaina Desai 0.50 Revise sale NDA (.4); correspond with
counterparty, PJT Partners re same (.1).
06/19/24 Sabrina Lieberman 0.60 Revise summary re NDA status (.2);
correspond with C. Ceresa and K&E team re
same (.2); correspond with NDA parties re
same (.2).
06/19/24 Savannah Malnar-Cole 7.60 Research and analyze re antitrust risk for
potential bidders (3.9); draft analysis of same
(1.7); continue to research and analyze re
antitrust risk for potential bidders (2.0).
06/19/24 Rebecca J. Marston 1.90 Correspond with K. Chiaghana, Y. Salloum,
K&E team re escrow account, funding
estimates (.6); correspond with J. Desai, K&E
team re RSA milestones (.3); correspond with
DIP lenders’ counsel re same (.2); review and
revise PJT declaration in support of bidding
procedures (.5); correspond with J. Desai re
same (.3).
06/19/24 Grant McClernon 1.50 Research into change of ownership
requirements for medical device manufacturer
and wholesaler licenses.
06/19/24 Ruan J. Meintjes 1.60 Research and analyze change of ownership
notification requirements (1.0);
correspond with K. Hardey, K&E team re
same (.6).
06/19/24 Ruan J. Meintjes 0.50 Correspond with ex-US counsel re
notification requirements in connection with
potential Section 363 transaction.
06/19/24 Michael William Morgan 1.50 Review and summarize documents uploaded
to data room (1.4); correspond with D.
O'Connor re same (.1).
06/19/24 Dan O'Connor 2.70 Telephone conference and correspond with
AlixPartners, PJT, Y. Salloum, S. Toth re
transaction considerations (.6); correspond
with AlixPartners, PJT, Y. Salloum, S. Toth
re same (.2); review, analyze material
contracts (.5); review, revise summary re
same (.4); prepare disclosure schedules (.6);
review, analyze materials re same (.4).

12
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 98 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102696
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
06/19/24 Joshua Raphael 0.80 Analyze, research re 9019 precedent.
06/19/24 Joshua Raphael 1.00 Review, revise NDA (.5); correspond with
counterparty, R. Marston, K&E team re same
(.5).
06/19/24 Steve Toth 0.70 Participate in telephone conference re process
update with AlixPartners, Y. Salloum, K&E
team and advisors.
06/19/24 Donatus Wang 1.00 Review, analyze correspondence from N.
Warther, K&E team re tax structuring of
potential asset sale transactions (.2);
conference with E. Goetz, K&E team re
Germany status, workstreams (.4); correspond
with C. Ceresa, K&E team re sale process,
Swiss entity workstreams (.4).
06/19/24 Nicholas Warther 0.70 Telephone conference with S. Zablotney,
K&E team, AlixPartners re sale process.
06/19/24 Spencer A. Winters, P.C. 0.90 Review and analyze issues re sale process,
case strategy (.4); telephone conferences with
Y. Salloum, K&E team re same (.5).
06/20/24 Marin Boney 0.80 Analyze antitrust issues.
06/20/24 Chris Ceresa 1.20 Telephone conference with Y. Salloum, K&E
team, Company, advisors re sale issues.
06/20/24 Kenny Chiaghana 1.40 Analyze, revise de minimis asset procedures
motion.
06/20/24 Jaina Desai 1.20 Draft sale organizational chart (.4);
correspond with AlixPartners re notice
drafting (.1); correspond with R. Marston re
same (.1); revise sale organizational chart (.6).
06/20/24 Amy Donahue 1.00 Draft and revise de minimis asset sale motion
and order.
06/20/24 Sabrina Lieberman 0.60 Review and analyze NDA (.3); correspond
with C. Ceresa and K&E team re same (.3).
06/20/24 Savannah Malnar-Cole 1.20 Correspond with D. O’Connor re antitrust
analysis and questions for Company re same.
06/20/24 Rebecca J. Marston 3.70 Correspond with J. Desai, K&E team re sale
summary (.5); review and revise sale
organizational chart (.3); correspond with J.
Desai, K&E team re same (.2); correspond
with J. Desai, K&E team re NDAs (.1);
review and revise same (2.6).

13
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 99 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102696
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
06/20/24 Ruan J. Meintjes 1.10 Review and analyze change of ownership
considerations for state licensure issues (.5);
prepare summary re same (.6).
06/20/24 Carolin Paus 0.60 Telephone conference with S. Zablotney,
K&E team re tax implications re sale process.
06/20/24 Joshua Raphael 0.40 Conference with potential transaction party re
NDA (.2); review, revise, NDA (.2).
06/20/24 Joshua Raphael 0.50 Research, analyze implications re 9019 (.2);
review, analyze precedent re same (.2);
correspond with C. Ceresa re same (.1).
06/20/24 Yusuf Salloum 1.20 Analyze issues re sale transactions.
06/20/24 Donatus Wang 1.30 Prepare for telephone conference with
Finkenhof re workstreams related to German
entities (.3); attend same (.5); correspond with
Munich tax team re structuring of potential
asset sale transaction (.5).
06/20/24 Spencer A. Winters, P.C. 2.10 Review and analyze issues re sale process,
case strategy (.3); telephone conference with
Y. Salloum, K&E team re same (.3); prepare
for and attend special committee call (.5);
prepare for and attend weekly telephone
conference with Company (.5); prepare for
and attend weekly telephone conference with
lender advisors (.5).
06/21/24 Chris Ceresa 0.30 Review, analyze draft NDA markups (.2);
correspond with S. Lieberman, K&E team re
same (.1).
06/21/24 Chris Ceresa 1.50 Analyze, comment on bidding procedures
declarations, sale motion.
06/21/24 Kenny Chiaghana 1.90 Analyze, revise de minimis asset procedures
motion.
06/21/24 Jaina Desai 2.20 Revise sale organizational chart (1.4);
correspond with R. Marston re same (.2);
correspond with C. Ceresa re same (.1);
review, analyze sales diligence (.2);
correspond with R. Marston, S. Lieberman re
same (.1); correspond with AlixPartners re
contract noticing (.1); revise sale organizer
(.1).
06/21/24 Amy Donahue 0.30 Research re de minimis asset sale exhibit
precedent.

14
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 100 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102696
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
06/21/24 Julia R. Foster 0.50 Draft exhibits B and C re de minimis asset
motion.
06/21/24 Sabrina Lieberman 1.90 Review and revise NDA summary (.4);
correspond with C. Ceresa and K&E team re
same (1.0); review and analyze NDA (.2);
correspond with NDA counterparties re same
(.3).
06/21/24 Savannah Malnar-Cole 0.30 Advise D. O’Connor re redaction practices for
customer contracts.
06/21/24 Rebecca J. Marston 1.90 Correspond with J. Desai, K&E team re sale
organizational chart, sale work streams (1.4);
correspond with Omni team re noticing of
sale-related filings (.1); review and revise
NDAs (.2); correspond with S. Lieberman,
K&E team re same (.2).
06/21/24 Dan O'Connor 5.00 Prepare disclosure schedules (2.5); review,
analyze document files re same (2.0);
correspond with AlixPartners, Company re
same (.5).
06/21/24 Spencer A. Winters, P.C. 0.90 Review and analyze issues re sale process,
case strategy (.6); telephone conferences with
interested parties re same (.3).
06/22/24 Anthony M. Del Rio 0.60 Review, analyze regulatory filing research.
06/22/24 Sabrina Lieberman 0.30 Review and revise NDA (.2); revise summary
re same (.1).
06/22/24 Rebecca J. Marston 0.30 Review and revise NDA (.2); correspond with
S. Lieberman, K&E team re same (.1).
06/22/24 Michael William Morgan 2.50 Analyze, summarize diligence documents.
06/22/24 Dan O'Connor 1.80 Correspond with Company re contract review
(.5); correspond with Company, AlixPartners,
PJT re disclosure schedules (.3); review and
revise material contract chart (1.0).
06/23/24 Jaina Desai 0.30 Revise sale process organizational chart (.1);
review, analyze correspondence re same (.1);
correspond with R. Marston re same (.1).
06/23/24 Sabrina Lieberman 0.20 Review, analyze NDAs (.1); correspond with
NDA counterparties re same (.1).
06/23/24 Rebecca J. Marston 0.50 Review, analyze sale organizational chart (.4);
correspond with J. Desai re same (.1).
06/23/24 Michael William Morgan 0.50 Review and summarize diligence documents
(.3); correspond with Dan O’Connor re
summary (.2).

15
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 101 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102696
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
06/24/24 Chris Ceresa 1.10 Review, analyze sale legal issues, including
sale NDA issues (.4); correspond with Y.
Salloum, K&E team re same (.2); conference
with Company, Y. Salloum, K&E team re
same (.5).
06/24/24 Chris Ceresa 0.50 Review, analyze sale, plan terms re RSA.
06/24/24 Adam Thomas Clifford, P.C. 1.00 Prepare for telephone conference with
Company re disclosure schedules (.4);
telephone conference with Company re same
(.6).
06/24/24 Anthony M. Del Rio 0.40 Review and analyze structural considerations.
06/24/24 Jaina Desai 2.80 Correspond with counterparty re NDA (.1);
review, analyze correspondence re sale
organization chart (.2); correspond with R.
Marston re same (.1); revise sale
organizational chart (.3) draft correspondence
re sale organizational chart (.2); correspond
with R. Marston re sale organizational chart
(.1); correspond with K. Chiaghana re sale
milestones (.1); research, analyze documents
re same (.1); revise bidding procedures PJT
declaration (.3); correspond with R. Marston
re same (.1); correspond with C. Ceresa re
same (.1); telephone conference with
AlixPartners, C. Ceresa, K&E team re
contract noticing (.3); prepare for call re same
(.1); correspond with R. Marston re same (.1);
correspond with C. Ceresa re same (.1).
review, analyze AlixPartners declaration (.1);
correspond with R. Marston, C. Ceresa re
same (.1); research, review contract noticing
precedent (.3).
06/24/24 Jaina Desai 0.60 Correspond with C. Ceresa, AlixPartners re
contract noticing precedent (.1); review,
analyze PJT comments to declaration (.2);
correspond with R. Marston, C. Ceresa re
same (.1); revise sale organizer (.2).
06/24/24 Sabrina Lieberman 1.00 Revise NDA (.2); correspond with
counterparties re same (.4); correspond with
PJT, C. Ceresa and K&E team re same (.1);
correspond with C. Ceresa and K&E team re
NDA summary (.1); revise same (.2).

16
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 102 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102696
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
06/24/24 Rebecca J. Marston 0.50 Prepare for and participate in conference with
Alix team, K&E team re contract noticing
(.3); correspond with J. Desai re sale-related
workstreams (.2).
06/24/24 Ruan J. Meintjes 3.60 Research and analyze state licensure change
of ownership considerations (3.0); prepare
summary of same (.5); correspond with K.
Hardey, K&E team re same (.1).
06/24/24 Michael William Morgan 1.20 Telephone conference with Company re
schedules (.8); prepare for same (.3); research
precedent re same (.1).
06/24/24 Trent Nachbar 6.00 Analyze asset purchase agreements and
schedules (3.9); research, analyze specialist
questions (1.0); continue to analyze asset
purchase agreements and schedules (1.1).
06/24/24 Dan O'Connor 5.90 Telephone conference with Company,
AlixPartners, PJT Partners, S. Toth, K&E
team re disclosure schedules (1.1); correspond
with AlixPartners, PJT, S. Toth, K&E team re
same (.4); review and revise material contract
summary chart (.6); correspond with
Company re same (.2); review, analyze VDR
materials (1.6); prepare disclosure schedules
(2.0).
06/24/24 Yusuf Salloum 2.40 Analyze issues re sale transactions (2.1);
conference with S. Toth, K&E team,
Company, AlixPartners team re asset
purchase agreements (.3).
06/24/24 Steve Toth 1.30 Telephone conference with Y. Salloum, K&E
team, AlixPartners, Company re asset
purchase agreements and disclosure schedules
(1.0); analyze tax structure memorandum (.3).
06/24/24 Spencer A. Winters, P.C. 1.20 Review and analyze issues re sale process,
case strategy (.4); telephone conference with
Y. Salloum re same (.3); prepare for and
attend standing update telephone conference
with Company and advisors re same (.5).
06/25/24 Chris Ceresa 1.40 Review, analyze sale legal issues, including
sale NDA issues (.8); correspond with Y.
Salloum, K&E team re same (.2); telephone
conference with Company, S. Lieberman,
K&E team re same (.4).

17
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 103 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102696
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
06/25/24 Adam Thomas Clifford, P.C. 0.50 Research, analyze carve-out and separation
matters.
06/25/24 Anthony M. Del Rio 1.80 Review and analyze regulatory filing
requirements.
06/25/24 Jaina Desai 1.70 Correspond with AlixPartners re contract
drafting (.1); review, analyze correspondence
re sale process materials (.1); review,
revise presentation re same (.1); correspond
with R. Marston re same (.1); revise 363 sale
process overview (.1); correspond with R.
Marston, Company re same (.1); review,
analyze asset sale diligence spreadsheet (.1);
correspond with C. Ceresa, R. Marston re
same (.1); review, analyze correspondence re
363 sale overview presentation (.1); review,
analyze 363 sale overview presentation (.1);
revise same (.1); correspond with R. Marston,
Company re same (.1); review, analyze PJT
comments re declaration (.5).
06/25/24 Emanuel Goetz 0.50 Conference with D. Wang, K&E team re
structuring considerations re potential sale.
06/25/24 Kate Hardey 0.30 Review, analyze correspondence re FDA
transfer considerations re German entities.
06/25/24 Olivia Kaufmann 4.20 Research and analyze state wind-down,
change of ownership and change of control
requirements for specific licenses (3.7);
conference with R. Meintjes re same (.5).
06/25/24 Sabrina Lieberman 0.70 Conference with NDA counterparty re NDA
(.1); correspond with PJT re NDA (.1); review
and revise NDA (.2); review and revise NDA
summary (.2); conference with C. Ceresa re
NDA (.1).
06/25/24 Rebecca J. Marston 4.60 Review and revise company slide deck re 363
sales (2.6); correspond with J. Desai, C.
Ceresa, K&E team re same (1.3); conference
with Company re same (.5); correspond with
PJT team re same (.2).
06/25/24 Ruan J. Meintjes 0.70 Research and analyze change of ownership
requirements for state licensure.

18
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 104 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102696
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
06/25/24 Dan O'Connor 5.40 Telephone conference with Company,
AlixPartners, Y. Salloum, S. Toth, K&E team
re transition services agreement matters (.4);
review, analyze VDR materials (3.0); prepare
disclosure schedules and punch list (1.0);
correspond with Company re same (.5);
correspond with Y. Salloum, D. Lewis, B.
Coppola, K&E team re transition services
agreement and transaction matters (.5).
06/25/24 Carolin Paus 1.00 Telephone conference with S. Zablotney,
K&E team re tax implications in asset vs
share deal of German RDX entity.
06/25/24 Yusuf Salloum 1.50 Review, analyze issues re sale transaction, tax
structuring, transition services agreement.
06/25/24 Scottie Shermetaro 0.20 Review due diligence re asset sale.
06/25/24 Steve Toth 0.80 Telephone conference re transition services
agreement with Company, AlixPartners and
K&E team (.5); analyze correspondence re
transition services agreement matters and
presentation (.3).
06/25/24 Donatus Wang 1.10 Review, analyze PJT update on sales process
(.2); draft options analysis for German asset
sale or share sale structures for RDx business,
correspond with A. Ziegler, K&E team re
same (.9).
06/25/24 Spencer A. Winters, P.C. 1.10 Telephone conference with PWC Germany re
tax issues (.5); review and analyze issues re
sale process, case strategy (.3); telephone
conference with Y. Salloum, K&E team re
same (.3).
06/26/24 Cooper Barghols 2.50 Research and summarize state licensure
change of ownership requirements (2.1);
correspond with R. Meintjes re edits to
auction draft asset purchase agreement (.4).
06/26/24 John G. Caruso 1.20 Review and revise asset purchase agreement.
06/26/24 Chris Ceresa 2.10 Telephone conference with Company,
advisors, Y. Salloum, K&E team re health
regulatory issues re potential sale scenarios
(1.1); conference with health regulatory
advisors re issues re same (1.0).

19
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 105 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102696
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
06/26/24 Chris Ceresa 7.10 Review, analyze sale legal issues, including
sale NDA issues (3.9); correspond with Y.
Salloum, K&E team re same (1.1); telephone
conference with Company, Y. Salloum K&E
team re same (.9); continue to review, analyze
sale legal issues, including sale NDA issues
(1.2).
06/26/24 Adam Thomas Clifford, P.C. 0.50 Review, analyze separation and carve-out
matters.
06/26/24 Bernadette Coppola 5.40 Conference with S. Shermetaro re purchase
agreement and transition services agreement
(.4); draft revisions to purchase agreement
(1.4); correspond with D. Lewis and K&E
team, Company and advisors re transition
services agreement (.3); correspond with A.
Del Rio, K&E team re transition services
agreement (.2); conference with D. Lewis,
K&E team re transaction structure and
strategy (.9); correspond with D. Lewis, K&E
team re same (.4); telephone conference with
Company, S. Shermetaro and K&E team re
intellectual property matters (.4); correspond
with Company re same (.4); analyze
disclosures (1.0).
06/26/24 Anthony M. Del Rio 2.10 Review and analyze regulatory filing
requirements (1.0); review and comment on
purchase agreement (1.1).
06/26/24 Jaina Desai 10.70 Review, analyze correspondence re sale
stream (.7); review, analyze asset purchase
agreement (3.0); correspond with R. Marston
re same (.3); review, analyze precedent re
same (2.0); revise asset purchase agreement
(2.0); conference with R. Marston re same
(.3); correspond with C. Ceresa, Y. Salloum
re same (.2); revise sale organizer (.3);
analyze, compile precedent re asset purchase
agreement (.3); correspond with K. Trevett re
bidding procedures order, case timeline (.1);
telephone conference with S. Toth, K&E
team, counterparty re asset purchase
agreement (1.0); telephone conference with B.
Coppola, K&E team re same (.5).

20
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 106 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102696
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
06/26/24 Michael Ehret 1.70 Correspond with E. Goetz, K&E team re
German tax structuring, transaction issues,
related considerations (.5); conferences with
E. Goetz, AlixPartners, PJT, Company, K&E
team re transaction considerations (.5);
review, analyze issues re same (.7).
06/26/24 Justin M. Garfinkle 2.70 Telephone conference with S. Toth, K&E
team re asset purchase agreement (.5); draft
comments to asset purchase agreement (2.2).
06/26/24 David Hackel 0.50 Review, analyze confidential party asset
purchase agreement.
06/26/24 Yoonie Han 0.30 Analyze asset purchase agreement.
06/26/24 Kate Hardey 1.50 Review, analyze revisions to merger
agreement (.7); conference with R. Meintjes,
K&E team team re same (.4); review, analyze
German entity filings and 510k listings re
asset transfer (.4).
06/26/24 Liz Ji 1.30 Revise asset purchase agreement.
06/26/24 Olivia Kaufmann 5.50 Research and analyze state wind-down,
change of ownership and change of control
requirements for specific licenses (3.9);
conference with R. Meintjes, C. Barghol re
same (.5); continue to research and analyze
state wind-down, change of ownership and
change of control requirements for specific
licenses (1.1)
06/26/24 Sooah Kim 1.00 Review and revise asset purchase agreement.
06/26/24 Daniel Lewis, P.C. 3.00 Analyze transition services agreement and
separation matters (1.0); telephone conference
with B. Coppola, K&E team re same (.5);
correspond with B. Coppola, K&E team re
same (.5); telephone conference with S. Toth,
K&E team re same (.5); analyze IP matters
(.5).
06/26/24 Sabrina Lieberman 1.50 Review and analyze bidding procedures
affidavit of service (.5); review and revise
NDA (.2); correspond with C. Ceresa, K&E
team re same (.2); review and revise NDA
summary and ancillary documents (.6).
06/26/24 Michael William Morgan 2.00 Draft and circulate the intellectual property
assignment agreement form (1.0); draft and
circulate bill of sale form (.5); revise working
group list (.5).

21
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 107 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102696
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
06/26/24 Trent Nachbar 8.20 Review and revise asset purchase agreements
and disclosure schedules (3.9); review and
research specialist questions and coordinate
markups (2.0); continue to review and revise
asset purchase agreements and disclosure
schedules (2.3).
06/26/24 Maureen D. O'Brien 1.00 Review and revise asset purchase agreement.
06/26/24 Dan O'Connor 9.20 Telephone conference with S. Toth, Y.
Salloum, K&E team, various parties re
confidential party bid (.6); telephone
conference with Company, PJT, Y. Salloum,
S. Toth, K&E team re transition services
agreement matters (.4); telephone conference
with bidder counsel, confidential party, PJT
Partners, Company re diligence matters (.7);
telephone conference with S. Toth, K&E team
re asset purchase agreement (1.0); telephone
conference with S. Toth, K&E team re
transaction matters (.5); review, analyze bid
asset purchase agreement and draft issues list
re same (3.4); correspond with S. Toth re
same (.2); correspond with B. Coppola and J.
Garfinkle re transaction matters (.5);
correspond with T. Nachbar and M. Morgan
re disclosure schedules and diligence matters
(.5); correspond with Company re disclosure
schedules (.8); prepare disclosure schedules
(.6).
06/26/24 Carolin Paus 1.80 Draft German sale presentation.
06/26/24 Risa Salins 0.50 Review M&A counterparty markup of auction
draft asset purchase agreement.
06/26/24 Adrian Salmen 3.10 Correspond with AlixPartners, C. Ceresa,
K&E team re asset purchase agreement draft
(.5); review, analyze creditor revisions to sale
order (.5); review, analyze precedent sale
order language (1.9); correspond with J.
Desai, R. Marston re sale workstream (.2).
06/26/24 Scottie Shermetaro 4.10 Review, revise asset purchase agreement
(2.1); conference with B. Coppola re deal
timeline and deliverables (.5); telephone
conference with B. Coppola and client re
approach to IP diligence (.6); conduct due
diligence (.5); correspond with B. Coppola re
IP searches (.4).

22
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 108 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102696
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
06/26/24 Matt Swanson 0.50 Review, analyze issues re purchase
agreement, related items.
06/26/24 Paul D. Tanaka, P.C. 1.90 Review and comment on asset purchase
agreement bid markup (1.6); correspond with
C. Ceresa, K&E team re same (.3).
06/26/24 Steve Toth 4.20 Telephone conference re transition services
agreement with Company, AlixPartners, PJT,
C. Ceresa, K&E team, bidder and bidder
advisors (.6); telephone conference re
structure chart with Company, S. Winters,
K&E team, bidder and bidder counsel (.4);
telephone conference with S. Winters, K&E
team re transition services agreement and
asset purchase agreement (.9); analyze asset
purchase agreement and prepare comments
and attorney notes (2.0); discuss IP matters
with Company, S. Winters, K&E team (.3).
06/26/24 Paul Vasiloff 2.00 Provide comments to asset purchase
agreement.
06/26/24 Donatus Wang 0.80 Review and revise draft German sale
presentation.
06/26/24 Spencer A. Winters, P.C. 2.20 Review and analyze issues re sale process,
case strategy (.4); telephone conferences with
Y. Salloum, K&E team re same (.3); prepare
for and attend standing special committee
meeting re same (.5); prepare for and attend
telephone conference with bidder counsel re
sale process (1.0).
06/27/24 John G. Caruso 1.50 Review and revise asset purchase agreement
(.6); review and revise asset purchase
agreement (.9).
06/27/24 Chris Ceresa 7.20 Review, analyze sale legal issues, including
sale NDA issues (3.9); correspond with Y.
Salloum, K&E team re same (.5); telephone
conference with Company, Y. Salloum, K&E
team re same (.5); continue to review, analyze
sale legal issues, including sale NDA issues
(2.3).

23
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 109 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102696
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
06/27/24 Bernadette Coppola 4.30 Telephone conference with Company and
AlixPartners re technology separation
planning (1.0); telephone conference with
buyer, AlixPartners, Company, S. Toth, K&E
team re transition services agreement due
diligence (.5); attend conference with buyer,
Company, S. Toth, K&E team re intellectual
property due diligence (.5); conference with
S. Shermetaro, K&E team re drafting strategy
and intellectual property-related matters (.9);
correspond with S. Toth, K&E team re same
(.3); correspond with advisors re intellectual
property disclosures (.3); analyze comments
to asset purchase agreement (.4); telephone
conference with advisor (.4).
06/27/24 Anthony M. Del Rio 2.40 Review and analyze regulatory filing
requirements (.8); prepare for and participate
in telephone conference with Company re
international considerations (.7); telephone
conference with EU counsel re transaction
considerations (.5); review and comment on
disclosure schedules (.4).
06/27/24 Jaina Desai 4.20 Revise asset purchase agreement (3.0);
correspond with S. Osborne, C. Ceresa re
same (.2); review, analyze bidding procedures
order (.3); revise bidding procedures order
(.2); correspond with A. Salmen re same (.1);
correspond with D. O'Connor, K&E team re
asset purchase agreement (.1); review,
analyze correspondence re asset purchase
agreement, sale (.3).

24
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 110 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102696
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
06/27/24 Jaina Desai 3.70 Review, analyze correspondence re sale
workstream (.4); correspond with A. Salmen,
C. Ceresa re same (.1); review, analyze sale
NDA (.2); correspond with C. Ceresa re same
(.3); conference with A. Salmen re bidding
procedures workstream (.3); review, analyze
precedent re sale orders (.3); correspond with
A. Salmen re same (.1); review, analyze
correspondence re escrow accounts (.1);
review, analyze precedent re same (.3);
correspond with Omni re same (.1); revise
PJT declaration (.3); correspond with C.
Ceresa re same (.1); research, analyze
precedent re bidding procedures order (.1);
revise bidding procedures order (.1); analyze,
compile bidding procedures declarations (.1);
draft correspondence re same (.1); telephone
conference with AlixPartners, Y. Salloum,
K&E team (.6); correspond with A. Salmen re
same (.1).
06/27/24 Jaina Desai 3.30 Review, analyze bidding procedures notices
(.5); revise sale organizer (.2); revise asset
purchase agreement (2.4); telephone
conference with S. Osborne re same (.2).
06/27/24 Michael Ehret 1.70 Telephone conference with Company re
regulatory implications, share deal vs asset
deal, requirement of transition services
agreement (1.2); correspond with PwC re
structuring considerations (.5).
06/27/24 Justin M. Garfinkle 4.00 Draft transition services agreement (3.3);
discuss matter with M. Ehret, K&E team (.7).
06/27/24 David Hackel 0.50 Review, analyze confidential party APA.
06/27/24 Kate Hardey 1.20 Conferences with Company, C. Weidner,
K&E team re German entities and related
device transfers.
06/27/24 Olivia Kaufmann 0.20 Conference with A. Del Rio, K&E team
re state wind-down, change of ownership and
change of control requirements.
06/27/24 Sooah Kim 1.60 Conference with M. O'Brien re employee
benefits issues (.2); review and revise asset
purchase agreement (1.4).
06/27/24 Maggie Kate King 1.00 Conference with D. Lewis, K&E team re sale
workstreams.

25
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 111 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102696
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
06/27/24 Maggie Kate King 2.00 Telephone conference with D. Lewis, K&E
team re transition services diligence call (.5);
telephone conference with D. Lewis, K&E
team re IP diligence (1.0); telephone
conference with Morgan Lewis re IP
diligence (.5).
06/27/24 Maggie Kate King 3.00 Revise transition services agreement.
06/27/24 Daniel Lewis, P.C. 1.50 Analyze transition services agreement and IP
matters (1.0); analyze asset purchase
agreements (.5).
06/27/24 Sabrina Lieberman 1.30 Correspond with NDA counterparties re NDA
(.2); review and revise same (.3); correspond
with C. Ceresa and K&E team re same (.3);
revise and revise summary re same (.3);
correspond with C. Ceresa and PJT re
interested parties (.2).
06/27/24 Ruan J. Meintjes 1.90 Review, revise bid asset purchase agreements
(1.8); correspond with A. Del Rio, K&E team
team re same (.1).
06/27/24 Ruan J. Meintjes 1.60 Review, revise regulatory components of
asset purchase agreement from bidders (1.2);
correspond with Y. Salloum, K&E team re
same (.4).
06/27/24 Michael William Morgan 0.70 Review, analyze purchase agreement and
amendment precedent to confirm accuracy of
schedules.
06/27/24 Jai Mudhar 1.00 Correspond with H. Crawford, K&E team
re sales process (.7); review, analyze issues
update from Swiss counsel (.2); conference
with D. Wang re same (.1).
06/27/24 Trent Nachbar 7.80 Review and revise asset purchase agreements
and disclosure schedules (3.9); analyze,
research, respond to and coordinate specialist
comments (1.8); continue to review and revise
asset purchase agreements and disclosure
schedules (2.1).
06/27/24 Michelle L. Nowicki 1.00 Coordinate with M. Morgan, K&E team re IP
due diligence.
06/27/24 Maureen D. O'Brien 1.00 Review and revise asset purchase agreement.

26
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 112 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102696
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
06/27/24 Dan O'Connor 9.80 Telephone conference with Company,
confidential potential buyer, PJT,
AlixPartners, S. Toth, K&E team re IP
diligence matters (1.0); telephone conference
with buyer counsel, S. Toth and Y. Salloum re
transaction matters (.5); telephone conference
with AlixPartners, S. Toth, Y. Salloum, K&E
team re transaction matters (.6); review and
revise issues list (.6); correspond with
Company, S. Toth, K&E team re same (.2);
correspond with S. Toth, K&E team re special
transaction matters (.6); review and revise
asset purchase agreements (3.5); review,
analyze contracts in VDR and prepare
disclosure schedules (2.8).
06/27/24 Sarah Osborne 6.60 Review, revise markup to asset purchase
agreement (2.4); correspond with C. Ceresa re
same (.1); further review, revise markup to
asset purchase agreement (3.4); correspond
with C. Ceresa, K&E team re same (.3);
compile issues list re same (.4).
06/27/24 Joshua Raphael 0.50 Review, revise NDA and correspond with
counterparty re same.
06/27/24 Adrian Salmen 4.30 Review, analyze precedent bidding
procedures language (1.7); correspond with J.
Desai, K&E team re same (.3); conference
with J. Desai re same (.3); revise addition to
bidding procedures order (.5); telephone
conference with Y. Salloum, K&E team re
asset purchase agreement proposal (.5);
review, revise sale related notices (.3);
review, analyze asset purchase agreement
issues (.7).

27
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 113 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102696
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
06/27/24 Scottie Shermetaro 5.70 Telephone conference with B. Coppola and
Company re RDx IT separation and transition
services agreement (1.0); telephone
conference with B. Coppola, M. King re
transition services agreement follow-up (.5);
conference with B. Coppola and PJT partners
re IP diligence (1.0); coordinate IP Searches
or all seller entities and separate by relevant
business unit (.3); review, revise transition
services agreement (1.5); conduct due
diligence and discuss findings with B.
Coppola, M. King and J. Garfinkel (1.0);
telephone conference with B. Coppola and
client's external IP counsel re IP issues (.4).
06/27/24 Matt Swanson 0.20 Review, analyze asset purchase agreement
related considerations.
06/27/24 Paul D. Tanaka, P.C. 1.20 Review and analyze multiple bid draft
purchase agreement markups (.9); correspond
with Y. Salloum, K&E team re same (.3).
06/27/24 Steve Toth 4.00 Telephone conference re transition services
agreement with Company, AlixPartners, Y.
Salloum, K&E team (1.0); analyze issues list
(.4); discuss transaction with bidder counsel,
Y. Salloum, K&E team (.3); revise asset
purchase agreement issues list (1.1); discuss
asset purchase agreement issues with
AlixPartners, Y. Salloum, K&E team (.6);
analyze correspondence re asset purchase
agreements (.2); revise issues list (.4).
06/27/24 Paul Vasiloff 1.30 Provide comments to asset purchase
agreement.
06/27/24 Spencer A. Winters, P.C. 2.90 Review and analyze sale process issues (.7);
correspond with Y. Salloum, K&E team re
same (.7); prepare for and attend standing
telephone conference with company advisors
re same (.5); prepare for and attend standing
telephone conference with lender advisors re
same (.5); prepare for and attend telephone
conference with bidder counsel re sale
process (.5).

28
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 114 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102696
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
06/28/24 Chris Ceresa 5.30 Review, analyze sale legal issues, including
sale NDA issues (3.3); correspond with Y.
Salloum, K&E team re same (1.0); telephone
conference with Company, K&E team re
same (1.0).
06/28/24 Bernadette Coppola 4.50 Telephone with D. Lewis re transition
services agreement and process (.3);
correspond with S. Shermetaro, K&E team re
intellectual property disclosures (.5); draft
revisions to purchase agreement (.5); draft
revisions to asset purchase agreement (1.7);
draft revisions to transition services
agreement (1.5).
06/28/24 Anthony M. Del Rio 1.90 Review and analyze regulatory filing
requirements (.5); review and
analyze structural considerations (.3); review
and comment on asset purchase agreements
(1.1).
06/28/24 Jaina Desai 1.60 Review, revise asset purchase agreement.
06/28/24 Jaina Desai 2.60 Revise asset purchase agreement.
06/28/24 Jaina Desai 3.20 Review, analyze correspondence re sale
workstream (.3); correspond with S. Osborne
re asset purchase agreements (.1); correspond
with AlixPartners re contract designation
process (.1); correspond with C. Ceresa re
same (.1); review, analyze escrow agreement
(.3); correspond with A. Salmen re same (.2);
review, analyze precedent re escrow
agreements (.8); review, research precedent re
U.S. Trustee comments re bidding procedures
(.8); revise escrow agreement (.4); correspond
with C. Ceresa re same (.1).
06/28/24 Jaina Desai 0.60 Correspond with C. Ceresa re asset purchase
agreements (.3); review, analyze escrow
agreement (.1); correspond with C. Ceresa re
same (.1); correspond with Omni re same (.1).
06/28/24 Jaina Desai 0.90 Revise asset purchase agreement.
06/28/24 Justin M. Garfinkle 3.20 Draft updates to asset purchase agreement
(.8); review, analyze comments from outside
counsel re disclosure schedules (1.2); draft
comments to asset purchase agreement (.8);
analyze transition services agreement (.4).

29
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 115 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102696
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
06/28/24 David Hackel 0.30 Review, analyze confidential party asset
purchase agreement.
06/28/24 Kate Hardey 0.80 Review, analyze Company clinical trials re
asset purchase agreement revisions.
06/28/24 Kate Hardey 1.50 Review, analyze asset purchase agreement
(1.0); conference with R. Meintjes re same
(.5).
06/28/24 Liz Ji 5.10 Review, analyze asset purchase agreement for
confidential parties (3.9); telephone
conference with N. Warther, K&E team re
intercompany debt (1.0); continue to Review,
analyze asset purchase agreement for
confidential parties (.2).
06/28/24 Olivia Kaufmann 4.70 Research and analyze state wind-down,
change of ownership and change of control
requirements re regulatory licenses (3.5);
correspond with state regulators re same (1.2).
06/28/24 Sooah Kim 0.80 Review, revise asset purchase agreement.
06/28/24 Maggie Kate King 1.50 Telephone conference re IP with Fox
Rothschild (.5); telephone conference re IP
with advisor (.5); coordinate with D. Lewis,
K&E team re intellectual property disclosures
(.5).
06/28/24 Maggie Kate King 1.00 Revise transition services agreement.
06/28/24 Daniel Lewis, P.C. 2.50 Analyze asset purchase agreements (.5);
analyze transition services agreement matters
(1.0); telephone conference with B. Coppola,
K&E team re transition services agreement
matters (1.0).
06/28/24 Sabrina Lieberman 0.80 Review and revise NDAs (.2); correspond
with NDA counterparties re same (.2); review
and revise NDA summary (.2); correspond
with C. Ceresa and K&E team re same (.2).
06/28/24 Ruan J. Meintjes 1.70 Research and analyze change of ownership
requirements (1.5); prepare summary of same
(.1); coordinate with Y. Salloum, K&E team
re same (.1).
06/28/24 Ruan J. Meintjes 1.80 Review and revise bid asset purchase
agreements (1.6); correspond with A. Del Rio
and K. Hardey re same (.2).
06/28/24 Michael William Morgan 1.20 Revise asset purchase agreement.

30
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 116 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102696
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
06/28/24 Trent Nachbar 10.00 Review and revise asset purchase agreements
and disclosure schedules (3.9); analyze and
respond to specialist comments (1.0);
continue to review and revise asset purchase
agreements and disclosure schedules (3.8);
further review and revise asset purchase
agreements and disclosure schedules (1.3)
06/28/24 Michelle L. Nowicki 2.50 Review, analyze IP disclosures and prior
K&E IP schedules, deal correspondence, and
corporate entity list (1.0); commence IP
ownership searches (.3); telephone conference
with H. Horter re IP searches (1.0);
correspond with D. Lewis, K&E team re IP
due diligence (.2).
06/28/24 Maureen D. O'Brien 1.00 Review, revise asset purchase agreement.
06/28/24 Dan O'Connor 9.90 Correspond with Company, S. Toth, K&E
team, PJT Partners, AlixPartners teams re
issues list (1.0); prepare issues lists and bid
comparisons (3.9); review and revise asset
purchase agreement (1.5); review, analyze
contracts in VDR and prepare disclosure
schedules (2.8); continue to prepare issues
lists and bid comparisons (.7)
06/28/24 Sarah Osborne 4.90 Review, revise asset purchase agreement
markup (3.9); correspond with C. Ceresa,
K&E team re same (.4); continue to review,
revise asset purchase agreement markup (.6).
06/28/24 Carolin Paus 1.40 Research re clawback risks (1.0); finalize
presentation on asset vs share deal (.4).
06/28/24 Yusuf Salloum 0.50 Analyze asset purchase agreements.
06/28/24 Adrian Salmen 1.90 Review, revise bidding procedures
language(1.4); correspond with C. Ceresa,
K&E team, contract counterparty re same
(.3); correspond with J. Desai, K&E team re
sale workstream issues (.2).
06/28/24 Scottie Shermetaro 3.80 Telephone conference with M. King and
external trademark counsel re trademark
portfolio disclosures (.5); telephone
conference with M. King and external patent
counsel re patent portfolio disclosures (.5);
review, revise transition services agreement
(1.5); review, revise asset purchase agreement
(1.3).

31
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 117 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102696
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
06/28/24 Steve Toth 6.30 Discuss asset purchase agreement issues with
Company, PJT, AlixPartners, S. Winters,
K&E team (1.3); analyze bidder asset
purchase agreement (1.6); analyze bidder
asset purchase agreement and prepare issues
list (2.3); revise issues lists and distribute
(1.1).
06/28/24 Sarah Ullathorne 1.20 Telephone conference with Y. Salloum, K&E
team re asset purchase agreement (.4); review,
analyze same (.4); correspond with
Y. Salloum, K&E team re antitrust and
foreign direct investment analysis (.4).
06/28/24 Paul Vasiloff 1.00 Provide comments to asset purchase
agreement.
06/28/24 Spencer A. Winters, P.C. 1.90 Prepare for and attend telephone conference
with Company re bidder asset purchase
agreement (1.5); review and analyze issues re
sale process, case status (.4).
06/29/24 Rebecca H. Arnall 6.50 Review, analyze asset purchase agreements
(3.9); correspond with S. Price re same (.5);
continue to review, analyze asset purchase
agreements (2.1).
06/29/24 Chris Ceresa 0.60 Review, analyze sale legal issues, including
sale NDA issues (.2); correspond with R.
Marston, K&E team re same (.1); telephone
conference with Company, Y. Salloum, K&E
team re same (.3).
06/29/24 Dominique Collins 0.20 Review, analyze deal summary and
correspondence re deliverables.
06/29/24 Dominique Collins 0.50 Review, revise asset purchase agreements.
06/29/24 Dominique Collins 1.00 Review, analyze precedent asset purchase
agreement.
06/29/24 Bernadette Coppola 2.00 Draft revisions to transition services
agreement (1.0); correspond with M. King,
K&E team re same (.2); correspond with J.
Garfinkle, K&E team re revisions to asset
purchase agreement (.2); review, analyze
revised draft of transition services agreement
(.3); correspond with M. King, K&E team re
same (.3).
06/29/24 Anthony M. Del Rio 0.90 Analyze structural considerations (.4); review
and comment on asset purchase agreements
(.5).

32
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 118 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102696
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
06/29/24 Jaina Desai 3.60 Review, analyze correspondence, documents
re bidding procedures order (1.8); research,
analyze precedent re U. S. Trustee comments
(1.6); draft correspondence re same (.2).
06/29/24 Justin M. Garfinkle 0.40 Draft comments to asset purchase agreement.
06/29/24 Kate Hardey 0.50 Conference with R. Meintjes re EU and other
country device lists and related coordination
with EU counsel.
06/29/24 Maggie Kate King 4.00 Revise transition services agreement bid draft
(3.0); research re same (1.0).
06/29/24 Daniel Lewis, P.C. 0.50 Analyze transition services agreement matters
(.4); correspond with B. Coppola, K&E team
re same (.1).
06/29/24 Sabrina Lieberman 0.20 Review, revise NDA (.1); revise summary re
same (.1).
06/29/24 Ruan J. Meintjes 1.20 Review, revise bid asset purchase agreements
(1.0); correspond with A. Del Rio and K.
Hardey re same (.2).
06/29/24 Dan O'Connor 4.30 Telephone conference with bidder counsel, S.
Toth re asset purchase agreement (.4); review,
analyze contracts in VDR and prepare
disclosure schedules (1.9); review and revise
asset purchase agreements (2.0).
06/29/24 Scott D. Price, P.C. 0.70 Review, analyze asset purchase agreements.
06/29/24 Scottie Shermetaro 2.10 Review, revise markup of auction draft asset
purchase agreement (.7); review, revise
transition services agreement (1.4).
06/29/24 Steve Toth 0.50 Discuss asset purchase agreement issues with
bidder counsel, S. Winters, K&E team (.4);
analyze related attorney notes (.1).
06/30/24 Bernadette Coppola 1.90 Draft revisions to transition services
agreement (1.0); correspond with S.
Shermetaro, K&E team re same (.4);
correspond with M. King, K&E team re
revisions to Company correspondence (.5).
06/30/24 Jaina Desai 1.40 Revise bidding procedures order (.3); revise
bidding procedures notices (.9); draft
correspondence re same (.1); correspond with
A. Salmen re same (.1).
06/30/24 Liz Ji 3.50 Revise asset purchase agreements for
numerous bidders.

33
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 119 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102696
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
06/30/24 Olivia Kaufmann 0.20 Research, analyze wind-down, change of
ownership, change of control requirements re
state license.
06/30/24 Maggie Kate King 2.00 Revise transition services agreement.
06/30/24 Sabrina Lieberman 0.30 Correspond with M&A counterparty re NDA
(.1); correspond with C. Ceresa re NDA
summary (.2).
06/30/24 Trent Nachbar 0.80 Review, revise asset purchase agreements and
disclosure schedules.
06/30/24 Michelle L. Nowicki 5.20 Correspond with D. Lewis, K&E team re IP
due diligence (.7); compare two sets of
trademark disclosures, prior K&E U.S.
trademark schedule and new trademark search
results (2.0); review, analyze related IP office
and Corsearch records (2.0); prepare
trademark schedule (.5).
06/30/24 Dan O'Connor 5.00 Review and revise asset purchase agreements
(3.9); correspond with S. Toth re same (.2);
correspond with S. Toth, K&E team re asset
purchase agreements (.8); continue to review
and revise asset purchase agreements (.1).
06/30/24 Scottie Shermetaro 6.30 Review, revise transition services agreement
(3.9); draft transition services agreement
issues list for Company (.6); review, analyze
IP-related diligence disclosures from client's
outside counsel (1.0); continue to review,
revise transition services agreement (.8).
06/30/24 Steve Toth 1.10 Analyze correspondence re transition services
agreement and diligence (.3); analyze asset
purchase agreement issues list (.8).

Total 572.80

34
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 120 of 631

601 Lexington Avenue
New York, NY 10022

FEIN 36-1326630

August 29, 2024

Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045

Attn: Vikram Bajaj

Invoice Number: 1050102697
Client Matter: 48520-11

In the Matter of Executory Contracts & Unexpired Leases

For legal services rendered through June 30, 2024
(see attached Description of Legal Services for detail) $ 28,606.00
Total legal services rendered $ 28,606.00

Austin Bay Area Beijing Boston Brussels Chicago Dallas Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 121 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102697
Vyaire Medical Inc. Matter Number: 48520-11
Executory Contracts & Unexpired Leases

Summary of Hours Billed

Name Hours Rate Amount
Tiffani Chanroo 0.90 1,265.00 1,138.50
David Hackel 22.00 975.00 21,450.00
Brian King 1.00 1,345.00 1,345.00
Sabrina Lieberman 0.50 815.00 407.50
Sarah Osborne 1.60 815.00 1,304.00
Joshua Raphael 0.60 975.00 585.00
Yusuf Salloum 1.00 1,595.00 1,595.00
Tanzila Zomo 2.20 355.00 781.00

TOTALS 29.80 $ 28,606.00

2
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 122 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102697
Vyaire Medical Inc. Matter Number: 48520-11
Executory Contracts & Unexpired Leases

Description of Legal Services

Date Name Hours Description
06/13/24 Yusuf Salloum 1.00 Analyze issues re sale transactions and
rejection.
06/14/24 Sabrina Lieberman 0.20 Correspond with T. Chanroo, parties in
interest and AlixPartners re executory
contract.
06/14/24 Joshua Raphael 0.60 Review, revise NDA (.5); review, analyze
master services agreement and correspond
with Y. Salloum re same (.1).
06/17/24 Sabrina Lieberman 0.30 Correspond with T. Chanroo and K&E team
re executory contract strategy.
06/17/24 Sarah Osborne 1.10 Review, analyze contracts with staffing
agency re executory status (.9); correspond
with J. Raphael re same (.2).
06/18/24 Tiffani Chanroo 0.90 Review, analyze executory contract (.7);
correspond with Company, C. Ceresa, K&E
team re same (.2).
06/18/24 David Hackel 0.70 Research contract rejection procedures (.3);
correspond with T. Chanroo, K&E team re
same (.1); review, analyze precedent re same
(.3).
06/18/24 Brian King 1.00 Prepare for and participate in conference with
K. Hardey, K&E team re regulatory
considerations to support lease rejections.
06/18/24 Tanzila Zomo 0.50 Research re contract rejection precedent (.3);
correspond with D. Hackel re same (.2).
06/19/24 David Hackel 4.10 Review, analyze precedent re contract
rejection procedures (.7); correspond with T.
Chanroo, K&E team re same (.1); draft, revise
contract rejection procedures pleadings (2.2);
research re same (1.1).
06/19/24 Tanzila Zomo 1.70 Research re contract rejection precedent.
06/20/24 David Hackel 4.60 Research re contract rejection procedures (.8);
correspond with T. Chanroo, K&E team re
same (.1); revise contract rejection procedures
pleadings (2.8); further research re same (.9).
06/21/24 David Hackel 3.80 Review, analyze precedent re contract
rejection procedures (.4); correspond with T.
Chanroo re same (.2); draft, revise contract
rejection procedures pleadings (2.9); research
re same (.3).

3
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 123 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102697
Vyaire Medical Inc. Matter Number: 48520-11
Executory Contracts & Unexpired Leases

Date Name Hours Description
06/22/24 David Hackel 0.60 Review, analyze contract rejection
procedures, related issues (.4); correspond
with Y. Salloum, K&E team re same (.2).
06/24/24 David Hackel 4.60 Review, analyze precedent re contract
rejection procedures (.7); correspond with T.
Chanroo, K&E team re same (.4); draft, revise
contract rejection procedures pleadings (2.8);
research re same (.7).
06/25/24 David Hackel 1.60 Review, revise contract rejection procedures
pleadings (.9); review, analyze issues re filing
same (.3); correspond with T. Chanroo, K&E
team re same (.2); review, revise notice re
same (.2).
06/25/24 Sarah Osborne 0.50 Prepare bar date, contract rejection motions
for filing (.3); review, revise notices for same
(.2).
06/26/24 David Hackel 1.30 Review, revise rejection procedures order
(.7); review, analyze precedent, research re
same (.4); correspond with T. Chanroo, K&E
team re same (.2).
06/27/24 David Hackel 0.20 Review, analyze issues re contract rejection
procedures.
06/28/24 David Hackel 0.50 Review, analyze contract rejection procedures
order (.3); review, analyze correspondence
from C. Ceresa re same (.1); correspond with
S. Lieberman re same (.1).

Total 29.80

4
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 124 of 631

601 Lexington Avenue
New York, NY 10022

FEIN 36-1326630

August 29, 2024

Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045

Attn: Vikram Bajaj

Invoice Number: 1050102698
Client Matter: 48520-12

In the Matter of Business Operations

For legal services rendered through June 30, 2024
(see attached Description of Legal Services for detail) $ 48,045.50
Total legal services rendered $ 48,045.50

Austin Bay Area Beijing Boston Brussels Chicago Dallas Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 125 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102698
Vyaire Medical Inc. Matter Number: 48520-12
Business Operations

Summary of Hours Billed

Name Hours Rate Amount
Cooper Barghols 4.40 815.00 3,586.00
Chris Ceresa 2.50 1,345.00 3,362.50
Anthony M. Del Rio 0.40 1,595.00 638.00
Kate Hardey 0.50 1,995.00 997.50
Partha Kar 1.50 2,305.00 3,457.50
Olivia Kaufmann 5.60 975.00 5,460.00
Brian King 1.40 1,345.00 1,883.00
Sabrina Lieberman 4.10 815.00 3,341.50
Ruan J. Meintjes 5.40 975.00 5,265.00
Sarah Osborne 0.20 815.00 163.00
Carolin Paus 14.90 620.00 9,238.00
Kyle Nolan Trevett 2.30 1,095.00 2,518.50
Donatus Wang 4.00 905.00 3,620.00
Ann-Kathrin Ziegler 4.30 1,050.00 4,515.00

TOTALS 51.50 $ 48,045.50

2
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 126 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102698
Vyaire Medical Inc. Matter Number: 48520-12
Business Operations

Description of Legal Services

Date Name Hours Description
06/10/24 Anthony M. Del Rio 0.40 Review, analyze regulatory notice
obligations.
06/10/24 Donatus Wang 3.50 Analyze German operations, shipping
considerations.
06/11/24 Sabrina Lieberman 0.70 Conference with P. Kar, K&E team, Baker
McKenzie and Company re Swiss audit (.5);
correspond with Y. Salloum and C. Ceresa re
same (.2).
06/11/24 Carolin Paus 1.10 Translate correspondence of Swiss auditor re
reporting obligations under Swiss Bankruptcy
law (.4); draft overview of intercompany
claims between Swiss and German entities
(.7).
06/11/24 Carolin Paus 1.40 Review and analyze new supply agreement
(1.2); revise contract review summary (.2).
06/11/24 Ann-Kathrin Ziegler 1.20 Conference with J. Mudhar re German
workstreams (.5); conference with German
counsel re restructuring considerations (.7).
06/12/24 Partha Kar 0.50 Telephone conference re Europe liquidity
forecasting with Company, AlixPartners.
06/12/24 Carolin Paus 1.80 Draft issues list with open questions re
standstill agreement, liquidity planning,
offsetting and settlement of inter-company
claims (1.0); review and revise clarification
correspondence re content and purpose of
standstill agreement (.8).
06/12/24 Ann-Kathrin Ziegler 2.00 Attend conference with Company, D. Wang
re German liquidity planning and future intra-
group shipping (1.0); prepare for same (.5);
review and revise draft correspondence to
Company re scope of standstill agreement
(.2); conference with D. Wang and J. Mudhar
re same (.3).
06/17/24 Kate Hardey 0.50 Conference with R. Meintjes re
manufacturing and FDA 510k transfers.
06/17/24 Sarah Osborne 0.20 Correspond with T. Chanroo re board
presentation for operations while in
bankruptcy.
06/17/24 Donatus Wang 0.20 Conference with Company re intercompany
payments and prepare for same.

3
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 127 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102698
Vyaire Medical Inc. Matter Number: 48520-12
Business Operations

Date Name Hours Description
06/18/24 Brian King 1.10 Prepare summary of regulatory notices and
filings addresses.
06/18/24 Ruan J. Meintjes 1.30 Review and analyze FDA device approval
issues (1.0); conference with AlixPartners re
same (.3).
06/19/24 Chris Ceresa 0.40 Correspond with Y. Salloum, K&E team,
Company re international operational issues.
06/19/24 Brian King 0.30 Review and analyze correspondence to
international regulatory counsel.
06/19/24 Carolin Paus 0.50 Telephone conference with Y. Salloum, K&E
team re liquidity planning of German entities.
06/20/24 Carolin Paus 0.50 Review and revise AMS restructuring letter to
CORDIS audit AG.
06/20/24 Carolin Paus 0.80 Telephone conference with Company and
Finkenhof re cashflow forecast and director
duties.
06/21/24 Cooper Barghols 0.50 Coordinate with R. Meintjes and O.
Kaufmann re licensure change of ownership
rules and regulations.
06/21/24 Chris Ceresa 1.00 Correspond with Y. Salloum, K&E team,
Company re international operational issues.
06/21/24 Olivia Kaufmann 0.40 Analyze and discuss change of control,
change of ownership research assignment
with R. Meintjes and C. Barghols (.3);
correspond with R. Meintjes, K&E team re
same (.1).
06/21/24 Sabrina Lieberman 2.50 Draft letter to Swiss auditor re stay of Swiss
proceedings (1.5); correspond with
AlixPartners, Y. Salloum and K&E team re
same (1.0).
06/21/24 Ruan J. Meintjes 0.90 Analyze state licensure change of license
ownership strategy (.8); coordinate with Y.
Salloum, K&E team re same (.1).
06/22/24 Ruan J. Meintjes 1.20 Research and analyze change of ownership
requirement for state licenses (1.0);
coordinate with Y. Salloum, K&E team re
same (.2).
06/24/24 Cooper Barghols 2.30 Research and summarize state licensure
change of ownership requirements.
06/24/24 Olivia Kaufmann 5.20 Research and analyze state wind-down,
change of ownership and change of control
requirements for specific licenses (3.7); draft
summary re same (1.5).

4
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 128 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102698
Vyaire Medical Inc. Matter Number: 48520-12
Business Operations

Date Name Hours Description
06/24/24 Sabrina Lieberman 0.90 Correspond with Company, AlixPartners, C.
Ceresa and K&E team re correspondence with
Swiss entities.
06/24/24 Carolin Paus 1.00 Review and revise comfort letter provided by
U.S. entities to Swiss entities (.7); draft
execution version of comfort letter (.3).
06/25/24 Cooper Barghols 0.80 Research and summarize state licensure
change of ownership requirements.
06/25/24 Donatus Wang 0.30 Conference with Y. Salloum, K&E team re
advisor engagement.
06/26/24 Chris Ceresa 0.50 Telephone conference with Y. Salloum, K&E
team, advisors re international business
operation issues.
06/26/24 Partha Kar 1.00 Correspond with Company re advisor
services.
06/26/24 Ruan J. Meintjes 2.00 Review and analyze state licensure change of
ownership requirements (1.8); coordinate with
C. Ceresa, K&E team re same (.2).
06/26/24 Carolin Paus 3.40 Review, summarize supplier agreements.
06/26/24 Ann-Kathrin Ziegler 0.30 Review, analyze correspondence re advisor
engagement, late filings of accounts.
06/27/24 Cooper Barghols 0.30 Conference with A. Del Rio and R. Meintjes
re state licensure change of ownership
investigation.
06/27/24 Chris Ceresa 0.60 Telephone conference with Y. Salloum, K&E
team, advisors re international business
operation issues.
06/27/24 Carolin Paus 4.40 Review and summarize supplier agreements
(3.0); research re same (1.4).
06/27/24 Kyle Nolan Trevett 0.50 Telephone conference with Company re
communications matters (.4); telephone
conference with C. Ceresa re same (.1).
06/27/24 Ann-Kathrin Ziegler 0.80 Review, analyze correspondence re shipping
of good from German to US entities and
alignment with D. Wang re next steps (.3);
review, analyze correspondence re Swiss
auditor and alignment with D. Wang re next
steps (.3); review, analyze correspondence re
German material contracts (.2).
06/28/24 Cooper Barghols 0.50 Review and revise due diligence investigation
re state licensure change of ownership rules.

5
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 129 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102698
Vyaire Medical Inc. Matter Number: 48520-12
Business Operations

Date Name Hours Description
06/28/24 Kyle Nolan Trevett 1.80 Review, revise communications materials
(1.7); correspond with C. Ceresa, Company re
same (.1).

Total 51.50

6
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 130 of 631

601 Lexington Avenue
New York, NY 10022

FEIN 36-1326630

August 29, 2024

Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045

Attn: Vikram Bajaj

Invoice Number: 1050102699
Client Matter: 48520-13

In the Matter of Claims Administration

For legal services rendered through June 30, 2024
(see attached Description of Legal Services for detail) $ 17,351.50
Total legal services rendered $ 17,351.50

Austin Bay Area Beijing Boston Brussels Chicago Dallas Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 131 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102699
Vyaire Medical Inc. Matter Number: 48520-13
Claims Administration

Summary of Hours Billed

Name Hours Rate Amount
Chris Ceresa 3.10 1,345.00 4,169.50
Tiffani Chanroo 3.00 1,265.00 3,795.00
Kenny Chiaghana 7.30 815.00 5,949.50
David Hackel 0.60 975.00 585.00
Sarah Osborne 3.50 815.00 2,852.50

TOTALS 17.50 $ 17,351.50

2
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 132 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102699
Vyaire Medical Inc. Matter Number: 48520-13
Claims Administration

Description of Legal Services

Date Name Hours Description
06/14/24 Kenny Chiaghana 1.00 Analyze, revise bar date motion.
06/18/24 Kenny Chiaghana 0.80 Research re bar date motion.
06/19/24 Sarah Osborne 2.30 Research re noticing parties (2.1); correspond
with C. Ceresa re same (.2).
06/20/24 Kenny Chiaghana 0.20 Draft bar date motion.
06/24/24 Chris Ceresa 0.30 Review, revise, analyze legal issues re bar
date motion, order, and notices (.2);
correspond with K&E team re same (.1).
06/24/24 Tiffani Chanroo 1.20 Review, revise bar date motion (.7);
correspond with K. Chiaghana re same (.2);
review, analyze issues re same (.3).
06/24/24 Kenny Chiaghana 3.50 Analyze and revise bar date motion (3.1);
research re same (.4).
06/24/24 Sarah Osborne 1.00 Correspond with D. Hackel re Omni claims
inquiries (.3); telephone conference with C.
Ceresa, K&E team re same (.3); correspond
with AlixPartners, D. Hackel, K&E team re
same (.4).
06/25/24 Chris Ceresa 2.80 Review, revise, analyze legal issues re bar
date motion, order, and notices (2.1);
correspond with T. Chanroo, K&E team re
same (.7).
06/25/24 Tiffani Chanroo 1.40 Review, analyze bar date motion (.8);
correspond with Gibson Dunn, Omni, Y.
Salloum, K&E team re same (.6).
06/25/24 Kenny Chiaghana 0.90 Analyze and revise bar date motion.
06/25/24 Sarah Osborne 0.20 Correspond with AlixPartners re vendor
inquiry.
06/26/24 Tiffani Chanroo 0.40 Conference with D. Hackel, K&E team re
general motion bar date research.
06/26/24 Kenny Chiaghana 0.40 Analyze and revise bar date order.
06/29/24 David Hackel 0.60 Research re administrative claims, setoff
rights (.5); correspond with K. Chiaghana,
K&E team re same (.1).
06/30/24 Kenny Chiaghana 0.50 Research re claims setoff.

Total 17.50

3
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 133 of 631

601 Lexington Avenue
New York, NY 10022

FEIN 36-1326630

August 29, 2024

Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045

Attn: Vikram Bajaj

Invoice Number: 1050102700
Client Matter: 48520-14

In the Matter of Schedules and Statements (SOFAs)

For legal services rendered through June 30, 2024
(see attached Description of Legal Services for detail) $ 34,467.50
Total legal services rendered $ 34,467.50

Austin Bay Area Beijing Boston Brussels Chicago Dallas Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 134 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102700
Vyaire Medical Inc. Matter Number: 48520-14
Schedules and Statements (SOFAs)

Summary of Hours Billed

Name Hours Rate Amount
Tiffani Chanroo 17.90 1,265.00 22,643.50
Kenny Chiaghana 1.10 815.00 896.50
Julia R. Foster 0.40 525.00 210.00
David Hackel 10.00 975.00 9,750.00
Sarah Osborne 1.10 815.00 896.50
Tanzila Zomo 0.20 355.00 71.00

TOTALS 30.70 $ 34,467.50

2
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 135 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102700
Vyaire Medical Inc. Matter Number: 48520-14
Schedules and Statements (SOFAs)

Description of Legal Services

Date Name Hours Description
06/17/24 Tiffani Chanroo 4.50 Conference with AlixPartners team re
statements of financial affairs and schedules
(.7); correspond with Y. Salloum re same (.8);
correspond with U.S. Trustee re reporting
obligations (.4); review, analyze materials re
same (2.6).
06/18/24 Tiffani Chanroo 5.70 Conference with AlixPartners team re SoFA,
SOLA status (.6); review, analyze materials re
same (.6); correspond with AlixPartners re
initial debtor interview materials (.8); review,
analyze materials re same (1.1); review,
analyze issues re same (2.2); coordinate initial
debtor interview preparation (.4).
06/20/24 Tiffani Chanroo 4.40 Review, analyze materials re statement of
financial affairs and schedules (2.8);
correspond with AlixPartners team, Y.
Salloum, K&E team re same (1.6).
06/20/24 Kenny Chiaghana 0.60 Analyze, revise, SoFA extension motion.
06/21/24 Tiffani Chanroo 0.40 Correspond with AlixPartners, U.S. Trustee re
341 meeting scheduling (.2); correspond with
AlixPartners team re status of SoFA, SOLA
(.2).
06/24/24 Tiffani Chanroo 2.00 Attend initial debtor interview (.6);
correspond with Y. Salloum re same (.3);
correspond with AlixPartners team re
statements of financial affairs (.5); review,
analyze issues re same (.6).
06/25/24 Tiffani Chanroo 0.60 Review, analyze issues re statements of
financial affairs.
06/25/24 David Hackel 0.80 Correspond with T. Chanroo, PJT re funded
debt numbers (.2); research re same,
statements of financial affairs and
schedules(.3); review, analyze precedent re
same (.3).
06/26/24 David Hackel 2.40 Correspond with T. Chanroo, K&E team, PJT
re funded debt numbers (.3); research re same,
statements of financial affairs and schedules
(.8); review, analyze precedent re same (1.3).
06/27/24 Tiffani Chanroo 0.30 Correspond with D. Hackel re statements of
financial affairs global notes.
06/27/24 Kenny Chiaghana 0.50 Research re SoFA extension motion.

3
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 136 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102700
Vyaire Medical Inc. Matter Number: 48520-14
Schedules and Statements (SOFAs)

Date Name Hours Description
06/27/24 David Hackel 1.40 Correspond with T. Chanroo, K&E team,
AlixPartners re funded debt numbers,
statements of financial affairs and schedules
(.3); research re same (.4); review, analyze
precedent re same (.1); review, analyze issues
re global notes for statements and schedules
(.6).
06/28/24 Julia R. Foster 0.40 Research precedent re global notes for
statements and schedules.
06/28/24 David Hackel 5.40 Correspond with T. Chanroo, K&E team re
funded debt numbers, statements of financial
affairs, schedules, global notes (.3); research
re same (1.2); review, analyze precedent re
same (2.0); review, revise re global notes for
statements and schedules (1.9).
06/28/24 Sarah Osborne 1.10 Research precedent re statements and
schedules purposes (.9); correspond with T.
Chanroo, K&E team re same (.2).
06/28/24 Tanzila Zomo 0.20 Research re global notes for statements and
schedules.

Total 30.70

4
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 137 of 631

601 Lexington Avenue
New York, NY 10022

FEIN 36-1326630

August 29, 2024

Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045

Attn: Vikram Bajaj

Invoice Number: 1050102701
Client Matter: 48520-15

In the Matter of Creditor and Stakeholder Communications

For legal services rendered through June 30, 2024
(see attached Description of Legal Services for detail) $ 8,472.00
Total legal services rendered $ 8,472.00

Austin Bay Area Beijing Boston Brussels Chicago Dallas Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 138 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102701
Vyaire Medical Inc. Matter Number: 48520-15
Creditor and Stakeholder Communications

Summary of Hours Billed

Name Hours Rate Amount
David Hackel 6.00 975.00 5,850.00
Sabrina Lieberman 0.50 815.00 407.50
Eric Nyberg 1.00 340.00 340.00
Quin Wetzel 2.30 815.00 1,874.50

TOTALS 9.80 $ 8,472.00

2
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 139 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102701
Vyaire Medical Inc. Matter Number: 48520-15
Creditor and Stakeholder Communications

Description of Legal Services

Date Name Hours Description
06/10/24 Sabrina Lieberman 0.50 Conference with T. Chanroo, Omni and Cole
Schotz re service plan.
06/20/24 David Hackel 0.50 Review, analyze issues re service log (.3);
correspond with S. Osborne, T. Chanroo,
Omni re same (.2).
06/21/24 David Hackel 0.90 Review, analyze issues re service log (.5);
correspond with S. Osborne, T. Chanroo,
Omni re same (.3); telephone conference with
Omni re same (.1).
06/22/24 David Hackel 0.50 Review, analyze issues re service log (.4);
correspond with S. Osborne, T. Chanroo,
Omni re same (.1).
06/24/24 David Hackel 1.40 Review, analyze issues re service log (.6);
correspond with S. Osborne, K&E team,
Omni re same (.2); conference with C.
Ceresa, K&E team re same (.4); telephone
conference with Omni re same (.1); prepare
for same (.1).
06/24/24 Eric Nyberg 1.00 Organize and review disclosures relating to
creditors/entities.
06/24/24 Quin Wetzel 1.20 Review, revise notice of commencement (.7);
correspond with T. Chanroo re same (.1);
telephone conference with Omni re service of
notice of commencement (.2); correspond
with Omni, Cole Schotz re same (.2).
06/25/24 David Hackel 1.60 Review, analyze issues re service log (1.2);
correspond with S. Osborne, K&E team,
Omni, advisors, Company re same (.4).
06/25/24 Quin Wetzel 1.10 Review, analyze service requirements (.6);
correspond with T. Chanroo re notice of
commencement (.3); correspond with Omni re
service to creditors (.2).
06/26/24 David Hackel 0.10 Review, analyze issues re service log,
stakeholder issues.
06/27/24 David Hackel 0.30 Review, analyze issues re service log,
stakeholder issues (.2); correspond with
Omni, S. Osborne, K&E team re same (.1).
06/28/24 David Hackel 0.30 Review, analyze issues re service log,
stakeholder issues (.2); correspond with S.
Osborne re same (.1).

3
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 140 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102701
Vyaire Medical Inc. Matter Number: 48520-15
Creditor and Stakeholder Communications

Date Name Hours Description
06/29/24 David Hackel 0.40 Review, analyze issues re service log,
stakeholder issues (.2); revise summary re
same (.2).

Total 9.80

4
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 141 of 631

601 Lexington Avenue
New York, NY 10022

FEIN 36-1326630

August 29, 2024

Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045

Attn: Vikram Bajaj

Invoice Number: 1050102702
Client Matter: 48520-16

In the Matter of U.S. Trustee Matters and Communications

For legal services rendered through June 30, 2024
(see attached Description of Legal Services for detail) $ 1,726.00
Total legal services rendered $ 1,726.00

Austin Bay Area Beijing Boston Brussels Chicago Dallas Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 142 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102702
Vyaire Medical Inc. Matter Number: 48520-16
U.S. Trustee Matters and Communications

Summary of Hours Billed

Name Hours Rate Amount
Tiffani Chanroo 1.30 1,265.00 1,644.50
Sabrina Lieberman 0.10 815.00 81.50

TOTALS 1.40 $ 1,726.00

2
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 143 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102702
Vyaire Medical Inc. Matter Number: 48520-16
U.S. Trustee Matters and Communications

Description of Legal Services

Date Name Hours Description
06/15/24 Sabrina Lieberman 0.10 Correspond with C. Ceresa and T. Chanroo re
monthly operating reports.
06/20/24 Tiffani Chanroo 0.80 Correspond with U.S. Trustee, AlixPartners re
initial debtor interview material.
06/21/24 Tiffani Chanroo 0.50 Conference with Company, AlixPartners,
Cole Schotz team re initial debtor interview
preparation.

Total 1.40

3
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 144 of 631

601 Lexington Avenue
New York, NY 10022

FEIN 36-1326630

August 29, 2024

Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045

Attn: Vikram Bajaj

Invoice Number: 1050102703
Client Matter: 48520-17

In the Matter of Hearings

For legal services rendered through June 30, 2024
(see attached Description of Legal Services for detail) $ 30,967.00
Total legal services rendered $ 30,967.00

Austin Bay Area Beijing Boston Brussels Chicago Dallas Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 145 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102703
Vyaire Medical Inc. Matter Number: 48520-17
Hearings

Summary of Hours Billed

Name Hours Rate Amount
Tiffani Chanroo 12.20 1,265.00 15,433.00
Sabrina Lieberman 3.30 815.00 2,689.50
Yusuf Salloum 3.00 1,595.00 4,785.00
Josh Sussberg, P.C. 2.40 2,305.00 5,532.00
Spencer A. Winters, P.C. 1.50 1,685.00 2,527.50

TOTALS 22.40 $ 30,967.00

2
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 146 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102703
Vyaire Medical Inc. Matter Number: 48520-17
Hearings

Description of Legal Services

Date Name Hours Description
06/11/24 Tiffani Chanroo 3.70 Review, analyze issues re first day hearing
(2.2); participate in and present at first day
hearing (1.1); assist with filing of first day
orders (.4).
06/11/24 Sabrina Lieberman 3.30 Revise talking points for first day hearing
(1.5); correspond with S. Osborne and K&E
team re same (1.8).
06/11/24 Yusuf Salloum 3.00 Attend and participate in first day hearing
(1.5); prepare for same (1.5).
06/11/24 Josh Sussberg, P.C. 2.40 Attend and participate in first day hearing
(1.5); prepare for same (.9).
06/11/24 Spencer A. Winters, P.C. 1.50 Attend and participate in first day hearing.
06/21/24 Tiffani Chanroo 4.00 Review, revise second day hearing motions
(1.2); correspond with Y. Salloum, K&E team
re same (.6); review, analyze issues re same
(2.2).
06/24/24 Tiffani Chanroo 4.50 Review, revise second day hearing motions
(2.4); review, analyze same (.8); correspond
with D. Hackel, K&E team re same (.6);
correspond with Q. Wetzel re notice of
commencement (.7).

Total 22.40

3
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 147 of 631

601 Lexington Avenue
New York, NY 10022

FEIN 36-1326630

August 29, 2024

Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045

Attn: Vikram Bajaj

Invoice Number: 1050102704
Client Matter: 48520-18

In the Matter of Insurance and Surety Matters

For legal services rendered through June 30, 2024
(see attached Description of Legal Services for detail) $ 1,026.00
Total legal services rendered $ 1,026.00

Austin Bay Area Beijing Boston Brussels Chicago Dallas Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 148 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102704
Vyaire Medical Inc. Matter Number: 48520-18
Insurance and Surety Matters

Summary of Hours Billed

Name Hours Rate Amount
Joshua Raphael 0.30 975.00 292.50
Quin Wetzel 0.90 815.00 733.50

TOTALS 1.20 $ 1,026.00

2
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 149 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102704
Vyaire Medical Inc. Matter Number: 48520-18
Insurance and Surety Matters

Description of Legal Services

Date Name Hours Description
06/20/24 Joshua Raphael 0.20 Review, analyze party in interest’s comments
to orders and correspond with C. Ceresa,
K&E team re same.
06/21/24 Joshua Raphael 0.10 Correspond with A. Salmen, K&E team,
Gibson Dunn re Chubb comments to first day
orders.
06/27/24 Quin Wetzel 0.90 Review, revise insurance order (.8);
correspond with T. Chanroo re same (.1).

Total 1.20

3
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 150 of 631

601 Lexington Avenue
New York, NY 10022

FEIN 36-1326630

August 29, 2024

Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045

Attn: Vikram Bajaj

Invoice Number: 1050102705
Client Matter: 48520-19

In the Matter of Utilities

For legal services rendered through June 30, 2024
(see attached Description of Legal Services for detail) $ 13,824.00
Total legal services rendered $ 13,824.00

Austin Bay Area Beijing Boston Brussels Chicago Dallas Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 151 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102705
Vyaire Medical Inc. Matter Number: 48520-19
Utilities

Summary of Hours Billed

Name Hours Rate Amount
Chris Ceresa 0.50 1,345.00 672.50
Tiffani Chanroo 5.50 1,265.00 6,957.50
Kenny Chiaghana 7.60 815.00 6,194.00

TOTALS 13.60 $ 13,824.00

2
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 152 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102705
Vyaire Medical Inc. Matter Number: 48520-19
Utilities

Description of Legal Services

Date Name Hours Description
06/21/24 Chris Ceresa 0.30 Correspond with T. Chanroo, K&E team re
utilities objection.
06/24/24 Chris Ceresa 0.20 Conference with T. Chanroo re utilities
objection.
06/25/24 Kenny Chiaghana 1.80 Research re objection to utilities motion.
06/26/24 Tiffani Chanroo 0.80 Correspond with K. Chiaghana re utilities
objection (.3); review, analyze issues re same
(.5).
06/26/24 Kenny Chiaghana 1.90 Research re utilities objection.
06/27/24 Tiffani Chanroo 3.10 Correspond with K. Chiaghana, K&E team,
counterparty re utilities objection (1.2);
analyze issues re same (1.9).
06/27/24 Kenny Chiaghana 2.00 Research re utilities objection.
06/28/24 Tiffani Chanroo 1.60 Review, analyze issues re utilities objection
(.9); conference with counterparty re same
(.3); correspond with C. Ceresa, K&E team re
same (.4).
06/28/24 Kenny Chiaghana 1.90 Analyze and revise settlement re utilities
objection (1.0); research re same (.9).

Total 13.60

3
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 153 of 631

601 Lexington Avenue
New York, NY 10022

FEIN 36-1326630

August 29, 2024

Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045

Attn: Vikram Bajaj

Invoice Number: 1050102706
Client Matter: 48520-20

In the Matter of Tax Matters

For legal services rendered through June 30, 2024
(see attached Description of Legal Services for detail) $ 142,679.50
Total legal services rendered $ 142,679.50

Austin Bay Area Beijing Boston Brussels Chicago Dallas Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 154 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102706
Vyaire Medical Inc. Matter Number: 48520-20
Tax Matters

Summary of Hours Billed

Name Hours Rate Amount
Hannah Crawford 0.50 1,595.00 797.50
Michael Ehret 12.30 1,895.00 23,308.50
Emanuel Goetz 3.00 620.00 1,860.00
Palmer Gunderson 33.80 845.00 28,561.00
Liz Ji 1.70 1,175.00 1,997.50
Partha Kar 7.80 2,305.00 17,979.00
Sabrina Lieberman 2.30 815.00 1,874.50
Jai Mudhar 3.90 1,265.00 4,933.50
Dan O'Connor 1.50 1,265.00 1,897.50
Florian Schuette 1.00 750.00 750.00
Donatus Wang 1.20 905.00 1,086.00
Nicholas Warther 20.20 1,665.00 33,633.00
Cristina Weidner 2.20 1,665.00 3,663.00
Sara B. Zablotney, P.C. 6.30 2,445.00 15,403.50
Ann-Kathrin Ziegler 4.70 1,050.00 4,935.00

TOTALS 102.40 $ 142,679.50

2
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 155 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102706
Vyaire Medical Inc. Matter Number: 48520-20
Tax Matters

Description of Legal Services

Date Name Hours Description
06/09/24 Jai Mudhar 1.00 Correspond with N. Warther, K&E team re
final points pre-filing.
06/09/24 Nicholas Warther 0.20 Telephone conference with PJT, M. Ehret and
K&E team re taxes motion.
06/09/24 Sara B. Zablotney, P.C. 0.70 Correspond with N. Warther, K&E team
structures and first day motions (.2); review,
discuss Swiss agreements (.5).
06/10/24 Michael Ehret 1.70 Telephone conference with BDO, PwC, S.
Zablotney re tax considerations (1.0);
conference with A. Ziegler, K&E team re
Germany, structuring considerations (.2);
review, analyze issues and comment on
documents re same (.5).
06/10/24 Palmer Gunderson 1.50 Telephone conference with BDO, PwC,
Company re tax planning re sale (1.0);
telephone conference with T. Chanroo re
NOL motion (.3); correspond with S.
Zablotney, K&E team re first day tax motions
(.2).
06/10/24 Liz Ji 1.00 Telephone conference with N. Warther, K&E
team, Company re tax planning.
06/10/24 Partha Kar 2.50 Correspond with Company re Switzerland
auditor issues (.8); review, analyze relevant
documents re same (1.2); telephone
conference with Swiss counsel re local audit
issues (.5).
06/10/24 Sabrina Lieberman 1.80 Review, revise tax motion (1.5); conference
with T. Chanroo re same (.3).
06/10/24 Jai Mudhar 0.20 Correspond with P. Kar re Swiss
subordination issue (.1); conference with D.
Wang re next steps (.1).
06/10/24 Dan O'Connor 1.50 Correspond with Y. Salloum, K&E team re
transaction matters, tax considerations (.5);
telephone conference with S. Zablotney, K&E
team, PwC, BDO, Company re tax matters
(1.0).
06/10/24 Donatus Wang 0.50 Conference with M. Ehret, K&E team re tax
workstreams.
06/10/24 Nicholas Warther 0.80 Telephone conference with BDO, PwC, S.
Zablotney, K&E team re tax analysis.

3
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 156 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102706
Vyaire Medical Inc. Matter Number: 48520-20
Tax Matters

Date Name Hours Description
06/10/24 Cristina Weidner 2.20 Telephone conference with Company, P. Kar,
K&E team re Swiss issues.
06/10/24 Sara B. Zablotney, P.C. 1.40 Telephone conference with BDO, PwC re tax
structure and modeling (1.0); telephone
conference with Company re same (.4).
06/10/24 Ann-Kathrin Ziegler 1.00 Correspond with D. Wang re German
workstreams (.8); conference with M. Ehret,
K&E team re German tax workstream (.2).
06/11/24 Hannah Crawford 0.50 Prepare for conference with Company, local
counsel re Switzerland entity issues.
06/11/24 Partha Kar 2.00 Correspond with Company re auditor issues
in Switzerland (.8); telephone conference with
Swiss counsel and Company re local audit
issues (.5); telephone conference and
correspond with J. Mudhar, K&E team re
same (.7).
06/11/24 Jai Mudhar 2.00 Conference with Company, Swiss counsel re
Switzerland auditor issues (.5); correspond
with Company, Swiss counsel re same (.8);
telephone conference with P. Kar re follow up
re same (.7).
06/11/24 Ann-Kathrin Ziegler 0.80 Conferences with J. Mudhar, Company, Swiss
counsel re auditor issues.
06/12/24 Palmer Gunderson 1.20 Review, analyze company structure re
structure presentation for sale process.
06/13/24 Palmer Gunderson 5.20 Draft presentation re tax structuring for
potential sale transactions (4.0); research re
same (1.2).
06/14/24 Palmer Gunderson 0.30 Correspond with N. Warther re structuring
and tax planning considerations.
06/15/24 Sabrina Lieberman 0.20 Correspond with C. Ceresa re corporate
structure, tax issue.
06/17/24 Michael Ehret 1.50 Conferences with E. Goetz, K&E team,
Company, PwC re German tax matters,
structuring, related considerations (1.2);
correspond with Company, PwC re same (.3).
06/17/24 Palmer Gunderson 0.50 Correspond with Company re company tax
planning and structuring issues.
06/17/24 Sabrina Lieberman 0.20 Correspond with Company, P. Gunderson and
K&E team re corporate financing tax
implications.
06/17/24 Nicholas Warther 0.20 Correspond with S. Zablotney, K&E team re
tax modeling.

4
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 157 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102706
Vyaire Medical Inc. Matter Number: 48520-20
Tax Matters

Date Name Hours Description
06/18/24 Michael Ehret 0.70 Conference with S. Zablotney, K&E team,
BDO re tax, structuring considerations (.6);
correspond with N. Warther, K&E team and
follow up re same (.1).
06/18/24 Palmer Gunderson 1.30 Telephone conference with Company
representative re tax planning and diligence
considerations (.6); telephone conference with
N. Warther and S. Zablotney re tax planning
considerations (.2); telephone conference with
M. Ehret and N. Warther re German tax
considerations (.5).
06/18/24 Liz Ji 0.70 Telephone conference with N. Warther, K&E
team, BDO re tax considerations.
06/18/24 Nicholas Warther 2.20 Telephone conference with BDO, S.
Zablotney, K&E team, Company re tax
modeling (.9); review and analyze tax
structuring (.5); correspond with S.
Zablotney, K&E team re German tax
structuring (.8).
06/18/24 Sara B. Zablotney, P.C. 0.50 Telephone conference with N. Warther, P.
Gunderson re tax planning considerations.
06/19/24 Emanuel Goetz 2.00 Review, analyze German tax implications
(.8); draft summary re analysis re same (1.2).
06/19/24 Partha Kar 0.70 Correspond with Company re Swiss auditor
requests and issues (.2); telephone conference
re liquidity issues for Europe with Company,
AlixPartners (.5).
06/19/24 Florian Schuette 1.00 Review, analyze structuring, German tax
considerations (.5); conference with E. Goetz
re same (.5).
06/20/24 Emanuel Goetz 1.00 Review, analyze German tax implications and
summary of relevant fact pattern in relation to
German entities.
06/20/24 Nicholas Warther 1.50 Correspond with S. Zablotney, K&E team re
German tax structuring (.8); review, revise
summary of same (.7).
06/20/24 Sara B. Zablotney, P.C. 0.30 Research re tax analysis.
06/20/24 Ann-Kathrin Ziegler 0.80 Review and comment on tax structuring
issues correspondence.
06/21/24 Ann-Kathrin Ziegler 0.40 Conference with M. Ehret re German tax
workstreams.
06/23/24 Nicholas Warther 0.70 Review, analyze tax structuring.

5
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 158 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102706
Vyaire Medical Inc. Matter Number: 48520-20
Tax Matters

Date Name Hours Description
06/24/24 Michael Ehret 1.70 Review, analyze amendment draft write-up in
relation to German tax implications
re elimination of intergroup receivables,
payables (.9); conference with E. Goetz re
same (.3); correspond with N. Warther, K&E
team re tax, structuring, related considerations
(.2); conference with N. Warther, K&E team
re same, next steps (.3).
06/24/24 Palmer Gunderson 0.10 Correspond with S. Zablotney, K&E team re
draft disclosure schedule and plan of
reorganization re tax considerations.
06/24/24 Partha Kar 1.20 Correspond with Company re auditor issues,
cash flows and comfort letter in Switzerland.
06/24/24 Nicholas Warther 1.20 Correspond with M. Ehret, K&E team re
German tax analysis (.8); review, analyze
plan and disclosures re tax considerations (.4).
06/25/24 Michael Ehret 2.70 Conference with D. Wang, K&E team re
structuring considerations, German
workstreams (1.1); conference with Company
re structuring considerations (.5); conference
with PwC, N. Warther, K&E team re advisor
engagement (.5); correspond with Company,
N. Warther, K&E team re same (.6).
06/25/24 Palmer Gunderson 5.80 Correspond with N. Warther, K&E team re
structure of tax disclosure (.4); review,
comment on disclosure statement re tax (3.9);
review, comment on plan re tax
considerations (.6); continue to review,
comment on disclosure statement re tax (.9).
06/25/24 Partha Kar 1.00 Correspond with Company re advisor services
(.5); telephone conference J. Mudhar re
advisor services (.5).
06/25/24 Donatus Wang 0.70 Conference with M. Ehret, K&E team on
potential tax structuring options for asset deal
and share deal.
06/25/24 Nicholas Warther 1.00 Telephone conference with PwC re German
tax analysis (.6); review, analyze structuring
re tax considerations (.4).
06/25/24 Sara B. Zablotney, P.C. 1.00 Telephone conference re non-US analysis
(.5); coordinate modeling and analysis (.3);
follow up re regulatory issues (.2).

6
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 159 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102706
Vyaire Medical Inc. Matter Number: 48520-20
Tax Matters

Date Name Hours Description
06/25/24 Ann-Kathrin Ziegler 1.70 Conference with M. Ehret, C. Weidner and D.
Wang re tax issues (.5); prepare for same (.4);
correspond with D. Wang, K&E team re
presentation outline re same (.6); conference
with N. Warther, K&E team re advisor
engagement (partial) (.2).
06/26/24 Palmer Gunderson 1.90 Review, prepare tax comments on bid asset
purchase agreement.
06/26/24 Jai Mudhar 0.70 Correspond with Company re EY services.
06/26/24 Nicholas Warther 1.20 Review, analyze structuring, tax
considerations (.6); correspond with S.
Zablotney, K&E team re same (.6).
06/26/24 Sara B. Zablotney, P.C. 0.20 Correspond with N. Warther, K&E team re
PwC analysis.
06/27/24 Palmer Gunderson 3.70 Correspond with N. Warther re tax
considerations re asset purchase agreements,
plan, disclosure statement (.8); review,
comment on tax considerations re asset
purchase agreement (2.9).
06/27/24 Partha Kar 0.40 Correspond with Company re advisor
services.
06/27/24 Sabrina Lieberman 0.10 Correspond with AlixPartners and C. Ceresa
re Hawai'i tax matter.
06/27/24 Nicholas Warther 4.00 Review, revise tax portions of asset purchase
agreement (.8); review, analyze questions re
tax modeling (1.6); review, revise tax portions
of plan (.3); correspond with BDO, Company
re tax modeling (.8); correspond with S.
Zablotney, K&E team re structuring (.5).
06/27/24 Sara B. Zablotney, P.C. 0.20 Correspond with N. Warther, K&E team re
tax structuring considerations.
06/28/24 Michael Ehret 2.50 Review, analyze asset purchase agreement,
documents re tax considerations (1.1);
conference with PwC re structuring, tax
considerations (1.0); correspond with PwC,
K&E team re same (.4).

7
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 160 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102706
Vyaire Medical Inc. Matter Number: 48520-20
Tax Matters

Date Name Hours Description
06/28/24 Palmer Gunderson 8.80 Correspond with N. Warther, K&E team re
potential sale transactions, related structuring
considerations (1.8); revise tax comments re
potential asset purchase agreement for
respiratory diagnostics business (3.1),
telephone conference with S. Zablotney, K&E
team, Company re intercompany debt, asset
basis, tax structure (.4); review, comment on
asset purchase agreement for re tax matters,
related considerations (3.5).
06/28/24 Nicholas Warther 3.50 Telephone conference with BDO re tax
modeling (1.0); review, revise tax portions of
asset purchase agreement (1.4); correspond
with S. Zablotney, K&E team re tax
structuring (.7); review, revise tax portions of
plan (.4).
06/28/24 Sara B. Zablotney, P.C. 2.00 Telephone conference with P. Gunderson,
Company re tax structure, related
considerations (.9); review, comment on asset
purchase agreement re tax considerations (.5);
analyze deposit (.6).
06/29/24 Palmer Gunderson 0.60 Correspond with S. Zablotney, K&E team re
asset purchase agreements and transaction
structure (.4); review, analyze asset purchase
agreement re tax matters (.2).
06/29/24 Nicholas Warther 1.70 Review, revise tax portions of plan and
disclosure statement (.8); correspond with M.
Ehret, K&E team re same (.6); correspond
with M. Ehret, K&E team re German tax
issues (.3).
06/30/24 Michael Ehret 1.50 Review, analyze correspondence from P.
Gunderson, N. Warther re draft asset purchase
agreement re tax considerations (.4); review,
analyze draft asset purchase agreement (.8);
correspond with N. Warther, K&E team re
same (.3).
06/30/24 Palmer Gunderson 2.90 Revise tax comments re asset purchase
agreements (2.1); correspond with N.
Warther, K&E team re asset purchase
agreements and transaction structure (.8).

8
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 161 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102706
Vyaire Medical Inc. Matter Number: 48520-20
Tax Matters

Date Name Hours Description
06/30/24 Nicholas Warther 2.00 Review, revise tax portions of asset purchase
agreements (1.6); review, revise tax
disclosures (.4).

Total 102.40

9
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 162 of 631

601 Lexington Avenue
New York, NY 10022

FEIN 36-1326630

August 29, 2024

Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045

Attn: Vikram Bajaj

Invoice Number: 1050102707
Client Matter: 48520-21

In the Matter of Case Administration

For legal services rendered through June 30, 2024
(see attached Description of Legal Services for detail) $ 101,014.50
Total legal services rendered $ 101,014.50

Austin Bay Area Beijing Boston Brussels Chicago Dallas Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 163 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102707
Vyaire Medical Inc. Matter Number: 48520-21
Case Administration

Summary of Hours Billed

Name Hours Rate Amount
Chris Ceresa 4.60 1,345.00 6,187.00
Tiffani Chanroo 23.80 1,265.00 30,107.00
Kenny Chiaghana 15.90 815.00 12,958.50
Hannah Crawford 0.90 1,595.00 1,435.50
Tabitha J. De Paulo 1.60 1,435.00 2,296.00
Jaina Desai 3.00 815.00 2,445.00
Amy Donahue 3.30 525.00 1,732.50
Julia R. Foster 7.20 525.00 3,780.00
David Hackel 5.90 975.00 5,752.50
Sabrina Lieberman 15.80 815.00 12,877.00
Rebecca J. Marston 3.70 1,265.00 4,680.50
Sarah Osborne 2.50 815.00 2,037.50
Carolin Paus 0.60 620.00 372.00
Joshua Raphael 1.20 975.00 1,170.00
Yusuf Salloum 2.00 1,595.00 3,190.00
Adrian Salmen 1.10 1,095.00 1,204.50
Seth Sanders 2.80 1,095.00 3,066.00
Josh Sussberg, P.C. 0.20 2,305.00 461.00
Donatus Wang 1.20 905.00 1,086.00
Cristina Weidner 1.00 1,665.00 1,665.00
Spencer A. Winters, P.C. 0.50 1,685.00 842.50
Tanzila Zomo 4.70 355.00 1,668.50

TOTALS 103.50 $ 101,014.50

2
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 164 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102707
Vyaire Medical Inc. Matter Number: 48520-21
Case Administration

Description of Legal Services

Date Name Hours Description
06/09/24 Hannah Crawford 0.20 Correspond with P. Kar and J. Madhur re
matter status.
06/09/24 Donatus Wang 1.20 Correspond with Company re execution of
standstill agreement.
06/10/24 Amy Donahue 1.00 Download filed motion and documents and
organize.
06/10/24 Carolin Paus 0.60 Update workstream summary (.3); summarize
open topics (.3).
06/11/24 Tiffani Chanroo 4.00 Correspond with S. Lieberman, K&E team re
case status (2.1); review, analyze correspond
re work in process (1.9).
06/11/24 Tabitha J. De Paulo 1.60 Conference with PJT for first‑day hearing
(.2); correspond with PJT re same (.2);
conference with AlixPartners and Company re
same (1.2).
06/11/24 Jaina Desai 0.50 Review, revise case timeline (.4); correspond
with K. Trevett re same (.1).
06/11/24 Amy Donahue 0.60 Create and revise calendar invites for
upcoming hearings and distribute to C.
Ceresa, K&E team (.3); coordinate technical
logistics re hearing listen-only line (.3).
06/11/24 Seth Sanders 1.00 Correspond with declarants re hearing prep
(.4); telephone conference with PJT re same
(.6).
06/11/24 Tanzila Zomo 0.50 Compile recently filed pleadings for
distribution to C. Ceresa, K&E team (.4);
correspond with C. Ceresa, K&E team re
same (.1).
06/11/24 Tanzila Zomo 0.50 Coordinate, monitor first day hearing line.
06/12/24 Tiffani Chanroo 4.40 Telephone conference with C. Ceresa re case
status (.8); correspond with C. Ceresa, K&E
team, AlixPartners team re work in process
(2.4); review, analyze materials re same (1.2).
06/12/24 Kenny Chiaghana 0.30 Draft summary of upcoming key dates and
deadlines re first day orders.
06/12/24 Jaina Desai 0.10 Correspond with T. Chanroo re post-petition
workstreams.

3
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 165 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102707
Vyaire Medical Inc. Matter Number: 48520-21
Case Administration

Date Name Hours Description
06/12/24 David Hackel 3.30 Review, analyze issues re first day pleadings
(.9); draft, revise summary re same (1.4);
correspond with R. Meintjes, K&E team re
same (.3); research re same, precedent re first
day pleading, hearing issues (.7).
06/12/24 Rebecca J. Marston 0.10 Correspond with D. Hackel re case
description.
06/12/24 Tanzila Zomo 0.50 Compile recently filed pleadings for
distribution to C. Ceresa, K&E team (.4);
correspond with C. Ceresa, K&E team re
same (.1).
06/13/24 Tiffani Chanroo 2.60 Conference with C. Ceresa, K&E team re
work in process (.5); conference with C.
Ceresa re case timeline (.6); review, analyze
issues re same (1.1); review, analyze
correspondence re case status (.4).
06/13/24 Kenny Chiaghana 1.90 Review, revise work in process summary
(1.4); conference with C. Ceresa, K&E team
re work in process (.5).
06/13/24 Jaina Desai 0.60 Telephone conference with C. Ceresa, K&E
team re case status, next steps (.5); correspond
with T. Chanroo re same (.1).
06/13/24 Amy Donahue 0.50 Telephone conference with C. Ceresa, K&E
team re work in process.
06/13/24 Julia R. Foster 1.30 Conference with C. Ceresa, K&E team re
work in process (.5); correspond with S.
Lieberman and K. Chiaghana re case
deadlines (.4); review, revise pleading
template (.4).
06/13/24 David Hackel 1.60 Review, analyze legal issues re first day
pleadings (.3); revise summary re same (.5);
correspond with C. Ceresa, K&E team re
same (.5); research re same, precedent re first
day pleading items (.3).
06/13/24 Sabrina Lieberman 0.30 Conference with C. Ceresa and K&E team re
work in process (partial).
06/13/24 Sarah Osborne 0.50 Telephone conference with C. Ceresa, K&E
team re case updates.
06/13/24 Joshua Raphael 0.40 Telephone conference with C. Ceresa, K&E
team re work in process (partial).

4
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 166 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102707
Vyaire Medical Inc. Matter Number: 48520-21
Case Administration

Date Name Hours Description
06/13/24 Seth Sanders 0.90 Review, revise work in process summary (.3);
correspond with K. Chiaghana re same (.1);
telephone conference with C. Ceresa, K&E
team re work in process (.5).
06/13/24 Tanzila Zomo 0.70 Compile recently filed pleadings for
distribution to C. Ceresa, K&E team (.1);
correspond with C. Ceresa, K&E team re
same (.1); K&E team re case status updates
(.5).
06/14/24 Tiffani Chanroo 2.10 Review, analyze correspondence re case
status (1.8); correspond with C. Ceresa, K&E
team re same (.3).
06/14/24 Kenny Chiaghana 0.80 Review, revise summary re upcoming key
case dates and deadlines re first day notions
and orders.
06/14/24 Sabrina Lieberman 0.20 Correspond with Cole Schotz and Omni re
master service list.
06/14/24 Rebecca J. Marston 0.20 Draft and submit weekly case report.
06/14/24 Tanzila Zomo 0.20 Compile recently filed pleadings for
distribution to C. Ceresa, K&E team (.1);
correspond with C. Ceresa, K&E team re
same (.1).
06/15/24 Sabrina Lieberman 0.10 Correspond with C. Ceresa and K&E team re
service list.
06/16/24 Sabrina Lieberman 0.30 Review and analyze correspondence from C.
Ceresa and K&E team re work in process.
06/17/24 Chris Ceresa 1.00 Review, analyze case materials (.7);
correspond with T. Chanroo, K&E team,
advisors re same (.3).
06/17/24 Kenny Chiaghana 1.20 Review, revise summary re key dates and
deadlines (.9); review, revise work in process
summary (.3).
06/17/24 Amy Donahue 0.20 Create and revise calendar invites for
upcoming hearings.
06/17/24 Julia R. Foster 0.30 Review, analyze pleading template.
06/17/24 Sabrina Lieberman 1.00 Conference with T. Chanroo and AlixPartners
re reporting obligations (.5); conference with
T. Chanroo, K&E team re work in process
(.4); correspond with C. Ceresa and T.
Chanroo re same (.1).
06/17/24 Spencer A. Winters, P.C. 0.50 Prepare for and attend weekly telephone
conference with Company and advisors.

5
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 167 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102707
Vyaire Medical Inc. Matter Number: 48520-21
Case Administration

Date Name Hours Description
06/17/24 Tanzila Zomo 0.20 Compile recently filed pleadings for
distribution to C. Ceresa, K&E team (.1);
correspond with C. Ceresa, K&E team re
same (.1).
06/18/24 Chris Ceresa 0.50 Review, analyze case materials (.3);
correspond with Y. Salloum, K&E team,
advisors re same (.2).
06/18/24 Tiffani Chanroo 1.10 Conference with Y. Salloum, K&E team,
Company re various case issues (.5);
conference with C. Ceresa re same (.6).
06/18/24 Tiffani Chanroo 2.10 Conference with Cole Schotz team, C. Ceresa
re second day hearing (.5); review, analyze
issues re same (.6); conference with C. Ceresa
re second day motions (.4); correspond with
Y. Salloum, K&E team re second day motions
(.6).
06/18/24 Kenny Chiaghana 0.90 Review, revise summary re case deadlines.
06/18/24 Jaina Desai 0.20 Review, revise work in process summary
chart (.1); correspond with K. Chiaghana, R.
Marston re same (.1).
06/18/24 Jaina Desai 0.30 Review, revise case timeline.
06/18/24 Julia R. Foster 0.70 Correspond with D. Hackel re first day orders
(.4); compile first day entered orders (.3).
06/18/24 Sabrina Lieberman 4.30 Conference with AlixPartners re noticing and
service (.5); conference with Omni re same
(.5); conference with C. Ceresa re same (.3);
conference with R. Meintjes and K&E team
re same (.2); correspond with PJT, Omni, C.
Ceresa and K&E team re same (1.9); research
noticing parties (.9).
06/18/24 Rebecca J. Marston 2.20 Research noticing parties (1.9); correspond
with S. Lieberman, K&E team re same (.3).
06/18/24 Tanzila Zomo 0.30 Compile recently filed pleadings for
distribution to C. Ceresa, K&E team (.2);
correspond with C. Ceresa, K&E team re
same (.1).
06/19/24 Tiffani Chanroo 0.80 Review, analyze materials re second day
hearing (.6); correspond with Y. Salloum,
K&E team re same (.2).

6
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 168 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102707
Vyaire Medical Inc. Matter Number: 48520-21
Case Administration

Date Name Hours Description
06/19/24 Sabrina Lieberman 1.00 Correspond with M. Boney and R. Marston re
anti-trust billing (.2); conference with Omni
re supplemental noticing (.1); correspond with
C. Ceresa re same (.2); review and analyze
correspondence from C. Ceresa and K&E
team re work in process. (.1); conference with
Omni (.1); review and analyze
correspondence re same (.3).
06/19/24 Cristina Weidner 1.00 Conference with A. Ziegler, K&E team re
work in process.
06/20/24 Chris Ceresa 0.30 Review, analyze case materials (.2);
correspond with T. Chanroo, K&E team,
advisors re same (.1).
06/20/24 Tiffani Chanroo 1.10 Conference with R. Marston, K&E team re
work in process (.5); conference with C.
Ceresa re case status (.6).
06/20/24 Tiffani Chanroo 1.60 Review, revise second day pleadings (1.2);
correspond with D. Hackel, K&E team re
same (.4).
06/20/24 Kenny Chiaghana 2.60 Review, revise summary re key dates and
deadlines (1.4); participate in conference with
K&E team, C. Ceresa re work in process (.2);
analyze, revise, work in process summary (1).
06/20/24 Jaina Desai 0.50 Telephone conference with T. Chanroo re
case status, next steps.
06/20/24 Amy Donahue 0.30 Telephone conference with T. Chanroo, K&E
team re work in process (partial).
06/20/24 Julia R. Foster 0.70 Telephone conference with T. Chanroo, K&E
team re work in process (.5); review, revise
post-petition pleading template (.2).
06/20/24 David Hackel 0.30 Conference with C. Ceresa, K&E team re case
status, next steps (partial).
06/20/24 Sabrina Lieberman 0.40 Conference with T. Chanroo and K&E team
re work in process (partial).
06/20/24 Rebecca J. Marston 0.50 Conference with C. Ceresa, K&E team re
work in process.
06/20/24 Sarah Osborne 0.50 Telephone conference with C. Ceresa, K&E
team re case updates.
06/20/24 Joshua Raphael 0.20 Telephone conference with C. Ceresa, K&E
team re work in process (partial).
06/20/24 Adrian Salmen 0.50 Conference with T. Chanroo, K&E team re
work in process.

7
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 169 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102707
Vyaire Medical Inc. Matter Number: 48520-21
Case Administration

Date Name Hours Description
06/20/24 Seth Sanders 0.40 Telephone conference with C. Ceresa, K&E
team re work in process (partial).
06/20/24 Tanzila Zomo 0.30 Compile recently filed pleadings for
distribution to C. Ceresa, K&E team (.2);
correspond with C. Ceresa, K&E team re
same (.1).
06/20/24 Tanzila Zomo 0.50 Telephone conference with J. Foster, K&E
team re case status updates.
06/21/24 Chris Ceresa 0.80 Review, analyze case materials (.4);
correspond with Y. Salloum, K&E team,
advisors re same (.4).
06/21/24 Hannah Crawford 0.20 Correspond with A. Chan and J. Mudhar re
list of local counsel.
06/21/24 Julia R. Foster 0.50 Compile filed first day motions and orders.
06/21/24 Sabrina Lieberman 0.50 Correspond with Omni re notice (.2); review
and analyze correspondence from Y. Salloum
and K&E team (.3).
06/21/24 Rebecca J. Marston 0.10 Draft weekly case report.
06/21/24 Yusuf Salloum 1.30 Review, revise second day pleadings.
06/22/24 Chris Ceresa 0.30 Review, analyze case materials (.2);
correspond with T. Chanroo, K&E team,
advisors re same (.1).
06/22/24 Tiffani Chanroo 0.30 Correspond with Y. Salloum, K&E team re
second day motions.
06/23/24 Tiffani Chanroo 0.30 Correspond with Gibson, Y. Salloum, K&E
team re second day motions.
06/24/24 Chris Ceresa 0.20 Conference with Y. Salloum re work in
process.
06/24/24 Kenny Chiaghana 2.50 Analyze and revise summary of upcoming
court dates and deadlines (1.7); analyze and
revise work in process summary (.8).
06/24/24 Jaina Desai 0.20 Review, revise work in process summary.
06/24/24 Sabrina Lieberman 0.10 Revise work in process summary.
06/24/24 Sabrina Lieberman 0.50 Correspond with C. Ceresa and R. Marston re
work in process.
06/25/24 Chris Ceresa 0.80 Conference with T. Chanroo K&E team re
work in process (.6); prepare for same (.2).
06/25/24 Tiffani Chanroo 0.80 Conference with C. Ceresa, K&E team re
work in process (.6); prepare for same (.2).
06/25/24 Tiffani Chanroo 1.70 Review, revise second day hearing motions
(1.3); correspond with C. Ceresa re same (.4).

8
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 170 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102707
Vyaire Medical Inc. Matter Number: 48520-21
Case Administration

Date Name Hours Description
06/25/24 Kenny Chiaghana 1.80 Analyze and revise work in process summary
(1.2); conference with K&E team and C.
Ceresa re work in process (.6).
06/25/24 Hannah Crawford 0.30 Correspond with Y. Salloum, K&E team re
case status.
06/25/24 Jaina Desai 0.60 Telephone conference with C. Ceresa, K&E
team re case status, next steps.
06/25/24 Amy Donahue 0.70 Telephone conference with C. Ceresa, K&E
team re work in process (.6); prepare for same
(.1).
06/25/24 Julia R. Foster 1.10 Conference with C. Ceresa, K&E team re
work in process (.6); review and revise orders
re July 9, 2024 hearing (.5).
06/25/24 Julia R. Foster 0.30 Coordinate calendar invites re July 17, 2024
341 meeting.
06/25/24 David Hackel 0.70 Conference with C. Ceresa, K&E team re case
status, next steps (.6); revise work in process
chart re same (.1).
06/25/24 Sabrina Lieberman 1.10 Conference with Y. Salloum and K&E team
re work in process (.6); review and analyze
correspondence from C. Ceresa and K&E
team re same (.5).
06/25/24 Rebecca J. Marston 0.60 Conference with C. Ceresa, K&E team re
work in process.
06/25/24 Sarah Osborne 0.50 Telephone conference with C. Ceresa, K&E
team re case updates (partial).
06/25/24 Joshua Raphael 0.60 Conference with C. Ceresa, K&E team re
work in process.
06/25/24 Yusuf Salloum 0.70 Conference with C. Ceresa, K&E team re
work in process (.6); prepare for same (.1).
06/25/24 Adrian Salmen 0.60 Conference with C. Ceresa, K&E team re
work in process.
06/25/24 Seth Sanders 0.50 Conference with C. Ceresa, K&E team re case
status (partial).
06/25/24 Josh Sussberg, P.C. 0.20 Review, analyze miscellaneous
correspondence.
06/25/24 Tanzila Zomo 0.20 Compile recently filed pleadings for
distribution to C. Ceresa, K&E team (.1);
correspond with C. Ceresa, K&E team re
same (.1).
06/25/24 Tanzila Zomo 0.50 Telephone conference with J. Foster, K&E
team re case status updates (partial).

9
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 171 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102707
Vyaire Medical Inc. Matter Number: 48520-21
Case Administration

Date Name Hours Description
06/26/24 Chris Ceresa 0.70 Review, analyze first day motions for second
day (.4); review, analyze other second day
hearing motions (.3).
06/26/24 Tiffani Chanroo 0.90 Review, analyze issues re second day hearing.
06/26/24 Kenny Chiaghana 2.10 Review, revise summary re key dates and
deadlines (1.1); analyze and revise work in
process summary (1).
06/26/24 Julia R. Foster 0.90 Review and revise pleading template (.7);
correspond with C. Ceresa re July 9, 2024
hearing (.2).
06/26/24 Sabrina Lieberman 0.60 Review and analyze correspondence from C.
Ceresa and K&E team re work in process.
06/27/24 Kenny Chiaghana 1.10 Review, revise summary of key dates and
deadlines (.7); review, revise work in process
summary (.4).
06/27/24 Hannah Crawford 0.20 Review, analyze correspondence re case
status.
06/27/24 Sabrina Lieberman 3.10 Conference with Omni re noticing plan (.3);
correspond with C. Ceresa and S. Osborne re
same (.2); review and analyze correspondence
from C. Ceresa and K&E team re work in
process. (2.6).
06/27/24 Sarah Osborne 1.00 Research re notice and master service list (.8);
correspond with Omni, C. Ceresa, K&E team
re same (.2).
06/27/24 Tanzila Zomo 0.30 Compile recently filed pleadings for
distribution to C. Ceresa, K&E team (.2);
correspond with C. Ceresa, K&E team re
same (.1).
06/28/24 Kenny Chiaghana 0.70 Review, revise summary re work in process.
06/28/24 Julia R. Foster 1.40 Review and revise pleading template (.5);
review and revise first day orders (.9).
06/28/24 Sabrina Lieberman 2.30 Correspond with C. Ceresa and K&E team re
work in process (1.3); research re same (1.0).

Total 103.50

10
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 172 of 631

601 Lexington Avenue
New York, NY 10022

FEIN 36-1326630

August 29, 2024

Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045

Attn: Vikram Bajaj

Invoice Number: 1050102708
Client Matter: 48520-22

In the Matter of Retention - K&E

For legal services rendered through June 30, 2024
(see attached Description of Legal Services for detail) $ 139,606.00
Total legal services rendered $ 139,606.00

Austin Bay Area Beijing Boston Brussels Chicago Dallas Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 173 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102708
Vyaire Medical Inc. Matter Number: 48520-22
Retention - K&E

Summary of Hours Billed

Name Hours Rate Amount
Chris Ceresa 6.60 1,345.00 8,877.00
Michael Y. Chan 16.50 395.00 6,517.50
Matthew Cooper 5.00 340.00 1,700.00
Marta Dudyan 9.00 340.00 3,060.00
Julia R. Foster 0.90 525.00 472.50
Susan D. Golden 1.80 1,600.00 2,880.00
Sabrina Lieberman 42.60 815.00 34,719.00
Rebecca J. Marston 48.60 1,265.00 61,479.00
Eric Nyberg 4.00 340.00 1,360.00
Sarah Osborne 6.20 815.00 5,053.00
Yusuf Salloum 7.40 1,595.00 11,803.00
Spencer A. Winters, P.C. 1.00 1,685.00 1,685.00

TOTALS 149.60 $ 139,606.00

2
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 174 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102708
Vyaire Medical Inc. Matter Number: 48520-22
Retention - K&E

Description of Legal Services

Date Name Hours Description
06/10/24 Rebecca J. Marston 0.40 Correspond with Y. Salloum, K&E team re
billing memorandum, post-filing matter
categories.
06/11/24 Sabrina Lieberman 0.10 Draft correspondence to R. Marston and K&E
team re postpetition billing procedures.
06/11/24 Rebecca J. Marston 1.70 Correspond with C. Ceresa re billing
memorandum, matter categories (.4);
correspond with S. Lieberman re timekeeper
list (.4); correspond with S. Lieberman, K&E
team re matter categories (.9).
06/12/24 Marta Dudyan 4.00 Draft conflict disclosures for schedules (3.5);
research re same (.5).
06/12/24 Julia R. Foster 0.40 Correspond with S. Lieberman re K&E
retention application.
06/12/24 Sabrina Lieberman 4.20 Revise K&E retention application (2.5);
correspond with R. Marston and K&E team re
same (.7); correspond with R. Marston re
conflicts reports and retention application
(.5); correspond with C. Ceresa and R.
Marston re postpetition billing (.3);
correspond with S. Osborne re conflicts
reports (.2).
06/12/24 Rebecca J. Marston 3.40 Correspond with C. Ceresa, K&E team re new
matter categories (.9); correspond with C.
Ceresa, K&E team re K&E retention
application, Pillowtex chart (1.3); review,
revise same (.6); correspond with C. Ceresa re
retention declaration (.2); correspond with S.
Lieberman re specific disclosures (.4).
06/12/24 Sarah Osborne 0.50 Review, revise parties in interest list re
potential conflicts.
06/13/24 Marta Dudyan 2.00 Analyze update for supplemental disclosure
of creditors/entities.
06/13/24 Sabrina Lieberman 1.90 Review, revise K&E retention application
(1.6); correspond with R. Marston and S.
Osborne re same (.3).
06/13/24 Rebecca J. Marston 5.40 Correspond with D. Wang, K&E team re
billing categories (.2); review, revise retention
application (3.9); correspond with C. Ceresa,
K&E team re same (.8); continue to review,
revise retention application (.5).

3
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 175 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102708
Vyaire Medical Inc. Matter Number: 48520-22
Retention - K&E

Date Name Hours Description
06/13/24 Sarah Osborne 3.00 Review, revise parties in interest list.
06/14/24 Chris Ceresa 4.90 Review, revise K&E retention application,
declaration in support, and related disclosures
(3.9); telephone conferences with R. Marston,
K&E team re same (.6); continue to review,
revise K&E retention application, declaration
in support, and related disclosures (.4).
06/14/24 Michael Y. Chan 4.00 Organize and prepare parties for conflicts
searching for creditors/entities (1.5); research
creditors/entities (1.5); analyze disclosure of
creditors/entities (1.0).
06/14/24 Matthew Cooper 2.00 Analyze disclosure of creditors/entities
submitted as tax authorities.
06/14/24 Marta Dudyan 2.50 Organize and review supplemental
disclosures relating to creditors/entities.
06/14/24 Julia R. Foster 0.50 Research precedent re K&E retention
applications.
06/14/24 Sabrina Lieberman 5.50 Conference with C. Ceresa re K&E retention
application (.9); conference with R. Marston
re same (.2); conference with K. Chiaghana re
same (.1); conference with D. O'Connor re
same (.1); correspond with D. O'Connor and
K&E team re same (.7); review, revise same
(3.5).
06/14/24 Rebecca J. Marston 5.40 Review, revise K&E retention application
(3.9); correspond and telephone conference
with S. Lieberman, K&E team re same (.6);
continue to review, revise K&E retention
application (.9).
06/15/24 Chris Ceresa 0.30 Review, revise K&E retention application,
declaration, disclosures re same (.2);
correspond with S. Lieberman, K&E team re
same (.1).
06/15/24 Sabrina Lieberman 4.00 Review, revise K&E retention application
(3.8); research re same (.2).
06/15/24 Rebecca J. Marston 5.50 Correspond with Y. Salloum, K&E team re
retention application (.4); review, revise same
(3.9); correspond with S. Lieberman re same
(1.2).
06/15/24 Yusuf Salloum 3.00 Review, revise retention application.

4
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 176 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102708
Vyaire Medical Inc. Matter Number: 48520-22
Retention - K&E

Date Name Hours Description
06/16/24 Sabrina Lieberman 2.60 Revise K&E retention application (1.5);
correspond with Y. Salloum and K&E team re
same (.1); review, analyze conflicts reports
(1.0).
06/16/24 Rebecca J. Marston 0.40 Correspond with Y. Salloum re retention
application, parties in interest list.
06/17/24 Michael Y. Chan 4.50 Organize and prepare parties for conflicts
searching for creditors/entities (.5); research
creditors/entities (.5); draft schedule 2 for
declaration (3.5).
06/17/24 Matthew Cooper 3.00 Organize and review disclosures relating to
all original creditors/entities (2.0); analyze
disclosure of creditors/entities submitted as
lenders and agents (1.0).
06/17/24 Sabrina Lieberman 1.80 Revise K&E retention application (1.6);
correspond with Y. Salloum and K&E team re
same (.2).
06/17/24 Rebecca J. Marston 1.40 Review, revise K&E retention application
(1.2); correspond with S. Lieberman re same
(.2).
06/17/24 Sarah Osborne 1.30 Review, analyze conflict reports re potential
conflict issues.
06/17/24 Yusuf Salloum 1.00 Review, revise K&E retention application.
06/18/24 Michael Y. Chan 2.50 Organize and prepare parties for conflicts
searching for creditors/entities (1.0); analyze
disclosure of creditors/entities (1.0); draft
schedule 2 for declaration (.5).
06/18/24 Sabrina Lieberman 1.60 Revise K&E retention application (.2);
correspond with Y. Salloum and K&E team re
same (.7); correspond with C. Ceresa and
K&E team re conflicts reports and surveys
(.7).
06/18/24 Rebecca J. Marston 0.40 Correspond with S. Lieberman re retention
work streams (.2); correspond with S. Golden
re K&E retention application (.2).
06/19/24 Sabrina Lieberman 1.00 Conference with C. Ceresa and R. Marston re
retention work in process.

5
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 177 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102708
Vyaire Medical Inc. Matter Number: 48520-22
Retention - K&E

Date Name Hours Description
06/19/24 Rebecca J. Marston 4.90 Correspond with S. Lieberman re
parties‑in‑interest survey results (.2); review,
analyze same (.4); correspond with K&E
billing team re fee estimates (.3); conferences
and correspond with C. Ceresa, S. Lieberman
re retention work streams (.8); review, revise
K&E retention application (3.0); correspond
and conference with S. Lieberman re same
(.2).
06/19/24 Spencer A. Winters, P.C. 1.00 Review, revise K&E retention application.
06/20/24 Michael Y. Chan 3.00 Organize, prepare parties for conflicts
searching for creditors/entities (.7); research
creditors/entities (.3); analyze disclosure of
creditors/entities (.6); draft schedules 2 for
declaration in support of retention (1.4).
06/20/24 Marta Dudyan 0.50 Review, analyze correspondence re conflicts
reports.
06/20/24 Susan D. Golden 1.20 Review, revise K&E retention application.
06/20/24 Sabrina Lieberman 1.50 Revise K&E retention application (.8);
correspond with Y. Salloum and K&E team re
conflicts reports (.7).
06/20/24 Rebecca J. Marston 0.40 Correspond with S. Lieberman re
parties‑in‑interest list survey results, K&E
retention application.
06/20/24 Yusuf Salloum 1.00 Review, revise retention application, budget.
06/21/24 Chris Ceresa 0.60 Review, comment on draft K&E retention
application materials.
06/21/24 Michael Y. Chan 2.50 Organize and prepare parties for conflicts
searching for creditors/entities (1.0); analyze
disclosure of creditors/entities (1.0); draft
schedules 1 & 2 for declaration (.5).
06/21/24 Sabrina Lieberman 1.00 Review, revise K&E retention application
(.5); correspond with R. Marston and K&E
team re conflicts reports (.1); review, analyze
same (.4).

6
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 178 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102708
Vyaire Medical Inc. Matter Number: 48520-22
Retention - K&E

Date Name Hours Description
06/21/24 Rebecca J. Marston 5.10 Correspond with S. Lieberman re disclosure
schedules (.3); correspond with C. Ceresa,
K&E team re ordinary course professional
and interim compensation motions (1.3);
correspond with U.S. Trustee re same (.2);
review, revise same (1.9); correspond with S.
Lieberman, K&E team re OCPs (1.1);
correspond with Omni team re noticing of
same (.3).
06/21/24 Sarah Osborne 1.40 Review, analyze conflicts reports re Schedule
2 disclosures (1.3); correspond with S.
Lieberman re same (.1).
06/22/24 Sabrina Lieberman 1.20 Review, analyze conflicts reports (.7); review,
revise K&E retention application (.2); review,
analyze K&E invoice re privilege and
confidentiality (.3).
06/23/24 Sabrina Lieberman 6.20 Revise K&E invoice re privilege and
confidentiality (3.9); correspond with Y.
Salloum re K&E retention application (.2);
review, revise same (.3); review, continue to
revise K&E invoice re privilege and
confidentiality (1.8).
06/23/24 Rebecca J. Marston 0.30 Correspond with Gibson Dunn team re
ordinary course professional, interim
compensation motions.
06/24/24 Susan D. Golden 0.60 Telephone conference with Y. Salloum re
K&E retention application (.2); review,
analyze precedent re same (.2); correspond
with Y. Salloum re same (.2).
06/24/24 Sabrina Lieberman 0.80 Revise K&E retention application (.2);
correspond with Y. Salloum and K&E team re
same (.6).
06/24/24 Rebecca J. Marston 8.50 Review, revise invoice (1.6); review, revise
ordinary course professional motion (3.1);
correspond with S. Lieberman re ordinary
course professionals (.8); correspond with C.
Ceresa re ordinary course professional
motion, interim compensation motion (.3);
review, revise interim compensation motion
(2.2); correspond with S. Lieberman re same
(.5).
06/24/24 Yusuf Salloum 1.60 Review, revise K&E retention application.

7
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 179 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102708
Vyaire Medical Inc. Matter Number: 48520-22
Retention - K&E

Date Name Hours Description
06/25/24 Sabrina Lieberman 4.20 Review, revise K&E retention application
(2.5); correspond with C. Ceresa and K&E
team re same (1.7).
06/25/24 Rebecca J. Marston 5.40 Review, revise ordinary course professional
motion (1.4); correspond with S. Lieberman,
K&E team re same (2.1); correspond with
Gibson Dunn re same (.2); correspond with S.
Winters, S. Golden, K&E team re interim
compensation motion (.4); review, revise
same (1.3).
06/25/24 Eric Nyberg 1.00 Organize, review disclosures relating to
creditors/entities.
06/25/24 Yusuf Salloum 0.80 Review, revise K&E retention application.
06/26/24 Sabrina Lieberman 2.90 Review, revise K&E retention application
(2.6); correspond with Y. Salloum and K&E
team re same (.1); conference with Y.
Salloum re same (.2).
06/26/24 Eric Nyberg 0.50 Review, analyze update for disclosure of
creditors/entities.
06/27/24 Sabrina Lieberman 0.30 Correspond with Y. Salloum and K&E team
re K&E retention application.
06/27/24 Eric Nyberg 2.00 Prepare list of parties for conflicts review
(1.0); review, analyze potential disclosures re
retention application (1.0).
06/28/24 Chris Ceresa 0.50 Review, comment on budget and staffing
memo re K&E retention (.3); correspond with
R. Marston, K&E team re same (.2).
06/28/24 Sabrina Lieberman 0.90 Correspond with Y. Salloum and K&E team
re K&E retention application and ancillary
documents.
06/28/24 Eric Nyberg 0.50 Review, analyze disclosure of
creditors/entities.
06/29/24 Chris Ceresa 0.30 Review, comment on budget and staffing
memo re K&E retention (.2); correspond with
R. Marston, K&E team re same (.1).
06/29/24 Sabrina Lieberman 0.90 Review, revise budget and staffing
memorandum.

Total 149.60

8
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 180 of 631

601 Lexington Avenue
New York, NY 10022

FEIN 36-1326630

August 29, 2024

Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045

Attn: Vikram Bajaj

Invoice Number: 1050102709
Client Matter: 48520-23

In the Matter of Retention - Non K&E

For legal services rendered through June 30, 2024
(see attached Description of Legal Services for detail) $ 64,777.50
Total legal services rendered $ 64,777.50

Austin Bay Area Beijing Boston Brussels Chicago Dallas Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 181 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102709
Vyaire Medical Inc. Matter Number: 48520-23
Retention - Non K&E

Summary of Hours Billed

Name Hours Rate Amount
Chris Ceresa 4.30 1,345.00 5,783.50
Amy Donahue 1.00 525.00 525.00
Susan D. Golden 0.40 1,600.00 640.00
Sabrina Lieberman 27.20 815.00 22,168.00
Rebecca J. Marston 21.80 1,265.00 27,577.00
Robert Orren 0.50 625.00 312.50
Sarah Osborne 9.10 815.00 7,416.50
Tanzila Zomo 1.00 355.00 355.00

TOTALS 65.30 $ 64,777.50

2
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 182 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102709
Vyaire Medical Inc. Matter Number: 48520-23
Retention - Non K&E

Description of Legal Services

Date Name Hours Description
06/10/24 Sabrina Lieberman 2.50 Review, revise motion to retain claims agent
(.5); revise motion to seal applications to
retain professionals (2.0).
06/10/24 Robert Orren 0.50 Retrieve Chief Restructuring Officer
engagement letter precedent (.3); correspond
with D. Hackel re same (.2).
06/11/24 Amy Donahue 1.00 Review, revise interim compensation motion.
06/11/24 Tanzila Zomo 1.00 Draft form application re professional
retentions.
06/12/24 Sabrina Lieberman 1.40 Revise PJT retention application.
06/12/24 Rebecca J. Marston 0.20 Correspond with AlixPartners re retention
applications.
06/13/24 Sabrina Lieberman 1.10 Review, revise PJT retention application (.2);
correspond with R. Marston re same (.1);
correspond with PJT, Omni, Cole Schotz,
BDO, AlixPartners, R. Marston re parties-
in‑interest list (.8).
06/13/24 Rebecca J. Marston 0.20 Correspond with S. Lieberman re PwC
retention.
06/14/24 Sabrina Lieberman 0.10 Correspond with R. Marston re PwC
retention.
06/14/24 Rebecca J. Marston 0.20 Correspond with S. Lieberman re PwC
retention.
06/17/24 Rebecca J. Marston 6.50 Correspond with S. Lieberman, K&E team re
PwC retention, service list parties, parties‑in
interest‑list, PJT, AlixPartners retention
applications (3.4); review, revise PJT
retention application (2.1); continue to
correspond with S. Lieberman, K&E team re
PwC retention, service list parties, parties‑in
interest‑list, PJT, AlixPartners retention
applications (1.0).
06/18/24 Sabrina Lieberman 1.90 Review, revise PJT retention application (.4);
correspond with C. Ceresa and R. Marston re
professional retention applications (.5);
correspond with AlixPartners, Omni and
BDO re same (.3); research precedent re
administrative advisor application (.7).
06/18/24 Rebecca J. Marston 0.20 Correspond with PwC, S. Lieberman, K&E
team re retention.

3
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 183 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102709
Vyaire Medical Inc. Matter Number: 48520-23
Retention - Non K&E

Date Name Hours Description
06/18/24 Rebecca J. Marston 1.40 Correspond with C. Ceresa, K&E team re
ordinary course professional motion, interim
compensation motion (1.1); correspond with
K&E team re ordinary course professional list
(.3).
06/19/24 Chris Ceresa 2.70 Telephone conference with R. Marston and
K&E team re professional retention matters
(.6); review, revise draft PJT application
(1.1); review, revise draft interim
compensation procedures motion (1.0).
06/19/24 Sabrina Lieberman 1.50 Conference with Omni re administrative agent
application (.1); correspond with Omni, Cole
Schotz, R. Marston, K&E team re same (.3);
review, revise PJT retention application (.9);
correspond with R. Marston and K&E team re
PwC retention application (.2).
06/19/24 Rebecca J. Marston 1.20 Correspond with BDO re fee estimates (.3);
correspond with S. Lieberman re Omni
retention application (.2); correspond with S.
Lieberman re retention of non-U.S. regulatory
counsel (.7).
06/19/24 Rebecca J. Marston 5.50 Draft ordinary course professional motion
(3.9); review, revise interim compensation
motion (1.2); correspond with S. Osborne re
same (.4).
06/19/24 Sarah Osborne 4.00 Draft interim compensation order (1.6);
research precedent re same (.3); correspond
with R. Marston re same (.2); review, revise
same (1.9).
06/20/24 Chris Ceresa 0.50 Review, comment on draft interim
compensation and ordinary course
professional motions.
06/20/24 Sabrina Lieberman 1.10 Correspond with AlixPartners, BDO, C.
Ceresa and K&E team re ordinary course
professionals.
06/20/24 Rebecca J. Marston 3.80 Review, revise ordinary course professional
motion, interim compensation motion (2.3);
correspond with Cole Schotz team re same
(.2); correspond with C. Ceresa, K&E team re
same (.6); correspond with AlixPartners team,
K&E team re ordinary course professionals
(.7).

4
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 184 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102709
Vyaire Medical Inc. Matter Number: 48520-23
Retention - Non K&E

Date Name Hours Description
06/20/24 Sarah Osborne 0.30 Review, revise interim compensation motion
(.1); correspond with C. Ceresa, K&E team re
same (.2).
06/21/24 Chris Ceresa 0.20 Review, comment on draft interim
compensation and ordinary course
professional motions.
06/21/24 Sabrina Lieberman 0.80 Correspond with AlixPartners, C. Ceresa and
K&E team re ordinary course professional
designations (.6); correspond with Y. Salloum
and C. Ceresa re non-K&E professional
retention applications (.2).
06/21/24 Rebecca J. Marston 0.20 Correspond with C. Ceresa, S. Lieberman re
ordinary course professional list.
06/21/24 Sarah Osborne 0.40 Review, revise interim compensation motion
(.3); correspond with R. Marston re same (.1).
06/22/24 Sabrina Lieberman 2.90 Revise PJT retention application (.4); revise
Omni retention application (1.8); correspond
with AlixPartners, BDO, Omni, PJT, PwC,
Cole Schotz, Y. Salloum and K&E team re
retention applications (.2); revise Cole Schotz
retention application (.5).
06/22/24 Rebecca J. Marston 0.50 Correspond with S. Lieberman re retention
applications (.1); review, revise PJT retention
application (.4).
06/23/24 Sabrina Lieberman 2.00 Review, revise PJT retention application (.3);
review, revise Cole Schotz retention
application (1.0); review, revise Omni
administrative agent application (.7).
06/23/24 Rebecca J. Marston 0.30 Correspond with S. Lieberman re PJT
retention application.
06/24/24 Chris Ceresa 0.60 Correspond with advisors, S. Lieberman,
K&E team re issues re retention.
06/24/24 Sabrina Lieberman 1.70 Review, revise PJT retention application (.1);
correspond with C. Ceresa, PJT re same (.1);
review, revise BDO retention application (.7);
correspond with AlixPartners, C. Ceresa and
K&E team re ordinary course professional
motion (.2); review, revise same (.6).
06/24/24 Rebecca J. Marston 0.40 Review, revise Cole Schotz retention
application (.3); correspond with S.
Lieberman re same (.1).

5
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 185 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102709
Vyaire Medical Inc. Matter Number: 48520-23
Retention - Non K&E

Date Name Hours Description
06/24/24 Sarah Osborne 1.70 Review, revise interim compensation motion
(.9); correspond with R. Marston re same (.2);
research re same (.6).
06/25/24 Chris Ceresa 0.30 Correspond with advisors, S. Lieberman,
K&E team re retention issues.
06/25/24 Susan D. Golden 0.40 Review, analyze interim compensation
motion (.3); correspond with R. Marston re
same (.1).
06/25/24 Sabrina Lieberman 3.90 Review, revise ordinary course professional
motion (1.0); correspond with AlixPartners,
C. Ceresa and K&E team re same (2.9).
06/25/24 Rebecca J. Marston 1.20 Conference with PwC team, K&E team re
retention (.5); prepare for and participate in
conference with K&E restructuring, corporate
teams re EY retention (.7).
06/25/24 Sarah Osborne 2.30 Review, revise interim compensation motion
(.3); correspond with C. Ceresa re same (.1);
compile proposed filing versions of ordinary
course professional and interim compensation
motions (.2); correspond with C. Ceresa,
K&E team re same (.1); review, revise ICP
motion (.3); correspond with S. Golden, K&E
team re same (.2); compile interim
compensation, ordinary course professional
motions for filing (.3); review, revise notices
re same (.2); correspond with Cole Schotz
team re filings (.6).
06/26/24 Sabrina Lieberman 2.20 Correspond with AlixPartners, C. Ceresa and
advisors re ordinary course professional
applications (1.3); review, revise BDO
retention application (.9).
06/26/24 Sarah Osborne 0.40 Review, analyze key dates and deadlines for
interim compensation motion (.3); correspond
with K. Chiaghana re same (.1).
06/27/24 Sabrina Lieberman 1.50 Correspond with AlixPartners, Cole Schotz
and C. Ceresa re sealing (.3); review, revise
PJT retention application (.3); correspond
with C. Ceresa re non-K&E retention
applications (.5); review, revise parties-
in‑interest lists (.2); correspond with C.
Ceresa, Reed Smith and AlixPartners re
Ordinary Course Professional designations
(.2).

6
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 186 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102709
Vyaire Medical Inc. Matter Number: 48520-23
Retention - Non K&E

Date Name Hours Description
06/29/24 Sabrina Lieberman 2.60 Review, revise AlixPartners retention
application.

Total 65.30

7
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 187 of 631

601 Lexington Avenue
New York, NY 10022

FEIN 36-1326630

August 29, 2024

Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045

Attn: Vikram Bajaj

Invoice Number: 1050102710
Client Matter: 48520-24

In the Matter of Vendor Matters

For legal services rendered through June 30, 2024
(see attached Description of Legal Services for detail) $ 21,509.50
Total legal services rendered $ 21,509.50

Austin Bay Area Beijing Boston Brussels Chicago Dallas Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 188 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102710
Vyaire Medical Inc. Matter Number: 48520-24
Vendor Matters

Summary of Hours Billed

Name Hours Rate Amount
Chris Ceresa 2.50 1,345.00 3,362.50
Tiffani Chanroo 9.90 1,265.00 12,523.50
Sabrina Lieberman 6.50 815.00 5,297.50
Sarah Osborne 0.40 815.00 326.00

TOTALS 19.30 $ 21,509.50

2
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 189 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102710
Vyaire Medical Inc. Matter Number: 48520-24
Vendor Matters

Description of Legal Services

Date Name Hours Description
06/10/24 Sabrina Lieberman 1.20 Review, revise critical vendors motion (1.0);
conference with T. Chanroo re same (.2).
06/13/24 Sabrina Lieberman 0.50 Correspond with C. Ceresa and T. Chanroo re
vendor issue (.2); correspond with vendor
counsel re same (.1); review, analyze vendor
contract (.2).
06/14/24 Chris Ceresa 0.30 Correspond with Company, T. Chanroo, K&E
team re vendor issues.
06/18/24 Chris Ceresa 0.50 Correspond with T. Chanroo, K&E team,
advisors re vendor matter (.2); telephone
conference with T. Chanroo, K&E team,
advisors re vendor issue (.3).
06/18/24 Tiffani Chanroo 0.60 Review, analyze issues re vendors (.3);
correspond with S. Lieberman, K&E team,
AlixPartners team re same (.3).
06/18/24 Sabrina Lieberman 0.20 Correspond with vendor and AlixPartners re
business-only call.
06/19/24 Tiffani Chanroo 1.30 Review, revise trade agreement (1.1);
correspond with C. Ceresa re same (.2).
06/23/24 Sarah Osborne 0.40 Research, analyze issues re vendor inquiries.
06/24/24 Tiffani Chanroo 0.80 Review, revise vendor trade agreement (.6);
correspond with AlixPartners re same (.2).
06/25/24 Chris Ceresa 0.20 Correspond with advisors, counsel re vendor
inquiries and matters (.1); conference with
advisors, counsel re same (.1).
06/25/24 Sabrina Lieberman 0.40 Correspond with C. Ceresa, T. Chanroo and
AlixPartners team re vendor inquiry (.2);
research 509(b)(3) and 546(c)(1) re same (.2).
06/26/24 Tiffani Chanroo 1.40 Review, analyze vendor communication (.8);
correspond with S. Lieberman re same (.6).
06/26/24 Sabrina Lieberman 0.70 Conference with T. Chanroo re vendor work
in process (.2); correspond with AlixPartners,
T. Chanroo, party in interest re vendor matter
(.1); correspond with AlixPartners, vendor
counsel, T. Chanroo re vendor matter (.1);
research re same (.3).
06/27/24 Chris Ceresa 0.60 Correspond with advisors, counsel re vendor
inquiries and matters (.2); conference with
advisors, counsel re same (.4).

3
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 190 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102710
Vyaire Medical Inc. Matter Number: 48520-24
Vendor Matters

Date Name Hours Description
06/27/24 Tiffani Chanroo 3.50 Review, analyze vendor issues (2.8);
correspond with S. Lieberman re same (.4);
conference with AlixPartners, S. Lieberman
re same (.3).
06/27/24 Sabrina Lieberman 1.50 Conference with AlixPartners, C. Ceresa and
T. Chanroo re various vendor issues (.5);
conference with C. Ceresa, T. Chanroo and
vendor party re same (.3); correspond with
AlixPartners, C. Ceresa, T. Chanroo and
vendor counterparties and counsel re same
(.7).
06/28/24 Chris Ceresa 0.50 Correspond with advisors, counsel re vendor
inquiries and matters (.2); conference with
advisors, counsel re same (.3).
06/28/24 Tiffani Chanroo 2.10 Review, analyze vendor issues (1.3);
correspond with S. Lieberman, K&E team,
Alix team re same (.8).
06/28/24 Sabrina Lieberman 1.40 Conference with AlixPartners, vendor
counsel, Company, T. Chanroo and K&E
team re vendor matter (.4); correspond with
AlixPartners, T. Chanroo and K&E team re
same (.8); review, revise summary re same
(.2).
06/29/24 Chris Ceresa 0.40 Correspond with advisors, counsel re vendor
inquiries and matters (.2); conference with
advisors, counsel re same (.2).
06/29/24 Sabrina Lieberman 0.60 Review, analyze vendor matters (.4);
correspond with T. Chanroo re same (.2).
06/30/24 Tiffani Chanroo 0.20 Correspond with S. Osborne re 503(b)(9)
research.

Total 19.30

4
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 191 of 631

601 Lexington Avenue
New York, NY 10022

FEIN 36-1326630

August 29, 2024

Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045

Attn: Vikram Bajaj

Invoice Number: 1050102711
Client Matter: 48520-25

In the Matter of Litigation

For legal services rendered through June 30, 2024
(see attached Description of Legal Services for detail) $ 23,939.50
Total legal services rendered $ 23,939.50

Austin Bay Area Beijing Boston Brussels Chicago Dallas Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 192 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102711
Vyaire Medical Inc. Matter Number: 48520-25
Litigation

Summary of Hours Billed

Name Hours Rate Amount
Chris Ceresa 2.30 1,345.00 3,093.50
Joseph A. D'Antonio 0.70 1,185.00 829.50
Tabitha J. De Paulo 11.20 1,435.00 16,072.00
Sabrina Lieberman 0.20 815.00 163.00
Jennifer Mancini 1.50 925.00 1,387.50
Michael William Morgan 0.10 975.00 97.50
Sarah Osborne 0.50 815.00 407.50
Joshua Raphael 0.60 975.00 585.00
Adrian Salmen 0.70 1,095.00 766.50
Noah Spector 0.50 1,075.00 537.50

TOTALS 18.30 $ 23,939.50

2
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 193 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102711
Vyaire Medical Inc. Matter Number: 48520-25
Litigation

Description of Legal Services

Date Name Hours Description
06/10/24 Tabitha J. De Paulo 8.50 Conference with PJT re witness preparation
(1.0); conference with AlixPartners re witness
preparation (.9); prepare for same (3.4);
prepare for and attend hearing preparation
session with Company (2.4); draft direct
examination outlines in preparation for
hearing (.8).
06/10/24 Joshua Raphael 0.60 Conference with PJT, T. De Paulo, K&E team
re witness preparations.
06/13/24 Sabrina Lieberman 0.20 Correspond with M. McKane, Y. Salloum and
Cole Schotz re litigation call.
06/13/24 Sarah Osborne 0.50 Review, revise notice of suggestion of
bankruptcy (.3); correspond with Company re
same (.2).
06/14/24 Chris Ceresa 0.30 Correspond with Company re suggestions of
bankruptcy process.
06/19/24 Adrian Salmen 0.70 Research re settlement motion precedent.
06/20/24 Chris Ceresa 2.00 Telephone conference with Company re
prepetition litigation matters and suggestions
of bankruptcy (.5); conference with PJT,
AlixPartners teams re same (.6); correspond
with Y. Salloum, K&E team, Company re
same (.9).
06/23/24 Joseph A. D'Antonio 0.70 Draft, revise stipulated confidentiality
agreement and protective order.
06/24/24 Tabitha J. De Paulo 1.50 Review, revise draft protective order (.3);
correspond with Cole Schotz team re same
(.2); review, revise Frejka declaration (1.0).
06/24/24 Jennifer Mancini 1.30 Draft, revise protection order.
06/25/24 Michael William Morgan 0.10 Review and analyze litigation materials.
06/27/24 Tabitha J. De Paulo 0.70 Review, analyze board meeting minutes and
address discovery issues re same.
06/28/24 Tabitha J. De Paulo 0.50 Conference with N. Specter and J. Mancini re
privileged document redactions (.3);
correspond with C. Ceresa and K&E team re
same (.2).
06/28/24 Jennifer Mancini 0.20 Conference with T. De Paulo and K&E team
re redacting privileged documents.

3
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 194 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102711
Vyaire Medical Inc. Matter Number: 48520-25
Litigation

Date Name Hours Description
06/28/24 Noah Spector 0.50 Conference with T. De Paulo, J. Mancini re
redaction of privileged materials (.2); review,
analyze documents of interest for privileged
information (.3).

Total 18.30

4
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 195 of 631

601 Lexington Avenue
New York, NY 10022

FEIN 36-1326630

August 29, 2024

Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045

Attn: Vikram Bajaj

Invoice Number: 1050102713
Client Matter: 48520-27

In the Matter of Non-Working Travel

For legal services rendered through June 30, 2024
(see attached Description of Legal Services for detail) $ 16,073.50
Total legal services rendered $ 16,073.50

Austin Bay Area Beijing Boston Brussels Chicago Dallas Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 196 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102713
Vyaire Medical Inc. Matter Number: 48520-27
Non-Working Travel

Summary of Hours Billed

Name Hours Rate Amount
Julia R. Foster 5.90 525.00 3,097.50
Yusuf Salloum 3.50 1,595.00 5,582.50
Josh Sussberg, P.C. 2.40 2,305.00 5,532.00
Kyle Nolan Trevett 1.70 1,095.00 1,861.50

TOTALS 13.50 $ 16,073.50

2
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 197 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102713
Vyaire Medical Inc. Matter Number: 48520-27
Non-Working Travel

Description of Legal Services

Date Name Hours Description
06/09/24 Kyle Nolan Trevett 1.70 Travel from Chicago, IL to New York, NY re
chapter 11 filing (billed at half time).
06/10/24 Julia R. Foster 2.80 Travel from Chicago, IL to Wilmington, DE
to attend hearing (billed at half time).
06/10/24 Yusuf Salloum 1.50 Travel from Chicago, IL to Wilmington, DE
re hearing (billed at half time).
06/11/24 Julia R. Foster 3.10 Travel from Wilmington, DE to Chicago, IL
return from hearing (billed at half time).
06/11/24 Yusuf Salloum 2.00 Travel from Wilmington, DE to Chicago, IL
return from hearing (billed at half time).
06/11/24 Josh Sussberg, P.C. 1.20 Travel from New York, NY to Wilmington,
DE for hearing (billed at half time).
06/11/24 Josh Sussberg, P.C. 1.20 Travel from Wilmington, DE to New York,
NY (billed at half time).

Total 13.50

3
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 198 of 631

601 Lexington Avenue
New York, NY 10022

FEIN 36-1326630

August 29, 2024

Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045

Attn: Vikram Bajaj

Invoice Number: 1050102714
Client Matter: 48520-28

In the Matter of Creditors’ Committee Matters

For legal services rendered through June 30, 2024
(see attached Description of Legal Services for detail) $ 9,859.00
Total legal services rendered $ 9,859.00

Austin Bay Area Beijing Boston Brussels Chicago Dallas Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 199 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102714
Vyaire Medical Inc. Matter Number: 48520-28
Creditors’ Committee Matters

Summary of Hours Billed

Name Hours Rate Amount
Chris Ceresa 0.30 1,345.00 403.50
Sarah Osborne 3.60 815.00 2,934.00
Joseph Cermak Profancik 0.20 975.00 195.00
Yusuf Salloum 1.00 1,595.00 1,595.00
Seth Sanders 3.90 1,095.00 4,270.50
Josh Sussberg, P.C. 0.20 2,305.00 461.00

TOTALS 9.20 $ 9,859.00

2
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 200 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102714
Vyaire Medical Inc. Matter Number: 48520-28
Creditors’ Committee Matters

Description of Legal Services

Date Name Hours Description
06/17/24 Seth Sanders 0.30 Correspond with C. Ceresa re committee
matters.
06/24/24 Sarah Osborne 0.90 Review, analyze board minutes for UCC due
diligence (.8); correspond with C. Ceresa,
K&E team re same (.1).
06/26/24 Chris Ceresa 0.30 Conference with S. Osborne, K&E team re
preparation for UCC due diligence items.
06/26/24 Seth Sanders 1.40 Review, analyze re UCC diligence requests.
06/27/24 Sarah Osborne 0.20 Correspond with AlixPartners re creditor
inquiry.
06/28/24 Sarah Osborne 1.60 Research re creditor committee engagement
letters, organizational documents (1.4);
correspond with S. Sanders re same (.2).
06/28/24 Yusuf Salloum 0.50 Prepare materials for creditors' committee.
06/28/24 Seth Sanders 2.20 Correspond with C. Ceresa, K&E team, PJT
re UCC diligence (.9); correspond with
McDermott Will & Emery re diligence
requests (.4); research re committee fees (.7);
correspond with S. Osborne re same (.2).
06/28/24 Josh Sussberg, P.C. 0.20 Correspond with UCC re matters.
06/29/24 Sarah Osborne 0.90 Research re committee engagement letters
(.7); correspond with S. Sanders re same (.2).
06/29/24 Joseph Cermak Profancik 0.20 Prepare existing loan documents for
distribution to UCC counsel.
06/29/24 Yusuf Salloum 0.50 Review, analyze creditor committee data
requests.

Total 9.20

3
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 201 of 631

601 Lexington Avenue
New York, NY 10022

FEIN 36-1326630

August 29, 2024

Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045

Attn: Vikram Bajaj

Invoice Number: 1050102715
Client Matter: 48520-29

In the Matter of Employee and Labor Matters

For legal services rendered through June 30, 2024
(see attached Description of Legal Services for detail) $ 27,170.00
Total legal services rendered $ 27,170.00

Austin Bay Area Beijing Boston Brussels Chicago Dallas Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 202 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102715
Vyaire Medical Inc. Matter Number: 48520-29
Employee and Labor Matters

Summary of Hours Billed

Name Hours Rate Amount
Rebecca H. Arnall 2.00 1,095.00 2,190.00
Chris Ceresa 1.80 1,345.00 2,421.00
Tiffani Chanroo 1.00 1,265.00 1,265.00
Maureen D. O'Brien 3.00 2,115.00 6,345.00
Dan O'Connor 0.70 1,265.00 885.50
Sarah Osborne 1.20 815.00 978.00
Evangelia Podaras 0.90 1,575.00 1,417.50
Scott D. Price, P.C. 2.20 2,245.00 4,939.00
Joshua Raphael 0.40 975.00 390.00
Risa Salins 2.10 2,115.00 4,441.50
Paul Vasiloff 1.50 1,265.00 1,897.50

TOTALS 16.80 $ 27,170.00

2
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 203 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102715
Vyaire Medical Inc. Matter Number: 48520-29
Employee and Labor Matters

Description of Legal Services

Date Name Hours Description
06/11/24 Maureen D. O'Brien 0.50 Draft correspondence pension issues.
06/12/24 Scott D. Price, P.C. 0.20 Review, analyze form of bonus plan.
06/13/24 Maureen D. O'Brien 1.50 Conference with D. O’Connor, K&E team re
employee benefits (.8); review, revise
summary of employee benefits plan (.7).
06/13/24 Dan O'Connor 0.70 Telephone conference with Company, M.
O’Brien, K&E team re employee benefits.
06/13/24 Sarah Osborne 0.50 Draft key employee agreement (.4);
correspond with C. Ceresa re same (.1).
06/13/24 Scott D. Price, P.C. 0.70 Reviewempolyee plan (.4); correspond and
conference re same (.3).
06/14/24 Sarah Osborne 0.70 Correspond with S. Price, K&E team re
employee agreement (.2); review, revise same
(.4); correspond with Company re same (.1).
06/14/24 Scott D. Price, P.C. 0.50 Review, revise empolyee plan.
06/16/24 Maureen D. O'Brien 0.50 Draft correspondence re pension benefits.
06/18/24 Joshua Raphael 0.40 Review, analyze staffing agreement and
correspond with C. Ceresa, K&E team re
same.
06/20/24 Chris Ceresa 1.30 Correspond with T. Chanroo, K&E team,
Company, advisors re potential contingency
items (.8); conference with T. Chanroo, K&E
team re same (.5).
06/20/24 Tiffani Chanroo 0.50 Conference with C. Ceresa, K&E team re
contingency planning.
06/20/24 Maureen D. O'Brien 0.50 Correspond with S. Price re contingency
employment matters.
06/20/24 Evangelia Podaras 0.40 Conference with C. Ceresa and K&E team re
contingency planning.
06/20/24 Risa Salins 0.30 Telephone conference with C. Ceresa, E.
Podaras and P. Vasiloff re employee matters
(.2); correspond with Company re employee
data (.1).
06/20/24 Paul Vasiloff 0.50 Telephone conference with S. Winters, K&E
team re employment contingency issues.
06/21/24 Risa Salins 0.30 Review, revise updated employee data
provided by Company.
06/25/24 Scott D. Price, P.C. 0.80 Review, analyze compensation brief (.3);
revise compensation brief (.5).

3
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 204 of 631
Legal Services for the Period Ending June 30, 2024 Invoice Number: 1050102715
Vyaire Medical Inc. Matter Number: 48520-29
Employee and Labor Matters

Date Name Hours Description
06/26/24 Chris Ceresa 0.30 Correspond with K&E team re employment
related updates.
06/26/24 Tiffani Chanroo 0.50 Conference with C. Ceresa, K&E team re
contingency planning.
06/26/24 Evangelia Podaras 0.50 Telephone conferences with K&E team, R.
Salins, P. Vasiloff re current status and
notices.
06/26/24 Risa Salins 0.50 Telephone conference with C. Ceresa, E.
Podaras and P. Vasiloff re employee matters
(.3); telephone conference with E. Podaras
and P. Vasiloff re contingency planning (.2).
06/26/24 Paul Vasiloff 1.00 Telephone conference with Y. Salloum, K&E
team re contingency planning (.5); update
draft notices (.5).
06/27/24 Rebecca H. Arnall 2.00 Conference with D. O'Connor, Company re
employment matters (.4); correspond with S.
Price re same (.2); review, analyze diligence,
purchase agreements re employment matters
(1.4).
06/28/24 Risa Salins 1.00 Review, revise notices.
06/29/24 Chris Ceresa 0.20 Correspond with T. Chanroo, K&E team re
employment related updates.

Total 16.80

4
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 205 of 631

601 Lexington Avenue
New York, NY 10022

FEIN 36-1326630

October 2, 2024

Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045

Attn: Vikram Bajaj

Invoice Number: 1050104432
Client Matter: 48520-5

In the Matter of Corporate & Governance Matters

For legal services rendered through July 31, 2024
(see attached Description of Legal Services for detail) $ 37,905.50
Total legal services rendered $ 37,905.50

Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 206 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104432
Vyaire Medical Inc. Matter Number: 48520-5
Corporate & Governance Matters

Summary of Hours Billed

Name Hours Rate Amount
Chris Ceresa 2.50 1,395.00 3,487.50
Hannah Crawford 1.30 1,595.00 2,073.50
David Hackel 0.60 1,095.00 657.00
Partha Kar 2.70 2,305.00 6,223.50
Sabrina Lieberman 0.50 975.00 487.50
Jai Mudhar 5.50 1,345.00 7,397.50
Sarah Osborne 10.60 975.00 10,335.00
Carolin Paus 4.60 750.00 3,450.00
William T. Pruitt 0.30 1,695.00 508.50
Josh Sussberg, P.C. 0.10 2,305.00 230.50
Steve Toth 0.50 1,820.00 910.00
Quin Wetzel 2.20 975.00 2,145.00

TOTALS 31.40 $ 37,905.50

2
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 207 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104432
Vyaire Medical Inc. Matter Number: 48520-5
Corporate & Governance Matters

Description of Legal Services

Date Name Hours Description
07/02/24 William T. Pruitt 0.30 Review, analyze indemnification and D&O
insurance issues (.2); correspond with C.
Ceresa re same (.1).
07/03/24 Sabrina Lieberman 0.10 Correspond with S. Osborne re governance
documents.
07/03/24 Sarah Osborne 0.40 Telephone conference with C. Ceresa, K&E
team, PJT, AlixPartners, special committee re
conference (.3); correspond with C. Ceresa re
same (.1).
07/08/24 Sarah Osborne 0.70 Draft special committee minutes (.6);
correspond with C. Ceresa re same (.1).
07/11/24 Chris Ceresa 0.60 Conference with S. Winters and special
committee re governance matters (.5); draft
minutes re same (.1).
07/11/24 Sabrina Lieberman 0.20 Correspond with Cole Schotz and Company
re special committee investigation diligence.
07/11/24 Sarah Osborne 3.40 Draft, review, revise resolutions re entry into
stalking horse agreement (2.7); research and
analyze precedent re same (.4); correspond
with C. Ceresa re same (.3).
07/16/24 Sarah Osborne 4.10 Review, analyze resolutions re formation of
special committee (.4); draft summary re
same (.8); correspond with C. Ceresa re same
(.2); draft omnibus consent re appointment of
D&O slate (1.9); research re same (.6);
correspond with C. Ceresa re same (.2).
07/16/24 Josh Sussberg, P.C. 0.10 Correspond with S. Winters re Company
officer legal issue.
07/17/24 David Hackel 0.60 Draft minutes re special committee meeting.
07/18/24 Chris Ceresa 0.60 Review, revise draft minutes re Special
Committee meeting.
07/18/24 Jai Mudhar 1.00 Conference with H. Crawford, K&E team re
Swiss entities and corporate governance
issues.
07/18/24 Quin Wetzel 0.60 Draft minutes for Special Committee meeting.
07/18/24 Quin Wetzel 0.60 Draft minutes re Special Committee meeting
(.5); correspond with C. Ceresa re same (.1).
07/23/24 Sabrina Lieberman 0.10 Correspond with R. Marston, K&E team re
special committee investigation diligence.

3
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 208 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104432
Vyaire Medical Inc. Matter Number: 48520-5
Corporate & Governance Matters

Date Name Hours Description
07/24/24 Partha Kar 0.70 Conference with local counsel re international
corporate law issues.
07/25/24 Chris Ceresa 0.60 Conference with S. Winters and special
committee re corporate matters (.4);
correspond with S. Osborne, K&E team re
same (.2).
07/25/24 Hannah Crawford 0.80 Conference with J. Mudhar, K&E team re
international entities re corporate issues (.3);
correspond with Company and J. Mudhar,
K&E team re intercompany issues (.2);
correspond with J. Mudhar re Swiss and
German entities (.3).
07/25/24 Partha Kar 1.50 Review, analyze intercompany amendment
request (.5); telephone conference with
Company re intercompany amendment
request (1.0).
07/25/24 Sarah Osborne 0.50 Draft, revise special committee minutes.
07/25/24 Steve Toth 0.50 Participate in special committee telephone
conference with Company, PJT, AlixPartners,
C. Ceresa and K&E team.
07/25/24 Quin Wetzel 1.00 Review, analyze meeting notes (.3); draft
special committee minutes re same (.7).
07/26/24 Partha Kar 0.50 Correspond with local counsel re
intercompany amendment request from
clients.
07/28/24 Hannah Crawford 0.20 Correspond with P. Kar re intercompany
corporate structure matters.
07/28/24 Jai Mudhar 0.50 Correspond with H. Crawford, K&E team re
intercompany governance considerations.
07/28/24 Carolin Paus 4.60 Research re intercompany claims and
dividend payments (3.4); prepare summary re
same (1.2).
07/29/24 Hannah Crawford 0.30 Correspond with A. Chan K&E team re
capital structure.
07/29/24 Sabrina Lieberman 0.10 Correspond with S. Sanders and K&E team re
board resolutions and presentation re
compensation.
07/29/24 Jai Mudhar 4.00 Review, analyze issues re intercompany
approach (3.5); correspond with H. Crawford,
K&E team regarding the same (.5).
07/29/24 Sarah Osborne 0.60 Draft special committee meeting minutes.
07/30/24 Sarah Osborne 0.90 Draft special committee meeting minutes.

4
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 209 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104432
Vyaire Medical Inc. Matter Number: 48520-5
Corporate & Governance Matters

Date Name Hours Description
07/31/24 Chris Ceresa 0.70 Conference with S. Winters and special
committee re corporate matters (.5); review,
analyze draft minutes re same (.2).

Total 31.40

5
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 210 of 631

601 Lexington Avenue
New York, NY 10022

FEIN 36-1326630

October 2, 2024

Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045

Attn: Vikram Bajaj

Invoice Number: 1050104433
Client Matter: 48520-6

In the Matter of Disclosure Statement/Plan/Confirmation

For legal services rendered through July 31, 2024
(see attached Description of Legal Services for detail) $ 30,285.50
Total legal services rendered $ 30,285.50

Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 211 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104433
Vyaire Medical Inc. Matter Number: 48520-6
Disclosure Statement/Plan/Confirmation

Summary of Hours Billed

Name Hours Rate Amount
Chris Ceresa 0.70 1,395.00 976.50
Amy Donahue 2.50 525.00 1,312.50
Julia R. Foster 1.70 525.00 892.50
David Hackel 6.80 1,095.00 7,446.00
Liz Ji 0.30 1,285.00 385.50
Sabrina Lieberman 3.80 975.00 3,705.00
Sarah Osborne 2.90 975.00 2,827.50
Joshua Raphael 1.50 1,095.00 1,642.50
Seth Sanders 3.60 1,265.00 4,554.00
Kyle Nolan Trevett 3.40 1,265.00 4,301.00
Quin Wetzel 2.30 975.00 2,242.50

TOTALS 29.50 $ 30,285.50

2
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 212 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104433
Vyaire Medical Inc. Matter Number: 48520-6
Disclosure Statement/Plan/Confirmation

Description of Legal Services

Date Name Hours Description
07/02/24 Liz Ji 0.30 Correspond with P. Gunderson and K&E
team re chapter 11 plan.
07/02/24 Sabrina Lieberman 0.50 Research re assumption or rejection of
executory contracts, unexpired leases re plan
effective date.
07/02/24 Seth Sanders 1.00 Analyze issues re plan rejections (.5);
correspond with C. Ceresa re same (.2);
conference with S. Lieberman re same (.3).
07/03/24 Sabrina Lieberman 3.30 Research re assumption and rejection of
executory contracts under plan.
07/03/24 Seth Sanders 1.00 Analyze research re assumption and rejection
issues re plan (.8); correspond with S.
Lieberman re same (.2).
07/08/24 Sarah Osborne 1.20 Review, revise disclosure statement re tax
considerations (1.1); correspond with K.
Trevett re same (.1).
07/08/24 Joshua Raphael 0.30 Review, analyze plan question re tax and
correspond with P. Gunderson, K&E team re
same.
07/08/24 Seth Sanders 0.90 Telephone conference with J. Raphael re plan
revisions (.3); analyze issues re same (.6).
07/08/24 Quin Wetzel 0.90 Review, analyze disclosure statement motion
re updated sale timeline (.7); correspond with
K. Trevett, J. Desai re same (.2).
07/10/24 Quin Wetzel 1.40 Review, analyze chapter 11 plan, bid
procedures order (.5); review, revise
disclosure statement motion re same (.9).
07/11/24 Sarah Osborne 0.20 Review, revise disclosure statement.
07/11/24 Kyle Nolan Trevett 3.00 Review, revise disclosure statement (1.2);
review, revise case timeline (1.7); correspond
with S. Osborne, C. Ceresa re same (.1).
07/16/24 Chris Ceresa 0.70 Review, analyze issues re plan and disclosure
statement.
07/16/24 Sarah Osborne 0.90 Review, revise disclosure statement for
addition of credit bid option (.6); research
precedent re same (.2); correspond with K.
Trevett re same (.1).
07/16/24 Joshua Raphael 0.30 Review, analyze, and revise plan.
07/16/24 Seth Sanders 0.40 Revise plan.

3
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 213 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104433
Vyaire Medical Inc. Matter Number: 48520-6
Disclosure Statement/Plan/Confirmation

Date Name Hours Description
07/16/24 Kyle Nolan Trevett 0.40 Review, analyze plan, disclosure statement re
legal issues (.3); correspond with C. Ceresa,
S. Osborne re same (.1).
07/17/24 Joshua Raphael 0.90 Review, revise plan (.8); correspond with S.
Sanders re same (.1).
07/18/24 Seth Sanders 0.30 Correspond with C. Ceresa re plan matters.
07/23/24 Julia R. Foster 0.50 Research precedent re confirmation briefs and
declarations in support thereof.
07/23/24 David Hackel 5.10 Correspond with S. Sanders, K&E team re
confirmation issues and workstreams (.3);
review, analyze precedent re confirmation
brief (2.2); research re same (2.6).
07/24/24 Amy Donahue 1.00 Prepare and revise draft shell confirmation
order.
07/24/24 Julia R. Foster 1.20 Prepare draft shell of confirmation brief.
07/24/24 David Hackel 1.10 Review, analyze precedent re confirmation
brief (.6); review, revise confirmation brief
(.5).
07/25/24 Amy Donahue 1.50 Prepare draft shell of confirmation order.
07/25/24 David Hackel 0.40 Review, analyze precedent re confirmation
brief (.2); review, analyze confirmation brief
(.2).
07/26/24 David Hackel 0.20 Review, analyze issues, precedent re
confirmation brief.
07/26/24 Sarah Osborne 0.60 Review, revise disclosure statement.

Total 29.50

4
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 214 of 631

601 Lexington Avenue
New York, NY 10022

FEIN 36-1326630

October 2, 2024

Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045

Attn: Vikram Bajaj

Invoice Number: 1050104434
Client Matter: 48520-7

In the Matter of DIP Financing and Cash Collateral

For legal services rendered through July 31, 2024
(see attached Description of Legal Services for detail) $ 110,306.00
Total legal services rendered $ 110,306.00

Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 215 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104434
Vyaire Medical Inc. Matter Number: 48520-7
DIP Financing and Cash Collateral

Summary of Hours Billed

Name Hours Rate Amount
Chris Ceresa 12.40 1,395.00 17,298.00
David Hackel 0.50 1,095.00 547.50
Yoonie Han 9.40 1,575.00 14,805.00
Rebecca J. Marston 0.50 1,345.00 672.50
Mark McKane, P.C. 0.40 2,065.00 826.00
Julienne Miranda 0.80 975.00 780.00
Joseph Cermak Profancik 4.90 1,095.00 5,365.50
Joshua Raphael 14.10 1,095.00 15,439.50
Yusuf Salloum 7.00 1,595.00 11,165.00
Adrian Salmen 33.20 1,265.00 41,998.00
Noah Spector 0.80 1,185.00 948.00
Josh Sussberg, P.C. 0.20 2,305.00 461.00

TOTALS 84.20 $ 110,306.00

2
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 216 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104434
Vyaire Medical Inc. Matter Number: 48520-7
DIP Financing and Cash Collateral

Description of Legal Services

Date Name Hours Description
07/01/24 Chris Ceresa 0.80 Review, analyze DIP issues.
07/01/24 David Hackel 0.50 Research re DIP issue (.2); review, analyze
CRO appointment materials re same (.2);
correspond with J. Raphael, K&E team re
same (.1).
07/01/24 Yoonie Han 0.50 Revise the DIP order (.5).
07/01/24 Mark McKane, P.C. 0.40 Conference with T. De Paulo re DIP and other
second day hearing issues.
07/01/24 Adrian Salmen 2.40 Correspond with C. Ceresa, K&E team,
lenders, parties in interest re DIP revisions
(1.7); review, analyze DIP order re reporting
requirements (.7).
07/02/24 Chris Ceresa 0.20 Review, analyze correspondence from A.
Salmen, K&E team re DIP issues.
07/02/24 Yoonie Han 0.20 Revise DIP order.
07/02/24 Joshua Raphael 0.10 Review, analyze GDC markup of final DIP
order and correspond with Y. Han, K&E team
re same.
07/02/24 Adrian Salmen 6.80 Correspond with C. Ceresa, K&E team,
lender counsel, insurer counsel re DIP
language (.9); review revised final DIP order
(1.1); correspond with C. Ceresa, K&E team
re DIP workstream (.8); review, analyze
committee issues list re DIP (2.1); prepare
final sealing order for filing (.4); review DIP
order precedent (.4); review, revise DIP reply
(1.1).
07/02/24 Noah Spector 0.80 Analyze DIP motion and related materials.
07/03/24 Chris Ceresa 3.30 Review, analyze correspondence from J.
Raphael, K&E team DIP issues
07/03/24 Yoonie Han 0.20 Correspond with S. Sanders re DIP credit
facility guarantors and lien searches and UCC
lien searches.
07/03/24 Julienne Miranda 0.80 Correspond with S. Osborne, Y. Han and S.
Sanders re guarantors list.

3
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 217 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104434
Vyaire Medical Inc. Matter Number: 48520-7
DIP Financing and Cash Collateral

Date Name Hours Description
07/03/24 Joshua Raphael 2.90 Review, analyze UCC issues list, GDC
responses and research re same (2.4);
correspond with A. Salmen, C. Ceresa re DIP,
related matters (.1); review, revise officer
certificate and correspond re same (.1);
review, analyze issue re same, signatory (.3).
07/03/24 Yusuf Salloum 1.50 Analyze comments to DIP documents.
07/03/24 Adrian Salmen 7.70 Review, analyze DIP precedent (2.7);
annotate UCC DIP issues list (2.4);
correspond with J. Raphael, K&E team re
same (.9); correspond with C. Ceresa, K&E
team, AlixPartners team, UCC, lenders re
professional fees issues (1.7).
07/04/24 Chris Ceresa 1.00 Review, analyze correspondence from Y.
Salloum, K&E team re DIP issues
07/04/24 Yusuf Salloum 1.00 Analyze issues re DIP financing documents.
07/04/24 Adrian Salmen 0.30 Correspond with interested parties re DIP
objection.
07/05/24 Chris Ceresa 0.50 Review, analyze DIP issues
07/05/24 Joshua Raphael 0.50 Correspond with C. Ceresa, K&E team,
advisors, AlixPartners re variance reporting,
professional fees (.2); review, analyze
variance reporting; correspond with C. Ceresa
re DIP (.3).
07/05/24 Adrian Salmen 1.60 Review, analyze DIP credit agreement re DIP
revisions (.9); correspond with J. Raphael,
K&E team, interested parties re DIP
objections, DIP issues (.7).
07/06/24 Chris Ceresa 0.20 Review, analyze correspondence from A.
Salmen, K&E team re DIP issues
07/06/24 Joshua Raphael 2.00 Review, analyze UCC comments to DIP order
(.2); draft talking points re final DIP order
(1.8).
07/06/24 Yusuf Salloum 1.00 Review, revise DIP order.
07/06/24 Adrian Salmen 3.90 Correspond with C. Ceresa, K&E team re DIP
workstream (.6); review, analyze DIP credit
agreement re DIP revisions (1.3); review,
analyze committee revisions to DIP order
(1.1); correspond with C. Ceresa, K&E team
re same (.4); review, revise DIP talking points
(.3); correspond with J. Raphael re same (.2).

4
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 218 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104434
Vyaire Medical Inc. Matter Number: 48520-7
DIP Financing and Cash Collateral

Date Name Hours Description
07/07/24 Joshua Raphael 0.40 Review, revise DIP talking points (.3);
correspond with Y. Salmen, K&E team re
same (.1).
07/07/24 Adrian Salmen 0.90 Correspond with Y. Salloum, K&E team,
Gibson Dunn re DIP revisions (.4); review,
analyze precedent re same (.5).
07/08/24 Chris Ceresa 0.30 Correspond with A. Salmen, K&E team re
DIP reporting items.
07/08/24 Yoonie Han 0.40 Correspond with S. Sanders re DIP collateral
package (.2); analyze DIP order (.2).
07/08/24 Yusuf Salloum 1.50 Review, analyze DIP order.
07/08/24 Adrian Salmen 2.30 Review, analyze DIP order revisions, issues
(1.8); correspond with AlixPartners, C.
Ceresa re same (.2); correspond with C.
Ceresa, AlixPartners re professional fee
disbursements (.3).
07/09/24 Chris Ceresa 1.20 Correspond with A. Salmen, K&E team re
DIP reporting items.
07/09/24 Yoonie Han 0.70 Analyze DIP credit agreement re excluded
property (.3); analyze DIP order re DIP
collateral package (.4).
07/09/24 Rebecca J. Marston 0.50 Conference with GDC team, UCC counsel,
Haynes & Boone, C. Ceresa, K&E team re
DIP issues.
07/09/24 Joseph Cermak Profancik 0.50 Review and analyze DIP credit agreement
schedules for backstop parties (.3);
correspond with lender’s counsel re same (.2).
07/09/24 Joshua Raphael 1.30 Review, analyze, revise final DIP order (.4);
conference with S. Winters, K&E team,
advisors re same (.3); correspond with ad hoc
group, UCC counsel, C. Ceresa, A. Salmen,
K&E team re same (.4); finalize same (.2).
07/09/24 Yusuf Salloum 1.00 Review, analyze revisions to DIP order.
07/09/24 Adrian Salmen 3.10 Correspond with interested parties re DIP
order (1.2); review, revise final DIP order
(1.5); conference with interested parties re
final DIP issues (.4).
07/10/24 Chris Ceresa 0.30 Correspond with A. Salmen, K&E team re
DIP reporting items.
07/10/24 Yoonie Han 0.50 Correspond with S. Sanders re DIP collateral
package issues.
07/10/24 Yusuf Salloum 1.00 Review and analyze revisions to DIP order.

5
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 219 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104434
Vyaire Medical Inc. Matter Number: 48520-7
DIP Financing and Cash Collateral

Date Name Hours Description
07/10/24 Adrian Salmen 2.20 Correspond with J. Raphael, K&E team,
AlixPartners, lenders re DIP issues (1.1);
review, analyze payment history re same
(1.1).
07/11/24 Adrian Salmen 0.30 Correspond with C. Ceresa, AlixPartners re
DIP issues.
07/12/24 Chris Ceresa 0.20 Correspond with J. Raphael, K&E team re
DIP reporting items.
07/12/24 Joshua Raphael 0.80 Draft certificate re variance reporting (.3);
review, revise, variance testing (.2);
correspond with AlixPartners, C. Ceresa, re
same (.2); correspond with advisors re same
(.1).
07/15/24 Yoonie Han 2.10 Analyze DIP credit agreement re interest
payment mechanism (.6); analyze DIP order
re obligations re prepetition debt (.6); analyze
restructuring support agreement re existing
debt roll‑up mechanism (.7); correspond with
A. Idrizovic re interest payment mechanism
(.2).
07/15/24 Joseph Cermak Profancik 0.50 Review and analyze DIP credit agreement
(.3); correspond with Company re reporting
requirements (.2).
07/16/24 Chris Ceresa 1.10 Review, analyze DIP reporting (.9);
correspond with A. Salmen, K&E team re
same (.2).
07/16/24 Yoonie Han 1.50 Conference with Y. Salloum re reporting
obligations under prepetition credit facilities
pursuant to DIP orders (.7); analyze roll‑up
mechanism under DIP credit agreement (.4);
analyze DIP credit agreement notice
requirements re employment notices (.4).
07/16/24 Joseph Cermak Profancik 1.00 Conference with Company re DIP compliance
and reporting requirements (.8); correspond
with Company re organizational documents
(.2).
07/17/24 Chris Ceresa 0.30 Review, analyze DIP reporting (.2);
correspond with J. Profancik, K&E team re
same (.1).

6
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 220 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104434
Vyaire Medical Inc. Matter Number: 48520-7
DIP Financing and Cash Collateral

Date Name Hours Description
07/17/24 Yoonie Han 0.90 Analyze DIP credit agreement and
restructuring support agreement re roll‑up
mechanism and reporting obligations (.4);
conference with Y. Salloum re same (.4);
correspond with Company re roll‑up
mechanism and reporting obligations (.1).
07/17/24 Joseph Cermak Profancik 0.50 Correspond with Company re DIP reporting
requirements; review and analyze credit
agreement.
07/17/24 Adrian Salmen 1.10 Correspond with C. Ceresa, K&E team,
AlixPartners, lender advisors re professional
fee issues re DIP (.6); review, analyze
correspondence re same (.5).
07/19/24 Chris Ceresa 0.20 Review, analyze DIP reporting (.1);
correspond with A. Salmen, K&E team re
same (.1).
07/19/24 Joshua Raphael 0.10 Draft officer certificate, variance report and
correspond re same.
07/20/24 Chris Ceresa 0.30 Review, analyze DIP reporting (.2);
correspond with J. Raphael, K&E team re
same (.1).
07/22/24 Chris Ceresa 0.40 Review, analyze legal issues re DIP draws
(.2); correspond with Company, advisors re
same (.2).
07/22/24 Joseph Cermak Profancik 0.30 Review and analyze credit agreement exhibits
(.2); correspond with C. Ceresa, K&E team re
withdrawal notice (.1).
07/22/24 Joshua Raphael 0.40 Draft declaration ISO reporting requirements
under DIP orders and credit agreement.
07/22/24 Joshua Raphael 0.80 Review, analyze form of withdrawals notice
(.2); correspond with C. Ceresa re DIP request
(.1); conferences and correspond with C.
Ceresa, AlixPartners re withdrawal notices
(.4); correspond with DIP agent re same (.1).
07/22/24 Joshua Raphael 0.10 Correspond with AlixPartners re wire info re
DIP withdrawal notice.
07/23/24 Joshua Raphael 0.10 Correspond with AlixPartners, AFS re wire
info re DIP withdrawal notice.
07/24/24 Chris Ceresa 0.50 Review, analyze legal issues re DIP draws
(.3); correspond with Company, advisors re
same (.2).

7
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 221 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104434
Vyaire Medical Inc. Matter Number: 48520-7
DIP Financing and Cash Collateral

Date Name Hours Description
07/24/24 Yoonie Han 0.80 Conference with Company and AlixPartners
re interest payment mechanism under DIP
credit agreement (.5); correspond with C.
Ceresa and S. Toth re obligations under DIP
credit facility, 1L and 2L (.3).
07/24/24 Joseph Cermak Profancik 0.50 Review and analyze existing credit facility
collateral package (.3); correspond with C.
Ceresa, K&E team re same (.2).
07/24/24 Joshua Raphael 1.60 Correspond with AlixPartners, C. Ceresa re
fee reporting for DIP, DIP funding (.2);
review, analyze fee estimate and correspond
with C. Ceresa re same (.3); correspond with
C. Ceresa re lenders, agent re reporting and
funding (.1); review, analyze perfection
memorandum and correspond with C. Ceresa,
Y. Han re same (.5); review, analyze DIP
order, credit agreement re collateral packages
(.4); correspond with C. Ceresa re foreign
equity pledges (.1).
07/24/24 Adrian Salmen 0.30 Correspond with J. Raphael, K&E team,
AlixPartners team re professional fees
reporting under DIP.
07/25/24 Joshua Raphael 0.60 Research precedent pleadings, transcripts re
motion to compel DIP funding draw.
07/25/24 Josh Sussberg, P.C. 0.20 Correspond with S. Winters re status with
DIP lenders.
07/26/24 Joshua Raphael 2.20 Research precedent re emergency DIP
funding requests (.9); review, analyze
pleadings (.5); correspond with C. Ceresa re
summaries of same (.4); draft responsible
officer certificate and correspond with C.
Ceresa, K&E team, AlixPartners re same (.2);
revise notice of funding request and
correspond with agent re same (.1); review,
analyze 1L credit agreement and correspond
with S. Toth, K&E team re same (.1).
07/29/24 Yoonie Han 1.30 Conference with Company re interest
payment under DIP credit agreement (.5);
correspond with agent’s counsel re DIP
interest notices (.5); correspond with A.
Idrizovic re updating DIP credit agreement
(.3).

8
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 222 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104434
Vyaire Medical Inc. Matter Number: 48520-7
DIP Financing and Cash Collateral

Date Name Hours Description
07/29/24 Joseph Cermak Profancik 1.20 Conference with Company and advisors re
DIP interest rate (.7); review and analyze
credit agreement re same (.3); correspond
with lenders’ counsel re same (.2).
07/30/24 Chris Ceresa 0.80 Review, analyze legal issues re financing (.5);
correspond with Y. Salloum and K&E team re
issues re same (.3).
07/30/24 Yoonie Han 0.30 Correspond with J. Profancik re DIP interest
mechanism.
07/30/24 Joseph Cermak Profancik 0.40 Correspond with lenders’ counsel and
company advisors re interest rate language.
07/30/24 Joshua Raphael 0.10 Prepare DIP withdrawal request.
07/31/24 Chris Ceresa 0.80 Review, analyze legal issues re DIP financing
(.5); correspond with Y. Salloum and K&E
team re issues re same (.3).
07/31/24 Joshua Raphael 0.10 Correspond and conference with A. Salmen re
professional fee budget.
07/31/24 Adrian Salmen 0.30 Correspond with J. Raphael, K&E team,
AlixPartners team re professional fees.

Total 84.20

9
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 223 of 631

601 Lexington Avenue
New York, NY 10022

FEIN 36-1326630

October 2, 2024

Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045

Attn: Vikram Bajaj

Invoice Number: 1050104435
Client Matter: 48520-8

In the Matter of Cash Management

For legal services rendered through July 31, 2024
(see attached Description of Legal Services for detail) $ 1,879.50
Total legal services rendered $ 1,879.50

Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 224 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104435
Vyaire Medical Inc. Matter Number: 48520-8
Cash Management

Summary of Hours Billed

Name Hours Rate Amount
Tiffani Chanroo 0.60 1,345.00 807.00
Kenny Chiaghana 1.10 975.00 1,072.50

TOTALS 1.70 $ 1,879.50

2
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 225 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104435
Vyaire Medical Inc. Matter Number: 48520-8
Cash Management

Description of Legal Services

Date Name Hours Description
07/02/24 Tiffani Chanroo 0.60 Correspond with Y. Salloum, K&E team re
cash management cap (.2); review, analyze
issues re same (.4).
07/07/24 Kenny Chiaghana 1.10 Analyze, revise cash management order.

Total 1.70

3
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 226 of 631

601 Lexington Avenue
New York, NY 10022

FEIN 36-1326630

October 2, 2024

Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045

Attn: Vikram Bajaj

Invoice Number: 1050104436
Client Matter: 48520-9

In the Matter of Automatic Stay Issues

For legal services rendered through July 31, 2024
(see attached Description of Legal Services for detail) $ 418.50
Total legal services rendered $ 418.50

Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 227 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104436
Vyaire Medical Inc. Matter Number: 48520-9
Automatic Stay Issues

Summary of Hours Billed

Name Hours Rate Amount
Chris Ceresa 0.30 1,395.00 418.50

TOTALS 0.30 $ 418.50

2
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 228 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104436
Vyaire Medical Inc. Matter Number: 48520-9
Automatic Stay Issues

Description of Legal Services

Date Name Hours Description
07/16/24 Chris Ceresa 0.30 Review, analyze issues re automatic stay.

Total 0.30

3
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 229 of 631

601 Lexington Avenue
New York, NY 10022

FEIN 36-1326630

October 2, 2024

Vyaire Medical Inc.
26125 North Riverwoods Blvd
Mettawa, IL 60045

Attn: Vikram Bajaj

Invoice Number: 1050104437
Client Matter: 48520-10

In the Matter of Asset Sales/Section 363 Issues: Use, Sale & Disposition of Property

For legal services rendered through July 31, 2024
(see attached Description of Legal Services for detail) $ 2,024,504.50
Total legal services rendered $ 2,024,504.50

Austin Bay Area Beijing Boston Brussels Chicago Dallas Frankfurt Hong Kong Houston London Los Angeles Miami Munich Paris Riyadh Salt Lake City Shanghai Washington, D.C.
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 230 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104437
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Summary of Hours Billed

Name Hours Rate Amount
Rebecca H. Arnall 5.40 1,265.00 6,831.00
Kon Asimacopoulos 4.50 2,305.00 10,372.50
Lauren Austgen 1.50 435.00 652.50
Cooper Barghols 4.30 975.00 4,192.50
Marin Boney 0.90 1,885.00 1,696.50
John G. Caruso 1.00 2,115.00 2,115.00
Chris Ceresa 86.70 1,395.00 120,946.50
Tiffani Chanroo 1.20 1,345.00 1,614.00
Adam Thomas Clifford, P.C. 4.00 1,995.00 7,980.00
Dominique Collins 0.40 1,265.00 506.00
Bernadette Coppola 43.10 1,575.00 67,882.50
Hannah Crawford 1.10 1,595.00 1,754.50
Sion Davies 0.70 1,575.00 1,102.50
Tabitha J. De Paulo 2.50 1,435.00 3,587.50
Anthony M. Del Rio 37.80 1,595.00 60,291.00
Jaina Desai 165.70 975.00 161,557.50
Amy Donahue 0.50 525.00 262.50
Michael Ehret 13.00 1,895.00 24,635.00
Luke Finn 74.30 1,345.00 99,933.50
Julia R. Foster 1.00 525.00 525.00
Justin M. Garfinkle 44.20 1,095.00 48,399.00
Luci Hague 0.20 1,575.00 315.00
Kate Hardey 22.70 1,995.00 45,286.50
Liz Ji 9.80 1,285.00 12,593.00
Partha Kar 2.00 2,305.00 4,610.00
Olivia Kaufmann 26.30 1,095.00 28,798.50
Sooah Kim 5.30 1,095.00 5,803.50
Maggie Kate King 33.10 1,265.00 41,871.50
Daniel Lewis, P.C. 8.80 1,910.00 16,808.00
Sabrina Lieberman 7.60 975.00 7,410.00
Savannah Malnar-Cole 3.90 1,265.00 4,933.50
Mario Mancuso, P.C. 0.20 2,400.00 480.00

2
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 231 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104437
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Name Hours Rate Amount
Rebecca J. Marston 44.90 1,345.00 60,390.50
Brandan Matthews 56.30 1,345.00 75,723.50
Ruan J. Meintjes 44.20 1,095.00 48,399.00
Ashley Brittanie Miller 0.70 355.00 248.50
Jake Moeller 5.60 1,095.00 6,132.00
Michael William Morgan 0.30 1,095.00 328.50
Jai Mudhar 5.40 1,345.00 7,263.00
Trent Nachbar 88.50 1,265.00 111,952.50
Michelle L. Nowicki 39.60 625.00 24,750.00
Maureen D. O'Brien 5.00 2,115.00 10,575.00
Dan O'Connor 101.90 1,345.00 137,055.50
Sarah Osborne 8.60 975.00 8,385.00
Carolin Paus 8.70 750.00 6,525.00
D. Taylor Petersen 28.60 975.00 27,885.00
Evangelia Podaras 8.80 1,575.00 13,860.00
Joshua Raphael 0.10 1,095.00 109.50
Risa Salins 0.70 2,115.00 1,480.50
Yusuf Salloum 40.70 1,595.00 64,916.50
Adrian Salmen 1.90 1,265.00 2,403.50
Anna Schwander 1.80 1,315.00 2,367.00
Scottie Shermetaro 65.40 1,575.00 103,005.00
Noah Shier 8.50 1,575.00 13,387.50
Daniel Shin 37.60 975.00 36,660.00
Hayley Smith 2.00 625.00 1,250.00
Noah Spector 1.30 1,185.00 1,540.50
Matt Swanson 1.20 1,345.00 1,614.00
Paul D. Tanaka, P.C. 8.20 2,115.00 17,343.00
Michael D. Thorpe 0.60 1,695.00 1,017.00
Steve Toth 129.20 1,820.00 235,144.00
Sarah Ullathorne 3.60 1,575.00 5,670.00
Paul Vasiloff 4.00 1,345.00 5,380.00
Donatus Wang 10.80 960.00 10,368.00
Nicholas Warther 9.60 1,665.00 15,984.00
Cristina Weidner 11.60 1,665.00 19,314.00
Dennis Williams 1.50 2,025.00 3,037.50
Spencer A. Winters, P.C. 69.20 1,685.00 116,602.00

3
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 232 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104437
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Name Hours Rate Amount
Sara B. Zablotney, P.C. 1.60 2,445.00 3,912.00
Ann-Kathrin Ziegler 23.80 1,070.00 25,466.00
Tanzila Zomo 3.70 355.00 1,313.50

TOTALS 1,499.40 $ 2,024,504.50

4
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 233 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104437
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Description of Legal Services

Date Name Hours Description
07/01/24 Chris Ceresa 3.80 Review, analyze issues re sale structuring
(2.3); correspond with R. Marston and J.
Desai re bidding procedures issues (1.1);
review NDA markups (.4).
07/01/24 Adam Thomas Clifford, P.C. 0.50 Discuss sale separation matters with
Company and advisors.
07/01/24 Bernadette Coppola 2.90 Correspond with AlixPartners and team re
transition services agreement (.1); conference
with Company, AlixPartners, C. Ceresa, K&E
team re transition services agreement (1.5);
conference with bidder, AlixPartners, C.
Ceresa, K&E team re due diligence, transition
services agreement and separation matters
(.5); correspond with Y. Salloum re transition
services agreement (.1); correspond with PJT
Partners, Y. Salloum, K&E team re transition
services agreement due diligence calls (.1);
correspond with M. Nowicki and K&E team
re intellectual property schedules (.3);
correspond with R. Meintjes and K&E team
re healthcare regulatory matter (.1);
correspond with Company and AlixPartners
re same (.2).
07/01/24 Tabitha J. De Paulo 1.20 Review and comment on bid procedures
declarations.
07/01/24 Anthony M. Del Rio 1.00 Review and analyze regulatory filing
requirements triggered by transaction (.5);
review and comment on transition services
considerations (.5).
07/01/24 Jaina Desai 1.20 Telephone conference with R. Marston re
bidding procedures status, next steps (.4);
correspond with S. Golden re publication
timeline (.1); review, analyze correspondence
re same (.2); review, analyze bidding
procedures order (.3); correspond with R.
Marston re bidding procedures notices (.2).
07/01/24 Jaina Desai 0.60 Telephone conference with Omni re escrow
agreement (.3); correspond with R. Marston
re same (.1); correspond with C. Ceresa re
same (.1); review, analyze escrow agreement
(.1).

5
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 234 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104437
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
07/01/24 Jaina Desai 1.40 Review, analyze correspondence re sale
stream (.4); correspond with R. Marston re
same (.1); correspond with C. Ceresa re sale
declarations (.1); review, analyze local rules
re procedures (.5); correspond with R.
Marston re same (.1); correspond with T. De
Paulo re declarations (.1); correspond with A.
Salmen re bidding procedures order (.1).
07/01/24 Jaina Desai 1.20 Review, analyze correspondence re escrow
account (.5); correspond with Omni re same
(.1); telephone conference with Omni re same
(.1); correspond with R. Marston re same (.1);
draft correspondence re second day hearing
witness preparation (.2); correspond with
AlixPartners, PJT re same (.1); correspond
with R. Marston re same (.1).
07/01/24 Jaina Desai 3.80 Revise bidding procedures declarations (2.6);
correspond with R. Marston, K&E team re
same (.4); correspond with PJT, AlixPartners
re same (.1); correspond with PJT,
AlixPartners re witness preparation (.2);
review, analyze comments re sale NDA (.3);
correspond with S. Lieberman re same (.1);
draft correspondence re declarations (.1).
07/01/24 Jaina Desai 0.60 Revise sale NDA (.5); correspond with R.
Marston, S. Lieberman re same (.1).
07/01/24 Jaina Desai 0.30 Correspond with AlixPartners, PJT, T. De
Paulo, K&E team re bid pros witness prep
coordination.
07/01/24 Justin M. Garfinkle 0.20 Review, analyze issues re ventilation
purchase agreement for M&A counterparty.
07/01/24 Kate Hardey 0.70 Review and revise APA re legal issues.
07/01/24 Liz Ji 3.20 Review, analyze asset purchase agreement for
numerous bidders (2.9); revise purchase price
allocation re same (.3).
07/01/24 Partha Kar 0.50 Correspond with Company re asset purchase
agreement legal issues.
07/01/24 Olivia Kaufmann 1.70 Correspond with NY regulator re change of
ownership and control (.6); revise analysis re
same (1.1).

6
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 235 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104437
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
07/01/24 Maggie Kate King 2.00 Conference with AlixPartners and client re
M&A counterparty TSA (1.0); telephone
conference with bidders for respiratory
diagnostics business (.5); summarize notes re
same (.2); correspond with D. Lewis, K&E
team re same (.3).
07/01/24 Daniel Lewis, P.C. 1.00 Review, analyze issues related to TSA matters
(.5); review, analyze matters related to IP
diligence (.5).
07/01/24 Sabrina Lieberman 0.30 Review and revise NDA summary (.2);
correspond with C. Ceresa and K&E team re
same (.1).
07/01/24 Ruan J. Meintjes 0.70 Review and revise bid asset purchase
agreement (.5); coordinate with K. Hardey re
same (.2).
07/01/24 Ruan J. Meintjes 0.50 Review and revise transition services
agreement.
07/01/24 Trent Nachbar 7.20 Review, analyze issues re asset purchase
agreement and schedules (3.9); further
review, analyze same (2.6); research specialist
questions re same (.5); summarize specialist
comments re same (.2).
07/01/24 Michelle L. Nowicki 12.00 Review, analyze issues re trademark
disclosures, prior K&E US trademark
schedule, new trademark search results (3.4);
analyze and review related intellectual
property office records re trademarks (2.1);
draft trademark schedule (2.9); review,
analyze issues re patent disclosures (2.1);
analyze and review related intellectual
property office records (.4); draft patent
schedule (.6); correspond with B. Coppola,
K&E team re intellectual property due
diligence (.5).

7
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 236 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104437
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
07/01/24 Dan O'Connor 8.30 Telephone conference with PJT team,
AlixPartners team, Y. Salloum, S. Toth, K&E
team members re work in process (.5);
telephone conference re legal diligence with
M&E Counterparty, AlixPartners team, A.
Cunha, B. Coppola and K&E team (.5);
telephone conference with S. Toth re
transaction matters (.3); telephone conference
with Company, S. Toth, K&E team re
transition services (.5); review and revise
M&A counterparty asset purchase agreement
(3.9); further review and revise same (.1);
correspond with S. Toth, T. Nachbar and
K&E team re same (.5); review and revise
disclosure schedules (.4); review, analyze IT
agreements in connection with disclosure
schedules (.8); correspond with Company,
K&E team re antitrust matters (.4); draft open
items summary for disclosure schedules (.3);
correspond with Company re same (.1).
07/01/24 D. Taylor Petersen 3.00 Draft disclosure schedules (1.2); review due
diligence (1.8).
07/01/24 Joshua Raphael 0.10 Review, execute sale NDA and correspond re
same.
07/01/24 Risa Salins 0.70 Review, revise purchase agreement.
07/01/24 Yusuf Salloum 2.00 Analyze, review issues re sale transactions.
07/01/24 Anna Schwander 1.50 Analyze German foreign direct investment
filing requirements in connection with
potential sale (1.0); draft RFI questionnaire
(.5).
07/01/24 Scottie Shermetaro 3.10 Review and revise asset purchase agreement
(1.9); review due diligence re same (.5);
review and revise TSA (.7).
07/01/24 Matt Swanson 1.00 Review, revise purchase agreement.
07/01/24 Paul D. Tanaka, P.C. 3.60 Review, revise auction draft markups of
purchase agreements (3.2); correspond with S.
Toth, K&E team re same (.4).

8
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 237 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104437
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
07/01/24 Steve Toth 6.30 Telephone conference with McDermott, Y.
Salloum, K&E team re introductions, case
status (.5); telephone conference with PJT,
AlixPartners, Y. Salloum, K&E team and
Company re case updates (.7); correspond
with AlixPartners, Company, Y. Salloum,
K&E team re TSA matters (.3); telephone
conference with bidder, bidder counsel, C.
Ceresa, K&E team and AlixPartners re
diligence and TSA matters (.4); draft issues
list re bidder asset purchase agreement (.9);
analyze and revise bidder asset purchase
agreement (2.9); correspond with
AlixPartners re TSA matters (.4); correspond
with D. O’Connor re schedules and asset
purchase agreement (.2).
07/01/24 Spencer A. Winters, P.C. 1.50 Review and analyze issues re sale, case
strategy (.8); correspond and telephone
conferences with multiple parties re same (.7).
07/02/24 Lauren Austgen 1.50 Correspond with H. Smith re copyrights (.2);
review and analyze research re copyrights
(.9); review and compare copyright schedules
(.4).
07/02/24 Chris Ceresa 7.30 Review, analyze sale related issues (3.6);
correspond with Company, advisors, Y.
Salloum, K&E team re same (1.9); review and
analyze NDA markups (.3); review and
comment on bidding procedures declaration,
notices, and key dates (1.5).
07/02/24 Adam Thomas Clifford, P.C. 2.00 Review, analyze stalking horse bid process
matters and related documentation.
07/02/24 Bernadette Coppola 2.90 Correspond with S. Toth and K&E team re
transaction perimeter and intellectual property
matters (.3); conference with S. Toth, K&E
team, client re purchase agreements and
associated workstreams (1.1); correspond
with M. Nowicki and K&E team re analysis
of intellectual property search results (.4);
conference with S. Shermetaro and K&E team
re checklist (.8); conference with M. King re
matter updates (.3).
07/02/24 Tabitha J. De Paulo 0.30 Review and revise draft declaration of M.
Schlappig in support of bid procedures.

9
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 238 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104437
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
07/02/24 Anthony M. Del Rio 3.20 Review and revise purchase agreement (1.5);
review, analyze research on regulatory filing
requirements and strategize on filing approach
(1.7).
07/02/24 Jaina Desai 1.30 Telephone conference with Company, S.
Toth, K&E team re asset purchase agreements
(1.2); correspond with R. Marston re same
(.1).
07/02/24 Jaina Desai 8.00 Revise bidding procedures declarations (2.6);
correspond with R. Marston re same (.4);
correspond with C. Ceresa, Y. Salloum re
same (.2); revise bidding procedures notices
(1.2); correspond with C. Ceresa re same (.2);
correspond with S. Golden re publication
notice (.1); revise bidding procedures order
(1.4); correspond with C. Ceresa re same (.1);
correspond with AlixPartners re bidding
procedures declaration (.2); telephone
conference with AlixPartners re same (.2);
correspond with PJT re budding procedures
declaration (.1); telephone conference with
PJT, R. Marston re bidding procedures
declaration (.2); further revise PJT bidding
procedures declaration (.3); review, analyze
precedent re notice requirement (.3);
correspond with G. Reardon re same (.1);
correspond with R. Marston re key dates (.2);
correspond with C. Ceresa re same (.2).
07/02/24 Luke Finn 8.10 Telephone conference with A. Clifford re case
introduction (.3); review, analyze bankruptcy
code 363 structure and precedent (.7);
telephone conference with client, S. Toth,
K&E team (1.4); telephone conference with
S. Toth, K&E team re allocation of bidders,
workstreams (.9); review, analyze deal
documents, asset purchase agreement (1.0);
review, revise updated M&A Counterparty
asset purchase agreement to include specialist
comments (3.8).

10
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 239 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104437
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
07/02/24 Justin M. Garfinkle 4.50 Review, analyze issues re registered
intellectual property schedules, chain of title
issues, schedules of international owners (.9);
review, analyze issues re respiratory
diagnostics disclosure schedules (2.5);
correspond with B. Coppola, K&E team re
case updates and workstreams (1.1).
07/02/24 Kate Hardey 1.80 Revise APA (1.3); review, analyze TSA and
confer with R. Meintjes re HIPAA (.5).
07/02/24 Liz Ji 0.70 Review, analyze transition services agreement
re tax matters.
07/02/24 Olivia Kaufmann 1.00 Conference with R. Meintjes re change of
ownership (.4); conference with A. Del Rio,
R. Meintjes re next steps (.3); review and
revise summary (.2); correspond with
regulator (.1).
07/02/24 Sooah Kim 0.30 Review, revise transition services agreement
re employment matters.
07/02/24 Maggie Kate King 1.30 Conference with J. Garfinkle, K&E team re
project workstreams and status updates (1.0);
conference with B. Coppola re matter updates
(.3).
07/02/24 Daniel Lewis, P.C. 1.30 Review, analyze TSA and separation matters
(.8); correspond with B. Coppola and K&E
team re same (.5).
07/02/24 Sabrina Lieberman 2.00 Conference with Y. Salloum, K&E team, PJT,
AlixPartners, Company re sale work in
process (1.7); review, analyze NDA (.1);
review, revise NDA summary (.2).
07/02/24 Rebecca J. Marston 4.20 Conferences with C. Ceresa, K&E team,
confidential sale parties re asset purchase
agreement drafts, sale matters (.5); correspond
with J. Desai, K&E team re same (3.2);
conference with C. Ceresa, K&E team re U.S.
Trustee comments to bidding procedures
order (.5).

11
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 240 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104437
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
07/02/24 Brandan Matthews 3.00 Conference with M&A Counterparty re
purchase agreement markup (.5); correspond
with client re vents and respiratory business
unit purchase agreements (1.5); correspond
with S. Toth, K&E team re administrative
matters (.5); review M&A counterparty asset
purchase agreement (.3); review, analyze
client request re same (.2).
07/02/24 Ruan J. Meintjes 1.80 Conference with O. Kaufman and A. Del Rio
re next steps on change of ownership
notifications (.2); research re change of
ownership (1.6).
07/02/24 Ruan J. Meintjes 0.80 Review and revise bid revisions to asset
purchase agreement.
07/02/24 Ashley Brittanie Miller 0.70 Revise domain disclosures based on search
results (.5); correspond with M. Nowicki and
H. Smith re same (.2).
07/02/24 Trent Nachbar 7.20 Review, analyze issues re asset purchase
agreement and schedules (3.9); further
review, analyze same (2.1); telephone
conference with B. Matthews, K&E team re
transaction updates (.5); review, analyze
specialist comments for asset purchase
agreement (.5); summarize same (.2).
07/02/24 Michelle L. Nowicki 10.40 Correspond with B. Coppola, K&E team re
intellectual property due diligence (.8);
review, revise patent schedule to include PPR
patents and industrial designs (3.4); review
and analyze related online intellectual
property office records (1.1); review and
revise domain schedule (1.9); summarize
Domain Tools database searches (.6); review,
analyze records re same (.6); review and
revise copyright schedule (.5); review and
revise patent schedule (.7); correspond with
B. Coppola, K&E team re copyright, domain
name and patent schedules (.8).

12
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 241 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104437
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
07/02/24 Dan O'Connor 10.50 Telephone conference with Cooley team, S.
Toth, K&E team re asset purchase agreement
(.5); review and revise purchase agreement
(1.5); telephone conference with A. Clifford,
S. Toth, B. Matthews, L. Finn, T. Nachbar
and T. Petersen re transaction matters (.7);
correspond with B. Matthews and L. Finn re
transaction matters (.5); telephone conference
with Company, PJT team, AlixPartners team,
S. Toth, Y. Salloum and K&E team re
transaction matters (1.4); review, analyze
VDR materials and prepare disclosure
schedules and open items punch list for M&A
counterparty (2.0); review, analyze VDR
(1.0); draft, summarize disclosure schedules
and open items punch list for M&A
Counterparty asset purchase agreement (1.5)
correspond with B. Coppola, K&E team re
transaction matters (.5); telephone conference
with T. Petersen re IT agreement review (.4);
correspond with AlixPartners team re
disclosure schedules and transaction matters
(.5).
07/02/24 Carolin Paus 0.70 Telephone conference with Company,
AlixPartners re cash flow forecast in prep for
sales.
07/02/24 D. Taylor Petersen 6.10 Summarize intellectual property due diligence
(2.4); draft summary re IT agreement terms
for ventilation and respiratory diagnostics
assets (3.7).
07/02/24 Yusuf Salloum 3.60 Analyze, review issues re sale transaction.
07/02/24 Scottie Shermetaro 4.50 Telephone conference with B. Coppola and
client re APAs (1.3); telephone conference
with S. Toth, K&E team re revisions to
purchase agreements (.8); review and revise
disclosure schedules (1.1); review and revise
intellectual property schedules (1.3).
07/02/24 Hayley Smith 2.00 Compile intellectual property due diligence
(.5); review, analyze schedules (1.1);
correspond with D. Peterson, K&E team re
same (.4).
07/02/24 Noah Spector 0.70 Analyze bid procedures motion and related
materials.

13
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 242 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104437
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
07/02/24 Steve Toth 7.20 Analyze correspondence re asset purchase
agreement schedules (.3) analyze, review
correspondence re non‑debtor matters (.3);
correspond with A. Clifford re asset purchase
agreement and schedule matters (.2);
telephone conference with bidder, bidder
counsel, Company, PJT, AlixPartners, A.
Clifford, K&E team re asset purchase
agreement issues (.5); analyze and prepare
correspondence re asset purchase agreement
issues (.5); telephone conference with
Company, PJT, AlixPartners, S. Winters,
K&E team re bidder asset purchase agreement
issues (1.3); correspond with S. Winters,
K&E team re APAs and schedules (.6);
analyze and revise bidder asset purchase
agreement (3.5).
07/02/24 Donatus Wang 0.90 Prepare for conference with Company on cash
flow forecast for German entities re sales (.3);
conference with Company, AlixPartners re
same (.6).
07/02/24 Spencer A. Winters, P.C. 1.50 Review and analyze issues re sale process and
case strategy (.7); correspond and telephone
conferences with multiple parties re same (.8).
07/02/24 Ann-Kathrin Ziegler 1.00 Prepare for conference with Company and
German management counsel re cashflow
forecast in prep for sales (.2); conference with
Company and German management counsel
re same (.8).
07/03/24 Marin Boney 0.30 Correspond with Y. Salloum, K&E team re
HSR filing.
07/03/24 Chris Ceresa 4.90 Review, analyze sale related issues (3.9);
further review, analyze same (.5) correspond
with Company, advisors, Y. Salloum, K&E
team re same (.5).
07/03/24 Adam Thomas Clifford, P.C. 1.00 Review, analyze stalking horse bidder
markups and diligence matters.

14
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 243 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104437
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
07/03/24 Bernadette Coppola 5.60 Conference with client, AlixPartners, bankers,
buyer, Y. Salloum, K&E team re transition
services agreement due diligence (1.0);
conference with Company, R. Meintjes and
K&E team re healthcare regulatory matters
and transition services agreement (.2);
correspond with S. Shermetaro and K&E
team re intellectual property matters (.4);
conference with S. Toth, Company and K&E
team re transaction strategy (.7); review draft
disclosure schedules (.2); revise same (.2);
conference with J. Garfinkle and K&E team
re same (.5); draft revisions to asset purchase
agreement (1.7); correspond with T. Nachbar
and K&E team re same (.1); analyze
Company materials re separation of
intellectual property assets (.2); correspond
with Company and K&E team re same (.1);
correspond with D. Lewis and K&E team re
matter updates (.2); correspond with M.
Nowicki and K&E team re intellectual
property schedules (.1).
07/03/24 Anthony M. Del Rio 2.10 Review and revise TSA and related regulatory
considerations (1.8); telephone conference
with Company and advisors re transition
services (.3).
07/03/24 Jaina Desai 1.00 Revise bidding procedures declarations (.2);
revise second day orders (.8).
07/03/24 Jaina Desai 1.80 Review, analyze comments re PJT bidding
procedure declaration (.2); revise same (.1);
correspond with R. Marston, PJT re same (.1);
revise AlixPartners bidding procedures
declaration (.2); correspond with R. Marston
re same (.1); correspond with AlixPartners re
same (.1); correspond with C. Ceresa re
bidding procedures (.1); correspond with T.
De Paulo, AlixPartners re witness preparation
meeting (.2); review, analyze correspondence
re second day orders (.2); revise second day
orders (.3); correspond with T. Chanroo re
same (.1); correspond with C. Ceresa re sale
NDA (.1).

15
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 244 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104437
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
07/03/24 Jaina Desai 5.10 Correspond with C. Ceresa re sale NDA (.1);
revise same (.7); correspond with PJT re same
(.1); revise bidding procedures declarations
(3.8); correspond with Y. Salloum, C. Ceresa
re same (.4).
07/03/24 Jaina Desai 1.10 Correspond with S. Golden re publication
notice (.1); revise publication notice (.1);
correspond with C. Ceresa re bidding
procedures order (.1); correspond with
AlixPartners re sale escrow account (.1);
summarize, analyze documents re same (.2);
revise sale summary (.3); review, analyze
correspondence re sale stream (.2).
07/03/24 Luke Finn 8.30 Telephone conference with client re
respiratory diagnostics representations and
warranties (.8); telephone conference with
client re M&A Counterparty representations
and warranties (1.5); review and revise M&A
Counterparty purchase representations and
warranties (1.0); review, analyze interim
operating covenants and ex‑US entity
structure (1.1); review, analyze revisions to
asset purchase agreement (1.0); correspond
with S. Toth re same (.2); review and revise
asset purchase agreement to include
intellectual property concerns (1.8);
summarize asset purchase agreement for
distribution to opposing counsel (.9).
07/03/24 Justin M. Garfinkle 5.00 Review, analyze issues re registered
intellectual property schedules and chain of
title issues (2.1); revise respiratory
diagnostics disclosure schedules (2.0);
correspond with outside intellectual property
counsel re same (.9).
07/03/24 Luci Hague 0.20 Review, analyze CFIUS due diligence
questions.
07/03/24 Kate Hardey 1.20 Review, analyze TSA provisions (.7); discuss
same with R. Meintjes, K&E team (.5).
07/03/24 Maggie Kate King 2.00 Conference with buyer re transition services
schedules (1.0); conference with D. Shin re
matter updates (.5); conference with client re
personal health information for transition
services agreement matters (.2); review IT
license summaries for assignability (.3).

16
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 245 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104437
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
07/03/24 Daniel Lewis, P.C. 0.50 Telephone conferences with B. Coppola,
K&E team re TSA matters.
07/03/24 Sabrina Lieberman 0.20 Review, revise NDA (.1); review, revise
summary re same (.1).
07/03/24 Savannah Malnar-Cole 0.70 Correspond with S. Winters, K&E team re
Hart Scott Rodino filing.
07/03/24 Mario Mancuso, P.C. 0.20 Review, revise CFIUS due diligence question.
07/03/24 Brandan Matthews 4.00 Review and revise ventilation business
stalking horse purchase agreement.
07/03/24 Ruan J. Meintjes 1.00 Review and revise transition services
agreement (.5); conference with Company re
protected health information diligence (.5).
07/03/24 Ruan J. Meintjes 0.80 Review and revise bid draft asset purchase
agreement comments from foreign counsel
(.5); coordinate with K. Hardey, K&E team re
the same (.3).
07/03/24 Jake Moeller 5.60 Review, analyze vendor and seller master
agreements, purchase orders and statements
of work (3.9); further review and analyze
same (.6); summarize results of same (1.0);
correspond with S. Toth, K&E team re results
(.1).
07/03/24 Trent Nachbar 7.10 Review, analyze issues re asset purchase
agreement and schedules (3.9); further
review, analyze same (2.7); review, analyze
issues re asset purchase agreement specialist
comments (.3); summarize same (.2).
07/03/24 Michelle L. Nowicki 0.50 Correspond with B. Coppola, K&E team re
intellectual property due diligence (.3); revise
patent schedule (.1); correspond with B.
Coppola, K&E team re same (.1).

17
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 246 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104437
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
07/03/24 Dan O'Connor 4.10 Telephone conference with Company re
respiratory diagnostics disclosure schedules
(.6); telephone conference with AlixPartners
team re bid comparisons (.8); telephone
conference with Company re transaction
matters (.4); telephone conference with
Company re interim operating covenants (.5);
correspond with S. Toth re same (.3);
correspond with Foley team re transaction
matters (.5); telephone conference with
Company, PJT team, AlixPartners team, S.
Toth, S. Winters, K&E team re transaction
strategy call (.5); correspond with M. Boney
and S. Malnar‑Cole re antitrust matters (.3);
correspond with T. Martin and T. Nachbar re
escrow matters (.2).
07/03/24 Dan O'Connor 3.60 Correspond with Goodwin, Cooley and PJT
teams re legal diligence matters (.4); review
and revise respiratory diagnostics disclosure
schedules (1.2); correspond with Crowell
team re same (.5); review and revise M&A
counterparty disclosure schedules (1.2);
correspond with Foley team re same (.3).
07/03/24 D. Taylor Petersen 4.60 Conduct due diligence (2.1); draft summary
sheet of comingled IT agreements (2.5).
07/03/24 Yusuf Salloum 1.20 Review, revise evidentiary support for bid
procedures.
07/03/24 Scottie Shermetaro 6.90 Telephone conference with B. Coppola and
client re TSA matters (1.0); review and revise
TSA (.3); telephone conference with J.
Garfinkle re intellectual property disclosure
schedules (.2); telephone conference with B.
Coppola and client re asset purchase
agreement markups (.7); review and revise
registered intellectual property portfolio (1.5);
review and revise disclosure schedules; (.4);
telephone conference with B. Coppola and J.
Garfinkle re disclosure schedule revisions
(.7); review, analyze intellectual property
disclosures (1.2); draft and revise intellectual
property mapping diligence questions (.9).

18
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 247 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104437
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
07/03/24 Daniel Shin 6.30 Correspond with M. King re diligence and
agreement status (.5); review, analyze IT
licenses for intellectual property license
assignment provisions (3.9); further review,
analyze same (.3); telephone conference with
client re Ventilation strategy (.4); correspond
with B. Coppola, K&E team re same (.3);
draft intellectual property assignment
agreement (.9).
07/03/24 Michael D. Thorpe 0.30 Analyze HSR reportability of the transaction.
07/03/24 Steve Toth 7.80 Telephone conference with Company,
AlixPartners, bidder, bidder advisors, S.
Winters, K&E team re TSA matters (1.0);
analyze correspondence re schedules and
asset purchase agreement (.3); correspond
with S. Winters re sale updates(.1); analyze
bidder asset purchase agreement (.8); analyze
and revise bidder asset purchase agreement
(2.9); telephone conferences with bidder,
bidder advisor, Company, Y. Salloum, K&E
team re sale issue (.6); correspond with D.
O’Connor and AlixPartners re asset purchase
agreement comparison (.3); analyze and
revise asset purchase agreement (.8);
telephone conference with PJT, AlixPartners,
Company, Y. Salloum, K&E team re sale
strategy (.6); correspond with Y. Salloum,
K&E team re APAs (.4).
07/03/24 Donatus Wang 0.20 Review, analyze summary of German license
agreements.
07/03/24 Spencer A. Winters, P.C. 3.50 Review and analyze issues re marketing
process (1.4); prepare for and participate in
standing special committee telephone
conference with Company (.5); prepare for
and participate in telephone conference with
bidder principals (1.0); correspond and
telephone conferences with multiple parties re
same (.6).
07/04/24 Chris Ceresa 0.50 Review, analyze sale related issues (.2);
correspond with Company, advisors, Y.
Salloum, K&E team re same (.3).
07/04/24 Bernadette Coppola 0.20 Correspond with D. O’Connor and K&E team
re disclosure schedules.

19
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 248 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104437
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
07/04/24 Jaina Desai 0.90 Review, analyze UCC comments to bidding
procedures order (.4); draft correspondence re
same (.2); review, analyze bidding procedures
order (.3).
07/04/24 Daniel Lewis, P.C. 0.50 Correspond with B. Coppola, K&E team re
asset purchase agreement and TSA matters.
07/04/24 Dan O'Connor 2.50 Correspond with Cooley team re foreign
subsidiaries (.4); review and revise respiratory
diagnostics disclosure schedules (1.0);
correspond with S. Toth, Company and
Crowell team re same (.5); draft open items
list for disclosure schedules (.4); correspond
with Company re same (.2).
07/04/24 Steve Toth 2.60 Correspond with AlixPartners re lease matters
(.4); draft correspondence re same (.5);
analyze correspondence re schedules
questions (.7); draft responses to same (.4);
analyze correspondence re transaction issues
(.6).
07/05/24 Chris Ceresa 3.90 Review, analyze sale related issues (3.4);
correspond with Company, advisors, Y.
Salloum, K&E team re same (.5).
07/05/24 Bernadette Coppola 1.40 Conference with S. Toth, K&E team, advisors
re sale strategy (.6); correspond with J.
Garfinkle and K&E team re disclosure
schedules (.4); correspond with S. Toth and
K&E team re transaction steps (.1);
conference with S. Mangal re transition
services agreement schedules (.2); correspond
with AlixPartners re same (.1).
07/05/24 Anthony M. Del Rio 1.10 Review and analyze filing requirements (.5);
review and revise purchase agreements (.6).
07/05/24 Jaina Desai 5.70 Revise bidding procedures order (3.3);
review, analyze re same (.6); correspond with
R. Marston re same (.4); correspond with C.
Ceresa, Y. Salloum re same (.8); review,
analyze precedent re same (.6).
07/05/24 Luke Finn 3.90 Review, analyze revisions to asset purchase
agreement re labor considerations (.6);
revise asset purchase agreement re same (.6);
review, analyze diligence materials in relation
to asset purchase agreement (2.0); correspond
with S. Toth, K&E team re sale updates (.7).

20
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 249 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104437
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
07/05/24 Justin M. Garfinkle 4.70 Review, analyze issues re registered
intellectual property schedules and related
chain of title issues (2.2); review, analyze
issues re disclosure schedules for ventilation
business (1.0); review, analyze disclosed
agreements re same (1.5).
07/05/24 Kate Hardey 0.50 Review, analyze APA (.3); conference with
R. Meintjes re same (.2).
07/05/24 Olivia Kaufmann 0.20 Correspond with A. Del Rio re change of
control and ownership to licenses.
07/05/24 Daniel Lewis, P.C. 0.50 Correspond with B. Coppola, K&E team re
TSA matters.
07/05/24 Sabrina Lieberman 0.10 Revise NDA summary.
07/05/24 Brandan Matthews 2.70 Correspond with client re tax representations t
(.7); revise M&A counterparty purchase
agreement (2.0).
07/05/24 Ruan J. Meintjes 1.10 Review and revise M&A counterparty asset
purchase agreement.
07/05/24 Trent Nachbar 2.90 Review, analyze issues re asset purchase
agreement and schedules (2.5); review,
analyze specialist comments to asset purchase
agreement (.2); summarize same (.2).
07/05/24 Dan O'Connor 4.10 Telephone conference with Company re tax
matters (.6); correspond with Company re
same (.3); telephone conference with PJT
team re transaction matters (.4); telephone
conference with S. Toth re transaction matters
(.2); telephone conference with M&A
counterparty, Company, AlixPartners, PJT
team, S. Toth, K&E team re respiratory
diagnostics transaction matters (.6); telephone
conference with M&A counterparty, Foley
team, PJT team, Company, S. Toth, Y.
Salloum, K&E team re asset purchase
agreement (1.0); correspond with Company re
representations and warranties (.2);
correspond with B. Matthews and L. Finn re
transaction matters (.3); correspond with PJT
team re VDR matters (.2); review, analyze
VDR files re same (.3).
07/05/24 D. Taylor Petersen 2.20 Draft disclosure schedules (1.8); review,
revise disclosure schedules (.4).

21
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 250 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104437
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
07/05/24 Evangelia Podaras 2.50 Review, revise bid APAs (2.2); correspond
with S. Toth, K&E team re same (.3).
07/05/24 Yusuf Salloum 2.30 Conferences with M&A counterparty,
Company, PJT, S. Toth, K&E team re sale
transaction, structuring (1.5); review, revise
bid procedures (.8).
07/05/24 Scottie Shermetaro 1.60 Review and revise TSA (.9); review and
revise intellectual property disclosure
schedules (.7).
07/05/24 Daniel Shin 5.00 Revise and review intellectual property
assignment agreement (.2); review and
analyze respiratory diagnostics respiratory
diagnostics IT agreements (1.9); review and
analyze ventilation IT agreements (2.9).
07/05/24 Steve Toth 4.60 Telephone conference with Company,
AlixPartners, PJT Y. Salloum, K&E team re
bidder updates and strategy (.6); analyze
correspondence re APAs and transaction
issues and status (.4); telephone
conference with bidder, bidder advisor,
Company, PJT, AlixPartners, D.
O’Connor, K&E team re sale transaction
updates (.6); correspond with D. O’Connor re
sale issues (.6); review, analyze
correspondence re sale issues (.3); telephone
conference with bidder, bidder advisors,
Company, AlixPartners, PJT, D. O’Connor,
K&E team re diligence, transaction
documents and schedules (.6); correspond
with AlixPartners re bidders, APAs, structure
(.3); telephone conference with bidder, bidder
advisors, Company, AlixPartners, PJT, D.
O’Connor, K&E team re diligence matters
(1.2).
07/05/24 Sarah Ullathorne 0.20 Review, analyze issues re antitrust.
07/05/24 Spencer A. Winters, P.C. 1.00 Review and analyze sale process issues (.6);
correspond and telephone conferences with
working group re same (.4).
07/06/24 Chris Ceresa 1.00 Review, analyze sale related issues (.8);
correspond with Company, advisors, Y.
Salloum, K&E team re same (.2).

22
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 251 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104437
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
07/06/24 Bernadette Coppola 0.90 Correspond with J. Garfinkle and team re
revisions to disclosure schedules (.3);
correspond with M. King and K&E team re
revisions to transition services agreement (.2);
correspond with AlixPartners and client re
transition services agreement schedules (.2);
correspond with Company re separation of
assets (.2).
07/06/24 Jaina Desai 1.00 Revise bidding procedures talking points (.6);
correspond with R. Marston re same (.2);
review, analyze cure schedule (.1); review,
analyze precedent re bidding procedures
talking points (.1).
07/06/24 Jaina Desai 5.00 Draft bidding procedures talking points (1.0);
review precedent re same (.3); analyze,
summarize transcripts (.6); correspond with
R. Marston re same (.2); correspond with R.
Marston re bidding procedures talking points
(.1); revise bidding procedures talking points
(.3); revise bidding procedures declarations
(.2); correspond with Y. Salloum, C. Ceresa
re same (.1); revise bidding procedures
notices (1.5); correspond with R. Marston re
same (.6); correspond with C. Ceresa re same
(.1).
07/06/24 Luke Finn 1.30 Review, analyze issues re M&A counterparty
bid (1.0); correspond with B. Matthews, K&E
team re sale status (.3).
07/06/24 Justin M. Garfinkle 1.00 Review, analyze issues re ventilation
disclosure schedules.
07/06/24 Maggie Kate King 1.50 Review and revise transition services
schedules (1.1); review and revise intellectual
property assignment agreement (.4).
07/06/24 Daniel Lewis, P.C. 0.50 Correspond with B. Coppola, K&E team re
TSA matters.
07/06/24 Scottie Shermetaro 1.30 Review and revise TSA.
07/06/24 Daniel Shin 7.50 Review and revise transition services
agreement schedules (3.9); review and
analyze supply agreements for ventilation
disclosure schedules (2.8); review and revise
intellectual property assignment agreement
(.8).

23
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 252 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104437
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
07/06/24 Steve Toth 1.20 Telephone conference with Company, PJT,
AlixPartners, D. O’Connor, K&E team re
transactions update (.9); analyze
correspondence re transaction matters and
status (.3).
07/07/24 Chris Ceresa 4.20 Review, analyze sale related issues (3.4);
correspond with Company, advisors, Y.
Salloum, K&E team re same (.8).
07/07/24 Adam Thomas Clifford, P.C. 0.50 Review, analyze issues re 363 sale process
matters.
07/07/24 Bernadette Coppola 2.50 Conference with S. Toth, K&E team, client,
advisors re transition services agreement
schedules (1.0); conference with S.
Shermetaro and M. King re revisions to
transition services agreement schedules (.8);
correspond with S. Toth and K&E team re
same (.2); correspond with D. Lewis and
K&E team re matter updates (.1); draft
revisions to transition services agreement
schedules (.2); correspond with M. King and
K&E team re same (.2).
07/07/24 Tabitha J. De Paulo 0.30 Review and comment on declarations in
support of bid procedures.
07/07/24 Jaina Desai 5.00 Revise bidding procedures declarations (.5);
correspond with R. Marston, K&E team re
same (.2); revise asset purchase agreement
(3.4); review, analyze asset purchase
agreement precedent (.4); correspond with Y.
Salloum, C. Ceresa re same (.2); revise sale
summary (.2); correspond with R. Marston re
same (.1).
07/07/24 Jaina Desai 1.90 Revise bidding procedures order (.9);
correspond with R. Marston re same (.2);
revise successful bidder notice (.3); review,
analyze correspondence re assumption and
assignment noticing exhibit (.3); correspond
with R. Marston re same (.2).
07/07/24 Luke Finn 1.50 Review, analyze issues re M&A counterparty
bid (.9); review disclosure schedules for
M&A Counterparty bid (.4); review, analyze
correspondence re same (.2).
07/07/24 Justin M. Garfinkle 0.60 Review, analyze issues re ventilation
disclosure schedules.

24
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 253 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104437
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
07/07/24 Maggie Kate King 3.20 Conference with AlixPartners and Company
re transition services schedules (1.1); revise
transition services schedules (2.1).
07/07/24 Daniel Lewis, P.C. 0.50 Correspond with B. Coppola, K&E team re
asset purchase agreement matters.
07/07/24 Savannah Malnar-Cole 0.50 Review and analyze client responses re
ventilation business and competition.
07/07/24 Brandan Matthews 4.90 Telephone conference with stalking horse
bidder re asset purchase agreement (.7);
review, analyze purchase agreement markup
(2.6); review, revise issues list matters (1.6).
07/07/24 Maureen D. O'Brien 0.50 Correspond with S. Toth, K&E team
re purchase agreement.
07/07/24 Dan O'Connor 1.70 Telephone conference with M&A
counterparty, PJT Partners, Company, S.
Toth, K&E team re transaction matters (.6);
telephone conference with AlixPartners,
Company, S. Toth and Y. Salloum re cure
costs (.7); correspond with B. Matthews re
asset purchase agreement (.4).
07/07/24 Yusuf Salloum 4.00 Conferences with PJT, Company,
AlixPartners, C. Ceresa, K&E team re sale
negotiations (1.8); review, analyze transaction
documents re legal issues re same (2.2).
07/07/24 Scottie Shermetaro 4.50 Telephone conference with B. Coppola, M.
King and Company re TSA (1.0); telephone
conference with M. King and B. Coppola re
TSA revisions (.5); review and revise TSA
schedules (1.9); review and revise intellectual
property schedules (1.1).
07/07/24 Noah Spector 0.60 Review and analyze declaration and bidding
procedures motion.

25
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 254 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104437
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
07/07/24 Steve Toth 7.10 Telephone conference with bidder, bidder
advisors, Company, PJT, Y. Salloum, K&E
team and AlixPartners re diligence and
transaction updates (.6); analyze
correspondence re transaction matters (.3);
analyze revised asset purchase agreement
(1.4); telephone conference with Company,
AlixPartners, D. O’Connor, K&E team re
cure costs (.9); revise attorney notes re APAs
and related issues and considerations (.6);
analyze and revise asset purchase agreement
issues list (.3); analyze correspondence re
deposits and TSA (.3); analyze
correspondence re asset purchase agreement
and TSA (.5); analyze correspondence re
schedules, IOCs and diligence (.5); telephone
conference with Company, AlixPartners, Y.
Salloum, K&E team re TSA matters (1.0);
analyze correspondence re asset purchase
agreement issues (.7).
07/08/24 Chris Ceresa 5.80 Review, analyze sale related legal issues
(1.8); review and comment on asset purchase
agreements re legal issues (2.4); correspond
with Company, PJT, AlixPartners, Y.
Salloum, K&E team re same (1.6).
07/08/24 Bernadette Coppola 2.90 Correspond with D. Lewis and K&E team re
transaction updates (.2); correspond with J.
Garfinkle and K&E team re intellectual
property schedules (.2); correspond with Alix
Partners, M. King and K&E team re transition
services agreement schedules (.4); conference
with S. Shermetaro and K&E team re
revisions to documents and matter updates
(.5); correspond with S. Shermetaro re same
(.2); draft revisions to purchase agreement
(.3); correspond with B. Matthews and K&E
team re same (.1); correspond with J.
Garfinkle re updates to intellectual property
schedules (.1); conference with S. Shermetaro
re revisions to purchase agreement and
transition services agreement schedules (.4);
correspond with M. King and K&E team re
revisions to transition services agreement
schedules (.5).

26
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 255 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104437
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
07/08/24 Anthony M. Del Rio 3.70 Review and revise purchase agreements (1.7);
review and analyze structure considerations
(1.4); telephone conference with UCC
counsel re transaction status (.4); prepare for
same (.2).
07/08/24 Jaina Desai 2.20 Telephone conference with PJT, Y. Salloum,
K&E team re second day hearing witness
preparation (.8); prepare for same (.3);
correspond with R. Marston re bidding
procedures declarations (.2); review, analyze
correspondence re sale stream (.1);
correspond with AlixPartners re second day
hearing (.1); draft correspondence re bidding
procedures hearing (.2); correspond with K.
Rasti, K&E team re same (.1); correspond
with R. Marston re bidding procedures order
(.2); correspond with K. Trevett, C. Ceresa re
bidding procedures talking points (.2).
07/08/24 Jaina Desai 0.90 Review, analyze bidding procedures order
(.2); revise bidding procedures order (.2);
correspond with C. Ceresa re same (.1); revise
bidding procedures talking points (.1);
correspond with K. Trevett, Y. Salloum re
same (.1); correspond with C. Ceresa re sale
notice, bidding procedures declarations (.1);
correspond with AlixPartners re escrow
account (.1).
07/08/24 Jaina Desai 1.10 Review, analyze UCC comments to bidding
procedures order (.1); correspond with R.
Marston re same (.2); revise bidding
procedures order (.6); correspond with R.
Marston re same (.2).
07/08/24 Jaina Desai 2.00 Telephone conference with AlixPartners, C.
Ceresa, K&E team re declarant witness
preparation (.3); correspond with R. Marston
re same (.1); review, analyze UCC comments
re bidding procedures (.1); revise bidding
procedures (.2); revise bidding procedures
order (1.0); correspond with R. Marston re
same (.1); revise bidding procedures
declarations (.2).

27
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 256 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104437
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
07/08/24 Jaina Desai 2.80 Correspond with C. Ceresa re status re sale
stream, next steps (.1); revise bidding
procedures order (.4); correspond with R.
Marston, C. Ceresa re same (.1); revise
bidding procedures declaration (.1); revise
bidding procedures order (1.8); correspond
with C. Ceresa re same (.2); telephone
conference with C. Ceresa re same (.1).
07/08/24 Jaina Desai 0.50 Revise bidding procedures order (.3);
correspond with C. Ceresa re same (.2).
07/08/24 Jaina Desai 0.20 Review, analyze correspondence re bidding
procedures order (.1); correspond with R.
Marston re same (.1).
07/08/24 Luke Finn 1.20 Telephone conference with Company re legal
issues re asset purchase agreement (.6);
review, analyze updated dataroom documents
(.6).
07/08/24 Justin M. Garfinkle 7.00 Review, revise ventilation purchase
agreement (1.2); review, analyze registered
intellectual property schedules, chain of title
questions, other missing information (3.9);
further review, analyze same (1.1) correspond
with L. Finn, K&E team re sale matters (.8).
07/08/24 Kate Hardey 3.10 Conference with R. Meintjes, K&E team re
state license change of ownership review (.5);
review and conference with R. Meintjes,
K&E team re comments to APA (1.5);
conference with R. Meintjes, K&E team re
transfer of products (1.1).
07/08/24 Liz Ji 2.30 Review, analyze tax legal issues re asset
purchase agreement.
07/08/24 Olivia Kaufmann 1.50 Review, revise asset purchase agreement re
health regulatory legal issues (.8); review,
analyze healthcare issues (.7).
07/08/24 Sooah Kim 0.60 Review and revise purchase agreement re
employment legal issues.
07/08/24 Maggie Kate King 2.60 Conference with B. Coppola, K&E team re
intellectual property and transition services
schedules (.5); review, analyze license
summary document (.5); revise transition
services agreement schedules (1.6).
07/08/24 Daniel Lewis, P.C. 0.30 Review, analyze issues re TSA matters.

28
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 257 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104437
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
07/08/24 Rebecca J. Marston 9.50 Correspond with J. Desai, K&E team re sale
related documents (2.3); telephone
conferences with PJT team, C. Ceresa, K&E
team, AlixPartners team re witness
preparation (1.0); correspond with J. Desai,
K&E team re bidding procedures order,
talking points (3.9); review and revise same
(2.3).
07/08/24 Brandan Matthews 8.00 Correspond with Company re purchase
agreement issues list (.5); correspond with
Company re representations and warranty
changes (.5); review, analyze issues re
purchase agreement matters (3.9); further
review, analyze same (3.1).
07/08/24 Ruan J. Meintjes 4.20 Review and revise M&A counterparty asset
purchase agreement (3.8); correspond with M.
O’Brien, K&E team re the same (.4).
07/08/24 Ruan J. Meintjes 0.40 Telephone conference with UCC regulatory
counsel re sale updates.
07/08/24 Ruan J. Meintjes 1.00 Review and analyze change of ownership
regulations (.5); review and analyze foreign
regulatory considerations (.4); correspond
with A. Del Rio, K&E team re same (.1).
07/08/24 Michael William Morgan 0.30 Review, analyze correspondence re sale
updates (.2); correspond with T. Nachbar re
same (.1).
07/08/24 Trent Nachbar 11.20 Review, analyze issues re asset purchase
agreement and schedules (3.9); further review
and revise same (2.6); correspond with M.
Morgan, K&E team re same (1.5); review,
analyze, incorporate specialist comments to
the same (3.2).

29
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 258 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104437
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
07/08/24 Michelle L. Nowicki 10.50 Correspond with B. Coppola, K&E team re
intellectual property due diligence (1.2);
review intellectual property counsel
comments re trademark portfolio (3.2);
review and revise trademark schedule (2.4);
review, analyze trademark issues (1.0);
correspond with B. Coppola, K&E team re
trademark schedule and issues list (.9);
review, analyze patent schedule, related
online intellectual property office records and
intellectual property counsel comments (1.0);
revise patent schedule (.5); correspond with
B. Coppola, K&E team reupdated patent
schedule (.3).
07/08/24 Maureen D. O'Brien 1.00 Review and revise purchase agreement re
employment matters.
07/08/24 Dan O'Connor 3.20 Telephone conference with Company, PJT
Partners, AlixPartners, S. Toth, K&E team re
M&A Counterparty asset purchase agreement
(.4); telephone conference with B. Coppola re
transaction matters (.2); telephone conference
with PJT team re weekly advisors check‑in
(.3); telephone conference with M&A
counterparty, Foley team, Company, S Toth,
K&E team re transaction matters (.2);
telephone conference with Company and B.
Matthews re representations and warranties
(.4); telephone conference with S. Toth re
transaction matters (.3); telephone conference
with B. Matthews re transaction matters (.4);
telephone conference with T. Nachbar re
transaction matters (.5); review and revise
escrow agreement (.2); correspond with M&A
counterparty re same (.3).
07/08/24 Dan O'Connor 4.40 Review and revise M&A counterparty asset
purchase agreement (.8); correspond with S.
Toth and B. Matthews re same (.2); review,
analyze contracts and other diligence
materials in VDR (1.0); draft M&A
counterparty disclosure schedules (1.0);
correspond with Company, S. Toth and T.
Nachbar re same (.8); correspond with R.
Meintjes, K&E team re transaction matters
(.6).

30
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 259 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104437
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
07/08/24 Sarah Osborne 2.40 Research re section 363 sale and COBRA
liabilities (2.2); correspond with A. Salmen,
K&E team re same (.2).
07/08/24 D. Taylor Petersen 1.40 Summarize issues list from M&A
Counterparty’s draft of disclosure schedules
(.4); review and revise disclosure schedules
(1.0).
07/08/24 Evangelia Podaras 1.20 Review, revise asset purchase agreement re
employment related matters.
07/08/24 Adrian Salmen 1.90 Research re COBRA liabilities in 363 sale
(1.3); correspond with S. Osborne re same
(.3); review, revise summary re same (.3).
07/08/24 Anna Schwander 0.30 Correspond with Y. Salloum, K&E team re
German foreign direct investment re sale
issues.
07/08/24 Scottie Shermetaro 8.50 Telephone conference with B. Coppola re
TSA (1.0); review and revise TSA (2.7); draft
and revise TSA issues list (1.2); review and
revise asset purchase agreement (1.1);
telephone conference with B. Coppola, K&E
team re sale status update (.2); telephone
conference with B. Coppola re TSA schedules
(.3); review due diligence re IP schedules
(2.0).
07/08/24 Daniel Shin 5.50 Review and revise intellectual property
schedules (.4); review and revise disclosure
schedules (.8); review M&A counterparty
contracts for IP ownership (.7); correspond
with M. King re diligence items and IT
contracts (.5); review and draft intellectual
property assignment agreement (2.3);
correspond with client re ownership of IP
under M&A counterparty contracts (.8).

31
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 260 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104437
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
07/08/24 Steve Toth 6.60 Analyze correspondence re asset purchase
agreement (.2); revise attorney notes re same
(.1); correspond with Company, PJT, Moelis,
D. O’Connor, K&E team re asset purchase
agreement issues list (.9); telephone
conference with Company, PJT, AlixPartners,
D. O’Connor, K&E team re sale status update
(.5); telephone conference with bidder, bidder
counsel, Company, PJT, Alix, Y. Salloum,
K&E team re asset purchase agreement and
TSA and diligence update (.4); analyze
correspondence re asset purchase agreement
(.4); analyze legal issues re asset purchase
agreement (1.0); revise same (.3); correspond
with MWE, Y. Salloum, K&E team re
transactions and regulatory matters (.5);
analyze asset purchase agreement (.5); revise
same (.5); correspond with D. O’Connor re
asset purchase agreement and schedules (.3);
further analyze, revise asset purchase
agreement (.6); analyze correspondence re
diligence matters (.4).
07/08/24 Steve Toth 1.10 Correspond with Company, AlixPartners, D.
O’Connor, K&E team re cure cost issues (.5);
analyze correspondence re APAs and bidder
updates (.6).
07/08/24 Sarah Ullathorne 1.20 Review, analyze responses to antitrust
questions.
07/08/24 Paul Vasiloff 1.00 Revise purchase agreement re employment
issues.
07/08/24 Spencer A. Winters, P.C. 1.50 Review and analyze sale process issues (.4);
correspond and telephone conferences with
working group re same (.3); draft talking
points for second day hearing re update re
same, case status (.8).
07/09/24 Chris Ceresa 5.20 Review, analyze sale related issues (2.4);
review, analyze legal issues re bidding
procedures and notices (.9); review and
comment on NDAs (.8); correspond with
Company, AlixPartners, PJT, Y. Salloum,
K&E team re issues re sale process (1.1).

32
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 261 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104437
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
07/09/24 Bernadette Coppola 4.30 Correspond with M. King and K&E team re
revisions to transition services agreement
services (.2); correspond with AlixPartners re
transition services agreement schedules (.1);
conference with S. Toth, client and advisors
re transition services agreement and
transaction updates (.9); conference with S.
Toth and K&E team re regulatory matters
(.2); correspond with J. Garfinkle and K&E
team re revisions to intellectual property
schedules (1.3); analyze comments from
client re intellectual property schedules (.2);
conference with D. O’Connor re asset transfer
process (.2); correspond with M. King and
K&E team re same (.1); conference with
client, S. Toth and K&E team re regulatory
matters re transition services agreement
services (.7); follow‑up re same (.1);
conference with S. Toth re revisions to
transition services agreement schedules (.3).
07/09/24 Bernadette Coppola 1.00 Correspond with Company, S. Shermetaro
and K&E team re intellectual property
questions (.5); correspond with Company,
AlixPartners, S. Toth and K&E team re
separation matters (.5).
07/09/24 Anthony M. Del Rio 3.50 Review and revise purchase agreements re
health regulatory issues (.6); review and
revise TSA re same (.9); review, analyze
proposed transaction structure (1.2); review
and analyze regulatory filing requirements
(.8).
07/09/24 Jaina Desai 3.50 Revise bidding procedures order (.5); revise
bidding procedures notices (1.5); summarize,
analyze same (1.0); correspond with R.
Marston, C. Ceresa re same (.5).
07/09/24 Jaina Desai 0.80 Telephone conference with S. Winters, K&E
team, MWE re bidding procedures (.3); revise
bidding procedures notices (.2); summarize,
analyze same (.2); correspond with R.
Marston, C. Ceresa re same (.1).
07/09/24 Jaina Desai 0.50 Review, analyze NDA (.2); review, revise
NDA (.2); correspond with S. Lieberman re
same (.1).

33
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 262 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104437
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
07/09/24 Jaina Desai 0.70 Correspond with R. Marston, AlixPartners re
disclosure schedule (.1); draft correspondence
re same (.2); analyze bidding procedures
notices (.3); correspond with Cole Schotz, C.
Ceresa re same (.1).
07/09/24 Luke Finn 0.60 Telephone conference with Cooley team re
M&A Counterparty bid (.2); correspond with
S. Toth, K&E team re Cooley call (.1);
review, analyze correspondence and team
communication re M&A counterparty bid
(.3).
07/09/24 Justin M. Garfinkle 6.00 Analyze issues re registered IP schedules
(3.9); further analyze same (1.1); review,
analyze issues re ventilation disclosure
schedules (1.0).
07/09/24 Kate Hardey 2.80 Conference with C. Ceresa, K&E team re
TSA (.6); conference with Company re
licenses, permits and TSA transfer services
(1.0); review, analyze legal entity lists related
to TSA (1.2).
07/09/24 Olivia Kaufmann 5.00 Conference with M&A counterparty re sale
(1.5); correspond with regulator re filings (.3);
review, analyze IP licenses (1.0); draft UCC
licenses summary (1.2); review and revise
UCC summary (.2); review, analyze UCC
licenses organization chart (.3); correspond
with K. Hardey, K&E team re same (.5).
07/09/24 Maggie Kate King 2.50 Revise transition services agreement
schedules (.8); correspond with buyer teams
re same (.2); conference with client re
revisions to same (1.0); revise IP assignment
agreement (.5).
07/09/24 Rebecca J. Marston 4.80 Correspond with J. Desai, K&E team, Cole
Schotz re bidding procedures order (1.3);
correspond with C. Ceresa re potentially
assumed and assigned contracts notice (.6);
correspond with S. Golden re sale notice
publication (.1); conference with C. Ceresa,
K&E team, counsel to potential sale
counterparty re sale issues (.5); review and
revise sale related notices (2.2); correspond
with J. Desai re same (.1).

34
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 263 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104437
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
07/09/24 Brandan Matthews 4.10 Review, analyze corporate issues re purchase
agreement matters (3.2); correspond with S.
Toth, K&E team re transition services
agreement matters (.5); conference with
M&A counterparty’s legal counsel re asset
purchase agreement issues (.2); review,
analyze correspondence re same (.2).
07/09/24 Ruan J. Meintjes 0.10 Review and analyze filing requirements under
US state permits.
07/09/24 Ruan J. Meintjes 3.30 Research and analyze change of ownership
considerations for state medical device and
drug distributor permits/licenses (3.0); draft,
revise summary re same (.3).
07/09/24 Trent Nachbar 6.70 Review, analyze issues re asset purchase
agreement and schedules (3.9); further
review, analyze same (2.1); revise same for
incorporation of specialist comments (.7).
07/09/24 Michelle L. Nowicki 0.20 Correspond with B. Coppola, K&E team re IP
due diligence.
07/09/24 Dan O'Connor 3.70 Correspond with T. Petersen re transaction
matters (.5); review and revise disclosure
schedules (.9); correspond with PJT team and
T. Petersen re same (.3); review and revise
M&A counterparty disclosure schedules (1.0);
review, analyze VDR contracts re same (.8);
correspond with Foley team re same (.2).
07/09/24 Dan O'Connor 3.60 Review and revise M&A counterparty
disclosure schedules (.9); correspond with
Company re same (.2); telephone conference
with S. Ullathorne and S. Davies re antitrust
matters (.3); correspond with S. Ullathorne,
K&E team re same (.2); telephone conference
with B. Coppola re transaction matters (.2);
telephone conference with Company re
license matters (.4); correspond with MWE
team re disclosure schedules (.2); review and
revise open items list for disclosure schedules
(.4); correspond with Company re same (.8).
07/09/24 D. Taylor Petersen 2.60 Revise disclosure schedules (1.4); draft
diligence responses to same (.4); draft tables
for disclosure schedules (.8).

35
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 264 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104437
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
07/09/24 Yusuf Salloum 3.00 Analyze legal issues re sale processes (2.3);
correspond with C. Ceresa and K&E team re
same (.7).
07/09/24 Scottie Shermetaro 8.20 Review and revise TSA and TSA schedules
(3.8); review due diligence (2.4); revise IP
disclosure schedules for same (1.3); review
and revise asset purchase agreement (.7).
07/09/24 Daniel Shin 7.00 Draft correspondence re deleted transition
services agreement items on schedules (.9);
telephone conference with client re TSA
schedules (.8); review and draft transition
services agreement schedules (3.9); further
review, draft same (1.0); review and analyze
legal issues re IT agreements (.4).
07/09/24 Steve Toth 1.30 Analyze correspondence re TSA and
diligence (.3); correspond with B. Coppola re
TSA and related matters (.3); analyze TSA
cost estimates (.2); draft correspondence re
same (.1); draft correspondence re asset
purchase agreement and transaction open
issues (.4).
07/09/24 Steve Toth 5.80 Analyze and respond to correspondence re
asset purchase agreement and TSA schedules
(.6); telephone conference with Company,
Alix, D. O’Connor, K&E team re TSA
matters (.9); correspond with D. O’Connor,
K&E team re TSA regulatory matters (.3);
analyze TSA schedules and related
correspondence (.4); analyze revised asset
purchase agreement (1.1); analyze
correspondence re TSA (.2); correspond with
Y. Salloum re asset purchase agreement and
open issues (.5); telephone conference with
AlixPartners, Company, D. O’Connor, K&E
team re regulatory TSA services (.8); analyze
correspondence re TSA (.4); correspond with
bidder, bidder counsel, D. O’Connor, K&E
team re asset purchase agreement and status
(.6).
07/09/24 Sarah Ullathorne 1.50 Review, analyze issues re antitrust.
07/09/24 Spencer A. Winters, P.C. 0.90 Review and analyze issues re sale process,
case status (.6); correspond and telephone
conferences with multiple parties re same (.3).

36
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 265 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104437
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
07/10/24 Cooper Barghols 1.20 Research and summarize applicability of state
transaction notice requirements on proposed
transaction.
07/10/24 Chris Ceresa 9.20 Review, analyze sale related legal issues
(3.9); review, comment on draft stalking
horse order, declaration and bid procedures
notices (3.1); review, comment on purchase
agreement markup re legal issues (1.3);
correspond with Company, PJT, AlixPartners,
Y. Salloum, K&E team re same (.9).
07/10/24 Bernadette Coppola 5.10 Correspond with Company re responses to
allocation of intellectual property rights (.2);
conference with S. Toth, K&E team, client
and local counsel re regulatory considerations
for transition services agreement services (.5);
follow‑up re same (.1); conference with S.
Toth, K&E team, client and bidder team re
all‑hands discussion of open issues (1.3);
follow‑up re same (.5); conference with S.
Toth, Y. Salloum and K&E team re regulatory
matters (.5); correspond with M. King and
K&E team re revisions to transition services
agreement (.2); conference with S. Toth, K&E
team, client and bidder team re all‑hands
discussion of open sale issues (1.0);
correspond with D. Shin, bidder and K&E
team re analysis in response to bidder
question (.4); correspond with M. King and
K&E team re revisions to disclosure
schedules (.4).
07/10/24 Bernadette Coppola 0.90 Correspond with D. O'Connor and K&E team
re transaction updates (.2); conference with S.
Shermetaro and J. Garfinkle re revisions to
intellectual property schedules (.3); follow up
re same (.2); draft revisions to disclosure
schedules (.2).
07/10/24 Anthony M. Del Rio 3.80 Review and revise purchase agreements (1.5);
review and revise TSA considerations (.7);
review, analyze proposed transaction structure
(1.1); review, analyze regulatory filing
requirements (.5).

37
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 266 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104437
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
07/10/24 Jaina Desai 1.10 Revise stalking horse order (.9); correspond
with R Marston re same (.1); correspond with
C. Ceresa re declaration in support of stalking
horse bidder (.1).
07/10/24 Jaina Desai 1.20 Revise stalking horse notices (1.0);
correspond with R. Marston re same (.2).
07/10/24 Jaina Desai 3.70 Analyze, review precedent re stalking horse
notices, declarations and orders (1.9);
correspond with C. Ceresa, R. Marston re
same (.4); telephone conference with Cole
Schotz re stalking horse designation extension
notice (.4); correspond with S. Osborne, C.
Ceresa re asset purchase agreement (.5);
review, analyze asset purchase agreement
(.1); review, analyze bidding procedures order
(.3); correspond with R. Marston re same (.1).
07/10/24 Jaina Desai 1.00 Correspond with C. Ceresa, R. Marston re
sale stream (.3); telephone conference with C.
Ceresa re same (.1); correspond with J.
Foster, K&E team re sale order, stalking horse
order (.1); review, analyze precedent re same
(.2); review, analyze asset purchase
agreement (.3).
07/10/24 Jaina Desai 0.30 Review, analyze precedent re stalking horse
selection notices (.2); correspond with C.
Ceresa, R. Marston re same (.1).
07/10/24 Jaina Desai 3.60 Revise stalking horse orders, notices (2.5);
correspond with R. Marston re same (.5);
review, analyze comments re same (.6).
07/10/24 Amy Donahue 0.50 Draft shell order to approve stalking horse
bidder (.3); correspond with J. Desai re same
(.2).
07/10/24 Luke Finn 4.50 Telephone conference with Foley and M&A
counterparty re sale (1.4); telephone
conference with M&A counterparty re sale
(1.0); telephone conference with M&A
counterparty re sale (1.4); review, analyze
M&A counterparty disclosure schedules and
diligence findings (.7).
07/10/24 Julia R. Foster 1.00 Draft shell notice of selection of stalking
horse bidder (.5); correspond with J. Desai re
bidding procedures (.5).

38
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 267 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104437
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
07/10/24 Justin M. Garfinkle 3.90 Review, analyze issues re ventilation
disclosure schedules (1.0); review, analyze
issues re registered IP schedules, including
foreign entity schedules (2.4); review, analyze
issues re respiratory diagnostics disclosure
schedules (.5).
07/10/24 Kate Hardey 5.10 Review and comment on buyer APA
revisions and disclosure schedules (3.9);
multiple telephone conferences re structure
and TSA considerations (1.0); continue to
review and comment on buyer APA revisions
and disclosure schedules (.2).
07/10/24 Olivia Kaufmann 1.80 Telephone conference with M&A
counterparty re asset purchase agreement
(1.0); review, analyze change of ownership
analysis (.8).
07/10/24 Olivia Kaufmann 4.50 Telephone conference with S. Toth, K&E
team re asset purchase considerations (.8);
correspond with M&A counterparty re next
steps re same (.3); revise change of control
analysis (.5); correspond with state regulators
re change of control (.2); telephone
conference with K&E team and M&A
counterparty re change of control (.4);
correspond with R. Meintjes re same (.5);
review, analyze asset purchase agreement
schedules (.4); review, analyze issues re
change of ownership analysis (.9); correspond
with R. Meintjes, K&E team re same (.5).
07/10/24 Maggie Kate King 5.00 Conference with S. Toth, K&E team re
transition services agreement schedules
revisions (1.0); revise transition services
agreement schedules (3.0); telephone
conference with M&A counterparty re sale
(1.0).
07/10/24 Daniel Lewis, P.C. 1.00 Review, analyze legal issues re TSA matters.
07/10/24 Sabrina Lieberman 1.50 Conference with Company, Y. Salloum and
K&E team re German entities and sale issues
(.7); conference with O. Kaufmann re same
(.1); correspond with O. Kaufmann re same
(.2); correspond with Y. Salloum, K&E team
and PJT re NDA (.2); review, revise NDA
summary (.3).

39
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 268 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104437
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
07/10/24 Savannah Malnar-Cole 1.90 Review and analyze issues re ventilation
business (1.0); correspond with client re same
(.2); draft summary for M. Boney re same
(.7).
07/10/24 Rebecca J. Marston 9.20 Correspond with J. Desai, C. Ceresa re sale
work streams (3.9); correspond with A&M
team re schedule of potentially assumed and
assigned contracts (.3); correspond with C.
Ceresa, K&E team re same (.5); correspond
with K&E team, stakeholders re potential
claims, sale process (.4); review and revise
stalking horse bidder designation notice (1.2);
review and revise deadline extension notice
(.4); review and revise stalking horse order
(.7); review and revise declaration in support
of stalking horse (1.3); correspond with S.
Toth, K&E team re possible sale escrow
account (.3); correspond with T. De Paulo,
K&E team re declaration (.2).
07/10/24 Brandan Matthews 7.80 Telephone conference with S. Toth, K&E
team re sale updates (1.3); telephone
conference with client re ventilation business
open items (1.3); telephone conference with
S. Toth, K&E team re same (1.2); review,
analyze issues re signing matters (3.9); further
review, analyze same (.1).
07/10/24 Ruan J. Meintjes 2.50 Telephone conference with client and EU
counsel re transaction structure and regulatory
considerations in ex‑US territories (.8);
research and analyze further structure
considerations for US regulatory
considerations (1.0); correspond with S. Toth,
K&E team re same (.7).
07/10/24 Ruan J. Meintjes 3.20 Review and revise M&A counterparty asset
purchase agreement and schedules (2.5);
conference with S. Toth, K&E team re same
(.7).
07/10/24 Trent Nachbar 9.20 Review, analyze issues re asset purchase
agreement and schedules (3.9); further
review, analyze same (1.8); revise asset
purchase agreement to incorporate specialist
comments (2.4); revise asset purchase
agreement schedules to incorporate specialist
comments (1.1).

40
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 269 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104437
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
07/10/24 Michelle L. Nowicki 2.00 Review, analyze correspondence with
Company re IP due diligence (.8); correspond
with B. Coppola, K&E team re same (.2);
revise IP schedules (.8); correspond with B.
Coppola, K&E team re IP schedules (.2).
07/10/24 Dan O'Connor 6.70 Telephone conference with PJT Partners,
Company, AlixPartners team, M&A
counterparty, S. Toth, S. Winters and Y.
Salloum re asset purchase agreement (1.4);
telephone conference with M&A
counterparty, Cooley team, Company, S.
Toth, L. Finn re legal diligence matters (1.0);
telephone conference with AlixPartners re
transaction matters (.5); telephone conference
with PJT team, Company, AlixPartners team,
S. Toth and K&E team re M&A counterparty
transaction matters (1.5); review and revise
lease and lease term sheet (.7); correspond
with Company and J. Caruso re same (.3);
telephone conference with M&A
counterparty, Foley team, PJT Partners team,
AlixPartners team, S. Toth and K&E team re
transaction matters (.7); review and revise
counterparty markup to disclosure schedules
(.3); correspond with counterparty re same
(.3).
07/10/24 Dan O'Connor 3.00 Correspond with counterparty counsel re
antitrust matters (.4); correspond with S. Toth,
K&E Team re transaction matters (.3);
correspond with M&A counterparty, counsel
re KYC matters (.2); correspond with B.
Coppola, K&E team re disclosure schedules
(.5); correspond with Company re same (.3);
correspond with Y. Salloum, K&E team re
escrow matters (.3); correspond with B.
Matthews, T. Nachbar and T. Petersen re
signing matters (1.0).
07/10/24 Sarah Osborne 1.10 Review, revise markup to asset purchase
agreement (.9); correspond with J. Desai,
K&E team re same (.2).
07/10/24 Carolin Paus 0.60 Telephone conference, with D. Wang, K&E
team re sale structuring.

41
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 270 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104437
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
07/10/24 D. Taylor Petersen 3.60 Telephone conference with S. Toth, K&E
team re sale status (.4); revise disclosure
schedules (.4); draft signature pages (.2);
revise disclosure schedules (2.6).
07/10/24 Yusuf Salloum 5.00 Analyze issues re sale transaction (3.4);
conferences with PJT, AlixPartners,
Company, S. Toth, K&E team re same (1.6).
07/10/24 Scottie Shermetaro 9.60 Telephone conference with S. Toth, K&E
team re sale updates (1.4); review and revise
TSA and TSA schedules (1.8); telephone
conference with B. Coppola and K&E team re
asset purchase considerations (.5); telephone
conference with S. Toth, K&E team re sale
status (1.0); review and revise disclosure
schedules (1.7); telephone conference with J.
Garfinkle and M. Nowicki re IP diligence and
schedules (.5); review and revise disclosure
schedules (2.7).
07/10/24 Daniel Shin 4.00 Review and analyze IP license agreement and
disclosure schedules (.3); review and revise IP
assignment agreements (.2); correspond with
J. Garfinkle re same (.1); review and revise
TSA schedules (.7); correspond with M. King
re same (.2); draft IP license list from IT
agreements (2.5).
07/10/24 Michael D. Thorpe 0.30 Analyze HSR reportability of sale transaction.

42
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 271 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104437
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
07/10/24 Steve Toth 5.40 Analyze and revise attorney notes re asset
purchase agreement and transaction issues
(.5); correspond with EU counsel, D.
O’Connor, K&E team and Company re
regulatory and transaction matters (.7);
analyze correspondence re TSA and
disclosure schedules (.2); telephone
conference with D. O’Connor, K&E team re
transaction issues (1.5); correspond with S.
Winters re transaction issues (.1); telephone
conference with bidder, bidder advisors,
Company, Alix, PJT, D. O’Connor, K&E
team re transaction perimeter and related
matters (.9); telephone conference with
bidder, bidder advisors, Company, Alix, D.
O’Connor, K&E team re TSA services (.8);
correspond with PJT and Y. Salloum re asset
purchase agreement status (.3); analyze and
revise attorney notes re transaction issues (.4).
07/10/24 Steve Toth 7.20 Telephone conference with Company, PJT,
AlixPartners, D. O’Connor, K&E team re
transaction update (1.6); correspond with N.
Warther re tax allocation (.1); analyze
correspondence re tax allocation and lease
amendment (.2); correspond with D.
O’Connor, K&E team re TSA needs (.5);
analyze correspondence re asset purchase
agreement and TSA (.5); telephone
conference with Y. Salloum, K&E team,
advisors re transaction issues (1.2);
correspond with B. Matthews re same (.1);
analyze correspondence and attorney notes re
asset purchase agreement issues (1.0); draft
issues list re same for lenders (.4); analyze
correspondence re TSA and schedules and
diligence updates (.3); analyze
correspondence re escrow matters, asset
purchase agreement exhibits and other signing
documents (1.3).
07/10/24 Donatus Wang 4.50 Conferences with A. Ziegler, K&E team and
Company re sale matters (1.6); review,
analyze legal issues re sale (1.9); conference
with A. Ziegler, K&E team re same debrief
(.6); summarize key considerations re same
(.4).

43
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 272 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104437
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
07/10/24 Cristina Weidner 1.00 Correspond with A. Ziegler, K&E team re
sale legal issues.
07/10/24 Spencer A. Winters, P.C. 2.50 Review and analyze issues re sale process,
case status (.6); correspond and telephone
conferences with multiple parties re same (.6);
prepare for and participate in telephone
conference with Vents bidder (1.3).
07/10/24 Ann-Kathrin Ziegler 4.00 Analyze legal issues re sale (2.0); conference
with D. Wang, K&E team re same (1.0);
telephone conference with Company, Y.
Salloum, K&E team re same (.5); review and
revise summary correspondence re same (.5).
07/10/24 Tanzila Zomo 1.70 Prepare draft stalking horse notice (.5); draft
declaration re same (.7); review, revise online
document folders (.5).
07/11/24 Marin Boney 0.30 Review, analyze issues re risk assessment
(.1); correspond with D. O’Conner, S.
Malnar‑Cole and M. Thorpe re HSR analysis
(.2).
07/11/24 Chris Ceresa 8.70 Review, analyze sale related legal issues
(3.9); review, comment on sale related court
draft filings (2.2); correspond with Company,
PJT, AlixPartners, Y. Salloum, K&E team re
sale process issues (2.6).
07/11/24 Tiffani Chanroo 1.20 Draft stalking horse notice (.5); draft
declaration re same (.7).
07/11/24 Dominique Collins 0.20 Review and analyze draft asset purchase
agreement.
07/11/24 Dominique Collins 0.20 Review and analyze opposing counsel’s
updated asset purchase agreement.

44
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 273 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104437
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
07/11/24 Bernadette Coppola 4.90 Conference with S. Shermetaro and J.
Garfinkle re revisions to intellectual property
schedules (.3); conference with Company, S.
Toth and K&E team re intercompany matters
and transaction steps (.8); conference with S.
Shermetaro re revisions to agreements (.1);
conference with D. Lewis re transition
services agreement (.1); draft revisions to
transition services agreement issues list (.3);
draft revisions to purchase agreement (.3);
correspond with client, D. O’Connor and
K&E team re same (.2); conference with S.
Toth, AlixPartners and K&E team re revisions
to transition services agreement (1.0);
follow‑up re same (.3); conference with S.
Shermetaro re revisions to transition services
agreement (.3); draft revisions to transition
services agreement (.9); correspond with S.
Toth and K&E team re same (.3).
07/11/24 Sion Davies 0.50 Conference and correspond with P. Kar, K&E
team re foreign filing analysis.
07/11/24 Tabitha J. De Paulo 0.70 Review and comment on declarations in
support of bid procedures.
07/11/24 Anthony M. Del Rio 2.80 Review and revise transaction documents
(2.2); review and analyze regulatory filings
triggered by transaction (.6).
07/11/24 Jaina Desai 1.00 Review, analyze comments re stalking horse
bidder (.2); correspond with C. Ceresa re
same (.1); review, analyze comments re
stalking horse declaration (.2); revise stalking
horse declaration (.4); correspond with R.
Marston re same (.1).
07/11/24 Jaina Desai 4.90 Revise stalking horse declaration (1.5);
correspond with R. Marston, C. Ceresa re
same (.3); review, analyze comments re same
(.3); further revise same (1.8); correspond
with R. Marston re same (.2); review, analyze
emails re same (.2); correspond with
AlixPartners re same (.2); telephone
conference with C. Ceresa re compiling
signatures re asset purchase agreement (.2);
correspond with C. Ceresa re same (.2).

45
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 274 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104437
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
07/11/24 Jaina Desai 5.00 Review, revise stalking horse notices (1.0);
review, revise bidding procedures notices
(1.6); correspond with R. Marston re same
(.4); revise, analyze signature pages (1.5);
correspond with Company, C. Ceresa re same
(.5).
07/11/24 Jaina Desai 0.30 Correspond with Cole Schotz re sale notices
(.2); correspond with S. Golden, C. Ceresa re
same (.1).
07/11/24 Michael Ehret 2.70 Correspond with C. Weidner re structuring
considerations, transfer of IP (.8); review,
revise draft TSA, asset purchase agreement
(1.2); correspond with P. Gunderson re same
(.7).
07/11/24 Luke Finn 4.30 Telephone conference with S. Toth, K&E
team re intercompany agreements, tax and
accounting (1.0); review, analyze updated
M&A Counterparty bid disclosure schedules
received from Cooley (.8); revise M&A
Counterparty bid disclosure schedules (1.5);
correspond with B. Matthews, K&E team re
M&A counterparty bid disclosure schedules
(.5); review, revise same (.5).
07/11/24 Justin M. Garfinkle 0.70 Draft revisions to ventilation purchase
agreement.
07/11/24 Kate Hardey 1.80 Review, revise draft APA re health regulatory
issues (1.3); conference with Company re
same (.5).
07/11/24 Liz Ji 2.40 Review, analyze asset purchase agreement
and transition service agreement re tax
considerations.
07/11/24 Olivia Kaufmann 0.20 Review, analyze asset purchase agreement.
07/11/24 Sooah Kim 0.50 Review and revise purchase agreement re
employment issues.
07/11/24 Maggie Kate King 7.70 Draft, revise transition services agreement
issues list (3.2); review, analyze, revise
transition services agreement from M&A
counterparty (3.9); conference with
AlixPartners re issues re same (.6).
07/11/24 Daniel Lewis, P.C. 0.70 Review, analyze legal issues re TSA.

46
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 275 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104437
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
07/11/24 Sabrina Lieberman 0.20 Correspond with C. Ceresa and K&E team re
NDAs (.1); conference with Omni re service
of bidding procedures filings (.1).
07/11/24 Brandan Matthews 10.20 Review, analyze issues re purchase agreement
matters (3.9); further review, analyze same
(3.9); further review, analyze same (1.0);
telephone conference with S. Toth, K&E team
re cure schedule (.2); revise transaction
documents (1.2).
07/11/24 Ruan J. Meintjes 3.00 Review and revise M&A counterparty
purchase agreements and associated
transaction schedules (2.8); analyze and
revise transition services agreement (.2).
07/11/24 Trent Nachbar 7.70 Review, analyze issues re asset purchase
agreement and schedules (3.9); further
review, analyze same (3.0); revise same to
implement specialist comments (.8).
07/11/24 Maureen D. O'Brien 1.00 Review, analyze issues re asset purchase
agreement and TSA.
07/11/24 Dan O'Connor 2.30 Review and revise lease term sheet (.2);
correspond with Company, AlixPartners re
same (.3); telephone conference with PJT
team, Company, S. Toth, Y. Salloum, B.
Coppola, K&E team re intercompany
amounts and transaction matters (.4);
telephone conference with PJT team,
AlixPartners team, Y. Salloum, K&E team re
advisors check‑in call for sale updates (.2);
telephone conference with PJT team,
AlixPartners team, Gibson Dunn team,
Rothschild team, Y. Salloum, K&E team re
transaction matters (.2); telephone conference
with Company and S. Toth re employment
matters (.2); telephone conference with Foley
team, S. Toth, N. Warther, K&E team re
transaction matters (.4); telephone conference
with B. Coppola, K&E team and AlixPartners
re TSA matters (.4).

47
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 276 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104437
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
07/11/24 Dan O'Connor 5.90 Correspond with R. Meintjes, K&E team re
transaction matters (.3); telephone conference
with Company, R. Meintjes and K&E team re
purchase agreement matters (.4); telephone
conference with B. Matthews re transaction
matters (.4); review and revise asset purchase
agreement (.5); correspond with S. Toth and
B. Matthews re same (1.3); review and revise
M&A counterparty markup to disclosure
schedules (.8); correspond with C. Ceresa re
purchase agreement matters (.4); review and
revise disclosure schedules (1.3); telephone
conference with AlixPartners and PJT teams
re cure costs (.5).
07/11/24 Sarah Osborne 5.10 Review, revise asset purchase agreement (.8);
correspond with C. Ceresa, K&E team re
same (.3); draft stalking horse order (1.1);
correspond with C. Ceresa re same (.1);
review, revise same (.6); draft stalking horse
designation notice (.9); correspond with C.
Ceresa re same (.2); review, revise same (.8);
research precedent re stalking horse
designation notice (.3).
07/11/24 D. Taylor Petersen 1.50 Review, analyze signatures for closing (.1);
revise documents for same (.6); revise TSA
documents for closing (.8).
07/11/24 Evangelia Podaras 2.40 Telephone conferences with R. Salins, K&E
team re purchase agreement (.5); review,
revise purchase agreement (1.5); correspond
with S. Toth, K&E team re same (.4).
07/11/24 Yusuf Salloum 3.80 Analyze sale transaction issues re potential
stalking horse bidders (3.4); correspond with
C. Ceresa and K&E team re issues re same
(.4).
07/11/24 Scottie Shermetaro 12.10 Review and revise disclosure schedules to
APA (3.9); further review, revise same (.9);
review and revise asset purchase agreement
(2.9); review and revise transition services
agreement (3.9); telephone conference with B.
Coppola re transition services agreement
revisions (.5).
07/11/24 Daniel Shin 2.30 Telephone conference with AlixPartners re
transition services agreement issues (.5);
review and analyze same (1.8).

48
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 277 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104437
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
07/11/24 Steve Toth 5.00 Correspond with Company, PJT,
AlixPartners, D. O’Connor, K&E team re
intercompany balances, taxes and settlement
(1.0); telephone conference with Company,
PJT, AlixPartners, D. O’Connor, K&E team
re sale status updates (.5); telephone
conference with PJT, AlixPartners, D.
O’Connor, K&E team and lender advisors re
sale updates (.3); analyze revised asset
purchase agreement (.5); revise same (.7);
correspond with Company and D. O’Connor
re Brazil matters (.2); telephone conference
with Company, PJT, AlixPartners, D.
O’Connor, K&E team re special committee
status updates (.5); analyze revised TSA (.5);
correspond with Company, PJT, AlixPartners,
D. O’Connor, K&E team re purchase
agreement, sale issues (.8).
07/11/24 Steve Toth 5.80 Draft correspondence re asset purchase
agreement edits (.2); telephone conference
with Foley, Y. Salloum, K&E team re asset
purchase agreement (.6); correspond with
AlixPartners, D. O’Connor and K&E team re
revised TSA (1.0); analyze and revise TSA
(.3); correspond with PJT re purchaser
finances (.1); analyze and revise TSA (.6);
telephone conference with UCC advisors,
AlixPartners, PJT, Y. Salloum, K&E team re
sale diligence (.4); correspond with Y.
Salloum re bidder qualification (.1);
correspond with N. Warther re prorated taxes
implicating sale process (.1); correspond with
E. Podaras re employee related asset purchase
agreement matters (.3); analyze
correspondence re asset purchase agreement
and labor questions (.3); analyze revised asset
purchase agreement and related
correspondence (1.1); analyze revised TSA
and related correspondence (.7).
07/11/24 Paul Vasiloff 0.50 Review, analyze purchase agreement re
employment issues.
07/11/24 Donatus Wang 1.80 Correspond with Company re sale issues (.8);
review, analyze draft asset purchase
agreement (1.0).

49
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 278 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104437
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
07/11/24 Nicholas Warther 3.50 Review and revise tax portions of asset
purchase agreement (1.3); correspond with P.
Gunderson, K&E team re same (.9);
conference with BDO, P. Gunderson, K&E
team re same (.8); review and revise tax
portions of TSA (.5).
07/11/24 Cristina Weidner 1.00 Correspond with A. Ziegler, K&E team re
entity structuring.
07/11/24 Spencer A. Winters, P.C. 4.70 Prepare for and participate in telephone
conference with advisors re sale process, case
status (.5); prepare for and participate in
telephone conference with lender advisors re
same (.5); prepare for and participate in
telephone conference with special committee,
Company re same (.5); review and analyze
issues re sale process (1.7); correspond and
telephone conferences with multiple parties re
same (1.5).
07/11/24 Ann-Kathrin Ziegler 1.50 Correspond with C. Weidner, K&E team re
MIM carve out (1.0); review draft asset
purchase agreement re MIM aspects (.5).
07/12/24 Kon Asimacopoulos 1.50 Review, analyze international issues re sale
process.
07/12/24 Cooper Barghols 1.40 Research and summarize applicability of state
transaction notice requirements on proposed
transaction (.6); review and revise
investigation notes re state change of
ownership requirements for Company’s
licensed entities (.8).
07/12/24 Chris Ceresa 2.10 Review, analyze sale related issues (1.1);
correspond with Company, PJT, AlixPartners
teams, Y. Salloum, K&E team re same (1.0).
07/12/24 Bernadette Coppola 2.40 Draft revisions to transition services
agreement (.7); correspond with S. Toth,
K&E team and bidder’s counsel re same (.2);
draft revisions to asset purchase agreement
(.8); correspond with bidder counsel, S. Toth
and K&E team re same (.1); correspond with
PJT re transition services agreement
schedules (.1); correspond with S. Toth and
K&E team re transaction updates and
revisions to documents (.3); correspond with
M. King re revisions to transition services
agreement (.2).

50
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 279 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104437
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
07/12/24 Anthony M. Del Rio 2.10 Review and revise transaction documents
(1.6); review and analyze regulatory filings
triggered by transaction (.5).
07/12/24 Jaina Desai 3.70 Correspond with B. Matthews, GDC re
escrow account (.2); review, analyze
correspondence re same (.2); correspond with
R. Marston re same (.1); draft correspondence
re same (.2); correspond with R. Marston re
noticing procedures (.1); research, analyze
precedent re sale order (1.7); correspond with
R. Marston, Cole Schotz re same (.2);
telephone conference with AlixPartners re
escrow account (.1); research, analyze
precedent re cure objection summary (.5);
correspond with R. Marston, C. Ceresa re
same (.2); revise sale summary (.2).
07/12/24 Michael Ehret 1.70 Correspond with C. Weidner, K&E team re
contemplated disposal of vents business (.7);
review, revise draft agreements, asset
purchase agreement, TSA (1.0).
07/12/24 Luke Finn 3.40 Telephone conference with PJT, AlixPartners,
S. Toth, K&E team re lenders
discussions (.6); review and revise M&A
counterparty disclosure schedules (1.0);
review, analyze changes between M&A
counterparties APAs (1.0); review, analyze
sale documents (.5); revise same (.3).
07/12/24 Justin M. Garfinkle 1.00 Revise ventilation purchase agreement re IP
issues.
07/12/24 Kate Hardey 0.70 Review, analyze revised disclosure schedules.
07/12/24 Olivia Kaufmann 3.00 Review, analyze state acquisition notification
law (2.5); correspond with C. Barghols and R.
Meintjes re same (.5).
07/12/24 Maggie Kate King 2.50 Correspond with J. Garfinkle, K&E team re
revisions to asset purchase agreement by
M&A counterparty (.4); revise transition
services agreement (2.1).
07/12/24 Sabrina Lieberman 0.10 Correspond with Y. Salloum and K&E team
re NDA summary.

51
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 280 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104437
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
07/12/24 Brandan Matthews 6.80 Review, analyze issues re purchase agreement
matters (3.9); further review, analyze same
(1.6); conference with Company re cure
schedule (.8); conference with bankers re
lender consent (.5).
07/12/24 Ruan J. Meintjes 1.50 Review and revise M&A counterparty asset
purchase agreement and schedules (1.1);
correspond with S. Toth, K&E team and
opposing counsel re same (.4).
07/12/24 Ruan J. Meintjes 1.60 Research and analyze material state
transaction notification laws applicable to
potential transactions (1.4); prepare summary
of the same (.2).
07/12/24 Trent Nachbar 2.60 Review, analyze issues re asset purchase
agreement and schedules.
07/12/24 Dan O'Connor 4.40 Telephone conference with AlixPartners
team, S. Toth and K&E team re cure costs
(.3); telephone conference with PJT team,
AlixPartners team, S. Toth, K&E team re
lender matters (.5); telephone conference with
PJT team, AlixPartners team, Gibson Dunn
team, Rothschild team, S. Toth, K&E team re
lender matters (.6); telephone conference with
AlixPartners and S. Toth, K&E team re cure
schedule (.5); correspond with M&A
counterparty, counsel re escrow agreement
(.4); review and revise disclosure schedules
(.8); correspond with Foley, BDO and
Company re same (.3); review and revise
M&A Counterparty disclosure schedules (.8);
correspond with L. Finn, T. Nachbar and T.
Petersen re same (.2).
07/12/24 D. Taylor Petersen 2.50 Revise disclosure schedules.
07/12/24 Evangelia Podaras 0.50 Correspond with R. Salins, K&E team re asset
purchase agreement drafts.
07/12/24 Yusuf Salloum 2.00 Conferences with S. Toth, K&E team,
AlixPartners, lenders, PJT teams re sale
transactions (1.4); analyze legal issues re
same (.6).
07/12/24 Scottie Shermetaro 2.30 Telephone conference with N. Shier and B.
Coppola re status of documents for sale of
ventilation business (.5); review and revise
asset purchase agreement (1.8).

52
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 281 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104437
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
07/12/24 Noah Shier 1.80 Correspond with Y. Salloum, K&E team re
open sale items (.5); review TSA (1.3).
07/12/24 Paul D. Tanaka, P.C. 1.10 Correspond with S. Toth, K&E team re
purchase agreements and bid drafts (.2);
review and analyze same (.9).
07/12/24 Steve Toth 4.50 Correspond with AlixPartners, D. O’Connor,
K&E team re contracts and cure schedule for
ventilation asset purchase agreement (.3);
telephone conference with AlixPartners, PJT,
Y. Salloum, K&E team re bid analysis (.5);
telephone conference with lender advisors,
AlixPartners, PJT, D. O’Connor, K&E team
re bid analysis (.6); analyze revised asset
purchase agreement (.4); draft correspondence
re same (.3); analyze revised TSA (.2);
correspond with AlixPartners, D. O’Connor,
K&E team re contracts and cures (.2); draft
correspondence re same (.2); analyze
correspondence re finalizing asset purchase
agreement and TSA (1.8).
07/12/24 Donatus Wang 1.20 Correspond with C. Weidner, K&E team,
advisors Company re sale issues.
07/12/24 Cristina Weidner 1.00 Correspond with A. Ziegler, K&E team re
entity structuring.
07/12/24 Spencer A. Winters, P.C. 3.10 Review and analyze issues re sale process
(1.6); correspond and telephone conferences
with multiple parties re same (1.5).
07/13/24 Bernadette Coppola 0.20 Draft revisions to transition services
agreement.
07/13/24 Michael Ehret 1.70 Review, analyze correspondence from
Company re novation issues re sale
structuring (.7), conference with Company,
PwC re same (.8); correspond with C.
Weidner, K&E team re German tax issues
(.2).
07/13/24 Maggie Kate King 1.80 Revise respiratory diagnostics transition
services agreement.
07/13/24 Daniel Lewis, P.C. 0.50 Correspond with B. Coppola and K&E team
re TSA issues.
07/13/24 Brandan Matthews 1.70 Review, analyze issues re M&A counterparty
purchase agreement.

53
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 282 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104437
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
07/13/24 Ruan J. Meintjes 0.20 Review and analyze M&A counterparty
transition services agreement (.1); revise same
(.1).
07/13/24 Ruan J. Meintjes 0.80 Review and analyze diligence items related to
Section 363 sales (.6); correspond with A. Del
Rio re the same (.2).
07/13/24 Dan O'Connor 1.40 Telephone conference with Company, S.
Toth, K&E team, PJT team, AlixPartners re
intercompany tax matters (.5); telephone
conference with PJT team, AlixPartners, S.
Winters and Y. Salloum re transaction matters
(.5); correspond with Company re insurance
matters (.4).
07/13/24 Yusuf Salloum 1.50 Analyze legal issues re sale transaction (1.2);
correspond with C. Ceresa and K&E team re
same (.3).
07/13/24 Scottie Shermetaro 0.20 Review and revise TSA for sale of respiratory
diagnostics business.
07/13/24 Noah Shier 1.00 Review, draft revisions re TSA.
07/13/24 Paul D. Tanaka, P.C. 0.60 Review and analyze purchase agreement and
bid drafts (.5); correspond with K&E team re
same (.1).
07/13/24 Steve Toth 2.70 Telephone conference with Company, D.
O’Connor, K&E team, PJT and AlixPartners
re bids update (.6); correspond with
Company, PwC, D. O’Connor, K&E team re
intercompany settlement (1.3); analyze
correspondence re asset purchase agreement
and transaction matters (.6); telephone
conference with lender advisors, PJT,
AlixPartners, D. O’Connor, K&E team re sale
updates (.2).
07/13/24 Donatus Wang 1.30 Conference with Company and tax advisors re
sale issues.
07/13/24 Cristina Weidner 3.10 Conference with Company, D. Wang, K&E
team re sale tax structuring and different
proposals.

54
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 283 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104437
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
07/13/24 Spencer A. Winters, P.C. 2.40 Review and analyze issues re stalking horse
bids (1.1); prepare for and participate in
telephone conference with Company and
advisors re same (.5); prepare for and
participate in telephone conference with
lender advisors re same (.5); correspond and
telephone conferences with multiple parties re
same (.3).
07/13/24 Ann-Kathrin Ziegler 2.50 Review, analyze intercompany summary (.5);
conference with Company, C. Weidner, K&E
team re intercompany structuring (1.0); and
conference with C. Weidner, K&E team, tax
advisors re same (1.0).
07/14/24 Chris Ceresa 1.30 Review, analyze legal issues re potential sale
and purchase agreements (1.0); correspond
with PJT, AlixPartners, Y. Salloum, K&E
team, Company re same (.3).
07/14/24 Jaina Desai 2.40 Revise stalking horse designation extension
notice (1.5); review, analyze correspondence
re same (.4); correspond with Gibson Dunn re
same (.1); correspond with R. Marston re
same (.4).
07/14/24 Luke Finn 0.80 Review, revise M&A counterparty disclosure
schedules.
07/14/24 Trent Nachbar 5.30 Review, analyze legal issues re asset purchase
agreement and schedules (2.2); incorporate
revisions to same (3.1).
07/14/24 Dan O'Connor 1.30 Telephone conference with Company, S.
Toth, K&E team, Company, AlixPartners re
intercompany tax matters (.5); review,
analyze issues re same (.8).
07/14/24 D. Taylor Petersen 0.80 Revise disclosure schedules.
07/14/24 Steve Toth 0.60 Analyze correspondence re tax and diligence
matters as it relates to sale.
07/14/24 Cristina Weidner 2.50 Conferences with A. Ziegler, K&E team, tax
advisors re sale proposals (1.4); correspond
with A. Ziegler, K&E team, tax advisors and
Company re same (1.1).
07/14/24 Ann-Kathrin Ziegler 2.00 Conference with C. Weidner, K&E team, tax
advisors re intercompany structuring (1.0);
conference with Company, C. Weidner, K&E
team, tax advisors re same (1.0).

55
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 284 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104437
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
07/15/24 Kon Asimacopoulos 1.50 Review, analyze international issues re sales.
07/15/24 Chris Ceresa 3.10 Review, analyze legal issues re potential sale
and purchase agreements (2.4); correspond
with PJT, AlixPartners, S. Toth, K&E team,
Company re same (.7).
07/15/24 Bernadette Coppola 0.10 Correspond with AlixPartners, S. Toth, K&E
team, advisors re transition services
agreement schedules.
07/15/24 Sion Davies 0.20 Correspond with K. Asimacopoulos, K&E
team re filing analysis re potential sales.
07/15/24 Anthony M. Del Rio 2.60 Telephone conference with buyer's counsel re
regulatory filings (.6); review and revise
transaction documents (1.1); review and
analyze filing requirements for same (.9).
07/15/24 Jaina Desai 0.60 Review, analyze correspondence re sale
stream (.2); revise sale stream summary (.4).
07/15/24 Jaina Desai 0.60 Telephone conference with S. Toth re asset
sale (.5); correspond with R. Marston re same
(.1).
07/15/24 Jaina Desai 1.00 Telephone conference with C. Ceresa, R.
Marston re sale stream status, next steps (.5);
correspond with R. Marston re same (.2);
review, analyze correspondence re timeline
updates (.1); correspond with Gibson Dunn re
same (.1); correspond with C. Ceresa re sale
order precedent (.1).
07/15/24 Jaina Desai 0.90 Correspond with R. Marston re stalking horse
declaration (.1); correspond with AlixPartners
re same (.2); review, analyze correspondence
re sale stream (.2); review, analyze sale order
precedent (.3); correspond with J. Foster,
K&E team re same (.1).
07/15/24 Jaina Desai 0.50 Correspond with R. Marston re stalking horse
declaration (.1); correspond with AlixPartners
re same (.2); review, analyze correspondence
re sale stream (.2).
07/15/24 Michael Ehret 1.50 Conference with Company, M&A
counterparty, Deloitte, re transaction (1.0),
review, analyze documents re same (.5).

56
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 285 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104437
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
07/15/24 Luke Finn 3.80 Revise draft of M&A counterparty disclosure
schedules (1.0); correspond with client re
open diligence questions and additional
requests (.6); review, revise, finalize M&A
counterparty disclosure schedules (1.8);
correspond with M&A counterparty re
same (.4).
07/15/24 Kate Hardey 0.50 Conference with opposing counsel re state
license transfer review.
07/15/24 Olivia Kaufmann 2.30 Correspond with state regulators re notice
requirements (.2); conference with R.
Meintjes re change of ownership research
(.4); participate in regulatory discussion with
bidder counsel (.3); review, analyze bidder
state license summary (.5); conference with
R. Meintjes re same (.3); update bidder state
summary (.6).
07/15/24 Sabrina Lieberman 1.10 Correspond with Y. Salloum, K&E team,
AlixPartners, PJT, Foley re German tax issues
related to sale (.5); correspond with Y.
Salloum, K&E team, AlixPartners, PJT, Foley
re German tax issues related to sale (.6).
07/15/24 Rebecca J. Marston 5.70 Conference with C. Ceresa, J. Desai re sale
work streams (.7); correspond with J. Desai re
same (2.1); correspond with C. Ceresa re tax
planning issue (.1); research same (1.9);
prepare for and conference with counsel to
potential bidder, K&E team, AlixPartners re
potential transaction (.9).
07/15/24 Ruan J. Meintjes 2.30 Review and analyze change of ownership
regulations applicable to ventilation business
(1.9); conference with buyer’s counsel re
same (.4).
07/15/24 Trent Nachbar 3.20 Review, analyze issues re asset purchase
agreement and schedules.
07/15/24 Dan O'Connor 1.70 Telephone conference with M&A
counterparty, Deloitte, N. Warther, K&E
team, Company re respiratory diagnostics tax
matters (.5); telephone conference with PJT
team, Gibson Dunn team, Company,
AlixPartners, S. Winters and S. Toth re
transaction matters (.7); telephone conference
with PJT team, AlixPartners, S. Toth, K&E
team re transaction matters (.5).

57
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 286 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104437
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
07/15/24 Carolin Paus 4.70 Summarize asset purchase agreement re tax
liabilities (3.8); review, analyze intercompany
issues re same (.9).
07/15/24 Yusuf Salloum 2.30 Prepare for and participate in conferences
with advisors, lenders, S. Toth, K&E team re
sale transaction (1.2); analyze legal issues re
same (1.1).
07/15/24 Steve Toth 3.70 Telephone conference with bidder advisors,
PwC, Company, D. O’Connor, K&E team re
intercompany settlement (.5); correspond with
S. Zablotney re tax issues related to sale (.1);
analyze correspondence re intercompany
issues and TSA (.2); correspond with lender
advisors, Company, D. O’Connor, K&E team,
PJT and AlixPartners teams re bids updates
(.7); telephone conference with Company,
PJT, AlixPartners, D. O’Connor, K&E team
re bid updates (.9); telephone conference with
Foley, D. O’Connor, K&E team, PJT and
AlixPartners re potential sale structure
alternatives (.4); analyze correspondence re
tax and diligence matters (.3); correspond
with D. O’Connor, K&E team re international
tax matters (.6).
07/15/24 Cristina Weidner 1.00 Correspond with A Ziegler, K&E team re
transaction structuring legal issues (.3);
analyze issues re same (.7).
07/15/24 Spencer A. Winters, P.C. 3.40 Review and analyze issues re sale and
marketing process and open legal issues, case
status (1.3); prepare for and participate in
telephone conference with lender advisors re
same (.5); prepare for and participate in
advisor telephone conference with advisors re
same (.5); correspond and telephone
conferences with multiple parties re same
(1.1).
07/15/24 Ann-Kathrin Ziegler 2.00 Conference with Company, potential sale
party, PJT, tax advisor re intercompany
reorganization (.5); draft summary re
potential asset sale re German legal
considerations (.8); review, revise internal
summary re tax indemnities under (.7).

58
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 287 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104437
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
07/16/24 Cooper Barghols 0.60 Correspond with R. Meintjes, A. Del Rio, B.
King and O. Kaufmann re organizational
materials and strategic process.
07/16/24 Chris Ceresa 3.00 Review, analyze legal issues re potential sale
and purchase agreements (2.2); correspond
with advisors, K&E team, Company re same
(.8).
07/16/24 Bernadette Coppola 0.30 Correspond with S. Toth, K&E team, advisors
and Company re transition services agreement
matters.
07/16/24 Anthony M. Del Rio 1.70 Review and comment on transaction
documents (.6); review and analysis of
licensure requirements (1.1).
07/16/24 Jaina Desai 0.80 Revise stalking horse designation extension
notice (.2); revise, review sale summary (.1);
correspond with R. Marston re same (.2);
draft cure objection summary (.2); correspond
with R. Marston re same, sale order precedent
(.1).
07/16/24 Jaina Desai 4.30 Review, analyze 363 sale order precedent
(3.1); correspond with R. Marston re same
(.2); review, analyze bidding procedures order
(1.0).
07/16/24 Jaina Desai 1.00 Analyze correspondence re sale cure
objections (.3); correspond with objectors re
same (.2); correspond with R. Marston re
same (.1); correspond with AlixPartners re
same (.1); revise cure objection summary (.3).
07/16/24 Justin M. Garfinkle 0.50 Review, analyze registered IP schedules for
RDx sale.
07/16/24 Kate Hardey 1.00 Conference with R. Meintjes, K&E team re
review of state license change of ownership
timing (.7); review, analyze correspondence
from R. Meintjes re state license change of
ownership re potential transaction timing
considerations (.3).

59
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 288 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104437
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
07/16/24 Olivia Kaufmann 1.90 Conference with K. Hardey, K&E team re
healthcare issues (.5); review, analyze
correspondence from K. Hardey, K&E team
(.2); conference with A. Del Rio re regulator
outreach (.1); correspond with regulator re
license (.1); correspond with A. Del Rio re
same (.2); review, analyze bidder summary
(.2); review, analyze licenses (.3); revise
summary re same (.3).
07/16/24 Rebecca J. Marston 3.80 Correspond with J. Desai re sale objection
parties (2.1); respond to counterparties re
same (.3); review, analyze sale order
precedent (.7); review, analyze sale reply
precedent (.5); correspond with K. Trevett re
sale timeline (.2).
07/16/24 Ruan J. Meintjes 1.40 Review and analyze change of ownership
considerations (.5); comment on bidder’s
counsel’s licensure proposal (.5); coordinate
with K. Hardey, K&E team re same (.4).
07/16/24 Trent Nachbar 2.80 Review, analyze asset purchase agreement
and schedules re corporate and specialist
issues.
07/16/24 Michelle L. Nowicki 3.50 Review, analyze of RDx IP disclosure
schedules and related online IP Office records
(1.1); correspond with S. Shermetaro, K&E
team re same (.2); draft summary of related
issues (1.8); draft trademark ownership
documentation (.4).
07/16/24 Yusuf Salloum 2.00 Analyze legal issues re sale transaction (1.2);
review status re same (.2); correspond with C.
Ceresa, K&E team, advisors re same (.6).
07/16/24 Scottie Shermetaro 0.30 Review and revise disclosure schedules.
07/16/24 Noah Shier 0.50 Correspond with Y. Salloum, K&E team re
TSA (.2); review disclosure schedules (.3).
07/16/24 Paul D. Tanaka, P.C. 1.20 Review and analyze bid drafts and purchase
agreements (.9); correspond with Y. Salloum,
K&E team re same (.3).
07/16/24 Dennis Williams 1.00 Conference with K. Hardey, K&E team re
review of state license change of ownership
timing (.6); review, analyze correspondence
from K. Hardey re state license change of
ownership re potential transaction timing
considerations (.4).

60
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 289 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104437
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
07/16/24 Spencer A. Winters, P.C. 1.20 Review and analyze bid drafts and purchase
agreements (.9); correspond with Y. Salloum,
K&E team re same (.3).
07/16/24 Ann-Kathrin Ziegler 0.80 Review and revise internal summary re tax
provisions in asset purchase agreements and
internal questions.
07/16/24 Tanzila Zomo 2.00 Prepare draft shell of sale order.
07/17/24 Kon Asimacopoulos 1.50 Review, analyze international issues re
potential sales.
07/17/24 Chris Ceresa 4.50 Review and analyze legal issues re potential
sales (1.6); analyze legal issues re sale order
precedent (.6); correspond with advisors, Y.
Salloum K&E team, Company re sale issues
(.8); telephone conferences with S. Winters,
K&E team, advisors re same (1.1);
correspond with J. Desai re bid procedures
and noticing issues (.4).
07/17/24 Bernadette Coppola 1.30 Correspond with J. Garfinkle and K&E team
re bidder comments to intellectual property
schedules (.2); conference with Deloitte,
AlixPartners, Company, S. Toth and K&E
team re transition services agreement
schedules (1.1).
07/17/24 Anthony M. Del Rio 1.20 Review and analysis of licensure
requirements (.8); review and comment on
transaction documents (.4).
07/17/24 Jaina Desai 0.40 Correspond with R. Marston, C. Ceresa, K.
Chiaghana re updated sale dates (.2);
conference with R. Marston re sale objection
call (.1); correspond with claims objector re
same (.1).
07/17/24 Jaina Desai 0.70 Revise sale objection summary (.2); review,
analyze correspondence re same (.3);
correspond with R. Marston, AlixPartners re
same (.2).
07/17/24 Jaina Desai 4.40 Review, analyze sale order (.8); analyze,
review sale order precedents (1.4); revise sale
order (2.2).
07/17/24 Jaina Desai 1.10 Review, analyze bidding procedures order
(.4); draft correspondence re key dates and
deadlines (.3); revise sale summary (.3);
correspond with R. Marston re same (.1).

61
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 290 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104437
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
07/17/24 Jaina Desai 0.80 Review, analyze cash management order,
taxes order for relevant terms impacting sale
order (.3); correspond with C. Ceresa re sale
notice publication (.1); correspond with Omni
re same (.1); revise stalking horse bidder
designation extension notice (.2); correspond
with C. Ceresa re same (.1).
07/17/24 Jaina Desai 0.20 Further revise stalking horse bidder
designation extension notice (.1); correspond
with Cole Schotz, C. Ceresa re same (.1).
07/17/24 Justin M. Garfinkle 1.00 Review, analyze RDx registered IP schedules.
07/17/24 Kate Hardey 0.50 Review, analyze EU conformity statements
(.3); conference with R. Meintjes re same;
review, analyze revised state license summary
(.2).
07/17/24 Olivia Kaufmann 0.70 Review, analyze licenses in disclosure
schedule (.2); revise license summary (.3);
review, analyze licenses (.1); conference with
R. Meintjes re same (.1).
07/17/24 Maggie Kate King 1.00 Revise transition services agreement (.5);
conference with M. Sheridan re deal
workstreams and assignments (.5).
07/17/24 Sabrina Lieberman 0.10 Correspond with Y. Salloum and K&E team
re NDAs.
07/17/24 Savannah Malnar-Cole 0.80 Review and revise clean team agreement.
07/17/24 Ruan J. Meintjes 1.10 Review and analyze vent device listings (.5);
prepare summary of same (.2); revise
transaction schedules (.3); correspond with O.
Kaufmann, K&E team re same (.1).
07/17/24 Michelle L. Nowicki 0.50 Review, analyze RDx documentation and
comments from IP counsel (.1); revise IP
schedules (.2); revise, analyze outstanding
issues (.1); correspond with M. King, K&E
team re RDx IP schedules and issues (.1).
07/17/24 Dan O'Connor 1.00 Telephone conference with PJT team,
Deloitte, Company, AlixPartners, S. Toth and
others re asset purchase agreement matters.
07/17/24 Yusuf Salloum 2.00 Analyze issues re sale transaction (1.3);
correspond with C. Ceresa and K&E team,
Company, advisors re same (.7).

62
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 291 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104437
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
07/17/24 Noah Shier 2.00 Conference with Y. Salloum, K&E team re
TSA (1.5); review, analyze revised patent and
trademark disclosure schedule (.3); review,
analyze TSA issues (.2).
07/17/24 Steve Toth 1.10 Prepare for and participate in telephone
conference with AlixPartners, Deloitte, D.
O’Connor K&E team re TSA and costs.
07/17/24 Dennis Williams 0.50 Review, analyze EU conformity statements
and conference with R. Meintjes re same (.3);
review, analyze revised state license summary
(.2).
07/17/24 Spencer A. Winters, P.C. 1.60 Prepare for and participate in telephone
conference with Company advisors, C. Ceresa
and K&E team re sale process (.5); telephone
conference with Company advisors re
waterfall issues (.5); review and analyze
issues re sale process, case status (.3);
correspond and telephone conferences with
multiple parties re same (.3).
07/18/24 Marin Boney 0.30 Revise team agreement markup.
07/18/24 Chris Ceresa 2.70 Review, analyze legal issues re potential sale,
purchase agreements, and pleadings (1.4);
correspond with advisors, J. Desai, K&E
team, Company re same (1.3).
07/18/24 Bernadette Coppola 0.20 Analyze statement of work re website
services.
07/18/24 Anthony M. Del Rio 1.10 Review and comment on transaction
documents (.6); review and comment on
outstanding diligence requests (.5).
07/18/24 Jaina Desai 2.00 Revise case timeline (.2); correspond with K.
Trevett re same (.1); revise stalking horse
notice (.2); revise stalking horse declaration
(.2); revise sale summary (.2); correspond
with R. Marston re same (.1); review, analyze
correspondence re sale (.1); correspond with
R. Marston re same (.1); draft sale date
extension notice (.3); correspond with R.
Marston, C. Ceresa re same (.2); correspond
with S. Lieberman re sale stream (.1);
correspond with informal sale objector re
objection deadline (.1); correspond with R.
Marston, C. Ceresa re same (.1).

63
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 292 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104437
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
07/18/24 Jaina Desai 1.80 Correspond with Cole Schotz, R. Marston re
sale date extension notice (.2); correspond
with AlixPartners re informal cure objections
(.1); correspond with R. Marston re same (.1);
revise cure objection summary (.2);
correspond with R. Marston re same (.1);
review, analyze correspondence re same (.1);
review, analyze sale presentation (.2);
correspond with S. Lieberman, R. Marston,
PJT re bids and IOIs (.2); correspond with
cure objector re assumption and cure matters
(.1); draft updated key dates and deadlines
extension notice (.4); correspond with R.
Marston re same (.1).
07/18/24 Jaina Desai 0.40 Telephone conference with cure objector, R.
Marston re cure objection (.3); correspond
with R. Marston re same (.1).
07/18/24 Jaina Desai 0.70 Telephone conference with AlixPartners, R.
Marston re cure and sale objections (.5);
correspond with R. Marston re same (.1);
correspond with S. Lieberman re sale process,
objection summary (.1).
07/18/24 Jaina Desai 1.70 Draft sale and cure objection summary (1.3);
correspond with R. Marston re same (.2);
review, analyze correspondence re cure
objections (.2).
07/18/24 Jaina Desai 0.80 Review, analyze objection (.3); draft
extension notice (.2); correspond with R.
Marston re same (.2); correspond with Omni,
Cole Schotz re filed notice (.1).
07/18/24 Luke Finn 1.60 Conference with PJT, advisors re sale (.9);
review, analyze correspondence re regulatory
pathway (.7).
07/18/24 Justin M. Garfinkle 0.70 Review, analyze RDx registered IP schedule
comments.
07/18/24 Olivia Kaufmann 1.00 Review, analyze data room documents for list
of vent products (.4); conference with R.
Meintjes re same (.3); correspond with A. Del
Rio and R. Meintjes re license applications
and deal structure (.3).
07/18/24 Brandan Matthews 0.90 Conference with D. O’Connor, K&E team re
lender materials re sales.

64
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 293 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104437
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
07/18/24 Ruan J. Meintjes 1.60 Coordinate with client re categorization of
product portfolios (.2); draft summary of
same (.8); correspond with A. Del Rio, K&E
team re transition service agreement questions
(.6).
07/18/24 Dan O'Connor 1.20 Telephone conference with PJT team,
Company, AlixPartners, S. Toth and others re
transaction matters (.5); telephone conference
with S. Winters, K&E team, PJT,
AlixPartners, lender advisors re transaction
matters (.7).
07/18/24 Yusuf Salloum 2.00 Analyze legal issues re sale transactions (1.0);
telephone conferences with S. Winters, K&E
team, and advisors (1.0).
07/18/24 Noah Shier 1.60 Revise disclosure schedules (1.2); review,
analyze software statement of work (.4).
07/18/24 Steve Toth 3.90 Participate in telephone conference with
AlixPartners, S. Winters, K&E team re
waterfall and winddown (.6); participate in
management update telephone conference
with Company, AlixPartners, PJT, S. Winters,
K&E team (.4); participate in telephone
conference with lender advisors, PJT,
AlixPartners, S. Winters, K&E team re sale
(.4); telephone conference with PJT and
AlixPartners re winddown info and lender
diligence preview (.5); draft comments on bid
summary deck (.3); participate in special
committee telephone conference with
Company, PJT, AlixPartners, S. Winters and
K&E team (.6); participate in telephone
conference with lenders, lender advisors, PJT,
AlixPartners, S. Winters, K&E team re bidder
updates (.7); conference with Company,
AlixPartners, S. Winters, K&E team re
intercompany matters (.4).

65
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 294 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104437
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
07/18/24 Spencer A. Winters, P.C. 4.60 Prepare for and participate in telephone
conference with Company advisors re
waterfall (.5); prepare for and participate in
telephone conference with Company and
advisors re sale process, open legal issues,
case status (.5); prepare for and participate in
weekly telephone conference with lender
advisors re same (.5); prepare for and
participate in special committee conference re
sale process, open legal issues, and case status
(.5); prepare for and participate in telephone
conference with lender principals re same
(.7); prepare for and participate in pre‑call
with Company advisors re same (.2); review
and analyze issues re sale and marketing
process (.8); correspond and telephone
conferences with multiple parties re same (.9).
07/19/24 Cooper Barghols 0.30 Correspond with R. Meintjes, K&E team
and international counsel re deal process and
strategic initiatives.
07/19/24 Anthony M. Del Rio 1.80 Participate in telephone conference with EU
counsel re transaction considerations (.6);
review and analyze open recall impact on
schedules and filing requirements (.7); review
and analyze license materials (.5).
07/19/24 Jaina Desai 0.80 Correspond with informal sale objectors (.5);
correspond with R. Marston re same (.1);
review, analyze extension notice (.2).
07/19/24 Jaina Desai 1.10 Draft correspondence re sale objections (.8);
correspond with R. Marston re same (.2);
analyze correspondence re sale (.1).
07/19/24 Jaina Desai 0.30 Revise sale objection summary (.2);
correspond with C. Ceresa, R. Marston re
same (.1).
07/19/24 Jaina Desai 0.40 Review, analyze correspondence re sale
objections (.2); revise summary re same (.1);
correspond with R. Marston re same (.1).
07/19/24 Luke Finn 1.80 Conference with lender advisors, Company re
sale legal issues (1.0); review, analyze
correspondence from Company re regulatory
transitions (.8).

66
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 295 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104437
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
07/19/24 Olivia Kaufmann 1.00 Review, analyze California licensure
application (.4); conference with R. Meintjes
and K&E team re same (.6).
07/19/24 Brandan Matthews 1.40 Conference with S. Toth, Company working
group re lender financial diligence items.
07/19/24 Ruan J. Meintjes 2.60 Review and analyze California department of
health change of ownership filing
requirements (1.5); review and analyze
company application diligence materials (.5);
conference with UK regulatory counsel re
transition services agreements (.6).
07/19/24 Yusuf Salloum 1.50 Analyze legal issues re sale transactions.
07/19/24 Steve Toth 2.20 Participate in telephone conference with
lenders, lender advisors, AlixPartners, PJT, S.
Winters, K&E team re sale process (1.2);
conference with B. Matthews re same (.2);
conference with PJT, AlixPartners, S.
Winters, K&E team re entities and liabilities
and assets (.8).
07/19/24 Spencer A. Winters, P.C. 2.80 Prepare for and participate in telephone
conference with lender advisors re sale
process (1.0); review and analyze issues re
same (.9); correspond and telephone
conferences with multiple parties re same (.9).
07/20/24 Jaina Desai 0.20 Review, analyze correspondence re cure
objections (.1); correspond with cure objector,
R. Marston re same (.1).
07/22/24 Cooper Barghols 0.80 Correspond with bidder team re regulatory
considerations in consummation of proposed
transaction.
07/22/24 Chris Ceresa 1.40 Review, analyze legal issues re sale (.5);
correspond with J. Desai, K&E team re same
(.5); telephone conference with J. Desai, K&E
team re same (.4).
07/22/24 Anthony M. Del Rio 1.00 Conference with bidder and bidder advisors re
transaction structure and transition of
regulatory approvals.
07/22/24 Jaina Desai 0.30 Review, analyze comments re key dates
extension notice (.1); revise same (.2).

67
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 296 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104437
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
07/22/24 Jaina Desai 1.10 Telephone conference with R. Marston re sale
stream updates (.6); further revise extension
notice (.4); correspond with R. Marston re
same (.1).
07/22/24 Jaina Desai 1.30 Correspond with informal sale objectors re
informal cure objections (.2); correspond with
AlixPartners, R. Marston re same (.2);
correspond with C. Ceresa re same (.1); revise
cure objection summary (.2); analyze
restructuring support agreement and DIP CA
for sale milestones (.3); correspond with C.
Ceresa, R. Marston re same (.3).
07/22/24 Jaina Desai 0.60 Telephone conference with R. Marston,
counterparty re informal sale and cure
objection (.2); draft correspondence re same
(.3); review, analyze correspondence re same
(.1).
07/22/24 Jaina Desai 0.60 Draft sale and cure objections summary (.5);
correspond with R. Marston re same (.1).
07/22/24 Luke Finn 4.20 Review, analyze APA disclosure schedules
and new dataroom documents (1.8); draft
initial incremental updates to disclosure
schedules (1.3); prepare for and participate in
conference with bidder, Company, PJT and
AlixPartners re regulatory topics (1.1).
07/22/24 Kate Hardey 1.00 Review, analyze business unit device lists
(.7); conference with R. Meintjes and O.
Kaufmann re same (.3).
07/22/24 Olivia Kaufmann 0.50 Conference with R. Meintjes and K. Hardey
re product lists re sales.
07/22/24 Sabrina Lieberman 0.30 Review, revise NDA summary.
07/22/24 Ruan J. Meintjes 1.60 Participate in telephone conference with
bidder counsel re EU permit transfer strategy
(1.0); correspond with EU counsel re UK
products (.5); correspond with Company re
same (.1).
07/22/24 Trent Nachbar 2.90 Review, analyze legal issues re asset purchase
agreement and schedules.
07/22/24 Dan O'Connor 1.20 Telephone conference with PJT team,
Company, AlixPartners, K. Hardey, K&E
team re regulatory matters (.9); telephone
conference with PJT, AlixPartners, S. Winters
and Y. Salloum re transaction matters (.3).

68
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 297 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104437
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
07/22/24 Steve Toth 0.20 Participate in telephone conference re bidder
updates with Company, PJT, AlixPartners, S.
Winters, K&E team.
07/22/24 Spencer A. Winters, P.C. 3.30 Prepare for and participate in telephone
conference with advisors re stand‑up costs
(.5); prepare for and participate in telephone
conference with Company and advisors re
sale process (.5); review and analyze issues re
sale process, case status (1.3); correspond and
telephone conferences with multiple parties re
same (1.0).
07/23/24 Chris Ceresa 0.50 Correspond and telephone conference with S.
Winters, K&E team re sale matters.
07/23/24 Bernadette Coppola 0.30 Correspond with S. Toth, K&E team advisors,
re transaction updates and transition services
agreement.
07/23/24 Anthony M. Del Rio 0.60 Review, analyze regulatory status and
registrations of devices.
07/23/24 Jaina Desai 1.20 Telephone conference with R. Marston re sale
(.1); telephone conference with AlixPartners,
R. Marston, K&E team re cure objections
(.5); correspond with R. Marston re same (.1);
revise key dates and deadlines extension
notice (.3); analyze bidding procedures order
(.2).
07/23/24 Jaina Desai 1.00 Telephone conference with AlixPartners, R.
Marston, K&E team re sale objections (.2);
revise cure objection summary (.5); revise
talking points re same (.2); correspond with
R. Marston, C. Ceresa re same (.1).
07/23/24 Jaina Desai 0.30 Conference with R. Marston re sale, auction
matters.
07/23/24 Jaina Desai 0.80 Correspond with informal objectors re
informal objection status, extending objection
deadline.
07/23/24 Jaina Desai 0.10 Correspond with S. Osborne re sale issues.
07/23/24 Jaina Desai 0.40 Review, analyze correspondence re informal
cure objection (.1); correspond with informal
objector re same (.1); revise second extension
notes re key dates and deadlines (.2).

69
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 298 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104437
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
07/23/24 Jaina Desai 0.60 Correspond with Omni, R. Marston re sale
(.1); revise second notice for deadline
extensions (.2); correspond with C. Ceresa re
same (.1); telephone conference with Omni re
certificate of service (.1); correspond with R.
Marston re same (.1).
07/23/24 Jaina Desai 0.90 Correspond with counterparty re informal sale
and cure objection (.6); revise summary re
same (.3).
07/23/24 Sabrina Lieberman 0.60 Review, analyze NDAs (.4); correspond with
PJT, NDA parties re same (.2).
07/23/24 Noah Shier 0.60 Review, analyze TSA service schedule
update.
07/23/24 Steve Toth 1.30 Conference with C. Ceresa, K&E team re tax
issues re sale (.5); analyze correspondence re
disclosure schedules and regulatory matters
from B. Coppola, K&E team (.4); analyze
correspondence re bid analysis (.4).
07/23/24 Donatus Wang 0.20 Correspond with local counsel and Company
re liquidity planning.
07/23/24 Spencer A. Winters, P.C. 1.50 Review and analyze issues re sale process,
case status (.8); correspond and telephone
conferences with working group re same (.7).
07/23/24 Ann-Kathrin Ziegler 4.50 Review, analyze correspondence with M&A
counterparty re sale (1.0); review, analyze
intercompany summary and legal issues re
same (3.5).
07/24/24 Chris Ceresa 3.20 Review, analyze legal issues re sale (2.1);
correspond and telephone conference with S.
Toth, K&E team re same (1.1).
07/24/24 Bernadette Coppola 0.20 Correspond with AlixPartners, M. O’Brien
and K&E team re transition services
agreement services.
07/24/24 Hannah Crawford 0.30 Correspond with P. Kar, K&E team re
intercompany settlement planning.
07/24/24 Jaina Desai 0.60 Review, analyze revised second sale
milestone extension notice (.2); revise
correspondence re same (.1); correspond with
R. Marston re same (.2); correspond with C.
Ceresa, Cole Schotz re same (.1).
07/24/24 Jaina Desai 0.10 Review, analyze lender presentation re vents
perimeter comparison.

70
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 299 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104437
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
07/24/24 Jaina Desai 1.40 Telephone conference with C. Ceresa, K&E
team, AlixPartners re cure objection (.4);
correspond with R. Marston re same (.3);
review, analyze correspondence re cure and
sale objections (.3); correspond with informal
cure objectors re same (.3); correspond with
AlixPartners re same (.1).
07/24/24 Jaina Desai 1.60 Review, analyze correspondence re informal
sale and cure objections (.1); correspond with
Y. Salloum, informal cure objector re same
(.2); telephone conference with informal cure
objector re invoices (.1); correspond with
informal cure objector re same (.1); revise
cure objection summary (.3); correspond with
R. Marston re same (.1); telephone conference
with AlixPartners re same (.1); analyze cure
objection summary (.1); correspond with
informal cure objector re informal cure
objection (.2); correspond with AlixPartners,
R. Marston re same (.3).
07/24/24 Jaina Desai 1.00 Review, analyze correspondence re informal
sale and cure objections (.3); correspond with
informal cure objectors re same (.3); revise
cure objection summary (.4).
07/24/24 Jaina Desai 1.40 Correspond with AlixPartners, contract
counterparties, C. Ceresa, K&E team re sale
and cure objections.
07/24/24 Jaina Desai 1.40 Revise sale and cure objection summary (.7);
draft cure objection summary (.5); correspond
with R. Marston, AlixPartners re same (.2).
07/24/24 Luke Finn 3.30 Conference with lenders re bids (.8); review,
analyze dataroom documents (1.1);
correspond with Y. Salloum, K&E team re
sale (.4); review, analyze asset purchase
agreement (1.0).
07/24/24 Sooah Kim 0.50 Review, analyze correspondence from M.
O’Brien, K&E team re TSA and benefits
transition matters.
07/24/24 Sabrina Lieberman 0.20 Review, analyze NDA (.1); review, revise
summary res same (.1).
07/24/24 Rebecca J. Marston 1.00 Correspond with J. Desai re cure objections
(.3); correspond with K&E team, Gibson team
re deadline extensions (.7).

71
Case 24-11217-BLS Doc 742-2 Filed 11/13/24 Page 300 of 631
Legal Services for the Period Ending July 31, 2024 Invoice Number: 1050104437
Vyaire Medical Inc. Matter Number: 48520-10
Asset Sales/Section 363 Issues: Use, Sale & Disposition of
Property

Date Name Hours Description
07/24/24 Jai Mudhar 0.50 Review, analyze correspondence from H.
Crawford, K&E team re intercompany issues
re sale planning.
07/24/24 Maureen D. O'Brien 1.00 Correspond with S. Kim, K&E team re TSA
issues.
07/24/24 Dan O'Connor 0.90 Telephone conference with lender advisors,
PJT, AlixPartners, S. Winters, K&E team re
transaction matters.
07/24/24 Noah Shier 0.30 Review, analyze TSA schedule update.
07/24/24 Steve Toth 5.50 Discuss foreign assets and liabilities with
AlixPartners, S. Winters and K&E team (.9);
participate in telephone conference with
Company, PwC, AlixPartners, BDO, Y.
Salloum, K&E team re intercompany
balances (1.3); conference with Y. Salloum,
K&E team re intercompany settlement,
restructuring, and corporate considerations
(.5); correspond with Y. Salloum, K&E team
re same (.2); correspond with M. O’Brien,
K&E team re TSA employment matters (.2);
conference with AlixPartners, PJT, lender
advisors re same (.9); conference with
AlixPartners, Y. Salloum, K&E team re same
(.6); conference with lenders, lender advisors,
AlixPartners and PJT re winddown and other
costs (.9).
07/24/24 Cristina Weidner 1.00 Review, analyze issues re treatment of
receivables, tax analysis re sales and APAs.
07/24/24 Spencer A. Winters, P.C. 3.80 Review and analyze issues re bids, waterfall
(1.4); telephone conferences with multiple
parties re same (.9); prepare for and
participate in telephone conference with
advisors re waterfall (.5); prepare for and
participate in telephone conference with
lender advisors re same (1.0).
07/25/24 Chris Ceresa 5.10 Review, analyze legal issues re transactions
(3.9); correspond with Y. Salloum, K&E team
re same (.7); telephone conferences with Y.
Salloum, K&E team re same (.5).
07/25/24 Hannah Crawford 0.50 Conference with Company re international
sale considerations.
07/25/24 Anthony M. Del Rio 0.40 Review, analyze filing analysis and related
workplan re health regulatory issues re sales.

Full text shows the first 300 of 631 pages; the complete document is the PDF above.

File and source

File: gov.uscourts.deb.193283.742.2.pdf
Size: 14,816,899 bytes
SHA-256: 1b6773ec59265ccc3497d87e729e64253c650f1347814a52f18c4125ee83509e
Our copy: gov.uscourts.deb.193283.742.2.pdf
Original: PACER (login required)

Winters Declaration

Summary

Full text

File and source

Related records